https://novapharmanews.com/companies/abbvie-ltd/projects/glecaprevir-pibrentasvir-hepatitis-c-virus-hcv 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/serono-europe-limited/projects/enpatoran-low-dose-systemic-lupus-erythematosus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/olaratumab-malignancy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/venglustat-gz402671-congenital-cystic-kidney-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/ferroquine-ssr97193-plasmodium-falciparum-infection 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/guerbet/projects/dotarem-primary-brain-tumor 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/hcd122-non-hodgkin-s-lymphoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/doxycycline-tuberculosis-meningeal 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/placebo-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chinese-pla-general-hospital/projects/anti-cd133-car-vector-transduced-t-cells-liver-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv-eu/projects/al-335-hepatitis-c-chronic 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/edoxaban-tosylate-du-176b-venous-thromboembolism 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/trastuzumab-herceptin-gastric-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/ruxolitinib-polycythemia-vera 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/iodex-balm-pain 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/insulin-lispro-low-mixture-type-2-diabetes-mellitus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shanghai-zhongshan-hospital/projects/human-umbilical-cord-mesenchymal-stem-cell-deriv-interstitial-lung-disease-ild 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/ly3537021-healthy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/mabxience-research-sl/projects/mb02-sp-healthy-volunteers 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/rocatinlimab-asthma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/avamys-aqueous-nasal-spray-110mcg-rhinitis-allergic-perennial 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/tarlatamab-small-cell-lung-cancer-sclc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/pcv21-vaccine-pneumococcal-immunization 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fudan-university/projects/tissue-of-origin-origin-panca-r-profiling-cancer-of-unknown-primary-site 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/selpercatinib-medullary-thyroid-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sun-yat-sen-university/projects/tpc-induction-chemotherapy-nasopharyngeal-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/swedish-orphan-biovitrum-ab-publ/projects/pacritinib-primary-myelofibrosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv-eu/projects/cilta-cel-multiple-myeloma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/ds-5141b-duchenne-muscular-dystrophy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/allergan-pharmaceuticals-international-limited/projects/xen45-glaucoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/rifaximin-oral-tablet-irritable-bowel-syndrome-with-diarrhea 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/changchun-genescience-pharmaceutical-co/projects/peg-somatropin-dwarfism 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/genmab-a-s/projects/rina-s-ovarian-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/mirikizumab-ulcerative-colitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-ltd/projects/risankizumab-iv-ulcerative-colitis-uc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/canakinumab-150-mg-type-2-diabetes-mellitus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-ltd/projects/placebo-rheumatoid-arthritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/evolocumab-dyslipidemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/the-university-of-hong-kong/projects/oral-hygiene-intervention-acute-stroke 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chinese-pla-general-hospital/projects/raltitrexed-combined-with-apatinib-colorectal-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/maridebart-cafraglutide-type-2-diabetes-mellitus-t2dm-obesity-overweight 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/tiragolumab-cervical-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/jian-li/projects/high-low-dose-radiotherapy-nasopharyngeal-carcinoma-npc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/tolebrutinib-non-relapsing-secondary-progressive-multiple-scl 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/trastuzumab-early-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/swedish-orphan-biovitrum-ab-publ/projects/anakinra-still-s-disease-juvenile-onset 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/lixisenatide-ave0010-acute-coronary-syndrome 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/iv-tulisokibart-ulcerative-colitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/tillotts-pharma-gmbh/projects/asacol-active-ulcerative-colitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/robot-assisted-surgery-rectal-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/sunitinib-pemetrexed-neoplasm-malignant 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/otsuka-novel-products-gmbh/projects/jnt-517-suspension-phenylketonuria 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/serono-europe-limited/projects/atacicept-75-mg-lupus-erythematosus-systemic 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sun-yat-sen-university/projects/terlipressin-septic-shock 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/viatris-healthcare-limited/projects/selatogrel-acute-myocardial-infarction 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/zhejiang-university/projects/hrs-4642-ag-nimotuzumab-borderline-resectable-pancreatic-adenocarcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sichuan-provincial-people-s-hospital/projects/skb103-for-injection-monotherapy-advanced-solid-tumors 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharmaessentia/projects/ropeginterferon-alfa-2b-primary-myelofibrosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/jian-li/projects/hs-10382-part-1-dose-escalation-cml-chronic-phase 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/abemaciclib-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-ireland-uc/projects/andecaliximab-crohn-s-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ono-pharmaceutical-co/projects/placebo-chronic-sinusitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/vamikibart-uveitic-macular-edema 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/pazopanib-gw786034-400-mg-neoplasms-breast 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/live-attenuated-japanese-encephalitis-chimeric-v-japanese-encephalitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hong-kong-baptist-university/projects/mazirenwan-mzrw-functional-gastrointestinal-disorders 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/sar442970-hidradenitis-suppurativa 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/necitumumab-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-ltd/projects/upadacitinib-systemic-lupus-erythematosus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/green-valley-shanghai-pharmaceuticals-co/projects/immunoglobulin-g-kawasaki-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/the-university-of-hong-kong/projects/dietary-colorectal-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-ltd/projects/upadacitinib-crohn-s-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/dapagliflozin-chronic-heart-failure-with-reduced-ejection-frac 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/etomidate-choledocholithiasis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/rapcabtagene-autoleucel-scleroderma-diffuse 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/osilodrostat-cushing-s-syndrome 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/aclidinium-bromide-formoterol-fixed-dose-combina-copd 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/benralizumab-30-mg-nasal-polyposis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shire-pharmaceutical-contracts-limited/projects/ontamalimab-crohn-s-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/folic-acid-pregnant-women 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amzell/projects/amz001-diclofenac-gel-osteoarthritis-of-knee 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/tritanrix-hepb-hiberix-kft-whole-cell-pertussis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eisai-gmbh/projects/e0302-mecobalamin-amyotrophic-lateral-sclerosis-als 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/qian-wenbin/projects/car-t-cells-b-cell-non-hodgkin-lymphoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/ranibizumab-retinopathy-of-prematurity-rop 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eisai-gmbh/projects/lenvatinib-osteosarcoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eisai-gmbh/projects/perampanel-epilepsy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/isatuximab-sar650984-plasma-cell-myeloma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/insulin-glargine-hoe901-diabetes-mellitus-type-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/pembrolizumab-cervical-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vifor-fresenius-medical-care-renal-pharma-france/projects/ferric-carboxymaltose-iron-deficiency 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astellas-pharma-europe-bv/projects/trk-100stp-berasus-la-healthy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pharma-eeig-eu/projects/nivolumab-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/h-lundbeck-a-s/projects/bifeprunox-schizophrenia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/kae609-cure-rate 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/ligelizumab-chronic-spontaneous-urticaria 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/etelcalcetide-secondary-hyperparathyroidism 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/peking-university-third-hospital/projects/protocol-based-management-of-perioperative-antit-antithrombotic-therapy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pharma-eeig-eu/projects/bms-906024-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/itacitinib-acute-graft-versus-host-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/testosterone-md-lotion-hypogonadism 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/povorcitinib-hidradenitis-suppurativa-hs 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/propranolol-healthy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/gabapentin-spinal-fusion 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/ombrabulin-ave8062-neoplasms-malignant 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/exenatide-once-weekly-type-2-diabetes-mellitus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/otsuka-novel-products-gmbh/projects/tolvaptan-hyponatremia-and-extracellular-fluid-in-cirrhoti 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sichuan-baili-pharmaceutical-co/projects/bl-b01d1-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-mesto/projects/faster-acting-insulin-aspart-diabetes 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/international-peace-maternity-and-child-health-hospital/projects/bivalent-killed-oral-cholera-vaccine-cholera 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shanghai-henlius-biotech/projects/hlx02-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shanghai-henlius-biotech/projects/azvudine-sars-cov-2-infection 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/microfracture-other-articular-cartilage-disorders 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/anvumetostat-advanced-mtap-null-solid-tumors 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/bi-695502-healthy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sumitomo-pharma-suzhou-co/projects/bbi608-malignant-pleural-mesothelioma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sun-yat-sen-university/projects/probiotics-compound-biolosion-advanced-urothelial-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/medi4736-squamous-cell-carcinoma-of-the-head-and-neck 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/secukinumab-s-c-injection-autoimmunity-inflammation 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/ramipril-hoe498-coronary-artery-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/dabigatran-dose-1-atrial-fibrillation 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/pemetrexed-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/kfa115-carcinoma-non-small-cell-lung 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shanghai-chest-hospital/projects/two-drug-chemotherapy-containing-platinum-includ-nsclc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/gefitinib-head-and-neck-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/kyowa-kirin-holdings-b-v/projects/placebo-healthy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-healthcare-ag/projects/estradiol-valerate-dienogest-natazia-qlaira-bay8-primary-dysmenorrhea 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pharma-eeig-eu/projects/bms-986165-systemic-lupus-erythematosus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/pregabalin-dose-level-1-partial-onset-seizures 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/real-tdcs-with-mi-bci-stroke 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/jsb462-metastatic-prostate-cancer-mcrpc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pharma-eeig-eu/projects/vinflunine-stomach-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ipsen-pharma/projects/botulinum-toxin-type-a-low-back-pain 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/second-affiliated-hospital-school-of-medicine-zhejiang-university/projects/inhaled-corticosteriod-long-acting-beta-agonist-asthma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/trastuzumab-deruxtecan-recurrent-or-metastatic-solid-tumors 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cellectar-biosciences/projects/rnl-vascostem-buerger-s-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/remifentanil-labor-pain 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/jian-li/projects/conventional-artificial-cycle-therapy-infertility-female 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chia-tai-tianqing-pharmaceutical-group-nanjing-shunxin-pharmaceutical-co/projects/triferdine-pregnancy-related 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/samsung-bioepis-nl-b-v/projects/avelumab-lymphoma-extranodal-nk-t-cell 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/medimmune/projects/motavizumab-palivizumab-respiratory-syncytial-virus-infections 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/johnson-johnson-medical-pty-ltd/projects/placebo-schizoaffective-disorder 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shanghai-henlius-biotech/projects/hlx07-carboplatin-pemetrexed-hlx07-nsqnsclc-high-egfr-expression 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/kyowa-kirin-holdings-b-v/projects/arq-197-advanced-hepatocellular-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chinese-university-of-hong-kong/projects/rituximab-systemic-lupus-erythematosus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cho-pharma/projects/cho-h01-non-hodgkin-lymphoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/dapagliflozin-type-2-diabetes-mellitus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/gsk-biologicals-gsk2340274a-two-different-formul-influenza 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/mgso4-plus-ropivacaine-efficacy-and-safety-of-mgso4-as-adjuvant-to-scal 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/iclepertin-schizophrenia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astellas-pharma-europe-bv/projects/isavuconazole-candidiasis-invasive 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-healthcare-ag/projects/ciprofloxacin-cipro-inhaie-bayq3939-pulmonary-disease-chronic-obstructive 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/the-university-of-hong-kong/projects/acupuncture-procedure-autistic-disorder 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-ltd/projects/placebo-to-upadacitinib-rheumatoid-arthritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/calcium-carbonate-1500-mg-with-vitamin-d-thyroid-neoplasm 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/tocilizumab-162-mg-rheumatoid-arthritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-ltd/projects/placebo-for-risankizumab-crohn-s-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/donanemab-cognitive-dysfunction 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/50mg-ezogabine-retigabine-epilepsy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/bepirovirsen-chronic-hepatitis-b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/intraosseous-cardiac-arrest 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/alglucosidase-alfa-pompe-disease-infantile-onset 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/zhejiang-provincial-people-s-hospital/projects/pucotenlimab-pancreatic-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astellas-pharma-europe-bv/projects/tacrolimus-capsule-myasthenia-gravis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/ce-326-597-100-mg-qd-weight-management 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/alosetron-irritable-colon 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv-eu/projects/paliperidone-palmitate-schizophrenia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/giredestrant-estrogen-receptor-positive-her2-negative-locally 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-ltd/projects/cariprazine-bipolar-i-disorder 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/pembrolizumab-metastatic-esophageal-squamous-cell-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/galderma-international/projects/adapalene-0-3-bpo-2-5-gel-acne-vulgaris 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv-eu/projects/placebo-depressive-disorder-major 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals/projects/sam-315-alzheimer-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/premeal-insulin-lispro-mixtures-diabetes-mellitus-type-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/lapatinib-breast-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pharma-eeig-eu/projects/relatlimab-neoplasms-by-site 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pharma-eeig-eu/projects/bms-986466-advanced-solid-tumors 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/atorvastatin-hyperlipidemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/international-peace-maternity-and-child-health-hospital/projects/external-beam-radiotherapy-squamous-cell-carcinoma-of-the-head-and-neck 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/jian-li/projects/daridorexant-healthy-volunteer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-ltd/projects/abbv-154-crohn-s-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-ltd/projects/standard-of-care-non-squamous-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/ultra-low-dose-chest-computed-tomography-uldct-tuberculosis-pulmonary 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/international-peace-maternity-and-child-health-hospital/projects/killed-oral-cholera-vaccine-cholera 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-ltd/projects/venetoclax-chronic-lymphocytic-leukemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/the-university-of-hong-kong/projects/decitabine-acute-myeloid-leukemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/ocrelizumab-iv-relapsing-multiple-sclerosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/durvalumab-soc-chemotherapy-carcinoma-non-small-cell-lung 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/durvalumab-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chinese-pla-general-hospital/projects/adoptive-immunotherapy-hepatocellular-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-ltd/projects/telisotuzumab-adizutecan-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/sodium-tetradecyl-sulfate-gastric-varices-bleeding 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/albiglutide-insulin-glargine-diabetes-mellitus-type-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pharma-eeig-eu/projects/nivolumab-bladder-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pharma-eeig-eu/projects/muraglitazar-diabetes-type-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/progesterone-preterm 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/risedronate-sodium-osteoporosis-postmenopausal 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hong-kong-baptist-university/projects/ckd-371-type-ii-diabetes-mellitus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celgene-europe-limited/projects/jcar017-lymphoma-non-hodgkin 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/drug-pembrolizumab-clear-cell-metastatic-renal-cell-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chinese-university-of-hong-kong/projects/nimotuzumab-esophageal-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-mesto/projects/ly2140023-schizophrenia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/green-valley-shanghai-pharmaceuticals-co/projects/quadrivalent-influenza-vaccine-influenza 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/secukinumab-plaque-psoriasis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/santhera-pharmaceuticals-deutschland-gmbh/projects/a-623-systemic-lupus-erythematosus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals/projects/tigecycline-skin-diseases-bacterial 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/durvalumab-muscle-invasive-bladder-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/vericiguat-chronic-heart-failure-with-reduced-ejection-frac 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/ff-umec-vi-asthma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/kyowa-kirin-holdings-b-v/projects/entinostat-advanced-or-recurrent-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/iptacopan-atypical-hemolytic-uremic-syndrome 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/prestige-biopharma-belgium/projects/hd201-her2-positive-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/artesunate-colorectal-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/oral-fluid-osteoarthritis-knee 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pharma-eeig-eu/projects/warfarin-atrial-fibrillation 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/vi-crm197-vaccine-typhoid-fever 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chinese-university-of-hong-kong/projects/cisplatin-and-doxorubicin-gastric-cancer-peritoneal-metastases 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sandoz-pharmaceuticals-d-d/projects/jpb898-induction-and-maintenance-melanoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/olodaterol-bi-1744-pulmonary-disease-chronic-obstructive 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pharma-eeig-eu/projects/nivolumab-brain-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/cetuximab-cisplatin-5-fluorouracil-leucovorin-stomach-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/gsk233705-12-5mcg-pulmonary-disease-chronic-obstructive 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/bi-1291583-bronchiectasis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-ltd/projects/placebo-for-risankizumab-iv-crohn-s-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/ocrelizumab-multiple-sclerosis-primary-progressive 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hunan-province-tumor-hospital/projects/chemotherapy-immunotherapy-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chinese-academy-of-sciences/projects/conventional-therapy-decompensated-cirrhosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/5-gene-classification-model-abo-blood-type-incompatible-kidney-transplantati 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/abp-206-melanoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/lebrikizumab-asthma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chia-tai-tianqing-pharmaceutical-group-nanjing-shunxin-pharmaceutical-co/projects/placebo-pcos-polycystic-ovary-syndrome 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/dapagliflozin-type-2-diabetes 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/otsuka-novel-products-gmbh/projects/delamanid-obr-multidrug-resistant-tuberculosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/lng-ius-endometriosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biotech-pharmaceutical-co/projects/pegcyte-breast-cancer-female 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/carboplatin-breast-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fudan-university/projects/igev-hodgkin-lymphoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv-eu/projects/erdafitinib-intravesical-delivery-system-non-muscle-invasive-bladder-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/auy922-advanced-her2-positive-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/azd0449-asthma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/bgf-mdi-hfo-320-14-4-9-6-g-copd-chronic-obstructive-pulmonary-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/samsung-bioepis-nl-b-v/projects/doxazosin-plus-tolterodine-sr-overactive-bladder 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/yang-xiaotian/projects/ilaprazole-erosive-esophagitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratoire-hra-pharma/projects/naabak-eyedrops-allergic-conjunctivitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/atm-avi-complicated-intra-abdominal-infection 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/isatuximab-relapsed-refractory-multiple-myeloma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/insulin-glargine-diabetes-mellitus-type-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pharma-eeig-eu/projects/nivolumab-hepatocellular-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/bi-695501-arthritis-rheumatoid 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/lg-chem/projects/tigulixostat-gout 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chia-tai-tianqing-pharmaceutical-group-nanjing-shunxin-pharmaceutical-co/projects/gum-chewing-recovery-of-bowel-function-due-to-gum-chewing 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/qeq278-carcinoma-non-small-cell-lung 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/nimenrix-infections-meningococcal 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/ain457-150-mg-moderate-to-severe-chronic-plaque-type-psoriasis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/bgf-mdi-320-14-4-9-6-g-copd-chronic-obstructive-pulmonary-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-ltd/projects/risankizumab-psoriasis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/telmisartan-amlodipine-40-5-mg-fixed-combination-hypertension 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pharma-eeig-eu/projects/deucravacitinib-sj-gren-s-syndrome 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eisai-gmbh/projects/e7766-lymphoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/lixisenatide-ave0010-diabetes-mellitus-type-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eastern-hepatobiliary-surgery-hospital/projects/tegafur-gimeracil-oteracil-potassium-s-1-krestin-gastric-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/capecitabine-breast-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/efavaleukin-alfa-ulcerative-colitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/bgf-mdi-320-28-8-9-6-g-asthma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/aripiprazole-first-episode-psychosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/the-university-of-hong-kong/projects/interferon-beta-1b-covid 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/anifrolumab-active-systemic-lupus-erythematosus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/alglucosidase-alfa-pompe-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sun-yat-sen-memorial-hospital-of-sun-yat-sen-university/projects/paclitaxel-oral-solution-plus-subcutaneous-pertu-breast-cancers 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv-eu/projects/olanzapine-bipolar-disorder 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/genmab-a-s/projects/gen3014-relapsed-or-refractory-multiple-myeloma-rrmm 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/v181-healthy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/cediranib-recurrent-glioblastoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/tofacitinib-5-mg-bid-psoriatic-arthritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-ltd/projects/placebo-psoriatic-arthritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pharma-eeig-eu/projects/repotrectinib-carcinoma-non-small-cell-lung 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/transepicardial-with-transseptal-cd-133-implanta-coronary-artery-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/pvrv-rabies 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/qmf149-150-80-g-mild-asthma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astellas-pharma-europe-bv/projects/gilteritinib-acute-myeloid-leukemia-aml 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/sasanlimab-prefilled-syringe-carcinoma-non-small-cell-lung 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/pegaptanib-sodium-macular-degeneration 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/peg-ifn-alfa-2a-ba-free-formulation-test-healthy-volunteers 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/kyowa-kirin-holdings-b-v/projects/khk4827-moderate-to-severe-plaque-psoriasis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/guangzhou-virotech-pharmaceutical-co/projects/et-01-transfusion-dependent-beta-thalassaemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/the-university-of-hong-kong/projects/dexamethasone-total-knee-replacement 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/tamoxifen-breast-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shine-europe-b-v/projects/normal-saline-breast-feeding 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/investigators-choice-of-soc-prostate-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chinese-university-of-hong-kong/projects/hydroxy-methylbutyrate-hmb-supplement-sarcopenia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/jin-lu-md/projects/bortezomib-systemic-amyloidosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/boserolimab-pharmacokinetics 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/trastuzumab-deruxtecan-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sichuan-baili-pharmaceutical-co/projects/si-b001-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/dtap-hb-prp-t-vaccine-diphtheria 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/idasanutlin-follicular-lymphoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/the-university-of-hong-kong/projects/mailed-nicotine-replacement-therapy-nrt-smoking-cessation 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pharma-eeig-eu/projects/nivolumab-gastric-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/jian-li/projects/hs-20094-injection-type-2-diabetes 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv-eu/projects/glimepiride-diabetes-mellitus-type-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/thor-707-malignant-melanoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/finerenone-heart-failure-and-preserved-ejection-fraction 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/apremilast-20mg-psoriatic-arthritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/hpv-self-collection-cervical-cancers 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/azithromycin-sr-zithromax-compound-cp-62-993-bronchitis-chronic 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/azd2281-ovarian-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/azd0780-cardiovascular-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shanghai-university-of-traditional-chinese-medicine/projects/recombinant-humanized-anti-il-36r-monoclonal-ant-healthy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/seqirus-s-r-l/projects/trivalent-influenza-vaccine-tivc-influenza 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/samsung-bioepis-nl-b-v/projects/sb11-proposed-ranibizumab-biosimilar-age-related-macular-degeneration 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/alectinib-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-ireland-uc/projects/tdf-chronic-hepatitis-b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/kyowa-kirin-holdings-b-v/projects/saxagliptin-diabetes-type-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shanghai-university-of-traditional-chinese-medicine/projects/mwn109-tablet-overweight-or-obesity 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/champix-tobacco-use-disorder 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/azd0292-bronchiectasis-with-pseudomonas-aeruginosa-colon 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/puxitatug-samrotecan-endometrial-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sichuan-provincial-people-s-hospital/projects/mecobalamin-sepsis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/darovasertib-ocular-melanoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/hippocampal-avoidance-wbrt-metastatic-malignant-neoplasm-to-brain 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hong-kong-baptist-university/projects/mutual-support-group-schizophrenia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-ltd/projects/mirvetuximab-soravtansine-plus-bevacizumab-ovarian-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/the-university-of-hong-kong/projects/ivabradine-usual-care-atrial-fibrillation-permanent 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/afuzosin-benign-prostatic-hyperplasia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/human-insulin-inhalation-powder-diabetes-mellitus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/placebo-to-match-albiglutide-diabetes-mellitus-type-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/livzon-pharmaceutical-group/projects/recombinant-sars-cov-2-fusion-protein-vaccine-covid19 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/indacaterol-150-g-chronic-obstructive-pulmonary-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/ro5323441-carcinoma-hepatocellular 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biotech-pharmaceutical-co/projects/peginterferon-lambda-hepatitis-c 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/argenx/projects/efgartigimod-ph20-sc-primary-sjogrens-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astellas-pharma-europe-bv/projects/asp8825-restless-legs-syndrome 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/vandetanib-locally-advanced-or-metastatic-medullary-thyroid 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/vandetanib-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pharma-eeig-eu/projects/bms-986148-advanced-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/amcenestrant-breast-cancer-metastatic 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/bococizumab-pf-04950615-cardiovascular-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/adefovir-dipivoxil-hepatitis-b-chronic 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/chimerivax-je-japanese-encephalitis-vaccine-encephalitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/engene-therapeutics/projects/atg-010-and-atg-008-relapsed-refractory-diffuse-large-b-cell-lymphom 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shanghai-general-hospital-shanghai-jiao-tong-university-school-of-medicine/projects/radiochemotherapy-1-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/trastuzumab-emtansine-metastatic-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/viiv-healthcare-b-v/projects/dolutegravir-abacavir-lamivudine-fdc-infection-human-immunodeficiency-virus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/glipizide-atherosclerosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/benralizumab-asthma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/cisplatin-inoperable-locally-advanced-or-metastatic-biliar 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv-eu/projects/jnj-77242113-colitis-ulcerative 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/ts-1-with-cisplatin-recurrent-gastric-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shandong-suncadia-medicine-co/projects/methylthioninium-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/lenvatinib-carcinoma-hepatocellular 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pharma-eeig-eu/projects/vinflunine-transitional-cell-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/international-peace-maternity-and-child-health-hospital/projects/tamoxifen-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/pf-07321332-covid-19 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/dexmedetomidine-mri-sedation 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/pd-0332991-breast-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/baricitinib-systemic-lupus-erythematosus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/zhongshan-ophthalmic-center-sun-yat-sen-university/projects/0-1-bromfenac-pterygium 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/zhongshan-ophthalmic-center-sun-yat-sen-university/projects/routine-iop-lowering-medications-open-angle-glaucoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/ramucirumab-urothelial-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chinese-university-of-hong-kong/projects/paricalcitol-iga-nephropathy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eisai-gmbh/projects/e0302-sr1-healthy-subjects 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amicus-therapeutics-europe-limited/projects/at2221-pompe-disease-late-onset 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/pregabalin-diabetic-neuropathy-painful 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/ldt600-telbivudine-chronic-hepatitis-b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/children-s-hospital-of-fudan-university/projects/dinutuximab-high-risk-neuroblastoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/empagliflozin-myocardial-infarction 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/iniparib-breast-cancer-metastatic 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beijing-zhifei-lvzhu-biopharmaceutical-co-ltd/projects/vagus-nerve-stimulation-refractory-epilepsy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/ds-1205c-non-small-cell-lung-cancer-nsclc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/jian-li/projects/14c-hrs-9190-healthy-adult-male 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astellas-pharma-europe-b-v-eu/projects/solifenacin-succinate-neurogenic-detrusor-overactivity 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/lendormin-tablet-healthy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/children-s-hospital-of-fudan-university/projects/temozolomide-brain-and-central-nervous-system-tumors 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/brigimadlin-liposarcoma-dedifferentiated 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/sb-497115-gr-12-5mg-chronic-idiopathic-thrombocytopenic-purpura 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-ltd/projects/methotrexate-mtx-psoriatic-arthritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astellas-pharma-europe-bv/projects/mirabegron-overactive-bladder-oab 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/jiangsu-alphamab-biopharmaceuticals-co-ltd/projects/kn046-esophageal-squamous-cell-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/the-university-of-hong-kong/projects/folic-acid-5-mg-acute-kidney-injury 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/medical-developments-international-limited/projects/total-intravenous-anesthesia-group-balanced-anesthesia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/artesunate-test-falciparum-malaria 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/rfviiifc-hemophilia-a-with-inhibitors 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/fluticasone-furoate-ff-100-mcg-asthma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/panobinostat-multiple-myeloma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/international-peace-maternity-and-child-health-hospital/projects/radiotherapy-cervix-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/byfavo-bronchoscopy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shire-pharmaceutical-contracts-limited/projects/elaprase-for-intravenous-iv-infusion-hunter-syndrome 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/andrositol-plus-male-infertility 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pharma-eeig-eu/projects/nivolumab-melanoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/otsuka-novel-products-gmbh/projects/sibeprenlimab-400-mg-immunoglobulin-a-nephropathy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/kae609-malaria 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/prestige-biopharma-belgium/projects/hd204-healthy-volunteers 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/seqirus-s-r-l/projects/qivc-influenza-human 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/valneva-austria-gmbh/projects/ic51-encephalitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/serono-europe-limited/projects/m5049-coronavirus-disease-2019 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shanghai-university-of-traditional-chinese-medicine/projects/mrg003-recurrent-or-metastatic-squamous-cell-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/pf-05280586-follicular-lymphoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bausch-health-ireland-limited/projects/0-59-mg-fluocinolone-acetonide-intravitreal-impl-diabetic-macular-edema 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/the-university-of-hong-kong/projects/bomedemstat-myelofibrosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/meningococcal-polysaccharide-serogroups-a-c-w-an-meningococcal-infection 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv/projects/tacrolimus-dermatitis-atopic 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gan-lee-pharmaceuticals-europe-gmbh/projects/gzr102-type-2-diabetes-mellitus-t2dm 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/neuroscience-trials-australia/projects/tranexamic-acid-intracerebral-haemorrhage 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/xijing-hospital/projects/intraoperative-identification-method-thyroid-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/anti-pd1-nasopharyngeal-carcinoma-npc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/volrustomig-sub-study-1-cervical-cancer-volrustomig-monother 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/bmp-655-acs-standard-of-care-or-standard-of-care-rotator-cuff-tear 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/the-university-of-hong-kong/projects/dapagliflozin-10mg-tab-lupus-nephritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/ly3532226-obesity 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beijing-zhifei-lvzhu-biopharmaceutical-co-ltd/projects/icp-022-mantle-cell-lymphoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/rad001-tuberous-sclerosis-complex-associated-refractory 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/trastuzumab-deruxtecan-advanced-or-metastatic-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daihong-liu/projects/car-t-cell-therapy-chidamide-and-pd-1-inhibitor-relapsed-or-refractory-diffuse-large-b-cell-lymp 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/bi-655130-dermatitis-atopic 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chinese-university-of-hong-kong/projects/acu-tens-pain 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bevacizumab-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv-eu/projects/dara-sc-multiple-myeloma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/pegylated-interferon-alpha-and-plus-ribavirin-chronic-hepatitis-c 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sun-yat-sen-university/projects/cytokine-induced-killer-cells-carcinoma-hepatocellular 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/ianalumab-systemic-lupus-erythematosus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/advanced-accelerator-applications/projects/sparc1613-recurrent-or-metastatic-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/mundipharma-gmbh/projects/buprenorphine-transdermal-patch-osteoarthritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-ireland-uc/projects/ldv-sof-hepatitis-c-virus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/blinatumomab-b-precursor-acute-lymphoblastic-leukemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/control-hallucinations-verbal-auditory 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv-eu/projects/esketamine-depressive-disorder-major 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/mundipharma-gmbh/projects/oxycodone-oxynorm-injection-pain 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/pf-06650833-rheumatoid-arthritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/eloralintide-obesity 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/zealand-pharma-a-s/projects/pembrolizumab-plus-denosumab-renal-cell-carcinoma-clear-cell 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/telbivudine-or-lamivudine-chronic-hepatitis-b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/children-s-hospital-of-fudan-university/projects/rituximab-lymphoproliferative-disorder 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/hp184-spinal-cord-injury 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chinese-university-of-hong-kong/projects/eus-guided-portal-vein-and-hepatic-vein-aspirati-circulating-tumor-cell 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/0-ul-of-ondansetron-blood-coagulation-disorder 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-ireland-uc/projects/tenofovir-df-chronic-hepatitis-b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/changchun-genescience-pharmaceutical-co/projects/peg-somatropin-growth-hormone-deficiency 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/morphine-pain-postoperative 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/jiaray-group/projects/jr8603-solid-tumors 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/tadalafil-hypertension-pulmonary 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/osimertinib-80-mg-40-mg-stage-ii-iiib-non-small-cell-lung-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/huabo-biopharm-co/projects/hb0017-healthy-subjects 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/avenciguat-chronic-kidney-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/spironolactone-25mg-atrial-fibrillation 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/neuroscience-trials-australia/projects/direct-endovascular-clot-retrieval-ischemic-stroke 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/azd9668-chronic-obstructive-pulmonary-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/pembrolizumab-advanced-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/pemigatinib-unresectable-cholangiocarcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/seqirus-s-r-l/projects/investigational-aqivc-influenza-human 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/jian-li/projects/radiotherapy-combined-with-tki-and-anti-pd-1-ant-stage-iiia-hepatocellular-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/simvastatin-obesity 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/video-capsule-endoscopy-overt-obscure-gastrointestinal-bleeding 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/capecitabine-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/pazopanib-neoplasms-colorectal 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/viatris-healthcare-limited/projects/selatogrel-stable-coronary-artery-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/ribociclib-metastatic-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/secukinumab-lupus-nephritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/guangzhou-virotech-pharmaceutical-co/projects/induction-of-labor-with-pge2-labor-induction 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/ly3484356-breast-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/bpf-ccrt-run-in-stage-iii-esophageal-squamous-cell-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pharma-eeig-eu/projects/entecavir-hepatitis-b-chronic 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amicus-therapeutics-europe-limited/projects/migalastat-hcl-150-mg-fabry-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/viiv-healthcare-b-v/projects/dtg-3tc-hiv-infections 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/drug-azd8931-breast-neoplasm 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/csl-behring-gmbh/projects/csl760-coronavirus-disease-2019-covid-19 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/as01-adjuvant-0-5-ml-intramuscular-immune-system-responses-and-trained-immunity-aft 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/apremilast-palmoplantaris-pustulosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-healthcare-ag/projects/elimusertib-bay1895344-advanced-solid-tumor 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/ly2127399-rheumatoid-arthritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ascentage-pharma-group/projects/phase-1b-apg-115-pembrolizumab-unresectable-or-metastatic-melanoma-or-advanced 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/radiation-radiation-therapy-biological-personali-advanced-tumors 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/bi-201335-hepatitis-c 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/tofacitinib-10-mg-healthy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/influenza-vaccine-gsk1562902a-formulation-1-influenza 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pharma-eeig-eu/projects/dasatinib-chronic-myeloid-leukemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/taselisib-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/budesonide-formoterol-as-needed-budesonide-place-asthma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biogen-idec-ltd/projects/placebo-multiple-sclerosis-remittent-progressive 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/placebo-schizophrenia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/abemaciclib-breast-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/advanced-accelerator-applications/projects/k0706-early-parkinson-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chinese-university-of-hong-kong/projects/endoscopic-submucosal-dissection-colorectal-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/atezolizumab-mpdl3280a-tecentriq-an-engineered-a-non-squamous-non-small-cell-lung-cancer-squamous 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/fluticasone-furoate-asthma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shenzhen-second-people-s-hospital/projects/cart19-cell-and-auto-hsct-leukemia-lymphocytic-acute-b-cell 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-healthcare-ag/projects/gadobutrol-gadavist-gadovist-bay86-4875-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/telbivudine-hepatitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biotech-pharmaceutical-co/projects/exobdnf-swp-cgpa01-pediococcus-acidilactici-caps-cognitive-functions-perceptual-disturbances 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/peking-university-third-hospital/projects/glucocorticoid-plus-iguratimod-autoimmune-diseases 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-ireland-uc/projects/presatovir-respiratory-syncytial-virus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/gsk2585823-cldm-1-bpo-3-gel-acne-vulgaris 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chinese-university-of-hong-kong/projects/baricitinib-4-mg-rheumatoid-arthritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/placebo-of-vildagliptin-type-2-diabetes-mellitus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chongqing-claruvis-pharmaceutical-co/projects/irinotecan-liposome-ii-combination-therapy-regim-non-muscle-invasive-bladder-urothelial-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/jian-li/projects/nemonoxacin-kidney-dysfunction 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/salbutamol-hfa-134a-asthma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/taiwan-liposome-company/projects/lipotecan-advanced-solid-tumors 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/symbicort-turbuhaler-160-4-5-asthma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-mesto/projects/activated-recombinant-human-factor-vii-acquired-bleeding-disorder 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/entecavir-hepatocellular-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/durvalumab-locally-advanced-cervical-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ferring-pharmaceuticals-a-s/projects/desmopressin-nocturia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/colchicine-0-5-mg-intracerebral-hemorrhage 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/neovascular-age-related-macular-degeneration-neovacular-age-related-macular-degeneration 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chinese-university-of-hong-kong/projects/unified-protocol-for-adolescents-up-a-depressive-disorder 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/kunming-hope-of-health-hospital/projects/experimental-venetoclax-in-combination-with-deci-elderly-aml-patients 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/gsk525762-solid-tumours 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/budesonide-asthma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/blueprint-medicines-netherlands-b-v/projects/avapritinib-gist 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/iron-isomaltoside-monofer-anemia-iron-deficiency 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/johnson-johnson-medical-pty-ltd/projects/doripenem-ventilator-associated-pneumonia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/alirocumab-atherosclerotic-cardiovascular-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ucb-pharma/projects/brivaracetam-epilepsy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/ribociclib-advanced-metastatic-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/botulinum-toxin-type-a-obesity 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/nordic-group-b-v/projects/smc021-oral-calcitonin-osteoarthritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/renji-hospital/projects/acarbose-100-mg-pcos 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/barley-beta-glucan-3-0g-overweight-hyperlipidemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/kunming-hope-of-health-hospital/projects/recombinant-adeno-associated-virus-administratio-menkes-syndrome 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/mifepristone-miscarriage 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eisai-gmbh/projects/pembrolizumab-endometrial-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/ly3053102-healthy-volunteers 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/warner-chilcott-deutschland-gmbh/projects/testosterone-transdermal-system-hypoactive-sexual-desire-disorder 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/amoxicillin-clavulanate-focal-infection-dental 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/tasocitinib-10-mg-oral-tablet-healthy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/eltrombopag-hepatitis-c-chronic 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/xijing-hospital/projects/bcma-cd19-dual-target-car-t-multiple-myeloma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/allogenic-expanded-natural-killer-cells-allonk1-nasopharyngeal-carcinoma-npc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sun-yat-sen-university/projects/probiotics-cardiometabolic-risk-factors 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/dexmedetomidine-thyroid-diseases 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/tabalumab-multiple-myeloma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sinobioway-cell-therapy-co/projects/the-chimeric-antigen-receptor-t-cell-immunothera-lymphoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/placebo-infections-papillomavirus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/clesrovimab-respiratory-syncytial-virus-infection 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biohaven-bioscience-ireland-limited/projects/bhv-1300-graves-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/clopidogrel-acute-coronary-syndrome 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/rotarix-infections-rotavirus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/trastuzumab-in-combination-with-ts-one-and-cispl-gastric-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/cholecalciferol-hematologic-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/alb-interferon-alfa-2b-chronic-hepatitis-c 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/children-s-hospital-of-fudan-university/projects/imatinib-mesylate-leukemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/survodutide-obesity 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv-eu/projects/guselkumab-dose-1-crohn-s-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/samsung-bioepis-nl-b-v/projects/placebo-for-motilitone-dyspepsia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/acalabrutinib-untreated-chronic-lymphocytic-leukemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/ranibizumab-0-5-mg-central-retinal-vein-occlusion 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/kyowa-kirin-holdings-b-v/projects/placebo-healthy-volunteers-essential-hypertension 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/engerix-b-hepatitis-b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/cetuximab-metastatic-colorectal-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/placebo-saline-sphingomyelin-lipidosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/placebo-chronic-kidney-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hong-kong-baptist-university/projects/ckd-581-myeloma-multiple 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/parsaclisib-lymphoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chemical-works-of-gedeon-richter-plc-gedeon-richter-plc/projects/sk-pc-b70m-alzheimer-s-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/docetaxel-prostate-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/midazolam-0-03mg-kg-child 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/advanced-accelerator-applications/projects/sparc1210-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/nemtabrutinib-chronic-lymphocytic-leukemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/nanjing-chia-tai-tianqing-pharmaceutical/projects/ntq5082-capsule-complement-mediated-hemolytic-diseases 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/lomond-therapeutics-holdings/projects/ze46-0134-aml-with-gene-mutations 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-ltd/projects/adalimumab-juvenile-psoriatic-arthritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/aur103-calcium-her-2-positive-gastric-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celltrion-healthcare-hungary-kft/projects/trastuzumab-her2-positive-carcinoma-of-breast 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biotech-pharmaceutical-co/projects/tg-873870-nemonoxacin-diabetic-foot-infections 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/herceptin-breast-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/international-peace-maternity-and-child-health-hospital/projects/zx008-fenfluramine-hydrochloride-dravet-syndrome 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-mesto/projects/eptacog-alfa-activated-acquired-bleeding-disorder 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/belzutifan-carcinoma-renal-cell 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/peginterferon-alfa-2a-hepatitis-c-chronic 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sichuan-baili-pharmaceutical-co/projects/bl-m07d1-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celgene-europe-limited/projects/thalidomide-multiple-myeloma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/aliskiren-hypertension 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/balcinrenone-dapagliflozin-15-mg-10-mg-and-match-chronic-kidney-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/12-5mg-sunitinib-with-cisplatin-and-gemcitabine-nasopharyngeal-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chinese-university-of-hong-kong/projects/colon-originated-neostigmin-colonoscopy-decompre-acute-lower-gastrointestinal-dysfunction 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/sargramostim-covid 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/dong-wang/projects/de-escalation-strategy-acute-myocardial-infarction 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chinese-academy-of-sciences/projects/placebo-transplantation-primary-ovarian-insufficiency 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/the-university-of-hong-kong/projects/paclitaxel-gemcitabine-or-liposomal-doxorubicin-recurrent-ovarian-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biotech-pharmaceutical-co/projects/nimotuzumab-and-chemotherapy-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/children-s-hospital-of-fudan-university/projects/cyclosporine-graft-versus-host-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/pramipexol-extended-release-early-parkinson-disease-early-pd 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/indacaterol-chronic-obstructive-pulmonary-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/dabrafenib-melanoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-ltd/projects/placebo-for-adalimumab-rheumatoid-arthritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biotech-pharmaceutical-co/projects/nimotuzumab-solid-tumors 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hong-kong-baptist-university/projects/starch-lens-opacity 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/gia632-atopic-dermatitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/roflumilast-copd 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sichuan-university/projects/pd-1-inhibitor-plus-chemotherapy-esophageal-squamous-cell-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/geron-netherlands-b-v/projects/imetelstat-myelofibrosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/sodium-zirconium-cyclosilicate-szc-hyperkalemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/pdr001-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/partner-therapeutics-limited/projects/cyclophosphamide-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/dostarlimab-neoplasms-head-and-neck 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amicus-therapeutics-europe-limited/projects/cipaglucosidase-alfa-pompe-disease-late-onset 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/belpharma-s-a/projects/npc-22-safety-and-pharmacokinetics 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/kaf156-acute-uncomplicated-plasmodium-falciparum-malari 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/rifaximin-decompensated-cirrhosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/romiplostim-n01-chemotherapy-induced-thrombocytopenia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/csl-behring-gmbh/projects/bms-945429-placebo-rheumatoid-arthritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/bez235-mek162-unspecified-adult-solid-tumor-protocol-specific 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shanghai-university-of-traditional-chinese-medicine/projects/yzj-1139-tablets-insomnia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biogen-idec-ltd/projects/tofersen-amyotrophic-lateral-sclerosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/z-brace-interbody-fusion-device-cervical-disc-degeneration 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/gabapentin-epilepsies-partial 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/bi-456906-diabetes-mellitus-type-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/baricitinib-systemic-juvenile-idiopathic-arthritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/the-university-of-hong-kong/projects/cinacalcet-kidney-failure 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/inotuzumab-ozogamicin-lymphoma-follicular 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/elmental-diet-gastro-oesophageal-reflux 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/ly3209590-sc-healthy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astellas-pharma-europe-bv/projects/asp5094-rheumatoid-arthritis-ra 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/dong-wang/projects/risedronate-sodium-35-mg-actonel-postmenopausal-osteoporosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/statin-hcc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/sildenafil-hypertension-pulmonary 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-mesto/projects/nnc-0172-0000-2021-congenital-bleeding-disorder 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/dexamethasone-and-n-acetylcysteine-nac-carbon-monoxide-poisoning 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/gw679769-postoperative-nausea-and-vomiting 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alcon-laboratories-u-k-limited/projects/hydroxypropyl-guar-galactomannan-dry-eye-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/acupuncture-peripheral-neuropathy-grade-2-or-greater 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/medimmune/projects/medi9929-atopic-dermatitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eisai-gmbh/projects/bexarotene-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv-eu/projects/azacitidine-myelodysplastic-syndromes 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/dragonboat-biopharmaceutical-company-limited/projects/anti-egfr-monoclonal-antibody-healthy-volunteers 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-healthcare-ag/projects/ciprofloxacin-bayq3939-dry-powder-for-inhalation-bronchiectasis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shanghai-university-of-traditional-chinese-medicine/projects/hb0056-healthy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/capivasertib-triple-negative-breast-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/fluticasone-furoate-rhinitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/fingolimod-multiple-sclerosis-ms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/azithromycin-sustained-release-pneumonia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/hypervision-proton-surgery-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shanghai-university-of-traditional-chinese-medicine/projects/sr419-peripheral-neuropathic-pain 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/breeze2-glucometer-diabetes 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/influenza-vaccine-gsk2321138a-influenza 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/hbv-mrna-vaccine-hepatocellular-carcinoma-hcc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/seqirus-s-r-l/projects/aqiv-or-ativ-influenza-human 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/sbrt-spine-metastases 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biotech-pharmaceutical-co/projects/laminectomy-acute-spinal-cord-injury 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alkermes-pharma-ireland/projects/alks-9072-low-dose-schizophrenia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/qaw039-asthma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/santhera-pharmaceuticals-deutschland-gmbh/projects/blisibimod-systemic-lupus-erythematosus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alkermes-pharma-ireland/projects/alks-9072-schizophrenia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pharma-eeig-eu/projects/bms-641988-ar-2-prostate-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sun-yat-sen-memorial-hospital-of-sun-yat-sen-university/projects/donepezil-hydrochloride-radiation-injuries 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chinese-university-of-hong-kong/projects/chinese-herb-covid-19 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/seroquel-sustained-release-sr-schizophrenic-disorder 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/ly2216684-major-depressive-disorder 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/quetiapine-fumarate-seroquel-drug-mood-stabilize-bipolar-disorder 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biotech-pharmaceutical-co/projects/sr-t100-gel-actinic-keratosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/inactivated-types-1-2-and-3-poliovirus-d-antigen-poliomyelitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/cilostazol-coronary-artery-stenosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/intismeran-autogene-malignant-melanoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/serono-europe-limited/projects/tepotinib-advanced-stage-iiib-iv-non-small-cell-lung-cance 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/efinopegdutide-non-alcoholic-fatty-liver-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chia-tai-tianqing-pharmaceutical-group-nanjing-shunxin-pharmaceutical-co/projects/topiramate-alcohol-dependence 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/trastuzumab-deruxtecan-breast-cancer-her2-positive-metastatic 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biotech-pharmaceutical-co/projects/ankascin-568-p-red-yeast-rice-capsules-hyperlipidemias 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/larotrectinib-high-grade-glioma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/sglt2-inhibitor-empagliflozin-25-mg-type2-diabetes 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/apatinib-soft-tissue-sarcoma-adult-stage-ii 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shanghai-university-of-traditional-chinese-medicine/projects/recombinant-oncolytic-herpes-simplex-virus-type-osteosarcoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/linagliptine-5-mg-diabetes-mellitus-type-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/car-t-cell-therapy-lymphoblastic-leukemia-acute-childhood 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/multitude-therapeutics/projects/amt-116-advanced-solid-tumor 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ptc-therapeutics-international-limited/projects/unesbulin-leiomyosarcoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astellas-pharma-europe-bv/projects/asp1941-healthy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/international-peace-maternity-and-child-health-hospital/projects/lcs-complete-mobile-bearing-knee-systems-knee-osteoarthritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/children-s-hospital-of-fudan-university/projects/asparaginase-acute-myeloid-leukemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/rosiglitazone-extended-release-2mg-alzheimer-s-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/rapcabtagene-autoleucel-anca-associated-vasculitis-aav 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/leflunomide-systemic-lupus-eythematosus-sle 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/brentuximab-vedotin-diffuse-large-b-cell-lymphoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pharma-eeig-eu/projects/stavudine-efavirenz-lamivudine-hiv-infections 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-healthcare-ag/projects/yaz-sh-t00186-bay86-5300-contraception 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/fgf401-hepatocellular-carcinoma-hcc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/tongji-hospital/projects/asc09f-oseltamivir-2019-ncov-pneumonia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/csj117-asthma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/miransertib-pik3ca-related-overgrowth-spectrum-pros-proteus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/afatinib-carcinoma-non-small-cell-lung 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/crovalimab-paroxysmal-nocturnal-hemoglobinuria 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/pf-06835375-primary-immune-thrombocytopenia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/rivastigmine-alzheimer-s-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/dtap-hb-prp-t-combined-vaccine-diphtheria 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/fluticasone-salmeterol-tiotropium-copd 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/kyowa-kirin-holdings-b-v/projects/kw-6500-parkinson-s-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sun-yat-sen-university/projects/araboxylan-subjects-with-hyperuricemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/artificial-intelligence-internal-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/gemcitabine-biliary-tract-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/silodosin-benign-prostatic-hyperplasia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/rosuvastatin-systemic-lupus-erythematosus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cansino-biologics/projects/recombinant-trivalent-poliomyelitis-vaccine-sf-r-poliomyelitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/allergan-pharmaceuticals-international-limited/projects/agn-195263-dry-eye-syndromes 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/tadalafil-2-5mg-tab-erectile-dysfunction 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/elan-pharma-international/projects/general-anesthesia-and-opioids-breast-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/digoxin-healthy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/ganciclovir-cytomegalovirus-infections 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astellas-pharma-europe-bv/projects/advagraf-renal-transplantation 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eurogen-pharmaceuticals-ltd/projects/autologous-bone-marrow-mononuclear-cell-transpla-spinal-cord-injury 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/18f-pmpbb3-apn-1607-pet-imaging-tau-distributions-in-patients-with-tauopathy-usi 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astellas-pharma-europe-bv/projects/asp8273-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv-eu/projects/jnj-73763989-hepatitis-b-chronic 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/v114-acute-otitis-media-aom 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chen-suning/projects/sitagliptin-type-2-diabetes 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/empagliflozin-heart-failure 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/pembrolizumab-solid-tumors 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/serelaxin-acute-heart-failure 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/huahui-health/projects/hh-003-20mg-kg-chronic-hepatitis-delta-virus-infection 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shanghai-university-of-traditional-chinese-medicine/projects/qing-e-pill-menopause 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/pazopanib-gw786034-neoplasms-uterine-cervix 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biotech-pharmaceutical-co/projects/taneasy-600mg-granules-copd-chronic-obstructive-pulmonary-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-mesto/projects/liraglutide-diabetes 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/midostaurin-acute-myeloid-leukemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/copegus-hepatitis-c-chronic 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/valdecoxib-pain-postoperative 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/talazoparib-plus-enzalutamide-prostate-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/lcz696-hypertension 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv-eu/projects/ibrutinib-chronic-lymphocytic-leukemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/durvalumab-non-small-cell-lung-cancer-nsclc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fresenius-kabi-deutschland-gmbh/projects/6-hydroxyethyl-starch-130-0-4-hypovolemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vir-biotechnology/projects/vir-2218-chronic-hepatitis-b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/zealand-pharma-a-s/projects/vitamin-c-shock-septic 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chemical-works-of-gedeon-richter-plc-gedeon-richter-plc/projects/fenugreek-seeds-extract-hypogonadism 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/olomorasib-healthy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/mirabegron-sjogren-s-syndrome 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/colgate-oral-care/projects/0-454-stannous-fluoride-calculus-dental 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sandoz-pharmaceuticals-d-d/projects/olaparib-tablets-150-mg-ovarian-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/jian-li/projects/626-healthy-subjects-hs 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/advanz-pharma-limited/projects/placebo-atrial-fibrillation 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chia-tai-tianqing-pharmaceutical-group-nanjing-shunxin-pharmaceutical-co/projects/hepatitis-b-vaccine-hepatitis-b-vaccination-hiv 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv-eu/projects/jnj-64281802-dengue 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbott-s-r-l/projects/ritonavir-sarcoma-kaposi 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/ianalumab-primary-immune-thrombocytopenia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/yang-i-pachankis/projects/nifedipine-30-mg-severe-acute-respiratory-syndrome-related-corona 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pharma-eeig-eu/projects/nivolumab-colorectal-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-healthcare-ag/projects/nifedipine-adalat-baya1040-hypertension 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shanghai-university-of-traditional-chinese-medicine/projects/sodium-thiosulfate-injection-hepatoblastoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biotech-pharmaceutical-co/projects/nanocovax-sars-cov-2-infection 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alexion-europe-sas/projects/danicopan-paroxysmal-nocturnal-hemoglobinuria 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beigene-ireland-ltd/projects/zanubrutinib-chronic-lymphocytic-leukemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-healthcare-ag/projects/sevabertinib-advanced-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/linked-color-imaging-early-gastric-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/eltrombopag-non-alcoholic-steatohepatitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-healthcare-ag/projects/ev-dng-qlaira-natazia-bay86-5027-metrorrhagia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/international-peace-maternity-and-child-health-hospital/projects/olokizumab-64mg-q4w-rheumatoid-arthritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biotech-pharmaceutical-co/projects/scb01a-head-and-neck-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chinese-university-of-hong-kong/projects/sirt-yttrium-90-cholangio-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/inavac-vaksin-merah-putih-ua-sars-cov-2-vero-cel-covid-19-pandemic 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/a-standardized-physical-therapy-program-frozen-shoulder 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bausch-lomb-ireland-limited/projects/budesonide-colitis-ulcerative 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biotech-pharmaceutical-co/projects/umooze-benign-prostatic-hyperplasia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/individual-lactation-counseling-and-educational-breastfeeding 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/trastuzumab-deruxtecan-gastric-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/incb099280-advanced-solid-tumor 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shanghai-zhongshan-hospital/projects/tocilizumab-takayasu-arteritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/cytarabine-aml 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biogen-idec-ltd/projects/dimethyl-fumarate-relapsing-remitting-multiple-sclerosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/ff-gw642444m-asthma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/azd8931-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv-eu/projects/guselkumab-colitis-ulcerative 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/pf-05280014-metastatic-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-ireland-uc/projects/evixapodlin-advanced-solid-tumors 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/live-attenuated-japanese-encephalitis-virus-yell-japanese-encephalitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beijing-chao-yang-hospital/projects/caspofungin-pneumocystis-pneumonia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/atara-biotherapeutics/projects/clopidogrel-coronary-artery-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-healthcare-ag/projects/finerenone-bay94-8862-diabetic-kidney-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biogen-idec-ltd/projects/felzartamab-immunoglobulin-a-nephropathy-igan 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/in10018-cervical-adenocarcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/short-course-palliative-radiation-cervical-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/ibandronate-bonviva-boniva-post-menopausal-osteoporosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bevacizumab-b-cell-lymphoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/suzhou-zelgen-biopharmaceuticals-co-ltd/projects/zg0895-hydrochloride-for-injection-advanced-solid-tumor 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chinese-university-of-hong-kong/projects/almonertinib-110-mg-rare-tumor 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/peking-university-third-hospital/projects/era-infertility-female 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eisai-gmbh/projects/e7080-solid-tumors 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/dienogest-endometriosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/international-peace-maternity-and-child-health-hospital/projects/on-site-radiologist-tuberculosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/pf-04236921-sc-injection-crohn-s-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/mochida-pharmaceutical-company/projects/placebo-hypertriglyceridemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/the-university-of-hong-kong/projects/sevelamer-hydrochloride-endstage-renal-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/nilotinib-amn107-gastrointestinal-stromal-tumor-gist 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pharma-eeig-eu/projects/bms-986165-lupus-nephritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chinese-university-of-hong-kong/projects/pegyinterferon-alfa-2a-chronic-hepaititis-b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biogen-idec-ltd/projects/bg00012-relapsing-remitting-multiple-sclerosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/allergan-pharmaceuticals-international-limited/projects/gatifloxacin-0-3-ophthalmic-solution-acute-bacterial-corneal-ulcers 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/tritanrix-hepb-hib-menac-whole-cell-pertussis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals/projects/tigecycline-appendicitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/mk-1167-alzheimer-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beigene-ireland-ltd/projects/tislelizumab-cervical-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/jian-li/projects/hrs-6213-patients-with-solid-tumors 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ono-pharmaceutical-co/projects/ono-4578-colorectal-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/generics-uk-limited/projects/cep-18770-multiple-myeloma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-mesto/projects/somapacitan-growth-hormone-disorder 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/medimmune/projects/durvalumab-oleclumab-stage-iii-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/ro7119929-carcinoma-hepatocellular 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/mbg453-myelodysplastic-syndromes 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/eriobotyra-japonica-lindley-extract-cognitive-function 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/ziprasidone-bipolar-disorder 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/etelcalcetide-hyperparathyroidism-secondary 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/metformin-topiramate-obesity 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/canakinumab-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/dexmedetomidine-cabg 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/hydroxychloroquine-z0188-cutaneous-lupus-erythematosus-systemic-lupus-ery 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/mitsubishi-tanabe-pharma-gmbh/projects/mt-1186-als 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-ireland-uc/projects/sof-hepatitis-c-virus-infection 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vera-therapeutics/projects/pregabalin-pain-postoperative 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/lei-li/projects/chemotherapy-plus-apatinib-recurrent-cervical-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/dor-isl-hiv-infection 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/second-affiliated-hospital-school-of-medicine-zhejiang-university/projects/3-n-butylphthalide-multiple-system-atrophy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/fospropofol-disodium-drug-safety 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/diaphragmatic-ultrasound-diaphragmatic-paralysis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/peking-university-third-hospital/projects/68ga-ny104-pet-ct-clear-cell-renal-cell-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/bms-986353-systemic-sclerosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bio-thera-solutions/projects/bat5906-injection-diabetic-macular-edema-dme 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/second-affiliated-hospital-of-xi-an-jiaotong-university/projects/linaclotide-bowel-preparation 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/transplantation-of-autologous-stem-cell-mncs-spinal-cord-injury 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/international-peace-maternity-and-child-health-hospital/projects/recombinant-human-arginase-1-peg5000-leukemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-mesto/projects/concizumab-haemophilia-a-without-inhibitors 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/atorvastatin-dyslipidemias 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/elan-pharma-international/projects/tmc125-hiv-1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/immunitybio-ireland-limited/projects/bcg-50mg-instillation-n-803-400-g-instillation-non-muscle-invasive-bladder-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/ocrelizumab-rheumatoid-arthritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chia-tai-tianqing-pharmaceutical-group-nanjing-shunxin-pharmaceutical-co/projects/lidocaine-spray-uterine-bleeding 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/taiho-pharma-netherlands-b-v/projects/tas-120-advanced-cholangiocarcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/infanrix-hexa-acellular-pertussis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-healthcare-ag/projects/aflibercept-eylea-vegf-trap-eye-bay86-5321-macular-edema 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/spesolimab-generalized-pustular-psoriasis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/midazolam-premedication-midazolam-premedication 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shanghai-proton-and-heavy-ion-center/projects/carbon-ion-radiotherapy-pancreatic-cancer-non-resectable 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/genmab-a-s/projects/gen1042-malignant-solid-tumor 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shanghai-university-of-traditional-chinese-medicine/projects/js001-triple-negative-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/methotrexate-plus-sulfasalazine-rheumatoid-arthritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/bi-764198-focal-segmental-glomerulosclerosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/the-university-of-hong-kong/projects/masticatory-muscle-training-exerciser-mastication 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/combination-with-disitamab-vedotin-and-with-tisl-gastric-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chinese-university-of-hong-kong/projects/du-huo-ji-sheng-tang-dhjst-knee-osteoarthritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/standard-dose-spirulina-platensis-hbv-carrier 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biotech-pharmaceutical-co/projects/sars-cov-2-mrna-vaccine-covid-19 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/doxycycline-tuberculosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/glycopyrronium-bromide-chronic-obstructive-pulmonary-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shine-europe-b-v/projects/rjk-rt2831-dose-escalation-phase-ia-hematologic-malignancies 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/efinopegdutide-20-mg-ml-nonalcoholic-fatty-liver-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shanghai-university-of-traditional-chinese-medicine/projects/donepezil-dihydroxynaphthalate-for-injection-alzheimer-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chia-tai-tianqing-pharmaceutical-group-co/projects/tqb3616-capsules-hr-positive-her2-negative-advanced-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/bisoprolol-hypertension 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/placebo-non-squamous-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/quadrivalent-influenza-modrna-vaccine-influenza-human 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-ireland-uc/projects/cobi-hiv 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/trastuzumab-deruxtecan-ovarian-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/changchun-genescience-pharmaceutical-co/projects/gentuximab-advanced-gastric-or-gastroesophageal-junction-ca 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/neoadjuvant-chemotherapy-squamous-cell-carcinoma-of-oral-cavity 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/enoxaparin-sodium-xrp4563-myocardial-infarction 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/terazosin-stent-related-symptoms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/phe885-multiple-myeloma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/temsirolimus-non-hodgkin-s-lymphoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chinese-university-of-hong-kong/projects/finerenone-patients-with-type-2-diabetes 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/grace-therapeutics/projects/imiquimod-5-cream-superficial-basal-cell-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/xijing-hospital/projects/folic-acid-stroke 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/taiwan-liposome-company/projects/lipotecan-hepatocellular-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/international-peace-maternity-and-child-health-hospital/projects/hbi-3000-atrial-fibrillation 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/dapagliflozin-10-mg-type-2-diabetes-mellitus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-healthcare-ag/projects/refametinib-bay86-9766-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biogen-idec-ltd/projects/dimethyl-fumarate-multiple-sclerosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/sb-659032-atherosclerosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chia-tai-tianqing-pharmaceutical-group-co/projects/tqf3250-placebo-hyperglycemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/aprepitant-nausea-and-vomiting 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/neuroscience-trials-australia/projects/tissue-plasminogen-activator-alteplase-stroke 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sun-yat-sen-university/projects/chemotherapy-nasopharyngeal-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ono-pharmaceutical-co/projects/ono-4578-metastatic-pancreatic-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/children-s-hospital-of-fudan-university/projects/carboplatin-central-nervous-system-nongerminomatous-germ-cel 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/m5049-low-dose-systemic-lupus-erythematosus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/suzhou-zelgen-biopharmaceuticals-co-ltd/projects/zg005-biliary-tract-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/menacwy-tt-meningococcal-acwy-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv-eu/projects/apalutamide-metastatic-castrate-sensitive-prostate-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/25-carbohydrate-solution-cho-drinking-type2diabetes 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/dydrogesterone-preterm-delivery 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/jian-li/projects/karelizumab-combined-with-etoposide-and-cisplati-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/cook-balloon-uterine-stent-intrauterine-adhesion 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eisai-gmbh/projects/zonisamide-epilepsy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-healthcare-ag/projects/bay2965501-advanced-solid-tumors 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eisai-gmbh/projects/e7080-cancer-solid-tumors 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biotech-pharmaceutical-co/projects/stimus-nng-depo-anemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/dato-dxd-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/ramucirumab-gastric-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/yung-na/projects/fimasartan-atorvastatin-combination-tablet-hypertension 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/sunitinib-malate-carcinoma-hepatocellular 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chinese-university-of-hong-kong/projects/sodium-valproate-epilepsy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pharma-eeig-eu/projects/nivolumab-prostate-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/shr-1210-renal-cell-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/yung-na/projects/dabigatran-atrial-fibrillation 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/mitsubishi-tanabe-pharma-gmbh/projects/mt-5547-osteoarthritis-knee-osteoarthritis-hip 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ascentage-pharma-group/projects/olverembatinib-ph-all 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biotech-pharmaceutical-co/projects/en-lac-perennial-allergic-rhinitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/docetaxel-castration-resistant-prostatic-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-mesto/projects/biphasic-insulin-aspart-30-diabetes 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-mesto/projects/semaglutide-overweight 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/valproic-acid-drug-resistant-epilepsy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/enzastaurin-glioblastoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/leo-pharma-a-s/projects/leo-90105-psoriasis-vulgaris 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/probiotic-cocktail-capsules-vancomycin-resistant-enterococci 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chinese-university-of-hong-kong/projects/programmed-cell-death-protein-1-inhibitor-locally-advanced-esophageal-squamous-cell-carcin 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/ianalumab-primary-immune-thrombocytopenia-itp 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/pf-02341066-carcinoma-non-small-cell-lung 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/dupilumab-asthma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/ro7507062-systemic-lupus-erythematosus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/palbociclib-metastatic-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shanghai-university-of-traditional-chinese-medicine/projects/syha1813-oral-solution-2-0g-25mg-healthy-participants 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/lee011-hormone-receptor-positive-her2-negative-advanced 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals/projects/refacto-hemophilia-a 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/children-s-hospital-of-fudan-university/projects/cyclophosphamide-stage-iii-kidney-wilms-tumor 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/children-s-hospital-of-fudan-university/projects/misoprostol-postpartum-hemorrhage 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-ireland-uc/projects/bictegravir-hiv-1-infection 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/lamivudine-hepatitis-b-chronic 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/ursodeoxycholic-acid-hepatitis-d 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/azd5363-olaparib-durvalumab-solid-tumor-adult 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/molnupiravir-coronavirus-disease-covid-19 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/indacaterol-150-g-chronic-obstructive-pulmonary-disease-copd 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shandong-suncadia-medicine-co/projects/bilateral-cerebellar-deep-brain-stimulation-stroke 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/yang-xiaotian/projects/aspirin-bleeding-complication-during-colon-polypectomy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/allergan-pharmaceuticals-international-limited/projects/botulinum-toxin-type-a-benign-prostatic-hyperplasia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/secukinumab-psoriatic-arthritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/gsk2269557-ellipta-dpi-pulmonary-disease-chronic-obstructive 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cutia-therapeutics-shanghai-co-ltd/projects/fmx101-acne-vulgaris 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/l-alanyl-l-glutamine-dipeptide-coronary-artery-bypass 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/children-s-hospital-of-fudan-university/projects/busulfan-juvenile-myelomonocytic-leukemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/xijing-hospital-of-digestive-diseases/projects/metformin-gastric-intestinal-metaplasia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/gefitinib-nsclc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/crenezumab-alzheimer-s-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-healthcare-ag/projects/asundexian-bay2433334-prevention-of-stroke-or-systemic-embolism 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/ly3039478-advanced-solid-tumor 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vera-therapeutics/projects/p2y12-antagonist-monotherapy-coronary-artery-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/symbicort-turbuhaler-asthma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/basilea-pharmaceutica-deutschland-gmbh/projects/oral-fosmanogepix-healthy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/enteric-coated-mycophenolate-sodium-ec-mps-renal-transplant 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/online-hdf-end-stage-renal-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/lgh447-aml-and-high-risk-mds 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/dental-stent-nasopharyngeal-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/baxdrostat-uncontrolled-hypertension 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/danoprevir-healthy-volunteer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/peg-interferon-alfa-2a-chronic-hepatitis-b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/dabrafenib-malignant-melanoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/fexofenadine-rhinitis-allergic-perennial 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/nxy-059-cerebral-stroke 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shanghai-university-of-traditional-chinese-medicine/projects/furmonertinib-lung-adenocarcinoma-stage-iii 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/bion-1301-single-dose-iga-nephropathy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/cabazitaxel-prostate-cancer-metastatic 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/centocor-b-v/projects/placebo-velcade-and-dexamethasone-multiple-myeloma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/yung-na/projects/fimasartan-and-rosuvastatin-essential-hypertension-dyslipidemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/seqirus-s-r-l/projects/csl-limited-influenza-vaccine-influenza 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/dabrafenib-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/the-university-of-hong-kong/projects/nicotine-replacement-therapy-smoking 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/mr-pet-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/avatrombopag-chemotherapy-induced-thrombocytopenia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/linagliptin-diabetes-mellitus-type-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/vay736-sjogren-syndrome 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/placebo-ankylosing-spondylitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/orforglipron-type-2-diabetes 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/nintedanib-idiopathic-pulmonary-fibrosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/satralizumab-120-mg-neuromyelitis-optica-spectrum-disorder 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/dapagliflozin-heart-failure-with-preserved-ejection-fraction-h 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/multitude-therapeutics/projects/amt-676-advanced-solid-tumors 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cspc-baike-shandong-biopharmaceutical-co/projects/paclitaxel-cationic-liposome-for-injection-colorectal-liver-metastases 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/ipatasertib-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/ph-797804-pulmonary-disease-chronic-obstructive 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/oral-nutritional-supplement-gastric-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-mesto/projects/concizumab-haemophilia-a-with-inhibitors 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv-eu/projects/jnj-56021927-prostatic-neoplasms-castration-resistant 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/ramucirumab-gastric-adenocarcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shionogi-b-v/projects/s-217622-sars-cov-2-infection 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/pf-07038124-or-vehicle-healthy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/the-university-of-hong-kong/projects/vortioxetine-cannabis-use-disorder 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/pioglitazone-diabetes-mellitus-type-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/intraosseous-morphine-pain-postoperative 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hong-kong-baptist-university/projects/bioamicus-complete-infantile-colic 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bial-portela-companhia-s-a/projects/eslicarbazepine-acetate-bia-2-093-partial-epilepsy-in-children-and-adolescents 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/afatinib-head-and-neck-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cansino-biologics/projects/batch-1-of-group-acyw135-meningococcal-conjugate-meningococcal-meningitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/enoxaparin-acute-illness 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/zigakibart-immunoglobulin-a-nephropathy-igan 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/otsuka-novel-products-gmbh/projects/rebamipide-stomach-ulcer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/glargine-diabetes-mellitus-type-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/zhejiang-university/projects/cetuximab-fruquintinib-colorectal-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sun-yat-sen-university/projects/gemcitabine-and-cisplatin-induction-chemotherapy-nasopharyngeal-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-healthcare-ag/projects/recombinant-factor-viii-bay81-8973-blood-coagulation-disorders 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-healthcare-ag/projects/bay2757556-larotrectinib-vitrakvi-solid-tumors-harboring-ntrk-fusion 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/mupirocin-peritoneal-dialysis-related-infection 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/tissue-plasminogen-activator-tpa-peritoneal-dialysis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alfasigma-s-p-a/projects/filgotinib-axial-spondyloarthritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/topical-anesthetic-radial-artery-spasm 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/vaginal-progesterone-preterm-birth 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/children-s-hospital-of-fudan-university/projects/dactinomycin-kidney-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/atezolizumab-urothelial-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chinese-university-of-hong-kong/projects/inactivated-ev71-vaccine-kmb-17-cells-hand-foot-and-mouth-disease-hfmd 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/children-s-hospital-of-fudan-university/projects/carboplatin-desmoplastic-nodular-medulloblastoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chinese-university-of-hong-kong/projects/epinephrine-gastric-neoplasm 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/tianjin-huanhu-hospital/projects/qt-019c-neuromyelitis-optica-spectrum-disorders 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/amlodipine-atorvastatin-single-pill-hypertension 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-mesto/projects/cagrilintide-overweight 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/daunorubicin-down-syndrome 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/the-university-of-hong-kong/projects/inactivated-influenza-vaccine-influenza-virus-infection 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/azd9291-80-mg-40-mg-stage-ib-iiia-non-small-cell-lung-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/darbepoetin-alfa-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/seqirus-s-r-l/projects/influenza-virus-vaccine-influenza 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/fluorometholone-pterygium-of-the-conjunctiva-and-cornea 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/telmisartan-cardiovascular-diseases 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cellseed-europe-ltd/projects/cls2901c-human-allogeneic-chondrocyte-sheets-osteoarthritis-of-the-knee 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-ltd/projects/matching-placebo-for-upadacitinib-crohn-s-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv-eu/projects/rilpivirine-hiv-1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/baxalta-innovations-gmbh/projects/factor-viii-inhibitor-bypassing-activity-nanofil-hemophilia-a-or-b-with-inhibitors 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/brinzolamide-1-brimonidine-0-2-fixed-combination-glaucoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/ticagrelor-90-mg-myocardial-infarction 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/bapineuzumab-alzheimer-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/taiwan-liposome-company/projects/bel-x-hg-advanced-solid-tumors 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/atezolizumab-melanoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/total-knee-arthroplasty-osteoarthritis-knee 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/ixekizumab-plaque-psoriasis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/dapagliflozin-heart-failure-with-preserved-ejection-fraction 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pharma-eeig-eu/projects/ipilimumab-melanoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/lebrikizumab-atopic-dermatitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/international-peace-maternity-and-child-health-hospital/projects/depuy-asr-hip-system-rheumatoid-arthritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/alogabat-angelman-syndrome 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/international-peace-maternity-and-child-health-hospital/projects/evaluation-of-social-cultural-and-behavioral-fac-cardio-vascular-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/taiwan-liposome-company/projects/cyclophosphamide-doxorubicin-vincristine-lamivud-non-hodgkin-s-lymphoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sun-yat-sen-memorial-hospital-of-sun-yat-sen-university/projects/trastuzumab-and-neratinib-early-stage-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/capivasertib-advanced-solid-tumours 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/bi-671800-asthma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/laser-acupuncture-postpartum-weight-retention 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/quetiapine-sr-major-depressive-disorder 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/sb497115-purpura-thrombocytopaenic-idiopathic 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/pembrolizumab-vibostolimab-coformulation-metastatic-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/placebo-osteoarthritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pharma-eeig-eu/projects/daclatasvir-hepatitis-c-virus-infection 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/poliorix-poliomyelitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/timolol-glaucoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/bovine-colostrum-severe-alcoholic-hepatitis-in-extremis-defined-b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/ivonescimab-20-mg-kg-nasopharyngeal-carcinoma-npc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/the-university-of-hong-kong/projects/25-agno3-solution-followed-by-5-naf-early-childhood-caries 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/prg-1801-immune-thrombocytopenia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-ireland-uc/projects/gs-0272-rheumatoid-arthritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-ltd/projects/navitoclax-acute-lymphoblastic-leukemia-all 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/kwong-wah-hospital/projects/n-acetycysteine-600mg-twice-daily-copd 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shine-europe-b-v/projects/pre-operative-chemotherapy-gastric-cancers 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/ro7239361-duchenne-muscular-dystrophy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astellas-pharma-europe-bv/projects/ramosetron-vomiting 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/second-affiliated-hospital-of-soochow-university/projects/esketamine-sulfentanil-or-and-remifentanil-opioid-analgesic-adverse-reaction 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/arm1-oral-squamous-cell-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/bgj398-recurrent-glioblastoma-or-other-glioma-subtypes 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/evolocumab-coronary-heart-disease-chd 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/ly2127399-systemic-lupus-erythematosus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/azd5363-when-combined-with-weekly-paclitaxel-advanced-or-metastatic-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/csl-behring-gmbh/projects/human-immunoglobulin-g-dermatomyositis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/medimmune/projects/placebo-asthma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shine-europe-b-v/projects/low-dose-lymphocyte-immunotherapy-unexplained-recurrent-miscarriage-and-recurrent 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chinese-university-of-hong-kong/projects/telbivudine-chronic-hepatitis-b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/zongertinib-lung-cancer-non-squamous-non-small-cell 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/the-university-of-hong-kong/projects/fluoxetine-depression 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/azd6244-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/innovent-biologics-suzhou-co/projects/ibi3016-hypertension 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sumitomo-pharma-suzhou-co/projects/placebo-bipolar-depression 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/pembrolizumab-locally-recurrent-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/5-fluorouracil-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/duke-university/projects/abraxane-metastatic-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/bismuth-based-susceptibility-guided-treatment-helicobacter-pylori 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/apixaban-atrial-fibrillation 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/jian-li/projects/68ga-fapi-04-fibrosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chinese-university-of-hong-kong/projects/computer-aided-diagnosis-upper-gastrointestinal-disorder 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/praxis-precision-medicines/projects/10-mg-prax-114-major-depressive-disorder 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/gw406381-osteoarthritis-knee 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/bevacizumab-proliferative-diabetic-retinopathy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/livzon-pharmaceutical-group/projects/recombinant-sars-cov-2-fusion-protein-vaccine-v-covid-19-pandemic 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/vitamin-d3-bronchiectasis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beijing-302-hospital/projects/twhf-human-immunodeficiency-virus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/tiotropium-high-dose-asthma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biotech-pharmaceutical-co/projects/pegfilgrastim-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/livespo-navax-acute-respiratory-tract-infections 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/disitamab-vedotin-urothelial-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/medi4736-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/mira-pharmaceuticals-inc/projects/pidotimod-recurrent-respiratory-tract-infections 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/basilea-pharmaceutica-deutschland-gmbh/projects/derazantinib-gastric-adenocarcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/johnson-johnson-medical-pty-ltd/projects/placebo-erectile-dysfunction 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/neuroscience-trials-australia/projects/tenecteplase-ischemic-stroke 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/cobimetinib-solid-tumors 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-mesto/projects/turoctocog-alfa-congenital-bleeding-disorder 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv-eu/projects/rilematovir-respiratory-syncytial-virus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-ireland-uc/projects/b-f-taf-hiv-1-hbv-co-infection 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/afimkibart-moderately-to-severely-active-crohns-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/atorvastatin-healthy-volunteer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/fostamatinib-rheumatoid-arthritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sumitomo-pharma-suzhou-co/projects/lurasidone-bipolar-i-depression 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/qbw251-pulmonary-disease-chronic-obstructive 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/ribavirin-rbv-hepatitis-c 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/ropivacaine-liver-diseases 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/systane-hydration-lubricant-eye-drops-dry-eye-syndromes 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chendu-diao-pharmaceutical-group-co-ltd/projects/da-302168s-overweight-and-obesity 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/otsuka-novel-products-gmbh/projects/tolvaptan-cardiac-edema 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/lactose-free-milk-formula-frisolac-lf-acute-gastroenteritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/daptomycin-for-injection-bacteremia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/magnetic-stimulation-neuropathic-pain 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/lixisenatide-ave0010-type-2-diabetes-mellitus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/azd9291-carcinoma-non-small-cell-lung 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/wujin-people-s-hospital/projects/amivita-amyotrophic-lateral-sclerosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/ofatumumab-leukaemia-lymphocytic-chronic 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/dutasteride-plus-tamsulosin-prostatic-hyperplasia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/anidulafungin-candidemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/interleukin-nk-cells-metastatic-nasopharyngeal 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/xijing-hospital-of-digestive-diseases/projects/fenofibrate-primary-biliary-cirrhosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/renji-hospital/projects/fruquintinib-stomach-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/inactivated-poliomyelitis-vaccine-imovax-poliomyelitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/placebo-ic-mpgn 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/zealand-pharma-a-s/projects/early-activity-and-mobilisation-critically-ill-mechanically-ventilated 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/6-month-clopidogrel-therapy-coronary-artery-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/international-peace-maternity-and-child-health-hospital/projects/iridoid-enriched-mixed-fruit-beverage-oxidative-stress 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/the-university-of-hong-kong/projects/atezolizumab-nsclc-stage-iiib 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hangzhou-zhongmei-huadong-pharmaceutical-co/projects/mb-102-dmid-kidney-diseases 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chinese-university-of-hong-kong/projects/per-oral-endoscopic-myotomy-primary-esophageal-motility-disorders-including 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/deferasirox-myelodysplastic-syndromes 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/genmab-a-s/projects/tisotumab-vedotin-solid-tumor 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/tofacitinib-with-methotrexate-rhematoid-arthritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shionogi-b-v/projects/s-337395-respiratory-syncytial-virus-infections 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/eltrombopag-aplastic-anemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/autologous-natural-killer-cell-therapy-hepatocellular-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/ro7247669-melanoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/dynavax-international-b-v/projects/z-1018-shingles 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-healthcare-ag/projects/sorafenib-nexavar-bay43-9006-carcinoma-hepatocellular 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/favezelimab-pembrolizumab-colorectal-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/fexofenadine-hcl-and-pseudoephedrine-hcl-rhinitis-allergic 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/tozorakimab-1-chronic-obstructive-pulmonary-disease-copd 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shanghai-university-of-traditional-chinese-medicine/projects/gv-971-alzheimer-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/tarlatamab-neuroendocrine-prostate-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/trastuzumab-emtansine-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/allergan-pharmaceuticals-international-limited/projects/rapastinel-depressive-disorder-major 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-healthcare-ag/projects/sorafenib-nexavar-bay43-9006-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-ltd/projects/lutikizumab-hidradenitis-suppurativa 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/jian-li/projects/hrs-2329-tablet-advanced-solid-tumors-harboring-ras-mutations-or 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/orforglipron-osa 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/cp-690-550-arthritis-rheumatoid 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/blood-draw-for-lp-a-cardiovascular-disease-and-lipoprotein-a 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/protein-supplementation-hip-fractures 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/probiotics-parkinson-s-disease-pd 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/celecoxib-arthritis-juvenile-rheumatoid 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hunan-province-tumor-hospital/projects/shr-1701-combined-with-fluazopalil-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/olaparib-300mg-tablets-newly-diagnosed 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astellas-pharma-europe-bv/projects/esn364-healthy-subjects 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv-eu/projects/topiramate-epilepsy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sumitomo-pharma-suzhou-co/projects/napabucasin-carcinoma-pancreatic-ductal 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/influenza-a-h5n1-virus-monovalent-vaccine-influenza 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biotech-pharmaceutical-co/projects/shj002-vehicle-dry-eye-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/mochida-pharmaceutical-company/projects/icosapent-mnd-2119-hypertriglyceridemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/bacillus-clausii-multi-atb-resist-diarrhea-infantile 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv-eu/projects/lumicitabine-respiratory-syncytial-viruses 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/samsung-bioepis-nl-b-v/projects/pemetrexed-colorectal-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv-eu/projects/daratumumab-multiple-myeloma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/adefovir-dipivoxil-hepatitis-b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/opb-51602-nasopharyngeal-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/pembrolizumab-200-mg-metastatic-castration-resistant-prostate-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/her3-dxd-advanced-solid-tumor 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fresenius-kabi-deutschland-gmbh/projects/msb11455-healthy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/68ga-nns309-pancreatic-ductal-adenocarcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharmaessentia/projects/p1101-polycythemia-vera-pv 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biogen-idec-ltd/projects/placebo-oral-capsule-healthy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/csl-behring-gmbh/projects/ald518-oral-mucositis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/green-valley-shanghai-pharmaceuticals-co/projects/hyalobarrier-thyroid-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/aflibercept-diabetic-macular-edema 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/orion/projects/sens-401-r-azasetron-besylate-hearing-loss 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/tesaglitazar-0-5-or-1-mg-type-2-diabetes 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/low-dose-midazolam-intubation 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharmaand-gmbh/projects/panobinostat-capsules-multiple-myeloma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/olaparib-breast-cancer-metastatic 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/sargramostim-pulmonary-alveolar-proteinosis-autoimmune 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/trastuzumab-deruxtecan-locally-advanced-or-metastatic-non-small-cell-lu 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/spesolimab-i-v-hidradenitis-suppurativa 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/mirikizumab-sc-ulcerative-colitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/mochida-pharmaceutical-company/projects/fyu-981-healthy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-ireland-uc/projects/sof-hcv-infection 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alexion-europe-sas/projects/danicopan-healthy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/carbidopa-levodopa-entacapone-parkinson-s-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/yung-na/projects/prednisone-jakavi-ruxolitinib-gvhd-graft-versus-host-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/trastuzumab-deruxtecan-advanced-solid-tumors-with-her2-mutation-eg-colo 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/pembrolizumab-renal-cell-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/pemetrexed-carcinoma-non-small-cell-lung 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sun-yat-sen-university/projects/online-adaptive-sbrt-adaptive-radiotherapy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/aliskiren-acute-decompensated-heart-failure 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/ff-gsk573719-asthma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sun-yat-sen-university/projects/benazepril-renal-function-disorder 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/capa-ivm-infertility-female 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/targanta-netherlands-b-v/projects/oritavancin-staphylococcal-skin-infections 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/oxycodone-postcraniotomy-pain 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/jiangsu-province-centers-for-disease-control-and-prevention/projects/h-pylori-vaccine-h-pylori-infection 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/csl-behring-gmbh/projects/csl689-hemophilia-a-with-inhibitors 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/the-university-of-hong-kong/projects/sdf-solution-dental-caries 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/hyperpolarized-13c-pyruvate-injection-gynecologic-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/h-lundbeck-a-s/projects/lu-af35700-treatment-resistant-schizophrenia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sun-yat-sen-university/projects/concurrent-chemotherapy-locally-advanced-lung-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-ireland-uc/projects/sof-vel-hepatitis-c-virus-infection 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/serum-life-science-europe-gmbh/projects/pmv-via-puffhaler-device-prophylaxis-for-the-measles-infection 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/paul-hartmann-pty-ltd/projects/spermine-premature-birth 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chinese-university-of-hong-kong/projects/clarithromycin-bronchiectasis-adult 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/gastric-scintigraphy-functional-dyspepsia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celgene-europe-limited/projects/lenalidomide-b-cell-chronic-lymphocytic-leukemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/doxorubicin-docetaxel-metastatic-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/avelumab-advanced-malignancies 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/teriparatide-femur-neck-fracture 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/jian-li/projects/bupivacaine-liposome-injection-local-analgesia-via-infiltration 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv-eu/projects/ad26-cov2-s-healthy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/chemotherapy-avelumab-followed-by-avelumab-talaz-ovarian-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/zigakibart-kidney-diseases 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/otsuka-novel-products-gmbh/projects/aripiprazole-im-depot-schizophrenia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/fulvestrant-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/arena-pharmaceutical-enterprises-limited/projects/apd334-pyoderma-gangrenosum 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/cp-751-871-figitumumab-carcinoma-large-cell 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/dutasteride-0-5mg-once-daily-for-4-years-prostatic-hyperplasia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/olaparib-continuous-28-day-cycle-300-mg-bd-metastatic-triple-negative-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/suzhou-ribo-life-science-co/projects/shr-a2009-aumolertinib-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/ranibizumab-retinopathy-of-prematurity 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/doxazosin-4-mg-daily-plus-celecoxib-200-mg-every-benign-prostatic-hyperplasia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/peking-university-third-hospital/projects/68ga-pentixafor-cushing-s-syndrome 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-ltd/projects/elsubrutinib-systemic-lupus-erythematosus-sle 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/children-s-hospital-of-fudan-university/projects/bleomycin-sulfate-childhood-germ-cell-tumor 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/zd6474-vandetanib-non-small-cell-lung-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-ltd/projects/abt-493-hepatic-impairment 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/lik066-obese-patients-with-non-alcoholic-steatohepatiti 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chiesi-farmaceutici-s-p-a/projects/chf-5993-100-6-12-5-g-copd-chronic-obstructive-pulmonary-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/seretide-rotacaps-asthma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/generics-uk-limited/projects/modakafusp-alfa-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/plasmalyte-solution-cardiac-surgery 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/alx-0061-lupus-erythematosus-systemic 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-ireland-uc/projects/gs-2829-chronic-hepatitis-b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/mupirocin-drug-biopsy-wound 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-ireland-uc/projects/e-c-f-tdf-acquired-immunodeficiency-syndrome 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/volrustomig-locally-advanced-head-and-neck-squamous-cell-car 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/durvalumab-solid-tumor 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/induced-moderate-hypothermia-traumatic-brain-injury 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/children-s-hospital-of-fudan-university/projects/doxorubicin-hydrochloride-childhood-renal-cell-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/tirzepatide-metabolic-dysfunction-associated-steatotic-liver 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/children-s-hospital-of-fudan-university/projects/radiation-therapy-brain-tumor 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hong-kong-baptist-university/projects/ckd-393-formulation-i-type-ii-diabetes 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/peking-university-third-hospital/projects/recombinant-human-endostatin-melanoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/giredestrant-early-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/lenalidomide-leavdo-antibiotics-unresponsive-malt-lymphoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/te-arai-biofarma-limited/projects/convalescent-plasma-convalescence 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals/projects/dvs-sr-depressive-disorder-major 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/johnson-johnson-medical-pty-ltd/projects/jnj-90301900-nbtxr3-carcinoma-squamous-cell 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/second-affiliated-hospital-of-soochow-university/projects/vedolizumab-ulcerative-colitis-uc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/gantenerumab-alzheimer-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/h5n1-adjuvanted-split-virus-vaccine-a-vietnam-11-influenza 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shanghai-mental-health-center/projects/phase-1-olanzapine-schizophrenia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/docetaxel-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/new-formulation-herpes-labialis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vera-therapeutics/projects/peginterferon-alfa-2a-hepatitis-b-chronic 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/tocilizumab-adamantinomatous-craniopharyngioma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fudan-university/projects/anlotinib-extensive-stage-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/lcz696-sacubitril-valsartan-acute-myocardial-infarction 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biotech-pharmaceutical-co/projects/study-subjects-will-be-vaccinated-with-3-three-v-diphtheria 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/platelet-rich-plasma-severe-oligoasthenoteratozoospermia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/rituximab-anti-neutrophil-cytoplasmic-antibody-associated 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/azd7762-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/dapagliflozin-10-mg-diabetes-mellitus-non-insulin-dependent 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/daxdilimab-lupus-nephritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-ireland-uc/projects/lanraplenib-inflammatory-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/international-peace-maternity-and-child-health-hospital/projects/elobixibat-10mg-chronic-constipation 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/seqirus-s-r-l/projects/adjuvanted-quadrivalent-subunit-influenza-virus-influenza-virus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/dong-jie/projects/pramipexole-restless-legs-syndrome 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/sar448501-b-cell-non-hodgkin-lymphoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/placebo-hepatocellular-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbott-s-r-l/projects/zomaxx-drug-eluting-coronary-stent-system-coronary-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/niraparib-neoplasms-breast 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eisai-gmbh/projects/eribulin-mesylate-erlotinib-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biotech-pharmaceutical-co/projects/tsb-9-w1-metastatic-colorectal-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beijing-zhifei-lvzhu-biopharmaceutical-co-ltd/projects/mcv-acyw135-vaccine-group-meningitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/chloroquine-malaria 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/ceritinib-ldk378-tumors-with-aberrations-in-alk 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/gynaecological-follow-up-infections-papillomavirus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sun-yat-sen-university/projects/bone-marrow-mesenchymal-stem-cells-low-dose-acute-on-chronic-liver-failure 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/eltrombopag-purpura-thrombocytopaenic-idiopathic 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/jian-li/projects/irinotecan-liposome-5-fluorouracil-leucovorin-second-line-treatment-for-locally-advanced-or-me 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv-eu/projects/lumicitabine-respiratory-syncytial-virus-infections 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv-eu/projects/amivantamab-colorectal-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pharma-eeig-eu/projects/bms-986165-granulomatous-colitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/bi-765063-head-and-neck-squamous-cell-carcinoma-hnscc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astellas-pharma-europe-bv/projects/fezolinetant-hot-flashes 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/yang-xiaotian/projects/sequential-combined-avs-primary-aldosteronism 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/renin-angiotensin-system-blockers-diabetes 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/etanercept-moderate-to-severe-psoriasis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/dong-wang/projects/da-4001c-androgenetic-alopecia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fudan-university/projects/eof5-gastric-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/zibo-municipal-hospital/projects/sbrt-combined-with-tislelizumab-followed-by-tisl-nsclc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/filgrastim-brain-and-central-nervous-system-tumors 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/sar443122-colitis-ulcerative 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-ltd/projects/mirvetuximab-soravtansine-epithelial-ovarian-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/lucentis-wet-macular-degeneration 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/xynomic-pharmaceuticals/projects/abexinostat-non-hodgkin-lymphoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/ly3493269-sc-healthy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/azd6793-chronic-obstructive-pulmonary-disease-copd 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sun-yat-sen-memorial-hospital-of-sun-yat-sen-university/projects/niraparib-platinum-resistant-recurrent-clear-cell-ovarian 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cosmo-technologies-ltd/projects/monofer-chronic-kidney-disease-stage-5-dialysis-dependen 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/iptacopan-immune-thrombocytopenia-itp 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/anifrolumab-lupus-nephritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/faropenem-pulmonary-tuberculosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/anhui-provincial-hospital/projects/donafenib-envafolimab-hepatocellular-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-mesto/projects/insulin-degludec-diabetes 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/samsung-bioepis-nl-b-v/projects/ssri-treated-group-depression 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/dostarlimab-female 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/gcsf-end-stage-liver-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/omeprazole-gastroesophageal-reflux-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ferring-pharmaceuticals-a-s/projects/follitropin-alfa-controlled-ovarian-simulation 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbott-s-r-l/projects/dydrogesterone-30-mg-female-infertility 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ucb-pharma/projects/levetiracetam-epilepsy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/trastuzumab-metastatic-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/ceftaroline-community-acquired-bacterial-pneumonia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/children-s-hospital-of-fudan-university/projects/dactinomycin-adult-kidney-wilms-tumor 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/autologous-adipose-derived-mesenchymal-stem-cell-aging-problems 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/placebo-congenital-heart-disease-in-children 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/rsv-mat-respiratory-syncytial-virus-infections 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/conventional-dose-epinephrine-croup 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/pregabalin-bone-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/sitaxsentan-pulmonary-arterial-hypertension 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/coffee-insulin-resistance 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shifeng-lou/projects/cytoxan-hemophagocytic-syndrome 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/ut-15c-treprostinil-diolamine-pulmonary-arterial-hypertension 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv-eu/projects/cetrelimab-carcinoma-non-small-cell-lung 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shanghai-university-of-traditional-chinese-medicine/projects/tqc2731-injection-chronic-obstructive-pulmonary-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/erlotinib-non-squamous-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/samsung-bioepis-nl-b-v/projects/gemcitabine-simvastatin-pancreatic-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/capecitabine-plus-temozolamide-neuroendocrine-neoplasia-s-nens 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biotech-pharmaceutical-co/projects/epi-321-facioscapulohumeral-muscular-dystrophy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/iv-tulisokibart-crohn-s-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hipra-human-health-s-l/projects/covid-19-vaccine-hipra-covid-19 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/pd-0332991-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alexion-europe-sas/projects/ravulizumab-atypical-hemolytic-uremic-syndrome-ahus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/zhujiang-hospital/projects/cd19-car-t-cell-cat19t2-b-cell-acute-lymphoblastic-leukemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/benralizumab-healthy-subjects 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/olmesartan-medoxomil-chronic-glomerulonephritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/ff-rhinitis-allergic-perennial 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/pelacarsen-atherosclerotic-cardiovascular-disease-ascvd 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/osimertinib-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/nilotinib-chronic-myeloid-leukemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/johnson-johnson-medical-pty-ltd/projects/rivaroxaban-atrial-fibrillation 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alexion-europe-sas/projects/alxn1840-wilson-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/placebo-schizophrenia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/neuroscience-trials-australia/projects/bone-marrow-derived-stem-cells-spinal-cord-injury 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/kaf156-malaria 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/bacillus-calmette-guerin-and-interferon-alpha-carcinoma-of-urinary-bladder-superficial 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chinese-university-of-hong-kong/projects/film-dressing-by-adhesive-chronic-peritoneal-dialysis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/medi4736-durvalumab-non-small-cell-lung-carcinoma-nsclc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chia-tai-tianqing-pharmaceutical-group-nanjing-shunxin-pharmaceutical-co/projects/mevac-a-vaccine-hav 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shandong-suncadia-medicine-co/projects/hrs-7058-pancreatic-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/changhai-hospital/projects/serplulimab-bevacizumab-rectal-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pharma-eeig-eu/projects/karxt-irritability-associated-with-autism-spectrum-dis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/belantamab-mafodotin-multiple-myeloma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/bgg492-adrenocortical-adenoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/jian-li/projects/placebos-advanced-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-ireland-uc/projects/b-f-taf-adult-strength-hiv-1-infection 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chinese-university-of-hong-kong/projects/amlodipine-telmisartan-amiloride-compound-simvas-essential-hypertension 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/gsk2118436-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pharma-eeig-eu/projects/nivolumab-head-and-neck-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-ltd/projects/placebo-ulcerative-colitis-uc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/qva149-chronic-obstructive-pulmonary-disease-copd 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/ag-013736-thyroid-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sun-yat-sen-university/projects/almonertinib-safety-of-almonertinib 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/rivaroxaban-2-5-mg-oral-tablet-chronic-kidney-diseases 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/empagliflozin-10-mg-diabetic-nephropathies 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pharma-eeig-eu/projects/atv-hiv-infections 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/gcpgc-neulasta-placebo-healthy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/treatment-a-asthma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/rabeprazole-20mg-twice-daily-chest-pain 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/rilvegostomig-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/deferasirox-granule-formulation-transfusion-dependent-anemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/fractional-co2-laser-treatments-of-striae-gravidarum 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/henan-provincial-people-s-hospital/projects/anlotinib-plus-pemetrexed-non-squamous-cell-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/placebo-diabetes-mellitus-type-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/insulin-glargine-lixisenatide-hoe901-ave0010-type-2-diabetes-mellitus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/allopurinol-tablet-300-mg-kidney-calculi 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/oxidized-regenerated-cellulose-orc-thyroidectomy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/inc280-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/zealand-pharma-a-s/projects/ropivacaine-pain-postoperative 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/radio-guided-sentinel-node-biopsy-cancer-of-the-breast 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/polyethylene-glycol-peg-acute-kidney-injury 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/pembrolizumab-ovarian-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/peking-university-third-hospital/projects/chlorhexidine-acetate-gargle-esophageal-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/children-s-hospital-of-fudan-university/projects/asparaginase-leukemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/testosterone-enanthate-100-mg-ml-injectable-solu-castration-resistant-prostate-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/human-rotavirus-liquid-vaccine-infections-rotavirus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/zealand-pharma-a-s/projects/panobinostat-rhabdoid-tumor 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/vaksin-merah-putih-ua-sars-cov-2-vero-cell-inact-covid-19-pandemic 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/bi-201335-hepatitis-c-chronic 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/pembrolizumab-carcinoma-non-small-cell-lung 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chinese-university-of-hong-kong/projects/tacrolimus-lupus-nephritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/servier-ireland-industries-ltd/projects/s-55746-chronic-lymphocytic-leukaemia-cll 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/6-hydroxy-ethyl-starch-130-0-4-intensive-care 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/otsuka-novel-products-gmbh/projects/tolvaptan-15mg-or-30mg-or-60mg-or-placebo-healthy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/paclitaxel-carboplatin-lapatinib-erbb2-positive-stage-i-iii-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sun-yat-sen-university/projects/postoperative-antimicrobial-prophylaxis-hepatocellular-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/hyaluronic-acid-shoulder-pain 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/minoxidil-lotion-2-hypotrichosis-of-eyebrows 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/morphine-respiratory-depression 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/pds-implant-with-ranibizumab-100-mg-ml-neovascular-age-related-macular-degeneration 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/peking-university-third-hospital/projects/luveris-infertility 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/gsk-2132231a-melanoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/repigel-acne 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/lei-xiaoming/projects/ropivacaine-cystic-adenomatoid-malformation-of-lung-congenit 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chinese-university-of-hong-kong/projects/methotrexate-rheumatoid-arthritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/warfarin-sodium-indications-for-warfarin-therapy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chinese-university-of-hong-kong/projects/apatinib-mesylate-shr-1210-hepatocellular-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/zhao-weili/projects/car-t-therapy-peripheral-t-cell-lymphoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/5-mg-tadalafil-benign-prostate-hyperplasia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sichuan-provincial-people-s-hospital/projects/radiation-18f-alf-fapi-04-tumor-solid 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/otsuka-novel-products-gmbh/projects/delamanid-tuberculosis-multidrug-resistant 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/argenx/projects/efg-ph20-sc-active-idiopathic-inflammatory-myopathy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/ast-120and-pentoxyphylline-ptx-acute-kidney-injury 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/oxaliplatin-5fu-leucovorin-biliary-cancer-metastatic 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astellas-pharma-europe-bv/projects/tacrolimus-kidney-transplantation 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/pregabalin-and-celecoxib-chronic-low-back-pain-with-a-neuropathic-compone 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals/projects/cyclosporine-or-tacrolimus-graft-rejection 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/obrixtamig-small-cell-lung-cancer-sclc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-healthcare-ag/projects/rivaroxaban-xarelto-bay59-7939-prevention-control 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-ltd/projects/risankizumab-palmoplantar-pustulosis-ppp 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/wuhan-humanwell-innovative-drug-research-and-development-center-limited-company/projects/hw071021-tablets-advanced-solid-tumors 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-ltd/projects/upadacitinib-spondyloarthritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv-eu/projects/rituximab-chronic-lymphocytic-leukemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/cyd-dengue-vaccine-dengue-fever 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-ltd/projects/risankizumab-ulcerative-colitis-uc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shi-yang/projects/atorvastatin-sleep-deprivation 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chinese-university-of-hong-kong/projects/intensive-bp-control-primary-hypertension 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/drotrecogin-alfa-activated-sepsis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/induction-therapy-3-cycles-of-bvc-brentuximab-ve-cd30-peripheral-t-cell-lymphoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/crystalloid-acute-kidney-injury 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/tianjin-hemay-pharmaceutical-co-ltd/projects/hemay020-neoplasms-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shandong-university/projects/msc-type-2-diabetes 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/medimmune/projects/tralokinumab-300-mg-q2w-asthma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shandong-university/projects/placebo-sedation 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/saxagliptin-diabetes 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv-eu/projects/canagliflozin-diabetes-mellitus-type-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/prm-151-zinpentraxin-alfa-idiopathic-pulmonary-fibrosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astellas-pharma-europe-bv/projects/linaclotide-chronic-constipation 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/capecitabine-gastric-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/rop-parkinson-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/everolimus-advanced-net-of-gi-origin 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shanghai-chest-hospital/projects/pd-1inhibitor-esophageal-squamous-cell-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/pembrolizumab-melanoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/anifrolumab-cutaneous-lupus-erythematosus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/hexaxim-diphtheria 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/ly2157299-carcinoma-hepatocellular 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/cetuximab-colorectal-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beigene-ireland-ltd/projects/tislelizumab-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/tezepelumab-asthma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv-eu/projects/jnj-40411813-focal-onset-seizures 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/semuloparin-sodium-venous-thromboembolism 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/aclidinium-bromide-formoterol-fixed-dose-combina-chronic-obstructive-pulmonary-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/minoxidil-lotion-1-eyebrow-hypotrichosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/quadriceps-strength-training-patellofemoral-pain-syndrome 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/insulin-glargine-diabetes-mellitus-type-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/ribociclib-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-healthcare-ag/projects/rivaroxaban-xarelto-bay59-7939-venous-thromboembolism 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/pg102p-uremic-pruritus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/allergan-pharmaceuticals-international-limited/projects/placebo-gastroparesis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/deferasirox-transfusion-dependent-iron-overload 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shionogi-b-v/projects/s-268019-b-sars-cov-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/elan-pharma-international/projects/imiquimod-lentigo-maligna 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/sildenafil-citrate-pulmonary-arterial-hypertension 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/semnur-pharmaceuticals/projects/ixabepilone-capecitabine-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/pregabalin-neuropathy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/pembrolizumab-carcinoma-renal-cell 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/huahui-health/projects/will-receive-hh-009-injection-20-mg-kg-q3w-advanced-or-unresectable-hepatocellular-carcinom 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/linagliptin-low-dose-diabetes-mellitus-type-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/peking-university-third-hospital/projects/glofitamab-mcl 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/hepatitis-b-adjuvanted-vaccine-hepatitis-b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/spesolimab-solution-for-infusion-netherton-syndrome 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/selpercatinib-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/peking-university-third-hospital/projects/ticagrelor-asa-cerebrovascular-accident 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/ss-1-sj-gren-s-syndrome 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-ltd/projects/venetoclax-acute-myeloid-leukemia-aml 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/viiv-healthcare-b-v/projects/bms-955176-hiv-infections 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/rabeprazole-plus-aspirin-versus-rabeprazole-plus-gastric-ulcer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/timmune-biotech/projects/alt-801-obesity 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/live-attenuated-recombinant-dengue-serotypes-1-2-dengue-fever 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/otsuka-novel-products-gmbh/projects/procaterol-asthma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-ltd/projects/upadacitinib-abt-494-ulcerative-colitis-uc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/pembrolizumab-renal-cell-carcinoma-rcc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/rsvpref-respiratory-tract-infection 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/abemaciclib-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/taping-and-sham-taping-stroke 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/entrectinib-solid-tumors 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/evolocumab-severe-familial-hypercholesterolemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/umbilical-cord-serum-eyedrops-recurrent-corneal-erosion 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/samsung-bioepis-nl-b-v/projects/pneumostem-pulmonary-arterial-hypertension-pah 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/baxalta-innovations-gmbh/projects/antihemophilic-factor-recombinant-plasma-albumin-hemophilia-a 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/sigvotatug-vedotin-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hong-kong-baptist-university/projects/ckd-501-0-5mg-diabetes-mellitus-type-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/denosumab-osteoporosis-postmenopausal 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/myovant-sciences-gmbh/projects/relugolix-prostate-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shire-pharmaceutical-contracts-limited/projects/shp615-nervous-system-diseases 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/orforglipron-peripheral-arterial-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-healthcare-ag/projects/rivaroxaban-xarelto-bay59-7939-pulmonary-embolism 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/msc2156119j-solid-tumors 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hong-kong-baptist-university/projects/glargine-exenatide-type-2-diabetes-mellitus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/yung-na/projects/fimasartan-hypertension 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/ff-gw642444-inhalation-powder-pulmonary-disease-chronic-obstructive 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/tozorakimab-viral-lung-infection-and-acute-respiratory-failu 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biotech-pharmaceutical-co/projects/olorofim-invasive-aspergillosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/pembrolizumab-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv-eu/projects/acetaminophen-healthy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shuguang-hospital/projects/entecavir-placebo-liver-cirrhosis-due-to-hepatitis-b-virus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/dong-wang/projects/rivastigmine-patch-alzheimer-s-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-healthcare-ag/projects/finerenone-bay94-8862-chronic-kidney-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-ireland-uc/projects/b-f-taf-hiv-1-infection 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sun-yat-sen-university/projects/pucotenlimab-colorectal-cancer-crc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/lanova-medicines-limited/projects/lm-302-advanced-solid-tumor 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/cetuximab-cisplatin-vinorelbine-non-small-cell-lung-cancer-nsclc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sun-yat-sen-university/projects/surufatinib-serplulimab-albumin-paclitaxel-gemci-locally-advanced-pancreatic-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/zoledronic-acid-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/eplerenone-heart-failure 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/otsuka-novel-products-gmbh/projects/opc-34712-schizophrenia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/recombinant-human-luteinizing-hormone-r-hlh-hypogonadism 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/ketogenic-diet-drug-resistant-epilepsy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/ly4268989-ulcerative-colitis-uc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/omeprazole-plus-amoxicillin-duodenal-ulcer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biotech-pharmaceutical-co/projects/chidamide-hepatocellular-carcinoma-hcc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-ireland-uc/projects/sacituzumab-govitecan-hziy-triple-negative-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/tobira-therapeutics/projects/placebo-nonalcoholic-steatohepatitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/taiwan-liposome-company/projects/magnesium-citrate-cognitive-function 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/otsuka-novel-products-gmbh/projects/sibeprenlimab-400-mg-s-c-q4weeks-immunoglobulin-a-nephropathy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sun-yat-sen-memorial-hospital-of-sun-yat-sen-university/projects/carrellizumab-capecitabine-breast-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/ly4006896-parkinson-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/aslan001-advanced-metastatic-hepatocellular-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ferring-pharmaceuticals-a-s/projects/budesonide-healthy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/purified-vero-rabies-vaccine-serum-free-vrvg-rabies 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sun-yat-sen-university/projects/palliative-chemotherapy-colorectal-neoplasms-malignant 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/autologous-peripheral-blood-stem-cell-injection-acute-myocardial-infarction 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/csl-behring-gmbh/projects/clazakizumab-antibody-mediated-rejection 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beijing-zhifei-lvzhu-biopharmaceutical-co-ltd/projects/biottt001-injection-locally-advanced-breast-cancer-labc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/henan-university-of-traditional-chinese-medicine/projects/bufei-yishen-granule-chronic-obstructive-pulmonary-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/atezolizumab-carcinoma-hepatocellular 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/abemaciclib-metastatic-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-healthcare-ag/projects/bay94-9027-hemophilia-a 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/lde225-0-75-sporadic-superficial-and-nodular-skin-basal-cell 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/levodopa-250mg-and-carbidopa-25mg-test-drug-tabl-bioequivalence 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/repatha/projects/ivacflu-influenza 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shandong-provincial-hospital/projects/mononuclear-cells-chronic-atrophic-gastritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shionogi-b-v/projects/cefiderocol-gram-negative-bacterial-infections 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/zealand-pharma-a-s/projects/target-protocol-en-1-5-kcal-ml-critical-illness 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/serono-europe-limited/projects/m9140-solid-tumors 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/ly3454738-atopic-dermatitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/atezolizumab-carcinoma-non-small-cell-lung 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/nilotinib-followed-by-treatment-free-chronic-myelogenous-leukemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/abbreviated-non-contrast-mri-of-the-liver-hepatocellular-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/seqirus-s-r-l/projects/h5n1-antigen-combined-with-mf59-adjuvant-influenza-human 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/valneva-austria-gmbh/projects/ixiaro-japanese-encephalitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/samsung-bioepis-nl-b-v/projects/pohim-rt-cervix-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/qingdao-university/projects/hs-it101-injection-solid-tumor 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv-eu/projects/apalutamide-salivary-gland-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/cs-3150-hypertension 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biotech-pharmaceutical-co/projects/lactobacillus-rhamnosus-f-1-allergic-rhinitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/pf-05190457-diabetes-mellitus-type-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/erlotinib-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/warfarin-atrial-fibrillation 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/trastuzumab-deruxtecan-breast-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pharma-eeig-eu/projects/enoxaparin-deep-vein-thrombosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/inca33890-solid-tumors 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/southern-xp-pty-ltd/projects/car-t-multiple-myeloma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/ceralasertib-advanced-solid-malignancies 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/zhongnan-hospital/projects/hydrochloride-anlotinib-uterine-cervical-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chiesi-farmaceutici-s-p-a/projects/experimental-chf6001-3200-g-uncontrolled-asthma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/pf-03446962-carcinoma-hepatocellular 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/duke-university/projects/liposomal-amphotericin-b-lamb-talaromycosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/the-university-of-hong-kong/projects/alcohol-injection-malignancy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/gefitinib-non-small-cell-lung-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/duloxetine-hydrochloride-diabetic-neuropathies 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/alirocumab-hypercholesterolemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/xinhua-hospital-shanghai-jiao-tong-university-school-of-medicine/projects/tianqi-pingchan-granule-levodopa-induced-dyskinesia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/international-peace-maternity-and-child-health-hospital/projects/typhoid-vi-vaccine-typhoid 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chinese-university-of-hong-kong/projects/rc48-adc-muscle-invasive-bladder-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/pf-06438179-rheumatoid-arthritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/remicade-anti-tumor-necrosis-factor-inhibitor-takayasu-s-arteritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-healthcare-ag/projects/ev-dng-qlaira-bay86-5027-oral-contraceptive 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/pemetrexed-head-and-neck-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pharma-eeig-eu/projects/cc-122-non-hodgkin-lymphoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/budesonide-formoterol-turbuhaler-asthma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/atosiban-repeated-implantation-failure 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/metformin-diabetes-mellitus-type-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ascendis-pharma-endocrinology-division-a-s/projects/once-weekly-subcutaneous-injection-of-transcon-h-growth-hormone-deficiency-pediatric 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hong-kong-baptist-university/projects/anvitra-gastric-suspension-gerd-heartburn-regurgitation-and-dyspepsia-frequ 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/gsk4527226-alzheimer-s-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/sarilumab-sar153191-regn88-rheumatoid-arthritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/flublok-quadrivalent-vaccine-influenza-vaccination 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/gsk1070806-dermatitis-atopic 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hui-sheng-chen/projects/intra-arterial-administration-of-neuroprotective-ischemic-stroke 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/sodium-zirconium-cyclosilicate-zs-hyperkalemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/docetaxel-nasopharyngeal-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/benralizumab-chronic-obstructive-pulmonary-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/placebo-plus-docetaxel-carcinoma-non-small-cell-lung 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/methoxy-polyethylene-glycol-epoetin-beta-mircera-anemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/fexofenadine-hcl-m016455-rhinitis-seasonal 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beigene-ireland-ltd/projects/sitravatinib-carcinoma-hepatocellular 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/guangzhou-general-hospital-of-guangzhou-military-command/projects/0-33-ropivacaine-250ml-pain 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/daoib-long-covid 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/teplizumab-type-1-diabetes-mellitus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chinese-university-of-hong-kong/projects/physiotherapy-knee-arthropathy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pharma-eeig-eu/projects/nivolumab-neoplasms-by-site 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/placebo-hypertension-in-pregnancy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/dabigatran-etexilate-venous-thromboembolism 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/second-affiliated-hospital-of-soochow-university/projects/cadonilimab-immunotherapy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/baxalta-innovations-gmbh/projects/bax855-hemophilia-a 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eisai-gmbh/projects/e6007-healthy-volunteers 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/mencevax-acwy-infections-meningococcal 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/meningococcal-vaccine-gsk134612-infections-meningococcal 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chinese-university-of-hong-kong/projects/fludrocortisone-100-mcg-daily-sepsis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/alvimopan-constipation 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/dexmedetomidine-hcl-100-mcg-ml-inj-congenital-heart-disease-in-children 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astellas-pharma-europe-bv/projects/ym060-diarrhea-predominant-irritable-bowel-syndrome 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-ltd/projects/abbv-552-alzheimer-s-disease-ad 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/group-c-saline-propofol-group-urologic-surgery 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/decitabine-homoharringtonine-aclarubicin-cytarab-acute-myeloid-leukemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/affiliated-hospital-of-jiangnan-university/projects/recombinant-human-growth-hormone-phelan-mcdermid-syndrome 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astellas-pharma-europe-bv/projects/ramosetron-irritable-bowel-syndrome 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/amlodipine-besylate-atorvastatin-calcium-single-hypertension 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/vemurafenib-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/peking-university-people-s-hospital/projects/tofacitinib-primary-sj-gren-s-syndrome 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/xiangya-hospital-of-central-south-university/projects/neoadjuvant-chemotherapy-high-grade-upper-tract-urothelial-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/5-fluoruracil-gastric-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/pregabalin-partial-seizures 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/taxane-gastric-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/the-university-of-hong-kong/projects/tiv-2010-2011-influenza-vaccine-influenza 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/cediranib-colorectal-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/oral-microbiota-dry-eye-syndrome 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/allergan-pharmaceuticals-international-limited/projects/agn-211745-choroid-neovascularization 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/kyowa-kirin-holdings-b-v/projects/khk6640-alzheimer-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biotech-pharmaceutical-co/projects/walvax-pcv13-tt-pneumococcal-disease-invasive 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hong-kong-baptist-university/projects/trans-resveratrol-eye-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beijing-anzhen-hospital/projects/corticosteroid-heart-valve-diseases 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/sacituzumab-tirumotecan-non-small-cell-lung-cancer-nsclc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/dtpw-hbv-hib-menac-conjugate-vaccine-diphtheria 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/sar440340-chronic-obstructive-pulmonary-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/samsung-bioepis-nl-b-v/projects/rebamipide-2-ophthalmic-solution-dry-eye-disease-ded 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cipla-eu-limited/projects/cbt124-healthy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/pembrolizumab-vibostolimab-lung-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/seqirus-s-r-l/projects/mf59-adjuvanted-quadrivalent-subunit-inactivated-influenza 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/otsuka-novel-products-gmbh/projects/diabecell-r-type-1-diabetes 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv-eu/projects/jnj-53718678-respiratory-syncytial-virus-infections 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/vitamin-d3-major-depression 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/akeso/projects/ak120-or-placebo-part-1-cohort-1-atopic-dermatitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/sb497115-thrombocytopaenia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-mesto/projects/nnc0487-0111-obesity 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/pemetrexed-500mg-m2-iv-nsclc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/baxdrostat-primary-hyperaldosteronism 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ferring-pharmaceuticals-a-s/projects/fe-999913-vaginal-tablet-luteal-hormone-supplementation 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/h-lundbeck-a-s/projects/lu-af28996-parkinson-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/ro5503781-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/dextrose-5-end-stage-kidney-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/inc280-single-agent-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eurogen-pharmaceuticals-ltd/projects/stem-cell-neurological-disorder-nervous-system 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/pf-06651600-induction-dose-alopecia-areata 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/suzhou-zelgen-biopharmaceuticals-co-ltd/projects/alkotinib-capsules-alk-positive-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/alendronate-non-traumatic-osteonecrosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/terbutaline-nonreassuring-fetal-status 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/rimonabant-obesity 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cansino-biologics/projects/tuberculosis-tb-vaccine-ad5-105k-tuberculosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eisai-gmbh/projects/tazemetostat-relapsed-or-refractory-b-cell-non-hodgkin-s-lymp 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/unilever-australia-limited/projects/brahmi-cognition 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/tozorakimab-asthma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/akeso/projects/ak104-advanced-malignant-tumors 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/eltrekibart-ulcerative-colitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/vemurafenib-malignant-melanoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/lapatinib-neoplasms-breast 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/inclisiran-familial-hypercholesterolemia-heterozygous 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ipsen-pharma/projects/odevixibat-biliary-atresia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/pf-03715455-healthy-volunteers 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/metformin-type-2-diabetes 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/suzhou-ribo-life-science-co/projects/utaa91-injection-rheumatoid-arthritis-ra 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/precision-cells-precision-cell-immunotherapy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/mlc901-alzheimer-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/warfarin-thromboembolism 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/gsk3196165-dose-1-arthritis-rheumatoid 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biotech-pharmaceutical-co/projects/faceptor-breast-cancer-metastatic 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/samsung-bioepis-nl-b-v/projects/docetaxel-sunitinib-advanced-gastric-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/osteosheet-r-orbital-trauma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/japanese-encephalitis-vaccine-japanese-encephalitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shanghai-university-of-traditional-chinese-medicine/projects/9mw3811-injection-pulmonary-fibrosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hong-kong-baptist-university/projects/prospan-cough-syrup-cough-severity 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beijing-luhe-hospital/projects/evolocumab-stemi 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/tranexamic-acid-100mg-ml-inj-vil-10ml-rotator-cuff-tears 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/erlotinib-pancreatic-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shanghai-zhongshan-hospital/projects/norepinephrine-gastrointestinal-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/olaparib-300mg-tablets-relapsed-ovarian-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/placebo-diabetes-mellitus-type-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/intercerebral-implantation-of-allogenic-cd34-ste-ischemic-stroke 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/piramal-critical-care-b-v/projects/p276-00-melanoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/durvalumab-advanced-hepatocellular-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/insulin-glulisine-diabetes-mellitus-type-1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/atorvastatin-vitiligo 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/cordyceps-cicadae-extract-myopia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pharma-eeig-eu/projects/bms-986500-advanced-solid-tumor 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/uk-453-061-dose-1-hiv-1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beijing-zhifei-lvzhu-biopharmaceutical-co-ltd/projects/yn001-cardiovascular-diseases 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-ireland-uc/projects/sof-vel-vox-hepatitis-c-virus-infection 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chinese-university-of-hong-kong/projects/tissue-plasminogen-activator-pleural-infection 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biogen-idec-ltd/projects/bardoxolone-methyl-pulmonary-hypertension 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/genmab-a-s/projects/pembrolizumab-advanced-endometrial-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/tezepelumab-chronic-obstructive-pulmonary-disease-copd 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/her3-dxd-non-small-cell-lung-cancer-nsclc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/jiangsu-province-centers-for-disease-control-and-prevention/projects/two-doses-of-middle-dose-recombinant-sars-cov-2-covid-19 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-healthcare-ag/projects/bay1002670-leiomyoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/centocor-b-v/projects/placebo-injections-rheumatoid-arthritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/vitamin-d3-overweight-and-obesity 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/symbicort-turbuhaler-budesonide-formoterol-320-9-chronic-obstructive-pulmonary-disease-copd 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbott-s-r-l/projects/nutritional-supplement-children 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/docetaxel-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/ain457-non-infectious-uveitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv-eu/projects/nipocalimab-sjogrens-syndrome 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/tremelimumab-hepatocellular-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/biological-pd-1-advanced-solid-tumor 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/sar441566-crohn-s-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biotech-pharmaceutical-co/projects/pi-88-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/tenecteplase-ischemic-stroke 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/combination-group-cardiac-arrest 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beijing-tiantan-hospital/projects/rt-pa-acute-ischemic-stroke 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/dipharma-arzneimittel-gmbh/projects/hmpl-306-acute-myeloid-leukemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/samsung-bioepis-nl-b-v/projects/carfilzomib-56-mg-kyprolis-multiple-myeloma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/allergan-pharmaceuticals-international-limited/projects/botulinum-toxin-type-a-pediatrics 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/lapatinib-neoplasms-head-and-neck 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/vildagliptin-diabetes-mellitus-type-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/balcinrenone-dapagliflozin-15-mg-10-mg-and-match-heart-failure-and-impaired-kidney-function 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/conbercept-polypoidal-choroidal-vasculopathy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/anhui-hemay-pharmaceutical-co-ltd/projects/hemay005-tablet-chronic-obstructive-pulmonary-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/the-university-of-hong-kong/projects/propofol-anesthesia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/bupivacaine-pain 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/eefooton-oral-solution-chronic-kidney-diseases 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/lgh447-relapsed-and-refractory-multiple-myeloma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/tiotropium-bromide-asthma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/pf-04937319-healthy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/serono-europe-limited/projects/xevinapant-debio-1143-squamous-cell-carcinoma-of-the-head-and-neck 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/umbilical-cord-blood-infusion-cerebral-palsy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/drugs-administration-rotator-cuff-tears-of-the-shoulder 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/moderna-biotech-spain/projects/mrna-1010-seasonal-influenza 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/ly3493269-healthy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals/projects/tigecycline-community-acquired-infections 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/vildagliptin-type-2-diabetes-mellitus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/samsung-bioepis-nl-b-v/projects/intermittent-hepatic-inflow-occlusion-ihio-end-stage-liver-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/placebo-colorectal-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/qmf149-asthma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/mtl-cebpa-advanced-hepatocellular-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/remibrutinib-chronic-spontaneous-urticaria 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/samsung-bioepis-nl-b-v/projects/evogliptin-type2-diabetes-mellitus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/jian-li/projects/hs-10345-84mg-treatment-resistant-depressive-disorder 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/silodosin-premature-ejaculation 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/jian-li/projects/part1-recombinant-two-component-covid-19-vaccine-covid-19 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/rilotumumab-gastric-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharmaand-gmbh/projects/rucaparib-ovarian-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/faricimab-diabetic-macular-edema 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/tislelizumab-pancreatic-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/pantoprazole-pantoloc-peptic-ulcers 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/doxorubicine-docetaxel-sequential-breast-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/prednisolone-pulmonary-disease-chronic-obstructive 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/pioglitazone-diabetes-mellitus-type-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/jemincare/projects/jmkx000623-diabetic-peripheral-neuropathic-pain 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/zilovertamab-vedotin-diffuse-large-b-cell-lymphoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/pembrolizumab-k-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/capmatinib-carcinoma-non-small-cell-lung 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/cetuximab-metastatic-colorectal-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chongqing-claruvis-pharmaceutical-co/projects/metronomic-adjuvant-chemotherapy-with-capecitabi-nasopharyngeal-cancinoma-npc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fresenius-kabi-deutschland-gmbh/projects/msb11456-healthy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/bi-764198-proteinuric-kidney-diseases 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/atezolizumab-mpdl3280a-an-engineered-anti-pd-l1-carcinoma-non-small-cell-lung 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/tarlatamab-extensive-stage-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hua-medicine-limited/projects/hms5552-type-ii-diabetes-mellitus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/patupilone-hepatocellular-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ista-pharma-limited/projects/kvd900-150-mg-hereditary-angioedema 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/yang-xiaotian/projects/blood-test-cancer-of-colon 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/mitsubishi-tanabe-pharma-gmbh/projects/mci-186-renal-impairment 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cyclosporine-reduced-exposure-everolimus-kidney-transplantation 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/bi-905711-gastrointestinal-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chinese-university-of-hong-kong/projects/western-therapy-hand-foot-and-mouth-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/infanrix-hexa-poliomyelitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/otsuka-novel-products-gmbh/projects/delamanid-multidrug-resistant-tuberculosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/sacituzumab-tirumotecan-breast-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celgene-europe-limited/projects/pomalidomide-multiple-myeloma-in-relapse 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-mesto/projects/semaglutide-diabetes 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/druid-ai-program-solid-organ-malignancies 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/sarcosine-and-d-serine-schizophrenias 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/fluvirin-tivf-influenza 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/eltrombopag-thrombocytopaenia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-healthcare-ag/projects/asundexian-bay2433334-prevention-of-ischemic-stroke 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hong-kong-baptist-university/projects/zl-1102-1-w-w-gel-bid-for-16-weeks-plaque-psoriasis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbott-s-r-l/projects/zemplar-paricalcitol-capsules-diabetic-nephropathy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/argenx/projects/efgartigimod-ph20-sc-bullous-pemphigoid 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/mitsubishi-tanabe-pharma-gmbh/projects/mt-1186-healthy-adult-subjects 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-healthcare-ag/projects/bay-59-7939-pulmonary-embolism 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/rimegepant-migraine 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/raltegravir-human-immunodeficiency-virus-hiv-infection 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/affiliated-hospital-of-nantong-university/projects/oral-zonisamide-therapy-epilepsies-partial 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/medtronic-biopharma-b-v/projects/coronary-artery-stenting-coronary-artery-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/insulin-peglispro-healthy-volunteers 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/advanced-accelerator-applications/projects/vodobatinib-k0706-capsules-healthy-for-part-a 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sun-yat-sen-university/projects/chidamide-peripheral-t-cell-lymphoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/erlotinib-tarceva-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/medi-546-systemic-lupus-erythematosus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/shanchol-oral-cholera-vaccine-killed-bivalent-o1-cholera 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/jian-li/projects/shr1459-tablet-b-cell-tumors 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/areg-trigger-pcos 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shine-europe-b-v/projects/tqb2101-for-injection-advanced-hematologic-malignancies 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/dabrafenib-solid-tumours 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/second-xiangya-hospital-of-central-south-university/projects/rivaroxaban-2-5-mg-acute-coronary-syndrome 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/guerbet/projects/gadoxetate-disodium-motor-function 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/atm-avi-serious-bacterial-infection 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/solabegron-overactive-bladder 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/enteric-coated-sevelamer-hypercholesterolemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/second-affiliated-hospital-of-soochow-university/projects/ipilimumab-pembrolizumab-or-ipilimumab-durvaluma-liver-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-mesto/projects/nonacog-beta-pegol-congenital-bleeding-disorder 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beigene-ireland-ltd/projects/tislelizumab-recurrent-or-metastatic-nasopharyngeal-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pharma-eeig-eu/projects/karxt-bipolar-disorder-type-i-with-mania 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/cannabidiol-oil-dementia-vascular 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chinese-university-of-hong-kong/projects/apatinib-head-and-neck-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/forward-pharmaceuticals-co/projects/fwd1802-metastatic-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biotech-pharmaceutical-co/projects/placebo-hemophilic-arthropathy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/peking-university-third-hospital/projects/combination-of-targeted-biopsy-and-systematic-bi-prostate-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/tirzepatide-healthy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/volasertib-low-dose-d1q3w-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/dapagliflozin-diabetes-mellitus-type-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chia-tai-tianqing-pharmaceutical-group-nanjing-shunxin-pharmaceutical-co/projects/lidocaine-spray-uterine-cervical-dysplasia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/international-peace-maternity-and-child-health-hospital/projects/olokizumab-rheumatoid-arthritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/bmmncs-retinitis-pigmentosa 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gritgen-therapeutics-co/projects/gs1191-0445-injection-hemophilia-a 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/tarlatamab-relapsed-refractory-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/immunocore-ireland-limited/projects/imc-i109v-single-ascending-dose-hepatitis-b-chronic 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-mesto/projects/ziltivekimab-heart-failure 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/mycophenolate-mofetil-cellcept-myasthenia-gravis-generalized 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/repatha/projects/primaquine-malaria-vivax 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/atezolizumab-advanced-ovarian-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-ireland-uc/projects/sofosbuvir-hepatitis-c 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/lamotrigine-300-mg-day-epilepsy-partial 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/tacrolimus-graft-vs-host-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/caz-avi-complicated-intra-abdominal-infection 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/fixed-dose-combination-of-telmisartan-amlodipine-hypertension 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/thor-707-metastasis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/otsuka-novel-products-gmbh/projects/aripiprazole-bipolar-i 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/xuanwu-hospital-beijing/projects/dimethyl-fumarate-intracerebral-hemorrhage 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/tocilizumab-roactemra-actemra-rheumatoid-arthritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/yongchang-zhang/projects/toripalimab-advanced-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/telmisartan-hypertension 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/gsk-biologicals-investigational-vaccine-gsk23402-influenza 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shanghai-university-of-traditional-chinese-medicine/projects/cis-platinum-carboplatin-pemetrexed-disodium-chemotherapy-adjuvant 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/rivastigmine-transdermal-patch-alzheimer-s-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/peking-university-third-hospital/projects/triptolide-wilfordii-hiv-infection-aids 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/pcv21-pneumococcal-infections 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/arena-pharmaceutical-enterprises-limited/projects/etrasimod-ulcerative-colitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/combination-cinacalcet-with-vitamin-d-analogue-secondary-hyperparathyroidism 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/seasonal-flu-vaccine-seasonal-influenza 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/dexamethasone-relapsed-multiple-myeloma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/edotecarin-glioblastoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beigene-ireland-ltd/projects/bgb-dxp593-covid19 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/medimmune/projects/caiv-t-influenza 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biotech-pharmaceutical-co/projects/2wipv-1sipv-poliomyelitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-healthcare-ag/projects/gadopentetate-dimeglumine-magnevist-bay86-4882-s-magnetic-resonance-angiography 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/second-hospital-of-jilin-university/projects/hydromorphone-combined-with-ropivacaine-inguinal-hernia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eisai-gmbh/projects/e7090-cholangiocarcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/secukinumab-ankylosing-spondylitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/pemebit-adenocarcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/otsuka-novel-products-gmbh/projects/100-mg-delamanid-multidrug-resistant-tuberculosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/progesterone-supplementation-assisted-reproductive-technology 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vera-therapeutics/projects/remifentanil-postoperative-pain 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/one-percent-ultrasound-power-in-cmics-cataract 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/ofatumumab-relapsing-multiple-sclerosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/ly3819469-healthy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/immunocore-ireland-limited/projects/imc-r117c-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/samsung-bioepis-nl-b-v/projects/lidocaine-iv-colorectal-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/ianalumab-s-c-q4w-lupus-nephritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/intravenous-methylene-blue-administration-severe-sepsis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/juventas-cell-therapy/projects/cnct19-cell-injection-neurological-autoimmune-diseases 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-mesto/projects/oral-semaglutide-diabetes-mellitus-type-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/centus-biotherapeutics-europe-limited/projects/fkb238-bevacizumab-carcinoma-non-small-cell-lung 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/medical-treatment-alone-intracranial-arteriosclerosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/nanjing-children-s-hospital/projects/prednisone-henoch-schoenlein-purpura-nephritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/xijing-hospital/projects/18f-p3bza-melanoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/otsuka-novel-products-gmbh/projects/escitalopram-major-depressive-disorder-mdd 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/pdr001-colorectal-cancer-non-small-cell-lung-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/peking-university-third-hospital/projects/roxadustat-coronary-artery-bypass 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/dong-wang/projects/da-5210-10-500mg-healthy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/yung-na/projects/bri-1501-gastric-ulcer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/bi-10773-diabetes-mellitus-type-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/infanrix-ipv-hib-acellular-pertussis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/dong-wang/projects/aricept-5mg-tablet-healthy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astellas-pharma-europe-bv/projects/ym150-thromboembolism 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/extraluminal-use-of-univent-bronchial-blocker-therapeutic-procedural-complication 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shenzhen-second-people-s-hospital/projects/immunomodulatory-dc-vaccines-to-target-prostate-prostate-cancer-indications 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/cytarabine-leukemia-myeloid-acute 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/docetaxel-and-ketoconazole-metastatic-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-mesto/projects/turoctocog-alfa-pegol-congenital-bleeding-disorder 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/meningococcal-polysaccharide-serogroups-a-c-y-an-meningococcal-immunization 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hong-kong-baptist-university/projects/a-master-ganoderma-detox-tea-eczema 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cstone-pharmaceuticals-ireland-limited/projects/cs1001-advanced-refractory-solid-tumors 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bevacizumab-avastin-liver-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/ranibizumab-neovascular-age-related-macular-degeneration-nam 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/reproductive-genetic-hospital-of-citic-xiangya/projects/follitropin-beta-msd-infertility 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/peg-ifn-alfa-2a-hepatitis-c-chronic 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/green-valley-shanghai-pharmaceuticals-co/projects/gc1107-bacterial-infections 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/magnesium-sulfate-myoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/moxifloxacin-chronic-bronchitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/entrectinib-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/secukinumab-75-mg-psoriatic-arthritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/samsung-bioepis-nl-b-v/projects/vistusertib-azd2014-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ono-pharmaceutical-co/projects/nivolumab-gastric-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shanghai-university-of-traditional-chinese-medicine/projects/sct-001-car-t-cells-ovarian-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/sarilumab-rheumatoid-arthritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/kyowa-kirin-holdings-b-v/projects/khk7580-hyperparathyroidism 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biotech-pharmaceutical-co/projects/neomycin-dexameythasone-xylometazoline-rhinosinusitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/zavegepant-migraine 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/epoetin-beta-neorecormon-anemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alexion-europe-sas/projects/alxn1850-hypophosphatasia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/bupivacain-arthroplasty-replacement-knee 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/miyarisan-bm-clostridium-butyricum-miyairi-clostridium-butyricum-miyairi 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/eyu688-dengue 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals/projects/double-blind-investigational-anti-arrhythmic-arrhythmias 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/otsuka-novel-products-gmbh/projects/aripiprazole-schizophrenia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/the-university-of-hong-kong/projects/indocyanine-green-anastomotic-leak 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/suzhou-ribo-life-science-co/projects/dose-escalation-of-sa030-obese 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/carfilzomib-multiple-myeloma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pharma-eeig-eu/projects/bms-986504-solid-tumors 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/3-minoxidil-lotion-beard-enhancement 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/arena-pharmaceutical-enterprises-limited/projects/apd334-primary-biliary-cholangitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/maraviroc-arthritis-rheumatoid 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chia-tai-tianqing-pharmaceutical-group-nanjing-shunxin-pharmaceutical-co/projects/aescin-in-horse-chestnut-anorectal-disorder 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bendamustine-chronic-lymphocytic-leukemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chinese-university-of-hong-kong/projects/mesalazine-colitis-ulcerative 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/paclitaxel-ovarian-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/qilu-pharma-spain-s-l/projects/qls1128-a-dose-1-5-and-ritonavir-covid-19 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sun-yat-sen-memorial-hospital-of-sun-yat-sen-university/projects/pregabalin-neuropathic-pain 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/fluticasone-furoate-vilanterol-pulmonary-disease-chronic-obstructive 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/lnp023-primary-iga-nephropathy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/the-university-of-hong-kong/projects/ping-on-ointment-temporomandibular-disorders 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/the-university-of-hong-kong/projects/dexmedetomidine-anxiety-separation 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/tiotropium-pulmonary-disease-chronic-obstructive 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shanghai-university-of-traditional-chinese-medicine/projects/jwcar029-cd19-targeted-chimeric-antigen-receptor-diffuse-large-b-cell-lymphoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/propofol-renal-cell-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shanghai-university-of-traditional-chinese-medicine/projects/tqh2722-injection-seasonal-allergic-rhinitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/ceftazidime-avibactam-complicated-intra-abdominal-infection 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/the-university-of-hong-kong/projects/nrt-s-smoking-cessation 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/pembrolizumab-gastric-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/peking-university-third-hospital/projects/dexmedetomidine-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/fulvestrant-metastatic-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/stemline-therapeutics-b-v/projects/tagraxofusp-acute-myeloid-leukemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/pbscs-hematological-malignancies 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shine-europe-b-v/projects/camrelizumab-plus-apatinib-unresectable-hepatocellular-carcinoma-hcc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/gsk1605786a-crohn-s-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shanghai-university-of-traditional-chinese-medicine/projects/ak0529-respiratory-syncytial-virus-infections 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/yung-na/projects/gemcitabine-muscle-invasive-bladder-urothelial-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/lmf237-50-250-mg-diabetes-mellitus-type-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-ltd/projects/adalimumab-psoriatic-arthritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/jian-li/projects/apl-1202-and-apl-1501-single-ascending-dose-bladder-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/raludotatug-deruxtecan-r-dxd-gastrointestinal-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bavarian-nordic-a-s/projects/chikv-vlp-vaccine-chikungunya-virus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eisai-gmbh/projects/folfiri-colon-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/peking-university-people-s-hospital/projects/furmonertinib-adenocarcinoma-of-lung 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/chlorhexidine-gluconate-liver-tumors 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/osimertinib-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/qaw039-150-mg-asthma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/tipranavir-hiv-infections 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chia-tai-tianqing-pharmaceutical-group-nanjing-shunxin-pharmaceutical-co/projects/dexamethasone-localized-primary-osteoarthritis-of-both-hips-di 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/placebo-stomach-neoplasm 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/international-peace-maternity-and-child-health-hospital/projects/letrozole-letrozole 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/ticagrelor-acute-coronary-syndrome 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/jian-li/projects/shr-1501-advanced-malignancies 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astellas-pharma-europe-bv/projects/tacrolimus-bone-marrow-transplantation 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/nk-cells-hepatocellular-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv-eu/projects/tmc207-tuberculosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/children-s-hospital-of-fudan-university/projects/doxorubicin-hydrochloride-adult-alveolar-soft-part-sarcoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/gw685698-gw642444-asthma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/satralizumab-neuromyelitis-optica-nmo 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-mesto/projects/rosiglitazone-diabetes 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/gepotidacin-urinary-tract-infections 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/cart-infusion-b-cell-lymphoma-refractory 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/bortezomib-multiple-myeloma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/spesolimab-psoriasis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-healthcare-ag/projects/tedizolid-bay119-2631-bacterial-infections 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/msc-and-prp-type-1-diabetes-mellitus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/tiotropium-18-mcg-pulmonary-disease-chronic-obstructive 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratoire-hra-pharma/projects/coagulation-factor-viia-recombinant-hemophilia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/midazolam-hepatitis-b-chronic 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/azd3514-prostate-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/atezolizumab-mpdl3280a-an-engineered-anti-pd-l1-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/ldk378-anaplastic-lymphoma-kinase-alk 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biotech-pharmaceutical-co/projects/lbt-3627-parkinson-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/olmesartan-alone-or-in-combination-with-hydrochl-essential-hypertension 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/jian-li/projects/basic-treatment-major-depressive-disorder 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/otsuka-novel-products-gmbh/projects/cilostazol-cerebral-infarction 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/oral-immunonutrition-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/onartuzumab-carcinoma-hepatocellular 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beigene-ireland-ltd/projects/bgb-3111-waldenstr-m-s-macroglobulinemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shiyou-wei/projects/dexmedetomidine-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/group-s-sugammadex-injection-head-and-neck-surgery 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/intravenous-thrombolysis-plus-tirofiban-acute-ischemic-stroke 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alexion-europe-sas/projects/eculizumab-neuromyelitis-optica 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/gsk5533524-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/the-university-of-hong-kong/projects/dapagliflozin-5-10-mg-daily-sglt2-inhibitor-ther-fontan 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/treatment-a-healthy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/zhongnan-hospital/projects/68ga-pentixafor-cxcr4 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sandoz-pharmaceuticals-d-d/projects/gme751-melanoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur-europe/projects/rilzabrutinib-immune-thrombocytopenia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beigene-ireland-ltd/projects/zanubrutinib-b-cell-malignancies 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/vitamin-d3-lupus-erythematosus-systemic 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/taiwan-liposome-company/projects/ga68-dolacga-injection-safety-issues 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/chidamide-aml 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-healthcare-ag/projects/copanlisib-aliqopa-bay80-6946-lymphoma-non-hodgkin 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/tiotropium-olodaterol-pulmonary-disease-chronic-obstructive 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/ferrous-fumarate-oral-tablet-iron-deficiency-anemia-treatment 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/children-s-hospital-of-fudan-university/projects/filgrastim-neuroblastoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/link-medical-products-pty-ltd/projects/bl0020-small-cell-carcinoma-of-lung 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/allergan-pharmaceuticals-international-limited/projects/brimo-ps-dds-patients-who-participated-in-an-intravitreal-bri 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/the-university-of-hong-kong/projects/exforge-hct-or-three-individual-drug-amlodipine-intracerebral-hemorrhage 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/jian-li/projects/ad5-ebov-ebola-virus-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/pembrolizumab-berahyaluronidase-alfa-squamous-cell-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/placebo-mad-healthy-volunteer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/nabriva-therapeutics-ireland-dac/projects/lefamulin-community-acquired-pneumonia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/azd0530-solid-tumor 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/anhui-hemay-pharmaceutical-co-ltd/projects/purified-protein-derivative-of-bcg-bcg-ppd-tuberculosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/tafenoquine-malaria-vivax 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chinese-university-of-hong-kong/projects/iparomlimab-tuvonralimab-locally-advanced-cervical-cancers 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/advate-low-dose-hemophilia-a 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chinese-university-of-hong-kong/projects/chinese-medicine-oral-rinse-formula-i-cmorf-i-head-and-neck-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-mesto/projects/insulin-degludec-insulin-aspart-diabetes 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/dong-wang/projects/telmisartan-amlodipine-hypertension-with-hyperlipidemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/ofc-infusion-leukaemia-lymphocytic-chronic 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/akeso/projects/ak112-cadonilimab-nab-paclitaxel-gemcitabine-metastatic-pancreatic-ductal-adenocarcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/nktr-118-opioid-induced-constipation 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/serono-europe-limited/projects/placebo-systemic-lupus-erythematosus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/p38-inhibitor-4-150mg-rheumatoid-arthritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-healthcare-ag/projects/finerenone-bay94-8862-heart-failure 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-mesto/projects/liraglutide-metabolism-and-nutrition-disorder 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/tiotropium-5mcg-day-asthma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/acetaminophen-elbow-fracture 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv-eu/projects/ustekinumab-dose-based-on-bsa-and-body-weight-colitis-ulcerative 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/gsk962040-50-mg-gastroparesis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/fixed-dose-combination-of-pertuzumab-and-trastuz-early-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shire-pharmaceutical-contracts-limited/projects/velaglucerase-alfa-gaucher-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vigonvita-life-sciences/projects/vv261-5mg-group-healthy-volunteers 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/selinexor-acute-myeloid-leukemia-adult 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/elan-pharma-international/projects/tmc435-hepatitis-c 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/vemlidy-chronic-hepatitis-b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/samsung-bioepis-nl-b-v/projects/azd9291-non-small-cell-lung-cancer-with-egfr-t790m-mutat 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/indacaterol-qab149-healthy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/gsk3196165-otilimab-arthritis-rheumatoid 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/snubh-nm-333-18f-alzheimer-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/gsk256066-asthma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/children-s-hospital-of-fudan-university/projects/cisplatin-localized-osteosarcoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/gsk221149a-obstetric-labour-premature 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/gsk2879552-leukaemia-myelocytic-acute 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/the-university-of-hong-kong/projects/3-second-sdf-application-early-childhood-caries 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/5-fluorouracil-cancer-advanced-stage 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pharma-eeig-eu/projects/nktr-214-melanoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beigene-ireland-ltd/projects/pamiparib-capsule-ovarian-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/azd1222-covid-19-sars-cov-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/forsteo-spine-deformity 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-mesto/projects/somapacitan-growth-hormone-deficiency-in-children 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/fluticasone-propionate-asthma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/pegylated-interferon-alfa-2a-chronic-myelogenous-leukemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ferring-pharmaceuticals-a-s/projects/fe-999326-bladder-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/yung-na/projects/fimasartan-essential-hypertension 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-mesto/projects/nnc0480-0389-healthy-volunteers-type-2-diabetes 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/lc-1000-coronary-artery-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/oral-dexamethasone-bronchiolitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/sar447537-alpha-1-antitrypsin-deficiency 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celgene-europe-limited/projects/cc-486-leukemia-myeloid-acute 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/nordic-group-b-v/projects/smc021-oral-calcitonin-osteoporosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/the-university-of-hong-kong/projects/trivalent-live-attenuated-seasonal-influenza-vac-influenza-virus-infection 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/cs-3150-diabetic-nephropathy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/sr34006-idraparinux-sodium-injection-pulmonary-embolism 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/trastuzumab-herceptin-healthy-volunteer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/h-lundbeck-a-s/projects/lu-aa34893-depression-in-patients-with-bipolar-disorder 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/tailored-ai-echocardiogram-analysis-and-reportin-heart-failure 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/jdq443-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/jieming-qu/projects/arbidol-2019-ncov 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/csl-behring-gmbh/projects/be1116-complex-cardiovascular-surgery-with-cardiopulmon 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/balapiravir-ro4588161-dengue 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/platelet-rich-plasma-combined-with-hyaluronic-ac-traumatic-olfactory-nerve-injury-with-anosmia-di 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/remimazolam-besylate-2-5-mg-in-1-ml-intravenous-hemodynamic-instability 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/screening-only-panic-attacks-and-disorders 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/fitusiran-hemophilia-a 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/coriolus-versicolor-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/dai-guanghai/projects/fruquintinib-colorectal-cancer-metastatic 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/allergan-pharmaceuticals-international-limited/projects/700-g-dexamethasone-macular-edema 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/yang-xiaotian/projects/ilaprazole-gastric-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/entecavir-pediatric-immuno-tolerant-chronic-hepatitis-b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/atezolizumab-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/continuos-epidural-infusion-analgesia-epidural 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/kyowa-kirin-holdings-b-v/projects/opc-262-type-2-diabetes 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biotech-pharmaceutical-co/projects/participants-will-receive-one-dose-of-vaccine-0-influenza 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/the-children-s-hospital-of-zhejiang-university-school-of-medicine/projects/msc-bpd-bronchopulmonary-dysplasia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/betta-pharmaceuticals-co/projects/sequential-icotinib-plus-chemotherapy-egfr-positive-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/placebo-ulcerative-colitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/expanded-activated-nk-cells-ewing-sarcoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/pembrolizumab-endometrial-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/bi-3011441-solid-tumors-kras-mutation 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/meningococcal-acwy-vaccine-infections-meningococcal 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chinese-pla-general-hospital/projects/chemotherapy-drug-gastric-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shanghai-university-of-traditional-chinese-medicine/projects/tqb2825-injection-subcutaneous-injection-cd20-positive-hematological-malignancies 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/nitric-oxide-gel-neuropathic-pain 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/bevacizumab-pfizer-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/otsuka-novel-products-gmbh/projects/opb-31121-non-hodgkin-s-lymphoma-nhl 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/docetaxel-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/durvalumab-hepatocellular-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/placebo-respiratory-syncytial-virus-infections 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/dupilumab-nephrotic-syndrome-in-children 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/mylan-ire-healthcare-limited/projects/trastuzumab-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/levofloxacin-urinary-tract-infection 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/dor-isl-hiv-1-infection 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/azd2265-fpi-2265-metastatic-prostate-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/experimental-tezepelumab-asthma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/generics-uk-limited/projects/reslizumab-eosinophilic-asthma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sun-yat-sen-memorial-hospital-of-sun-yat-sen-university/projects/fulvestrant-combined-with-pyrotinib-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/santen-oy/projects/betamethasone-microsphere-de-102-low-dose-diabetic-macular-edema 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/pf-07275315-dose-1-moderate-to-severe-chronic-obstructive-pulmonary 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/moxonidine-0-2-mg-central-sympathetic-nervous-system-diseases 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/durvalumab-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/afatinib-once-daily-od-breast-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-ltd/projects/upadacitinib-non-segmental-vitiligo 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hong-kong-baptist-university/projects/biolizin-feeding-and-eating-disorders-of-childhood 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/mk-2214-early-alzheimer-s-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/finished-herbal-product-such-as-suan-tsao-jen-ta-menopausal-women 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celgene-europe-limited/projects/ace-536-beta-thalassemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biogen-idec-ltd/projects/felzartamab-immunoglobulin-a-iga-nephropathy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/mirikizumab-intravenous-iv-colitis-ulcerative 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/1-apical-pleurectomy-pneumothorax 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/nis793-metastatic-pancreatic-ductal-adenocarcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/xie-congying/projects/capecitabine-gastric-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/denosumab-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-and-company-limited/projects/tasisulam-sodium-melanoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/connect-biopharm/projects/cbp-307-autoimmune-diseases 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/pembrolizumab-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/innovent-biologics-suzhou-co/projects/placebo-healthy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/inotuzumab-ozogamicin-dose-level-2-leukemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astellas-pharma-europe-bv/projects/gilteritinib-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/pf-06801591-non-muscle-invasive-bladder-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-healthcare-ag/projects/sorafenib-nexavar-bay43-9006-plus-doxorubicin-carcinoma-hepatocellular 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/teriflunomide-relapsing-multiple-sclerosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/amg386-plus-pld-fallopian-tube-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-ltd/projects/adalimumab-pyoderma-gangrenosum 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-mesto/projects/insulin-icodec-diabetes-type-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/cervarix-infections-papillomavirus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/h-lundbeck-a-s/projects/lu-ae58054-schizophrenia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/guangzhou-psychiatric-hospital/projects/olanzapine-schizophrenia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/durvalumab-carcinoma-non-small-cell-lung 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/kyowa-kirin-holdings-b-v/projects/amg531-aplastic-anemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/tang-du-hospital/projects/tocilizumab-injectable-product-myasthenia-gravis-generalized 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/the-university-of-hong-kong/projects/pembrolizumab-t-cell-lymphoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shanghai-jiao-tong-university-school-of-medicine/projects/usual-care-hypertension 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/paliperidone-er-schizophrenia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beijing-anzhen-hospital/projects/cyp2c19-genotype-testing-angina-stable 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/fentanyl-anesthesia-spinal 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv-eu/projects/guselkumab-arthritis-psoriatic 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/tiragolumab-esophageal-squamous-cell-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/suzhou-ribo-life-science-co/projects/rbd7022-hyperlipemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/5-minoxidil-milky-lotion-objective-goal 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/jian-li/projects/gst-hg121-tablets-pharmacokinetics 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/zavicefta-ceftazidime-avibactam-hospital-acquired-pneumonia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/mk-8527-human-immunodeficiency-virus-hiv 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chinese-university-of-hong-kong/projects/fezolinetant-vasomotor-symptoms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/doravirine-human-immunodeficiency-virus-hiv-infection 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/azd0901-gastric-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/asciminib-chronic-myelogenous-leukemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/international-peace-maternity-and-child-health-hospital/projects/chemotherapy-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/imatinib-acetaminophen-chronic-myeloid-leukemia-cml 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/anifrolumab-systemic-lupus-erythematosus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beijing-zhifei-lvzhu-biopharmaceutical-co-ltd/projects/pneumococcal-disease-prevention-pneumococcal-vaccines 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-ltd/projects/botox-masseter-muscle-prominence 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/aleglitazar-diabetes-mellitus-type-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/panitumumab-metastatic-colorectal-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/sniffing-emotional-tears-obesity 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/astaxanthin-2mg-lycopene-1-8mg-d-alpha-tocophero-skin-aging 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/roxadustat-anemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/test-montelukast-respiratory-disorders 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/the-university-of-hong-kong/projects/traditional-chinese-acupuncture-phonotraumatic-injuries 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/otsuka-novel-products-gmbh/projects/spm-962-parkinson-s-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/lugol-s-solution-1-5-esophageal-squamous-cell-neoplasm 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beijing-zhifei-lvzhu-biopharmaceutical-co-ltd/projects/icp-022-systemic-lupus-erythematosus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/atuliflapon-asthma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/ceftazidime-avibactam-caz-avi-complicated-urinary-tract-infection 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pharma-eeig-eu/projects/muraglitazar-diabetes-mellitus-type-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pierre-fabre-medicament/projects/vinflunine-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/zoledronic-acid-paget-s-disease-of-the-bone 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/rosuvastatin-20mg-homozygous-familial-hypercholesterolemia-hofh 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/remibrutinib-chronic-inducible-urticaria 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/yung-na/projects/pregabalin-diabetic-peripheral-neuropathy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/belpharma-s-a/projects/npc-22-healthy-adult-subjects 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/dong-wang/projects/evogliptin-type-2-diabetes-mellitus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/empagliflozin-chronic-kidney-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-ltd/projects/upadacitinib-hidradenitis-suppurativa-hs 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/savolitinib-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/placebo-pulmonary-fibrosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/medimmune/projects/medi8968-600-mg-iv-300-mg-sc-chronic-obstructive-pulmonary-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/jian-li/projects/shr20004-obesity 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/0-9-nacl-physiological-saline-acute-respiratory-tract-infections 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/lapatinib-neoplasms-breast 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/other-placebo-menopausal-and-female-climacteric-states 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/eplerenone-hypertension 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/simethicone-colonoscopy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ipsen-pharma/projects/ipn10200-episodic-migraine 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/international-peace-maternity-and-child-health-hospital/projects/cy-tb-test-latent-tuberculosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pharma-eeig-eu/projects/deucravacitinib-alopecia-areata 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/vicadrostat-chronic-kidney-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biotech-pharmaceutical-co/projects/olorofim-invasive-fungal-infections 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-mesto/projects/biphasic-insulin-aspart-diabetes 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/hydrolysed-collagen-prot-gen-plus-fragility-fracture 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-ireland-uc/projects/sofosbuvir-chronic-hcv-infection 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/kyowa-kirin-holdings-b-v/projects/kw-2478-multiple-myeloma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biotech-pharmaceutical-co/projects/covaxin-bbv152-corona-virus-infection 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gain-therapeutics/projects/combined-fixed-dose-combination-tuberculosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/otsuka-novel-products-gmbh/projects/aripiprazole-bipolar-disorder 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/international-peace-maternity-and-child-health-hospital/projects/olokizumab-64-mg-sc-q4w-rheumatoid-arthritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/the-university-of-hong-kong/projects/atosiban-subfertility 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shanghai-university-of-traditional-chinese-medicine/projects/jmt108-unresectable-locally-advanced-or-metastatic-mela 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/mk-6194-systemic-lupus-erythematosus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/bosutinib-chronic-myeloid-leukemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-mesto/projects/insulin-detemir-diabetes 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/organon-n-v/projects/e6005-atopic-dermatitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ipsen-pharma/projects/lanreotide-autogel-120-mg-acromegaly 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/centers-for-disease-control-and-prevention/projects/rifapentine-tuberculosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/secukinumab-150-mg-provided-in-1-0-ml-pre-filled-ankylosing-spondylitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biogen-idec-ltd/projects/biib019-daclizumab-relapsing-remitting-multiple-sclerosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/partner-therapeutics-limited/projects/exemestane-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/jian-li/projects/shr-1210-locally-advanced-or-metastatic-and-unresectable 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-ltd/projects/upadacitinib-ulcerative-colitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/isoniazid-rifampin-pyrazinamide-hepatitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biotech-pharmaceutical-co/projects/oligo-fucoidan-nsclc-stage-iv 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/jian-li/projects/shr2554-and-itraconazole-healthy-adult-subjects 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbott-s-r-l/projects/maternal-nutritional-supplement-breast-feeding 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/prevnar-13-pneumococcal-infections 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-mesto/projects/faster-aspart-diabetes-mellitus-type-1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/taxotere-epirubicin-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-mesto/projects/nnc6019-0001-transthyretin-amyloid-cardiomyopathy-attr-cm 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/formosa-1-breath-free-nricm101-influenza-viral-infections 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-healthcare-ag/projects/radium-223-dichloride-xofigo-bay88-8223-breast-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/oxaliplatin-uterine-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/the-university-of-hong-kong/projects/rivaroxaban-2-5-mg-oral-tablet-xarelto-atherosclerosis-coronary 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/daprodustat-2-mg-tablet-anaemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/medi4736-recurrent-or-metastatic-pd-l1-positive-squamous 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer/projects/bevacizumab-renal-cell-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/guerbet/projects/gadoterate-meglumine-hepatocellular-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/mallinckrodt-pharmaceuticals-ireland-limited/projects/stanate-hyperbilirubinemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/medimmune/projects/monalizumab-advanced-solid-tumors 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/ropivacaine-femoral-fracture 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-ltd/projects/upadacitinib-atopic-dermatitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/the-university-of-hong-kong/projects/paracetamol-influenza 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sun-yat-sen-university/projects/furmonertinib-non-small-cell-lung-cancer-metastatic 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/10mg-ds-8500a-tablet-type-2-diabetes-mellitus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/green-valley-shanghai-pharmaceuticals-co/projects/gc1102-hepatitis-b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biotech-pharmaceutical-co/projects/cd19-tricar-t-silk-non-hodgkin-lymphoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/the-university-of-hong-kong/projects/oral-arsenic-trioxide-acute-myeloid-leukemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/motion-analysis-of-patients-leg-length-discrepancy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/flulaval-quadrivalent-influenza 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/dapagliflozin-diabetes-mellitus-type-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/otsuka-novel-products-gmbh/projects/cilostazol-polyneuropathy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-ireland-uc/projects/azli-75-mg-two-times-a-day-bid-three-times-a-day-cystic-fibrosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biogen-idec-ltd/projects/biib115-healthy-volunteer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/albiglutide-diabetes-mellitus-type-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chinese-university-of-hong-kong/projects/lactate-group-lactate-acide-clearance-directed-g-shock-septic 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/panobinostat-classical-hodgkin-s-lymphoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/the-university-of-hong-kong/projects/brolucizumab-age-related-macular-degeneration 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/liquid-biopsy-spot-mas-assay-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/moxifloxacin-intra-abdominal-infection 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/cisplatin-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ptc-therapeutics-international-limited/projects/vatiquinone-friedreich-ataxia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/pembrolizumab-triple-negative-breast-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/samsung-bioepis-nl-b-v/projects/azd2014-cancer-of-stomach 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/atezolizumab-mpdl3280a-an-engineered-anti-pd-l1-renal-cell-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/samsung-bioepis-nl-b-v/projects/zydena-udenafil-vascular-dementia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/utaa91-injection-rheumatoid-arthritis-ra 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-healthcare-ag/projects/regorafenib-bay73-4506-colorectal-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/nintedanib-lung-diseases-interstitial 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/ds-1062a-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/sacituzumab-tirumotecan-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-ireland-uc/projects/sof-vel-vox-hcv-infection 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/v114-pneumococcal-infections 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/warfarin-deep-venous-thromboembolism 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/tesaglitazar-type-2-diabetes 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/bi-1744-cl-2-g-pulmonary-disease-chronic-obstructive 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/serono-europe-limited/projects/avelumab-first-line-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/johnson-johnson-medical-pty-ltd/projects/rivaroxaban-2-5-mg-acute-coronary-syndrome 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/ro5503781-mbp-myelogenous-leukemia-acute 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chia-tai-tianqing-pharmaceutical-group-nanjing-shunxin-pharmaceutical-co/projects/risperidone-neuroleptic-induced-tardive-dyskinesia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beigene-ireland-ltd/projects/surzebiclimab-locally-advanced-or-metastatic-solid-tumors-for 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/paclitaxel-esophageal-squamous-cell-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pharma-eeig-eu/projects/bms-986202-psoriasis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals/projects/etanercept-methotrexate-rheumatoid-arthritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv-eu/projects/tapentadol-ir-50-mg-hallux-valgus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celltrion-healthcare-hungary-kft/projects/ct-g11-healthy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/xanomeline-and-trospium-chloride-capsules-schizophrenia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/the-university-of-hong-kong/projects/capecitabine-pancreatic-adenocarcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biotech-pharmaceutical-co/projects/recombinant-human-vegf-receptor-fc-fusion-protei-neovascular-age-related-macular-degeneration 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/samsung-bioepis-nl-b-v/projects/bevacizumab-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chengdu-university-of-traditional-chinese-medicine/projects/loperamide-diarrhea-predominant-irritable-bowel-syndrome 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/pembrolizumab-200-mg-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/betta-pharmaceuticals-co/projects/1-icotinib-hydrochloride-cream-psoriasis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biotech-pharmaceutical-co/projects/tuberculosis-vaccine-tuberculosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/satralizumab-nmdar-autoimmune-encephalitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/blueprint-medicines-netherlands-b-v/projects/elenestinib-indolent-systemic-mastocytosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/pembrolizumab-urinary-bladder-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/baloxavir-marboxil-influenza 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/trimebutine-100-mg-helicobacter-pylori-infection 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hong-kong-baptist-university/projects/ckd-381-gerd 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vera-therapeutics/projects/herzuma-her2-enriched-subtype-breast-cancer-herzuma-pam5 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/acz885-muckle-wells-syndrome 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shandong-university/projects/bismuth-containing-quadral-therapy-based-on-anti-helicobacter-pylori 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/otsuka-novel-products-gmbh/projects/opc-108459-atrial-fibrillation 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/allergan-pharmaceuticals-international-limited/projects/botulinum-toxin-type-a-cervical-dystonia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/viatris-healthcare-limited/projects/cenerimod-lupus-erythematosus-systemic 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/wuhan-yzy-biopharma-co/projects/y150-relapsed-or-refractory-multiple-myeloma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celltrion-healthcare-hungary-kft/projects/ct-p41-healthy-male-subjects 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/medimmune/projects/medi8897-respiratory-syncytial-virus-infections 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/zoledronic-acid-paget-s-disease-of-bone 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/salmeterol-fluticasone-propionate-or-formoterol-asthma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-ireland-uc/projects/bsf-208075-pulmonary-hypertension 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celltrion-healthcare-hungary-kft/projects/ct-p6-sc-healthy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/pembrolizumab-vibostolimab-carcinoma-non-small-cell-lung 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biotech-pharmaceutical-co/projects/rhgm-csf-group-mycoses 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/oav101-spinal-muscular-atrophy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sichuan-provincial-people-s-hospital/projects/rsifn-co-carcinoma-non-small-cell-lung 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/belpharma-s-a/projects/npc-11-for-intravenous-or-oral-administration-apnea-of-prematurity 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sichuan-baili-pharmaceutical-co/projects/bl-b01d1-cervical-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ignis-therapeutics-suzhou-limited/projects/solriamfetol-sleep-apnea-obstructive 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/implantation-bone-loss 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/ro5024048-hepatitis-c-chronic 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/yung-na/projects/rabeprazole-sodium-10mg-gastroesophageal-reflux-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/osimertinib-savolitinib-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/dbv-technologies/projects/dbv712-allergy-peanut 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/meda-ab/projects/empagliflozin-non-alcoholic-fatty-liver-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/anhui-provincial-hospital/projects/metabolically-armed-cd19-car-t-cells-acute-lymphoblastic-leukemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/qilu-pharma-spain-s-l/projects/ql2108-injection-atopic-dermatitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/rituximab-rtx-diffuse-large-b-cell-lymphoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/lou064-blinded-chronic-spontaneous-urticaria 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/obinutuzumab-lymphocytic-leukemia-chronic 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/third-affiliated-hospital-sun-yat-sen-university/projects/peginterferon-alfa-chronic-hepatitis-b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/azd0780-heterozygous-familial-hypercholesterolaemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shanghai-university-of-traditional-chinese-medicine/projects/emb-01-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/the-university-of-hong-kong/projects/bupivacaine-injection-marcaine-acute-pain 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hong-kong-baptist-university/projects/ceftriaxone-1000mg-doxycycline-100-mg-neisseria-gonorrhoeae-infection 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/generics-uk-limited/projects/tev-56248-asthma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/lunsekimig-asthma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/cefazolin-with-daptomycin-periprosthetic-joint-infection 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biotech-pharmaceutical-co/projects/chidamide-relapsed-or-refractory-peripheral-t-cell-lymphom 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/glycerine-magnesium-sulphate-paste-infection 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/evolocumab-hyperlipidemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/roflumilast-asthma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/oral-prednisolone-30mg-day-for-28-days-esophageal-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/calcium-supplement-hypocalcemia-in-pregnancy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/h-lundbeck-a-s/projects/eptinezumab-migraine 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-ltd/projects/levodopa-carbidopa-intestinal-gel-lcig-advanced-parkinson-s-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/liposorber-la-15-system-cholesterol-embolism 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/edoxaban-cardiac-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/surovatamig-chronic-lymphocytic-leukaemia-or-small-lymphocyt 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shanghai-tong-ren-hospital/projects/decitabine-acute-myeloid-leukemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/jian-li/projects/doxycycline-amyloidosis-systemic 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/peking-university-third-hospital/projects/dexmedetomidine-aged 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/zoledronic-acid-osteoporosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eye-ent-hospital-of-fudan-university/projects/usual-care-vestibular-disorder 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/lee-s-pharmaceutical-limited/projects/azilsartan-zhaoke-bioequivalence-of-two-azilsartan-formulations 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-ltd/projects/upadacitinib-hidradenitis-suppurativa 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/lundbeck-australia-pty-ltd/projects/melperone-hcl-parkinson-s-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv-eu/projects/siltuximab-multicentric-castleman-s-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/zealand-pharma-a-s/projects/pantoprazole-40mg-oncology 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celgene-europe-limited/projects/pomalidomide-multiple-myeloma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv-eu/projects/oros-hydromorphone-cancer-pain 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/zambon-spa/projects/cms-non-cystic-fibrosis-bronchiectasis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alexion-europe-sas/projects/14c-danicopan-healthy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv-eu/projects/pimodivir-600-mg-influenza-a 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/taiho-pharma-netherlands-b-v/projects/tas-303-stress-urinary-incontinence 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/oncopeptides-ab-publ/projects/melflufen-multiple-myeloma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv/projects/tramadol-hci-acetaminophen-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/cutting-balloon-followed-by-paclitaxel-coated-ba-dialysis-access-malfunction 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shire-pharmaceutical-contracts-limited/projects/shp611-metachromatic-leukodystrophy-mld 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-ireland-uc/projects/vox-hepatitis-c-virus-infection 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/colgate-oral-care/projects/0-454-stannous-fluoride-oral-malodor 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/taiho-pharma-netherlands-b-v/projects/tas-205-duchenne-muscular-dystrophy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv-eu/projects/lhrha-prostatic-neoplasms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv-eu/projects/jnj-77242113-plaque-psoriasis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hong-kong-baptist-university/projects/ckd-495-75mg-gastritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/johnson-johnson-medical-pty-ltd/projects/trabectedin-ovarian-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shire-pharmaceutical-contracts-limited/projects/maribavir-cytomegalovirus-cmv 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/loc387715-htra1-genotyping-age-related-macular-degeneration 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/qvm149-150-50-160-asthma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shire-pharmaceutical-contracts-limited/projects/recombinant-human-arylsulfatase-a-metachromatic-leukodystrophy-mld 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shanghai-chest-hospital/projects/neoadjuvant-anti-pd-1-esophageal-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/menarini-international-operations-luxembourg-s-a/projects/placebo-acute-pain 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/allergan-pharmaceuticals-international-limited/projects/abicipar-pegol-macular-degeneration 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/repatha/projects/live-attenuated-sa-14-14-2-vaccine-encephalitis-japanese-b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/metronidazole-helicobacter-pylori-infection 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/placebo-irritable-bowel-syndrome-with-constipation-ibs-c 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/allergan-pharmaceuticals-international-limited/projects/bimatoprost-ophthalmic-solution-formulation-a-glaucoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv-eu/projects/icotrokinra-crohn-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shine-europe-b-v/projects/s-ketamine-opioid-use-unspecified 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv-eu/projects/hydromorphone-16-mg-healthy-volunteers 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/olaparib-platinum-sensitive-relapsed-ovarian-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/atezolizumab-advanced-liver-cancers 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv-eu/projects/golimumab-1-mg-per-kg-colitis-ulcerative 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shine-europe-b-v/projects/rezvilutamide-prostate-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/kiora-pharmaceuticals-inc/projects/kio-101-dry-eye-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/windtree-therapeutics-inc-de/projects/rostafuroxin-hypertension 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/galmed-pharmaceuticals/projects/aramchol-fatty-liver 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/puma-biotechnology-inc/projects/neratinib-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/apellis-pharmaceuticals/projects/apl-2-paroxysmal-nocturnal-hemoglobinuria 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/akebia-therapeutics/projects/vadadustat-anemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/puma-biotechnology-inc/projects/neratinib-her2-metastatic-breast-cancer-mbc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/puma-biotechnology-inc/projects/neratinib-advanced-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/zentalis-pharmaceuticals/projects/zn-d5-healthy-volunteers 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/lexicon-pharmaceuticals-inc/projects/sotagliflozin-heart-failure 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/enanta-pharmaceuticals-inc/projects/edp-305-dose-1-non-alcoholic-steatohepatitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biocryst-pharmaceuticals-inc/projects/bcx9930-paroxysmal-nocturnal-hemoglobinuria 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/assembly-biosciences-inc/projects/abi-4334-chronic-hepatitis-b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/lakefront-biotherapeutics-nv/projects/filgotinib-crohn-s-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biocryst-pharmaceuticals-inc/projects/bcx7353-hereditary-angioedema 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biocryst-pharmaceuticals-inc/projects/avoralstat-diabetic-macular-edema-dme 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/nektar-therapeutics/projects/bempegaldesleukin-renal-cell-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/enanta-pharmaceuticals-inc/projects/edp-938-respiratory-syncytial-virus-rsv 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bicara-therapeutics/projects/ficerafusp-alfa-metastatic-head-and-neck-squamous-cell-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/olema-pharmaceuticals/projects/op-1250-hormone-receptor-positive-breast-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/arcturus-therapeutics-holdings/projects/arct-165-covid-19 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/io-biotech/projects/io102-io103-melanoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/karyopharm-therapeutics/projects/selinexor-myelofibrosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vor-biopharma/projects/telitacicept-systemic-lupus-erythematosus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sunshine-biopharma/projects/hec74647-chronic-hepatitis-c 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bright-minds-biosciences-inc/projects/bf-methyldopa-250mg-tablet-healthy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/apellis-pharmaceuticals/projects/pegcetacoplan-pnh 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/avenue-therapeutics-inc/projects/adapalene-0-003-mg-mg-benzoyl-peroxide-0-025-mg-acne-vulgaris 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/lakefront-biotherapeutics-nv/projects/glpg1837-dose-1-cystic-fibrosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/apellis-pharmaceuticals/projects/pegcetacoplan-c3g 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/aurinia-pharmaceuticals/projects/voclosporin-high-dose-lupus-nephritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/protara-therapeutics/projects/tara-002-non-muscle-invasive-bladder-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/viridian-therapeutics-inc-de/projects/veligrotug-vrdn-001-thyroid-eye-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/assembly-biosciences-inc/projects/abi-h2158-chronic-hepatitis-b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/spero-therapeutics/projects/tbp-pi-hbr-urinary-tract-infection 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/enanta-pharmaceuticals-inc/projects/edp-494-hepatitis-c 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/silence-therapeutics-plc/projects/sln124-non-transfusion-dependent-thalassemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/arrivent-biopharma/projects/furmonertinib-240-mg-oral-daily-metastatic-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/agios-pharmaceuticals-inc/projects/placebo-matching-mitapivat-transfusion-dependent-alpha-thalassemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/syndax-pharmaceuticals-inc/projects/axatilimab-chronic-graft-versus-host-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/an2-therapeutics/projects/an2-502998-healthy-volunteers 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biocryst-pharmaceuticals-inc/projects/bcx10013-paroxysmal-nocturnal-hemoglobinuria 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/reviva-pharmaceuticals-holdings-inc/projects/rp5063-acute-schizophrenia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/integrated-biopharma-inc/projects/quiklean-sodium-phosphate-monobasic-monohydrate-bowel-preparation 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/arbutus-biopharma-corp/projects/ab-836-chronic-hepatitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pliant-therapeutics-inc/projects/pln-74809-idiopathic-pulmonary-fibrosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cumberland-pharmaceuticals-inc/projects/ibuprofen-fever 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/assembly-biosciences-inc/projects/vbr-chronic-hepatitis-b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/aura-biosciences/projects/bel-sar-choroidal-melanoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/coherus-oncology/projects/chs-114-metastatic-solid-tumor 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sinovac-biotech-ltd/projects/inactivated-covid-19-vaccine-covid-19 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/atea-pharmaceuticals/projects/at-752-dengue-fever 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/lakefront-biotherapeutics-nv/projects/glpg1690-idiopathic-pulmonary-fibrosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sinovac-biotech-ltd/projects/sinovac-pcv13-pneumococcal-infectious-diseases 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/first-tracks-biotherapeutics/projects/apatinib-advanced-solid-tumors 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/arcus-biosciences/projects/ab598-advanced-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/arcus-biosciences/projects/etrumadenant-tnbc-triple-negative-breast-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/arrowhead-pharmaceuticals-inc/projects/aro-ang3-mixed-dyslipidemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/catalyst-pharmaceuticals-inc/projects/marzaa-hemophilia-a-with-inhibitor 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/terbinafine-hydrochloride-1-tinea-pedis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vedolizumab-sc-108-mg-crohn-s-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vedolizumab-300-mg-iv-colitis-ulcerative 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/lactezin-hormonal-acne 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vedolizumab-ulcerative-colitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amneal-pharmaceuticals/projects/diclofenac-sodium-topical-gel-1-osteoarthritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/mirum-pharmaceuticals/projects/maralixibat-progressive-familial-intrahepatic-cholestasis-pf 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/oruka-therapeutics/projects/orka-001-healthy-volunteers 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/nucresiran-transthyretin-amyloidosis-with-cardiomyopathy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/enliven-therapeutics/projects/elvn-002-her2-mutant-non-small-cell-lung-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/9vhpv-vaccine-dengue-fever 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-438-gastric-ulcer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tinoridine-hcl-pain 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/jazz-pharmaceuticals-plc/projects/defibrotide-veno-occlusive-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/revolution-medicines/projects/rmc-6291-non-small-cell-lung-cancer-nsclc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/wbrt-bladder-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/arrowhead-pharmaceuticals-inc/projects/aro-c3-c3-glomerulopathy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/placebo-iga-nephropathy-igan 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ionis-pharmaceuticals-inc/projects/olezarsen-severe-hypertriglyceridemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-935-epilepsy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/ub-621-herpes-simplex-virus-infection 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/home-non-invasive-ventilation-hypercapnic-respiratory-failure 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/zilebesiran-high-risk-cardiovascular-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vortioxetine-depressive-disorder-major 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn3918-paroxysmal-nocturnal-hemoglobinuria 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-b2033-metastatic-hepatocellular-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/tislelizumab-advanced-malignancies 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/sonrotoclax-mature-b-cell-malignancies 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/patisiran-amyloidosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/zasocitinib-psoriatic-arthritis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vortioxetine-major-depressive-disorder 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vedolizumab-sc-colitis-ulcerative 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vedolizumab-iv-ulcerative-colitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vedolizumab-colitis-ulcerative 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/trelagliptin-type-2-diabetes 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/takeda-s-tetravalent-dengue-vaccine-candidate-td-dengue-fever 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-816-dpt-takeda-immunization 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-771-primary-immunodeficiency-diseases-pid 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-672-acquired-hemophilia-a 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-360-idiopathic-hypersomnia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-280-unresectable-locally-advanced-or-metastatic-canc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/nucresiran-hereditary-transthyretin-mediated-amyloidosis-wi 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-085-hyperlipidemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/syr-472-diabetes-mellitus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ideaya-biosciences/projects/ide196-metastatic-uveal-melanoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-743-300-mg-hereditary-angioedema 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/syr-322-met-clinical-pharmacology 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/resatorvid-sepsis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/ponatinib-myeloid-leukemia-chronic-chronic-phase 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/pantoprazole-gerd 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/blb-750-vaccine-qinghai-rg-strain-pandemic-influenza-prevention 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/pantoprazole-gastroesophageal-reflux-disease-gerd 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/panitumumab-tas-102-colorectal-cancer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/mezagitamab-kidney-disease 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/maribavir-cytomegalovirus-cmv 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-allergic-bronchopulmonary-aspergillosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/fasiglifam-type-2-diabetes-mellitus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/fasiglifam-tak-875-diabetes-mellitus-type-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/elritercept-myelodysplastic-syndromes 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/brentuximab-vedotin-hodgkin-lymphoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/azilsartan-medoxomil-essential-hypertension 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/alogliptin-type-2-diabetes-mellitus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/alogliptin-diabetes-mellitus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn3918-paroxysmal-nocturnal-hemoglobinuria-pnh 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/arrowhead-pharmaceuticals-inc/projects/plozasiran-injection-severe-hypertriglyceridemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn1033-healthy-volunteers 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/ravulizumab-paroxysmal-nocturnal-hemoglobinuria 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/praluent-alirocumab-hypercholesterolemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-121-tez-d-iva-cystic-fibrosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/placebo-atopic-dermatitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/pemetrexed-carcinoma-non-small-cell-lung 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/odronextamab-follicular-lymphoma-fl 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aflibercept-retinopathy-of-prematurity 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/intravitreal-aflibercept-injection-iai-nonproliferative-diabetic-retinopathy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cemiplimab-squamous-cell-carcinoma-scc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aln-ang3-healthy-volunteers-with-hyperlipidemia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/odronextamab-b-cell-non-hodgkin-lymphoma-b-nhl 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-135-chronic-hepatitis-c 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/povetacicept-immunoglobulin-a-nephropathy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/ponatinib-pediatric-philadelphia-chromosome-positive-acute 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-019-coronavirus-disease-covid-19 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/0-5-ivermectin-lotion-pediculosis-capitis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/ixazomib-multiple-myeloma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/placebo-cerebral-amyloid-angiopathy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/catalyst-pharmaceuticals-inc/projects/pf-05280602-hemophilia-a 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/denali-therapeutics/projects/dnl343-healthy-volunteers 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/arrowhead-pharmaceuticals-inc/projects/aro-dux4-for-injection-facio-scapulo-humeral-dystrophy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/ub-421-sc-db4c7c22-6-mab-hiv-1-infection 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/elx-tez-iva-cystic-fibrosis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/alogliptin-and-pioglitazone-diabetes-mellitus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/arcus-biosciences/projects/casdatifan-metastatic-clear-cell-renal-cell-carcinoma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/2024-511857-23-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cero-therapeutics-holdings-inc/projects/2024-519052-82-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-512628-12-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-511977-31-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-516025-30-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2023-508718-40-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-514491-40-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2023-505592-69-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-514489-38-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2025-523898-42-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2024-517796-21-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pierre-fabre-m-dicament/projects/2025-524256-64-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/nordic-group-b-v/projects/2023-509255-14-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-515312-50-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/2024-513214-34-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2025-522240-40-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2024-519892-24-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2023-506648-18-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/2024-514931-63-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/2025-524008-32-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/dompe-farmaceutici-s-p-a/projects/2024-513940-27-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/2023-507075-22-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-514598-23-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2024-514154-73-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-513310-36-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-514428-18-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2023-507065-26-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2024-515122-89-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2024-511506-22-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/2023-509182-21-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-512968-57-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/2023-506248-18-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-513394-42-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2024-519460-40-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-516427-13-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/2023-507325-42-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2023-507489-20-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2023-507843-12-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2024-517002-28-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2024-517002-28-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-513729-22-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/2025-524111-37-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2024-519407-99-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2024-519394-19-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-514073-22-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/2023-509853-29-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/2024-514195-40-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-511010-21-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2024-515271-35-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-514615-10-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/2023-508895-13-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/intrabio-ireland-limited/projects/2025-523828-51-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2025-520972-24-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-515387-31-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-mesto/projects/2024-517304-12-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-512553-25-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-520305-39-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2024-516808-42-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2024-512642-42-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2025-524045-27-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-517485-42-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/2023-504892-25-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/2023-508992-35-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/2024-514829-36-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/2024-513173-44-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2025-522864-34-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2025-521468-36-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2025-524901-33-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-514612-27-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-512353-24-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/2024-512368-79-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2024-513200-34-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-516265-37-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2023-509675-16-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2024-519895-23-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/2024-516103-16-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/philogen-s-p-a/projects/2024-518531-10-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/philogen-s-p-a/projects/2025-523230-77-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/philogen-s-p-a/projects/2025-523231-19-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2023-505095-29-03 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-518355-36-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fate-therapeutics-inc/projects/2025-524821-42-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2025-520640-15-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2025-520642-29-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-520090-12-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/2023-509021-53-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/dyne-therapeutics/projects/2023-510353-42-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-516488-99-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/2024-511858-44-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2025-522111-42-02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2024-517594-24-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2023-509661-21-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/2024-519260-41-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-ag/projects/2025-520623-24-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/2024-512375-12-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2024-517402-28-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2024-515032-76-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2025-521962-83-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-517783-37-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/2023-505789-27-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-511127-33-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alterity-therapeutics-ltd/projects/2025-524317-88-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/2023-506580-34-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/2023-508515-23-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/2023-509030-19-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/2023-507035-37-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/2025-522287-32-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/2023-507874-42-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/2024-518581-27-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/2024-519499-22-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/2024-515307-19-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/2025-523165-19-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/2023-504403-92-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/2024-515150-24-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pasithea-therapeutics/projects/2024-510900-34-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/corbus-pharmaceuticals-holdings/projects/2024-515020-36-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2025-520560-18-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2024-512467-31-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2025-521163-12-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-520037-76-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-518865-85-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/2023-510304-53-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/insight 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20250004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/precision-biosciences-inc/projects/prax-628-102 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/ex6018-4979 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn6018-4914 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/ms202359-0002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-7240-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-7240-008 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-7240-014 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-7240-015 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chiesi-farmaceutici-s-p-a-eu/projects/cli-05993aa3-06 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/crd-750-202 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/vtx002-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratoire-hra-pharma/projects/sb-421a-006-99-10-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratoire-hra-pharma/projects/sb-421a-006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/act17012 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/efc18156 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/efc17236 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/lts17261 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vera-therapeutics/projects/lts16637 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/pdy16744 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shire-pharmaceutical-contracts-limited/projects/shp611-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shire-pharmaceutical-contracts-limited/projects/hgt-mld-071 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp220832 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-ag/projects/22423 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ista-pharma-limited/projects/rcaphm19-0374 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/aln-6400-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/tmp-2204-2021-47 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/efc18359 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/v940-011 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/moderna-biotech-spain/projects/mrna-3927-p101-ext 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2023-508583-30-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/uniqure-biopharma-b-v/projects/ct-amt-130-02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/intrabio-ireland-limited/projects/ib1001-303 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/64042056alz2001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/4202-hem-202 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/ker-050-d301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/ker050-md-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-6024-017 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/p170706j 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn6019-4958 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/h-lundbeck-a-s/projects/20432a 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/suith 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/63723283luc1001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9833-8243 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9833-8242 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/nl71347-078-20 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/nl74742-078-20 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/hp002-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharm-research-associates-uk-limited/projects/ptf301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp220881 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cero-therapeutics-holdings-inc/projects/ico-2023-17 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/aspect-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/19097 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/11304 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/hippocrates 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/blue-earth-diagnostics-ireland-ltd/projects/bed-fap-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/iibsp-dow-2022-150 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/iibsp-fpi-2019-108 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp210360 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2023-507938-24-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/134826 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/advanced-accelerator-applications/projects/caaa603a12101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca240-0008 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-9999-01a 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/axim-biotechnologies-inc/projects/2023-505262-28-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/verona-pharma-ireland-limited/projects/2024-518859-27-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bicycle-therapeutics/projects/bt8009-202 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-279-vt-2001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-279-hs-2001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-279-pso-3003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-279-ibd-2001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/sc-ta1-cf-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/2023-510184-35-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-513186-39-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/2023-510453-41-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2024-518617-25-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/tour-hekla/projects/2023-505733-28-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/xenon-pharmaceuticals/projects/xpf-008-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/xenon-pharmaceuticals/projects/xpf-010-d302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/xenon-pharmaceuticals/projects/xpf-010-b302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biogen-idec-ltd/projects/enepc-cli-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biodexa-pharmaceuticals-plc/projects/mtx230-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/2025-522486-29-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/2024-517471-21-02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/elan-pharma-international/projects/wve-006-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/axim-biotechnologies-inc/projects/sp-pt18uda 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharm-research-associates-uk-limited/projects/ws2202 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/eyp001-208 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/p19-040 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/viiv-healthcare-bv/projects/218806 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/gs-248-203 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alexion-europe-sas/projects/alxn2030-amr-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2024-514420-16-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2023-509551-14-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-513981-21-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ptc-therapeutics-inc/projects/ptc743-neu-003e-fa 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2024-3993-ezhiswitch 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/ds3201-a-u202 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx20-880-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx23-670-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-24-670-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx24-407-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx22-264-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx21-147-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vera-therapeutics/projects/vs-6766-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/viridian-therapeutics-inc-de/projects/vrdn-001-303 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/viridian-therapeutics-inc-de/projects/vrdn-003-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/viridian-therapeutics-inc-de/projects/vrdn-003-303 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/2023-508844-24-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vir-biotechnology/projects/vir-chdv-v203 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vir-biotechnology/projects/vir-chdv-v201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2024-511631-10-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cvhb937b12201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp180618 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/vda-cp-06-p2b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/ccfz533h12201bc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cvay736a2301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/tour-hekla/projects/ivami 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/213998-vns-20-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/213997-vns-20-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/214002-vns-20-004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2024-519017-62-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-mesto/projects/chrd2115 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ut002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/ms201924-0001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/ms201924-0003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2023-506436-33-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2023-506437-29-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/2024-512108-20-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bp42155 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/2024-515857-93-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/id-090-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/genmab-a-s/projects/gct1057-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/genmab-a-s/projects/gct1079-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/tu31-kh1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/nl85300-041-23 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/the-tils001-trial 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/asnd0042 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ascendis-pharma-bone-diseases-a-s/projects/transcon-pth-tcp-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/asnd0036 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/asnd0045 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/periversion 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9180c00003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9181c00002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9185c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9180c00012 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/axim-biotechnologies-inc/projects/2024-511510-20-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/crd-750-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2024-515333-14-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/taiho-pharma-netherlands-b-v/projects/astx660-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/toldec-combinem 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-mesto/projects/rpn-nls01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-512616-21-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/elite-pharmaceuticals-inc-nv/projects/lbs-008-ct03 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1403-0001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celgene-europe-limited/projects/cc-90010-st-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/woe-de-2023-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp230845 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/aslan004-004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2024-513778-23-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/1046-25 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/1053-25 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/1028-25 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sciencepharma-sp-z-o-o/projects/sph-01-2024 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/1048-25 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/23u-0502 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/molefy-ap-2-2025-pha 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/2025-522234-31-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9388-8175 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/chf6467-opg 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/century-therapeutics/projects/cnty-101-151-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2024-510596-37-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gedeon-richter-ltd/projects/2025-521301-40-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m25-279 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m24-534 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/viridian-therapeutics-inc-de/projects/vrdn-003-302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-518422-32-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/tour-hekla/projects/2024-514604-14-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/2024-512002-26-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alexion-europe-sas/projects/alxn1820-anca-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/axim-biotechnologies-inc/projects/sp-mh19pro 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/030-z-md24076 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-518036-36-03 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/bhv2000-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/nl202100762 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/viiv-healthcare-bv/projects/218307 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sangamo-therapeutics-inc/projects/tx200-kt03 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sangamo-therapeutics-inc/projects/tx200-kt02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/iibsp-eda-2020-18 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/aop-orphan-pharmaceuticals-gmbh/projects/trepaed 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2024-518656-23-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sana-biotechnology/projects/d-against-gvh 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/ctqj230a12302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/ctqj230a12301e1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-511532-27-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2025-523428-39-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cjdq443a12101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/cl1-95035-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/tl-895-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ms200662-0001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/ctin816a12201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-518666-27-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/tv53408-imm-20042 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/tv48574-imm-20038 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eupraxia-pharmaceuticals-inc/projects/ep-104iar-102 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2024-510596-37-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2024-518972-30-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/2023-506763-33-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2024-513931-26-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2024-515681-14-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2024-519262-42-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/td001-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/2024-517090-24-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/tarian-007 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/tarian-014 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/rein-therapeutics/projects/2023-507847-13-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2025-521385-10-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/verona-pharma-ireland-limited/projects/crcfc-tamoxi063 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/baxalta-innovations-gmbh/projects/tak-881-3002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-861-1012 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-861-2003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-861-3001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-861-3002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-279-cd-2001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-279-uc-2001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2024-517424-18-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-514693-47-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-514693-47-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ijb-sp01-2025 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/bmmnc-cli-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/bmmnc-pta-003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m23-422 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2023-506698-36-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-516415-24-03 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/tnb383b-0001-m22-466 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celgene-europe-limited/projects/cc-90010-gbm-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hutchmed-europe-b-v/projects/2022-523-glob1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/cbr-cmr316-3001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ionis-pharmaceuticals-inc/projects/262sp101-ion464-cs1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m23-647 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m24-893 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cvay736j12101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cdky709a12101c 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/genmab-a-s/projects/gct1056-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/u31402-a-u102 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/tesaro-bio-netherlands-b-v/projects/amber 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/nio752b12201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/74856665aml1001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vita-europe-limited/projects/cibi3009a101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-international-limited/projects/gs-us-707-7297 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-international-limited/projects/gs-us-667-6882 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cegf816x2102 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-11417-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2022-3418-indigo 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m24-209 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/sovateltide-acis-ind 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-510949-34-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-mesto/projects/kct10-2022-leash 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/moonlake-immunotherapeutics/projects/m1095-ppp-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/moonlake-immunotherapeutics/projects/m1095-hs-303 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/moonlake-immunotherapeutics/projects/m1095-axspa-202 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/moonlake-immunotherapeutics/projects/m1095-psa-303 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/2025-524942-87-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharm-research-associates-uk-limited/projects/hm-glp2-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/2023-506598-36-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharm-research-associates-uk-limited/projects/kohplak 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/thea-hlf-1-21 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/2024-513828-42-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-511090-30-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2025-520483-17-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2023-506792-94-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2025-520540-15-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sana-biotechnology/projects/2024-518452-23-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/airc-id-21939 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/bcg-ris-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2023-506795-27-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/r4-four-pet 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/zealand-pharma-a-s/projects/zp9830-23005 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/silycus-21 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c6461020 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/otsuka-novel-products-gmbh/projects/417-201-00042 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/viatris-healthcare-limited/projects/id-076a301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9724c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharm-research-associates-uk-limited/projects/mopad 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/om-85older 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biogen-idec-ltd/projects/299ar301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1474-0002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/neurocrine-biosciences-inc/projects/nbi-1117570-1769 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/neurocrine-biosciences-inc/projects/nbi-1076986-1761 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/arbutus-biopharma-corp/projects/ab-101-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharm-research-associates-uk-limited/projects/tpt0301-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/nl58686-000-16 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/sad18184-mad18185 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biontech-manufacturing-gmbh/projects/bnt164-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/philogen-s-p-a/projects/ph-il12l19l19-01-19 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/s-r-o/projects/cpa-556-24 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sana-biotechnology/projects/gn-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-513390-50-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/santen-oy/projects/101090401in 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/stoke-therapeutics/projects/stk-002-oa-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/stoke-therapeutics/projects/stk-001-ds-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sangamo-therapeutics-inc/projects/st-920-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sangamo-therapeutics-inc/projects/st-920-lt01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/spyre-therapeutics/projects/spy123-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/spyre-therapeutics/projects/spy002-072-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/spi-62-cl-2001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/fpi-2505-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/nordic-group-b-v/projects/csci-skt-b1001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/2024-516373-77-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vita-europe-limited/projects/prin-20227ea9an-59-20-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vita-europe-limited/projects/prin-20227ea9an 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/2024-514609-76-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/rov-sie-2025-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/2024-513934-40-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/karyopharm-therapeutics/projects/2024-513167-68-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cseg101a2301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cseg101a2401b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/scd-044-19-14 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/scd-044-19-16 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/2024-511437-35-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/sad20411-mad20412 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/act17841 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/act18207 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/dri18252 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/lts18300 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/act18134 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/efc17905 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/genzyme-europe-b-v/projects/efc15467 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/lts13588 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/lts13619 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/mylan-dura-gmbh/projects/myl-1603n-3001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-516324-34-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/explas 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-999-3002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9180c00004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/u1111-1305-0044 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/cl1-230815-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shionogi-b-v/projects/2405n1221 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-510926-19-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/protagonist-therapeutics-inc/projects/verify 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bp41674 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-0616-037 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ropidol 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20230053 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d7020c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cosmo-technologies-ltd/projects/cb-01-35-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/rialta 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/syndax-pharmaceuticals-inc/projects/sndx-5613-0700 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/aspire-biopharma-holdings/projects/asp-ret-ct001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/2024-512331-72-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/2025-gmf-1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/dompe-farmaceutici-s-p-a/projects/rep0122 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp200056 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j1g-mc-laki 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp220257 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/citisilong 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/2024-513665-40-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/2025-523054-14-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bioprojet-pharma/projects/p22-03 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ista-pharma-limited/projects/microprep-iii 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/ds6000-126 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-5909-005 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/ror-ph-303 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharm-research-associates-uk-limited/projects/rt51ep1902 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/bazooka-221 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2025-524635-39-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2025-521086-28-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2025-521316-19-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/wc45725 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/wc45726 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/cs45943 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/ga45332 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/ga45330 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/wa45846 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/cs45570 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/ga45331 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bp43963 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bn42489 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bn43703 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/co44195 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bn42358 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bp39529 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bn44715 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bp39054 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/mo42720 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/revolution-medicines/projects/rmc-lung-101d 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/relay-therapeutics/projects/rly-2608-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/restore 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-pharmaceutica-n-v/projects/2024-512889-33-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/rise 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ferring-pharmaceuticals-a-s/projects/2023-508430-34-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r131l1265-hemb-2318 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r7544-sih-2435 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r7257-raa-1947 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r7041-niu-24123 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r4461-mob-2471 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r13335-pah-2365 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/rc03t001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp191047 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/2024-514677-22-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/advanced-accelerator-applications/projects/abx-ct-302eu-eagle-i 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r7999-bthal-2350 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/collegium-pharmaceutical-inc/projects/chim-nb-pl 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ct-p1-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/18870 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/d24-p003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/curium-romania-s-r-l/projects/iason-fc303 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cero-therapeutics-holdings-inc/projects/ico-2023-16 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/instituto-grifols-s-a/projects/ppro24-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-mesto/projects/rpn-nls02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/223105 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratoire-hra-pharma/projects/lt10430-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2025-520884-42-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-516509-22-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/iibsp-pre-2024-198 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r3918-pnh-2483 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/fit-05 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/fit-piv 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/incb054707-801 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/incb-54707-312 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/incb-54707-208 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/incb-54707-306 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/incb-54707-304 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c3651011 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ip-001-24 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/cq-001-19 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/v116-013 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/btiimd-02-ec-23-ojos 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ura-prgf-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/btiimd-01-ec-23-pied 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/elan-pharma-international/projects/hznp-dax-202 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/xenon-pharmaceuticals/projects/xpf-010-b301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/apislit-dd-g-2025-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9490-8294 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn7535-7807 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ep-262-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/a-menarini-industrie-farmaceutiche-riunite-s-r-l/projects/2024-516569-35-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/oric-pharmaceuticals/projects/agnomed 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/blue-earth-diagnostics-ireland-ltd/projects/cl-bfb759-003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bial-portela-companhia-s-a/projects/2019-abm-01-00074 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/apogee-therapeutics/projects/apg777-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-512544-27-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j2a-mc-gzps 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j3r-mc-ydaf 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/vp-c21-011 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j4f-mc-cyab 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j2p-mc-lxbd 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j3e-mc-ezdb 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j1i-mc-gzqd 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j2o-mc-ekbg 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j2s-mc-gzme 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j5p-mc-gzra 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/tv56286-ndg-20039 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/h-lundbeck-a-s/projects/20297a 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/protara-therapeutics/projects/tara-001-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alkermes-pharma-ireland/projects/alks-2680-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alkermes-pharma-ireland/projects/alks-2680-202 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ptc-therapeutics-inc/projects/ptc518-cns-002-hd 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-international-limited/projects/cb8025-41837 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cvay736a2302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/medice-arzneimittel-p-tter-gmbh-co-kg-eu/projects/6630-9450-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/ctqj230a12203 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/ctqj230a12301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/incb-54707-305 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/incb-54707-303 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/lupin-europe-gmbh/projects/mex-dm-302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/214760 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/220929 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-7240-008-study-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-7240-011 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-6194-007 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-1167-008 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cltp001a12202 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c5091017 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c1091009 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cartesian-therapeutics/projects/rnac-mg-002-aurora 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merz-therapeutics-gmbh/projects/m602011084 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cbyl719f12201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1493-0002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-ag/projects/22419 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/avalo-therapeutics/projects/avtx-009-hs-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/argenx/projects/argx-119-2303 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/argenx/projects/argx-117-2003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/argenx/projects/argx-117-2301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/argenx/projects/argx-113-2007 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/blueprint-medicines-netherlands-b-v/projects/blu-263-1201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/shr8735-303 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ag881-c-004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/eortc-2427-btg 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/mhicc-2021-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/cor1167-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/arrowhead-pharmaceuticals-inc/projects/aroang3-3001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp200072 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratoire-hra-pharma/projects/nal-ii-23-1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ipsen-pharma/projects/clin-10200-457 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/tmp-18122023-58 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/galectin-therapeutics-inc/projects/gt-031 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/dr-falk-pharma-gmbh/projects/cec-013-cel 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r2477-fop-2175 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r9933-dvt-2308 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r7508-cat-2392 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/dianthus-therapeutics-inc-de/projects/dnth103-cidp-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/blueprint-medicines-netherlands-b-v/projects/blu-808-1201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1434-0027 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1397-0014 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1305-0069 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/a35-009 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/icp-cl-00609 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/neumora-therapeutics/projects/nmra-335140-303 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biotest-pharma-gmbh/projects/1001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c3651003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c4921003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/zealand-pharma-a-s/projects/zp8396-23094 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/zealand-pharma-a-s/projects/zp1848-23029 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/argenx/projects/argx-117-2402 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/argenx/projects/argx-113-2409 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/cv029-1001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/seaport-therapeutics/projects/spt-300-2024-203 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/ror-ph-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/precision-biosciences-inc/projects/prax-628-321 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/aln-ttrsc04-003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20230227 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/env-202 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/maplight-therapeutics/projects/ml-007c-ma-221 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-7240-013 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-7240-012 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/mira-pharmaceuticals-inc/projects/m-00223-20 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/keros-therapeutics/projects/ker-012-a201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/95597528adm2001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/223125 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/viiv-healthcare-bv/projects/212580 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/react 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/219231 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/219288 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/202009 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biohaven-bioscience-ireland-limited/projects/bhv7000-303 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r7508-dvt-24120 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d8820c00003-prism 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9440c00004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d7830c00004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20230222 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20220093 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20230143 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ag946-c-003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/acp-204 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m25-268 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp180591 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp180587 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp200042 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vor-biopharma/projects/rc18g006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ferring-pharmaceuticals-a-s/projects/tri-001-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2025-521153-16-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ipsen-pharma/projects/d-ca-60130-452 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/argenx/projects/argx-113-2302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/78278343pcr3001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j1i-mc-gzbo 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/42847922mdd3003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-513486-39-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/efc17045-peridot 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/nmd670-02-0001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cvay736b2201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cexv811a12301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn6018-8195 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/ex6018-4758 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratoire-hra-pharma/projects/sb-110-007 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/787-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/piromelatine-psg-rbd 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/umcg-neolync-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/aln-4324-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/14-xc-cl 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ray902ct 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/hs235-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/caaa603c12101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/proicm-2019-03-mes 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ray903ct 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/esteve-pharmaceuticals/projects/esteve-sanf-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pierre-fabre-medicament/projects/f60087ci101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ds101-ct-01-58-18-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ds101-ct-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/pm14-a-001-17 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bial-portela-companhia-s-a/projects/bia-28-6156-111 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cmgy825a12101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/ciag933a12101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/c20-48 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cfxx489a12101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/pm54-a-002-24 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/pm534-a-002-24 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/pm534-a-001-22 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/cset-n-2020-3188 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/cset-2020-3187 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn6706-8282 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn6706-8212 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2023-3668 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2024-515580-64-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/revolution-medicines/projects/rmc-6291-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/95597528edi1001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/bdr17182 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/syndax-pharmaceuticals-inc/projects/sndx-5613-0708 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pyxis-oncology/projects/pyx-201-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pyxis-oncology/projects/pyx-106-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/loxo-idh-20001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/olema-pharmaceuticals/projects/op-3136-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/89402638gic1001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/immunocore-ireland-limited/projects/imc-p115c-1005 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d8530c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20180146 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/ms201491-0001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r9533-hv-2411 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/aln-f1202-hv-2412 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/95566692lym1001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/cbd-in-gbm 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/oric-pharmaceuticals/projects/silmakin 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/mino-pk 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/zaklady-farmafarmaceutyczne-polpharma-s-aceutyczne-polpharma-s-a/projects/2024-520019-41-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/oric-pharmaceuticals/projects/oric-944-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp240512 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2024-514765-19-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2025-520676-26-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/dbv-technologies/projects/v712-305-epopex 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/dbv-technologies/projects/v712-308 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/u31402-277 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/u31402-a-u201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/401gsdia02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/dtx401-cl401 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-mesto/projects/kct23-2022-zoom-in 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/orion/projects/3133004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/maze-therapeutics/projects/ngam-16 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2024-517565-16-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-international-limited/projects/gs-us-409-5704 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/ft04carcik 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ptc-therapeutics-inc/projects/ptc923-md-004-pku 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ptc-therapeutics-inc/projects/ptc857-cns-001-als 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bial-portela-companhia-s-a/projects/2020-abm-01-00074 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp211046 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-511585-36-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-518639-12-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/psk00010 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/clinuvel-europe-limited/projects/cuv803 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/clinuvel-europe-limited/projects/cuv901 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/clinuvel-europe-limited/projects/cuv158 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-517709-10-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2024-517861-18-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/2024-514353-30-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/precision-biosciences-inc/projects/prax-628-322 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/precision-biosciences-inc/projects/prax-628-323 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/precision-biosciences-inc/projects/prax-628-212 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/precision-biosciences-inc/projects/prax-222-311 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cppy988a12203b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/pm14-a-002-20 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/lpi-2501 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/pro-rct-gram-2025-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/pro-rct-gram-2022 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fulcrum-therapeutics/projects/1821-fsh-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cpkn605a12201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m25-692 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/zealand-pharma-a-s/projects/zp8396-25077 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c6231002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c5001001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c5001004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c4891026 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/var2-2024-cs01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9690c00007 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-516125-31-02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pmv-pharmaceuticals/projects/pmv-586-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/argenx/projects/argx-113-2010 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/2024-512297-96-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2025-524177-16-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2023-504690-21-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2025-521170-33-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/jam-mc-pwmp-pw01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j2a-mc-gzpo 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j2a-mc-gzpr 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j2a-mc-gzpw 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j2a-mc-gzpt 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-517258-85-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ann-008 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chiesi-farmaceutici-s-p-a-eu/projects/cli-06657aa1-03 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/immunitybio-ireland-limited/projects/quilt-2-005 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20230191 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2024-516797-29-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/lex-210 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-516788-96-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/was-tlt003-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/centessa-pharmaceuticals-plc/projects/orx750-0201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/centessa-pharmaceuticals-plc/projects/orx750-202 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/oruka-therapeutics/projects/orka-001-114 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/oric-pharmaceuticals/projects/oric-114-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j2a-mc-gzpl 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/tour-hekla/projects/2024-514293-46-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2024-519591-39-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-513635-24-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/axim-biotechnologies-inc/projects/pnoc023 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/axim-biotechnologies-inc/projects/pnoc022 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/omtx705-006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ic-2021-07 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/orion/projects/3133003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/747-308 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/977-311 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/dri17822 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chiesi-farmaceutici-s-p-a-eu/projects/cli-10196aa1-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2025-524778-41-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/larimar-therapeutics/projects/clin-1601-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2023-506857-40-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/imb101-010 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/maze-therapeutics/projects/norm-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2024-519993-38-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-2140-006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-1026-003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/eip22-nfd-505 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/sts-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/stemness-panc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/can-fite-biopharma/projects/cf102-212ld 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/215336 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp241595 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/2024-511790-30-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/215344 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/nl79665-058-22 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/nxp800-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/nurix-therapeutics/projects/nx-5948-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/dr-falk-pharma-gmbh/projects/nut-022-psc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/dr-falk-pharma-gmbh/projects/nuc-5-psc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/2024-514565-18-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ns229-p2-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/noe-tts-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9490-8024 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9490-8021 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9490-8293 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9490-8025 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9490-8266 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9490-8559 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9490-8026 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/neumora-therapeutics/projects/nmra-335140-501 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/nmd670-02-0003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/nmd670-02-0002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/nektar-therapeutics/projects/23-358-06 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cero-therapeutics-holdings-inc/projects/2024-519971-25-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-516718-39-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-519626-21-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cnio752a12301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ista-pharma-limited/projects/2023-508664-30-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pierre-fabre-medicament/projects/v00018pc303 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/neurocrine-biosciences-inc/projects/nbi-74788-cah2011 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/neurocrine-biosciences-inc/projects/nbi-1117570-scz2035 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/neurocrine-biosciences-inc/projects/nbi-1117568-scz3030 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/neurocrine-biosciences-inc/projects/nbi-1117568-scz3032 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/neurocrine-biosciences-inc/projects/nbi-1065845-mdd3027 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/neurocrine-biosciences-inc/projects/nbi-1065845-mdd3026 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/neurocrine-biosciences-inc/projects/nbi-1065845-mdd3025 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/neurocrine-biosciences-inc/projects/nbi-1065845-mdd3028 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/dr-falk-pharma-gmbh/projects/nat-19-gpx 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/dri18450 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-516645-39-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-514255-15-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bp45910 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/im034-1000 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j6i-mc-owaa 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2026-526044-12-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/p-monofer-chf-02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/u23-0607 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2026-525163-41-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/aln-app-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2024-517082-16-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/up0152 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-079-3002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-079-3001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-079-3003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/lupin-europe-gmbh/projects/mex-dm-303 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/aur1-1-313-drtb-hdt 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/piaii 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2023-509732-25-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/elan-pharma-international/projects/gh001-trd-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/67953964mdd3007 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/67953964mdd3005 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/22774 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/madrigal-pharmaceuticals-inc/projects/mgl-3196-11 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bioprojet-pharma/projects/p22-04-bp1-7881 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bioprojet-pharma/projects/p24-05 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biogen-idec-ltd/projects/283pd201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/act18301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-279-pso-3006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-279-psa-3002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-279-psa-3003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/can-fite-biopharma/projects/cf101-302ps 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bioprojet-pharma/projects/p24-04 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bioprojet-pharma/projects/p23-05 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/act17754 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/act18053 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/efc18419 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/act18421 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/efc16819 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/lts18420 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/efc18326 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/efc17504 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/act16877 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/dri18212 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/dri17849 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/viiv-healthcare-bv/projects/223803 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m24-991 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/mpoh06 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/maze-therapeutics/projects/mze829-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp240201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/2025-520573-39-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/mt-7117-a-302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/mt-7117-a-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca240-0009 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/mylan-dura-gmbh/projects/mr-130a-01-td-2002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-517646-34-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-8591a-033 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-7480-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-7091-003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-6194-006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-4646-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-4318-005 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3543-017 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3475a-f65 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3120-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3120-003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-2420-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-2214-004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-2060-007 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-0616-015 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-0616-029 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-0616-019 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/madrigal-pharmaceuticals-inc/projects/mgl-3196-19 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/2024-517764-38-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/2024-516965-35-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-513924-41-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-511580-28-02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-511580-28-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp230872 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/breakfast 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/2025-520940-14-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/d7060c00003-m26-031 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/partner-therapeutics-limited/projects/mcla-128-cl01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/axim-biotechnologies-inc/projects/sp-mb21pac 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/844700336-0156-1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cmas825j12201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/ms202650-0001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/ms202659-0001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/ms202329-0010-19-74-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/ms202329-0010-17-34-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/ms202329-0010 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ic-2022-10 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2024-516842-21-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2024-516841-38-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m25-056 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m20-465 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/blue-earth-diagnostics-ireland-ltd/projects/bet-psma-121 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/id-069a302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/h-lundbeck-a-s/projects/18252a 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fulcrum-therapeutics/projects/fis-002-2019 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fulcrum-therapeutics/projects/fis-001-2019 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2024-512484-31-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m19-345 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2025-520619-15-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/tenax-therapeutics-inc/projects/tnx-103-07 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/panama-id-116348 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/colebu 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2024-516148-24-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2024-519790-19-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/nordic-group-b-v/projects/2024-516327-14-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-514210-12-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-510904-36-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/meda-ab/projects/lamiferon 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/dompe-farmaceutici-s-p-a/projects/ldx0319 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/iph4102-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-514769-20-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/vph-gxl-2025-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/1-bob1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cadpt09a12201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/im0271015 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/im027068 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/lp352-303 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/lp352-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/clou064m12101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/clou064a2306b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biocodex/projects/bowell-sb252 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/clna043a12202 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-513883-24-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/dream-gr-2018-12367 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pierre-fabre-m-dicament/projects/2025-523777-41-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/cset-2021-3373-80-36-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/cset-2021-3373 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/collegium-pharmaceutical-inc/projects/hyp-nor 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/2023-509604-15-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/clxh254c12201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/elite-pharmaceuticals-inc-nv/projects/lbs-008-ct08 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/aop-orphan-pharmaceuticals-gmbh/projects/lb208-1-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-513363-15-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2025-524876-43-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/panc-cap-3001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/2023-506721-11-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/nl77785-078-21 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/cn012-0036 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/cn0120056 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/cn012-0046 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/cn012-0037 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/cn012-0038 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/cn0120020 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/cn012-0024 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/cn012-0023 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/cn012-0052 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/cn012-0025 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/cn012-0051 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/kamada-biopharma-limited-at-fieldfisher-llp/projects/kamadaaatinhaled008 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/kyverna-therapeutics/projects/kyv101-004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/kvd900-303 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/kvd900-302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/kymera-therapeutics/projects/kt621-as-202 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/kymera-therapeutics/projects/kt621-ad-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/kiniksa-pharmaceuticals-international-plc/projects/kpl-387-c212 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/kura-oncology/projects/ko-2806-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/kyowa-kirin-holdings-b-v/projects/8123-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/kedrion-s-p-a/projects/kb072 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/2023-507365-26-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cardiff-oncology/projects/2024-515369-33-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/tour-hekla/projects/2023-506329-12-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/kailera-therapeutics/projects/k9531-3103 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/2024-516105-23-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/jazz-pharmaceuticals-plc/projects/jzp598-206 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-gmp-2505 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/at861-g-22-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/jr-441-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/jr-141-gs32 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/otsuka-novel-products-gmbh/projects/jnt517-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/88545223psa2001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/79635322mmy2001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/77242113psa3002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/77242113crd3001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/77242113pso3001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/partner-therapeutics-limited/projects/2024-512288-29-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/61186372nsc2012 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/67953964mdd3003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ac-055-312 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/tour-hekla/projects/sogug2020iec-vej-11 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/61186372nsc3004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/61186372pansc2002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/2023-506587-13-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/54767414smm3001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/42756493can2002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/17000139blc2002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/17000139blc2001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/2024-517622-25-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2024-516798-54-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cjdq443b12201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/jab-21822-1001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/act18018 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/efc16750 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/efc18418 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/lts18133 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/pdy16967 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp180613 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/mom-m281-006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/maze-therapeutics/projects/ngam-12 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/maze-therapeutics/projects/cone-02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-516260-29-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-510617-15-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/collegium-pharmaceutical-inc/projects/dices 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9490-7611 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn6582-4838 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/zealand-pharma-a-s/projects/zp8396-25041 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9490-8153 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r3918-amd-2501 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/2023-506211-18-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/h-lundbeck-a-s/projects/20453a 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/proicm-2019-08-int 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2025-524680-21-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/nl79259-078-21 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-ag/projects/12916 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cardiol-therapeutics/projects/cardiol-100-004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ap-recap-csa-rd-0201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/inhibikase-therapeutics/projects/ikt-001-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/ds7300-203 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3475-06f 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/kailera-therapeutics/projects/k9531-3104 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/neurocrine-biosciences-inc/projects/nbi-1065845-mdd3024 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/77242113uco3001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/lum-201-10 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m24-555 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/axim-biotechnologies-inc/projects/2024-517846-32-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/italfarmaco-s-p-a/projects/dsc-14-2357-51 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/italfarmaco-s-p-a/projects/dsc-14-2357-52 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ionis-pharmaceuticals-inc/projects/isis-721744-cs8 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ionis-pharmaceuticals-inc/projects/isis721744-cs3 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ionis-pharmaceuticals-inc/projects/isis-721744-cs7 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ionis-pharmaceuticals-inc/projects/isis702843-cs4 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ionis-pharmaceuticals-inc/projects/isis-678354-cs13 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ionis-pharmaceuticals-inc/projects/isis-678354-cs7 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-514013-34-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/2024-510580-28-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ipsen-pharma/projects/clin-60300-450 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ipsen-pharma/projects/clin-10200-454 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ipsen-pharma/projects/clin-01203-450 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ipsen-pharma/projects/clin-01195-450 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-516127-14-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/iph6501-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ionis-pharmaceuticals-inc/projects/ion582cs1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ionis-pharmaceuticals-inc/projects/ion582-cs2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ionis-pharmaceuticals-inc/projects/ion440-cs1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ionis-pharmaceuticals-inc/projects/ion373-cs1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ionis-pharmaceuticals-inc/projects/ion363-cs1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ionis-pharmaceuticals-inc/projects/ion-682884-cs13 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/axim-biotechnologies-inc/projects/ps22pet 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/axim-biotechnologies-inc/projects/ps21gap 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/inz701-104 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/inz701-105 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/inz701-106 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/inz701-304 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2024-515372-12-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/inflarx-gmbh/projects/inf904-p2-1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-511966-36-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/incb-00928-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/61186372pansc2001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/inbrx101-01-202 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chiesi-farmaceutici-s-p-a-eu/projects/cli-05993aa5-06 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/hiper-reset 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/2023-508100-38-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-514597-42-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/2023-505514-15-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-516753-45-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/immunocore-ireland-limited/projects/imc-m113v-103 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-516511-24-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-510924-38-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/idp-121-2-mycrocytic 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/idp-121-1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/id-091a201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ideaya-biosciences/projects/ide196-010 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/supernus-pharmaceuticals-inc/projects/817p203 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/pauf-i 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/btiimd-02-ec-23-ojos-57-15-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ionis-pharmaceuticals-inc/projects/ion269-cs1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biogen-idec-ltd/projects/296fa301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ctsp-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/elan-pharma-international/projects/hznp-hzn-1116-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-341-2001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hoth-therapeutics/projects/cleer-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hemab-therapeutics-holdings/projects/hmb-001-cl101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/hdp-101-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/intrabio-ireland-limited/projects/ib1001-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/giro-t1d 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cognition-therapeutics-inc/projects/ucab-ct-05 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/nl72125-078-19 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2024-513949-37-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/zealand-pharma-a-s/projects/zp1848-17127 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/zealand-pharma-a-s/projects/zp1848-20110 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/zealand-pharma-a-s/projects/zp1848-25009 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2025-521870-33-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/autolus-therapeutics-plc/projects/2024-512903-38-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alexion-europe-sas/projects/alxn1720-mg-302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/2025-523306-33-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-519884-16-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2024-515228-36-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-516922-70-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cgxv813b12201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/gtx-102-cl301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/gtx-102-cl210 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gensight-biologics-s-a/projects/gs030-clin-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-international-limited/projects/gs-us-611-6464 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-international-limited/projects/gs-us-611-6472 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-international-limited/projects/gs-us-567-6968 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/great-pk 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/rani-therapeutics-holdings/projects/grt-1c102 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ip-001-21 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp200175 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/sp-gl0034-02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cgia632a12201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/genmab-a-s/projects/gct1078-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/genmab-a-s/projects/gct1047-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/2023-510015-19-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-516708-40-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-514233-37-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ap01-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/fur-05-24 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/act17010 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/efc18098 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2024-518611-18-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/dompe-farmaceutici-s-p-a/projects/df2755a-hv-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-510903-12-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2024-513376-17-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-513933-18-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/hebro-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/predict-study 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2024-515624-36-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/i9x-mc-mtae 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-schering-pharma-ag/projects/22049 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/ds2243-054 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/turn-therapeutics/projects/ca177-1036 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/ds1471-079 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/ds9051-079 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r20423-hv-2555 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/ds3610-071 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bp45770 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/onkure-therapeutics/projects/oki-219-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/aln-snca-pd-2482 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/300163 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/km023-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2023-507213-97-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/delay 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/elan-pharma-international/projects/hznp-hzn-825-302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/estetra-sprl/projects/2024-517890-26-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/77242113pso3003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cero-therapeutics-holdings-inc/projects/2024-519208-29-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ironpad 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/hi-cor-65 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-518041-16-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biogen-idec-ltd/projects/299ar201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/rp-l102-0116-ltfu 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cfwy003a12201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2023-507485-10-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fate-therapeutics-inc/projects/ft819-102 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cero-therapeutics-holdings-inc/projects/2025-522108-26-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp231308 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ferrer-internacional-s-a/projects/fnp223-ct-2301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-517700-12-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-518908-46-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cero-therapeutics-holdings-inc/projects/ico-2023-25-optimise 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biomarin-pharmaceutical-inc/projects/351-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biomarin-pharmaceutical-inc/projects/351-202 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ipsen-pharma/projects/clin-10200-458 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/2024-517566-42-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chiesi-farmaceutici-s-p-a-eu/projects/cli-05993bb1-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chiesi-farmaceutici-s-p-a-eu/projects/cli-06467ac1-02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/2023-509752-34-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ag181-c-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cero-therapeutics-holdings-inc/projects/tep-64cu-atsm-rectum 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/17651 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/2023-509452-34-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn7535-7822 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/4202-hem-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ic-2022-12 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/euct-2024-511805-42 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/mediwound-germany-gmbh/projects/mw2022-06-22 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/genmab-a-s/projects/2023-504832-16-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp-190183 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/p160931j 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp180572 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp241418 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/72189812 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/2023-503378-19-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2024-515557-22-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/tv56286-ndg-20041 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j3r-mc-ydag 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j3r-mc-ydal 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j3r-mc-ydao 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2024-514416-28-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/rt2019-13 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/argenx/projects/argx-113-2301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/argenx/projects/argx-113-1902 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/proicm-2021-02-gab 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/pdy17892 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/neurocrine-biosciences-inc/projects/nbi-921355-1785 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/cooperation-2-0 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-518554-17-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-520392-27-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-516755-40-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-226-3001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pierre-fabre-medicament/projects/edelife 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j2j-mc-jzla 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-0160-1003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/enhance 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp230864 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eikon-therapeutics/projects/eik1004-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/clee011x2x01b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/italfarmaco-s-p-a/projects/effi2021-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/enanta-pharmaceuticals-inc/projects/edp-938-104 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/edgewise-therapeutics/projects/edg-5506-203 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/efc18325 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/efc18327 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-513516-99-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/tv56192-pd-10191 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp180583 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp211053 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biontech-manufacturing-gmbh/projects/bnt152-01c 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/2024-511900-17-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r5459-1979-ln-2459 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/medice-arzneimittel-p-tter-gmbh-co-kg-eu/projects/6630-9450-01-64-35-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cero-therapeutics-holdings-inc/projects/ico-202-28-dopacer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c5731006-sgndv-006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/api-eab-2024-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/api-eao-2025-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/advanced-accelerator-applications/projects/api-eal-2024-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2023-507481-43-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/panama-id-8070 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/0600-pg-psc-218 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/76712 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharm-research-associates-uk-limited/projects/debio-4228-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharm-research-associates-uk-limited/projects/debio-0123-106 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20230050 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/2023-505552-22-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/philogen-s-p-a/projects/phl19il2tnfnmsc04-19 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/philogen-s-p-a/projects/phl19il2tnfcomb04-24 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/philogen-s-p-a/projects/ph-l19il2tnf-02-15 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cdyp688a12101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/2024-515942-18-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/duo2025-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/dt-dec01-dmd-ct-1-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d967vc00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d967mc00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9673c00007 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/ds8201-0001-cis-ma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-gmp-2402 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/romast-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/ds3939-077 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-518549-27-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/vph-gxl-2025-1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp201183 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/levomems 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/dianthus-therapeutics-inc-de/projects/dnth103-mmn-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/agp100-c01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/chdr2227 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2023-509898-23-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cadpt15a12201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/2025-521090-14-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/2024-511855-16-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sana-biotechnology/projects/treat-lmna 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/dcc-3084-01-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/dcc-3014-03-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/dcc-3014-01-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/2024-516221-31-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/db-oto-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2023-510433-29-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1438-0008 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1438-0007 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1438-0009 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/revolution-medicines/projects/rmc-6236-304 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2024-511635-94-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-516126-54-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cero-therapeutics-holdings-inc/projects/2024-513515-27-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-511008-17-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2504-lis-054-an 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2024-515641-42-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/gr-met-19 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/panama-code-113071 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/060018-pg-psc-217 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fresenius-kabi-deutschland-gmbh/projects/fyb202-004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/s221237-176 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/nl66938-041-19 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biontech-manufacturing-gmbh/projects/bnt116-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ado-01-24 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/aly688er-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/116650 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/clean 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/tmp-23062025-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2023-508722-99-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-514919-10-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/2024-515237-15-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-514488-24-02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/duo2022-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/noprodalz0005 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/viatris-healthcare-limited/projects/id-064a301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/viatris-healthcare-limited/projects/id-064a302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/viatris-healthcare-limited/projects/id-064a303 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celgene-europe-limited/projects/cc-93538-ee-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r3918-pnh-2050 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-512950-13-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/2024-514808-13-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chiesi-farmaceutici-s-p-a-eu/projects/cli-06001aa1-09 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cardiol-therapeutics/projects/cardiol-100-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/acp-101-302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/acp-101-303 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2024-519669-23-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2025-522962-58-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2024-516800-40-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/2024-514031-20-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/2024-519986-23-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/cx11202 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c4891024 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/k-001-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/crd-4730-202 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/2025-521230-29-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/ccpk850x2202 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cdak539a12001b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/corcept-therapeutics-inc/projects/cort113176-652 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ic-lv-acz-pchc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/23eu-ct11 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/don3 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2024-511637-35-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-516414-38-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2024-516862-12-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/genzyme-europe-b-v/projects/lte15174 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/tmp-05062025-1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merz-therapeutics-gmbh/projects/m602011085 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cullinan-therapeutics/projects/cln-081-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chiesi-farmaceutici-s-p-a-eu/projects/cli-06001aa1-04 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chiesi-farmaceutici-s-p-a-eu/projects/cli-06001ac1-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cogent-biosciences/projects/cgt9486-20-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2024-518987-11-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2025-522027-95-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2023-508731-31-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-512030-15-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/cd5car-nk 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celgene-europe-limited/projects/im045-1018 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celgene-europe-limited/projects/cc-92480-mm-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/iibsp-car-2023-74 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/2024-514481-39-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2024-517704-10-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2024-513920-40-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-514620-17-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2024-519007-10-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-514049-13-02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2023-509821-29-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c6081001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c6001001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c5951001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c4531029 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c4531002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-516493-30-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2024-515588-67-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2025-522160-32-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2024-516435-27-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/217023 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/204852 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/dr-falk-pharma-gmbh/projects/bus-006-rap 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/jasper-therapeutics/projects/jsp-cp-014 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j2s-mc-gzmr 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ori2025-46 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/disc-1459-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/disc-1459-501 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/dhm-eph-01-2022 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cfub523a12302b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cfub523a12201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/gebro-i-56-1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/orion/projects/3135003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/orion/projects/3135004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/uechup-alt-rsv-26-1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/n-lop-25-303 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/n-lop-25-296 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/n-lop-24-289 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/n-lop-25-298 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/n-bil-24-288 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/a-menarini-industrie-farmaceutiche-riunite-s-r-l/projects/bila-4124-ped 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2025-522194-11-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pliant-therapeutics-inc/projects/pln-74809-ipf-206 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/fp2cli004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/lp352-302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/0796-19 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cns-pharmaceuticals/projects/cns-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/rani-therapeutics-holdings/projects/ber-pum-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/psp002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20210104 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharm-research-associates-uk-limited/projects/cr6086-1-04 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/lts19689 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2023-510431-11-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cbyl719p12201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cbyl719f12202 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cbyl719f12401 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/bw-20805-2001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/dr-falk-pharma-gmbh/projects/bul-5-esd 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bicycle-therapeutics/projects/bt8009-duravelo-3 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/bv-2020-08 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/bv-2020-09 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/kibb01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biontech-manufacturing-gmbh/projects/bnt329-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biontech-manufacturing-gmbh/projects/bnt324-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biontech-manufacturing-gmbh/projects/bnt323-03 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biontech-manufacturing-gmbh/projects/bnt314-02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biontech-manufacturing-gmbh/projects/bnt326-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biontech-manufacturing-gmbh/projects/bnt314-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biontech-manufacturing-gmbh/projects/bnt211-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biontech-manufacturing-gmbh/projects/bnt142-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca2560001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca2540001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca230-1019 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2025-520735-16-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2024-519067-17-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2024-519050-37-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/blue-earth-diagnostics-ireland-ltd/projects/bjt-778-304 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/blue-earth-diagnostics-ireland-ltd/projects/bjt-778-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/imprimido 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2024-517357-27-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/denali-therapeutics/projects/dnli-c-0009 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biogen-idec-ltd/projects/nsr-chm-os2-273ch201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biogen-idec-ltd/projects/233as303 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biogen-idec-ltd/projects/230le305 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ib-2023-02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1403-0032 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1403-0019 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1436-0007 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1434-0004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1434-0017 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1366-0055 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1404-0041 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1404-0056 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1404-0040 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1404-0038 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1504-0001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1504-0003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1509-0004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1490-0004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1462-0004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1485-0018 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1479-0009 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1305-0023 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1305-0031 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biohaven-bioscience-ireland-limited/projects/bhv7000-304 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biohaven-bioscience-ireland-limited/projects/bhv7000-302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biohaven-bioscience-ireland-limited/projects/bhv7000-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/2023-506948-17-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/blue-earth-diagnostics-ireland-ltd/projects/cl-bfb759-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2024-516843-15-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/2024-514400-14-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/aura-biosciences/projects/au-011-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp180668 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp220822 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beam-therapeutics/projects/btx-302-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/bcx17725-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bp45381 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/17000139blc3002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-ag/projects/22551 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-ag/projects/21656 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-ag/projects/22040 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-ag/projects/22752 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-ag/projects/19429 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-gtg-2310 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/2024-510840-30-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-ag/projects/21683-velocity 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/inca034176-355 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/inca034176-256 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2024-517200-10-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2024-516844-25-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2023-506395-27-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/rc-4-24-treat-uti 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/crn04894-13 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/crn04894-12 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d7552c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/medice-arzneimittel-p-tter-gmbh-co-kg-eu/projects/6520-9970-08 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cardiol-therapeutics/projects/search 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/d24-p017 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/atn-108 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vera-therapeutics/projects/vt-001-0051 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vera-therapeutics/projects/vt-001-0060 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vera-therapeutics/projects/vt-001-0020 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-ag/projects/21174 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp180619 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/orion/projects/sens-401-202 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/synact-cs010 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/synact-cs003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/ms743701-0001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/axim-biotechnologies-inc/projects/sp-ps21din 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/ms201460-0001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/fleca-ed 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharming-technologies-b-v/projects/kl1333-2025-104b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/2025-522921-37-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/int18404 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biontech-manufacturing-gmbh/projects/ntc-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/cx842b2111 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1346-0014 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/845900241-0147-1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-516781-10-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/lts17231 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ip-ct-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d853ac00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/77242113pso1007 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ipsen-pharma/projects/clin-01194-450 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eisai-gmbh/projects/bb-1701-g000-205 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/platformpacan1001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/dcr-phxc-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/cset-n-2021-3339 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ideaya-biosciences/projects/ide397-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/ga46438 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/hs135-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/tg1-cl-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9180c00006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-515824-35-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/iibsp-fas-2020-120 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/dri17509 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/lts17367 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/dri17963 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/dri18180 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/act17967 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2025-521770-34-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alexion-europe-sas/projects/alxn1920-pmn-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/300356 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/300336 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/mira-pharmaceuticals-inc/projects/m-00alm-04 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/instituto-grifols-s-a/projects/ig1407 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/til-in-nsclc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/vanish-trial 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2024-515333-14-03 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2025-522084-15-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sana-biotechnology/projects/abc2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d7040c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d7270c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d6830c00003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9690c00006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9690c00005 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9570c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d7860c00006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d5339c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/titanium 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d7260c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d8210c00005 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d8210c00003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/allight-d9891c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9890c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d8930c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d8620c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d7770c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9640c00003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9804c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/pursuit 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d7960c00015 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d7960c00012 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d7960c00013 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9520c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d7700c00003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/syndax-pharmaceuticals-inc/projects/sndx-6352-0506 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/otsuka-novel-products-gmbh/projects/20-avp-786-307 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/otsuka-novel-products-gmbh/projects/20-avp-786-306 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/aurinia-pharmaceuticals/projects/aur-200-2024-02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/aclaris-therapeutics/projects/ati-045-ad-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amicus-therapeutics-europe-limited/projects/atb200-07 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astellas-pharma-gmbh/projects/atx-mtm-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/taiho-pharma-netherlands-b-v/projects/astx727-06 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-international-limited/projects/cb8025-31731-re 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astellas-pharma-gmbh/projects/2957-cl-0101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/d20180302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/artelo-biosciences-inc/projects/art27-13-100 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/arrowhead-pharmaceuticals-inc/projects/aroc3-1001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/arrowhead-pharmaceuticals-inc/projects/aroapoc3-3001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/arrowhead-pharmaceuticals-inc/projects/aroapoc3-3006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/arrowhead-pharmaceuticals-inc/projects/aroapoc3-2003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/argenx/projects/argx-999-2-mg-20001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/argenx/projects/argx-113-1803 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/argenx/projects/argx-113-2005 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/apl2-ga-305 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/apogee-therapeutics/projects/apg777-202 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/illuminate 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ap31969-m201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/cs008 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ap02-003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/2023-509399-40-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/minoryx-therapeutics-s-l/projects/mt-2-02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/crn04894-09 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/a35-004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/orapat-ie-games 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/2024-513744-28-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2023-509156-34-02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20230294-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20240031 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20220127 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20210023 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20230223 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20230167 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20230153 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20210181 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20230225 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20210184 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20190218 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20220196 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alexion-europe-sas/projects/alxn2220-attrcm-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alexion-europe-sas/projects/alxn1850-hpp-305 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alexion-europe-sas/projects/alxn1850-hpp-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alexion-europe-sas/projects/alxn1720-mg-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alexion-europe-sas/projects/alxn2050-neph-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alexion-europe-sas/projects/alxn2040-ga-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alexion-europe-sas/projects/alxn2040-pnh-302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/2024-514611-98-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alkermes-pharma-ireland/projects/alks-2680-203 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alkermes-pharma-ireland/projects/alks-2680-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2025-522427-10-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2025-522659-24-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/al8326-us-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/al8326-us-001-67-24-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/adx-038-202 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/adx-038-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/fjd-uhc-19-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c4391010 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-516277-68-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/p160924 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/id-086b201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp220800 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-518122-33-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/ac-203-ebs-007 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/abt-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ltfu-abo-102 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m25-191 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/77242113pso1008 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/h-lundbeck-a-s/projects/21117a 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9470c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d8990c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9723c00002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d8340c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d5084c00016 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d533bc00003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gruenenthal-gmbh/projects/hp6019-07 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/viatris-healthcare-limited/projects/id-064-108 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/petadeferitrin-ba-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/77242113pso1010 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn6706-8230 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1404-0011 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/h-lundbeck-a-s/projects/20653a 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bp45361 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1493-0008 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1530-0002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1438-0003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/2001-0001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1530-0001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1524-0001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1507-0001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1516-0002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn1471-5026 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn1471-7712 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1543-0001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1519-0002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1480-0001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1404-0009 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1516-0003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1438-0001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1454-0015 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1538-0001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1456-0001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1472-0001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/revolution-medicines/projects/rmc-6291-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bp46355 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-ag/projects/22806 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-ag/projects/22600 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/up0124 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c4151008 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-ag/projects/2023-503547-33-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c5961001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-ag/projects/22375 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c5911001-sgn-cd25v 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-ag/projects/22723 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-ag/projects/22665 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-ag/projects/22265 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-ag/projects/22534 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-ag/projects/22700 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/64619178edi1001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/221615 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/220104 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/pkm23567 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/bdr17530 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d740ac00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/bdr18228 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/oncopeptides-ab-publ/projects/op-701 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/cl1-221237-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1505-0001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astellas-pharma-gmbh/projects/5834-cl-1001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/agomab-therapeutics-nv/projects/agmb101-01-cl-102 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/90106848edi1001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/70035108edi1001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/inca-33989-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bp44382 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/o3r-5671-cl-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biohaven-bioscience-ireland-limited/projects/bhv2100-112 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/galmed-pharmaceuticals/projects/cga23001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/88545223pso1001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/loxo-fra-24001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j5j-ox-jzza 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/amo-02-md-1-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/centauri-biotech-sl/projects/ctx-187-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/argenx/projects/argx-121-2401 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/vhio20001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/i8h-mc-bddg 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/argenx/projects/argx-113-2405 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celgene-europe-limited/projects/ca059-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/io-biotech/projects/sc201-victoria-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-ag/projects/20511 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/agomab-therapeutics-nv/projects/agmb129-01-cl-109 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/arcus-biosciences/projects/arc-12 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/mira-pharmaceuticals-inc/projects/m-27312-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/222261 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j5q-ox-jrda 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cadpt01c12101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2022-501910-79-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9838-4944 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/blue-earth-diagnostics-ireland-ltd/projects/bs-02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pierre-fabre-medicament/projects/pfl721ci101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/loxo-pik-21001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astellas-pharma-gmbh/projects/3082-cl-0101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astellas-pharma-gmbh/projects/2138-cl-0101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cine963a02103 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bp45325 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bp46037 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bp46585 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bp45801 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn6705-8141 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bp45800 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bp45670 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/bex17850 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/leo-pharma-a-s/projects/lp0189-2318 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1458-0006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1403-0004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/2012-0001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1527-0001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1403-0002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/67953964mdd1011 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ferring-pharmaceuticals-a-s/projects/000414 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1434-0005 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1397-0022 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1378-0027 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1305-0039 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1434-0006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1397-0021 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1404-0074 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1305-0051 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1305-0037 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1404-0099 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1404-0103 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1404-0015 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1404-0118 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1519-0004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1485-0013 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/2007-0001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1526-0001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1519-0001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1516-0001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1490-0006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1484-0017 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1447-0010 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-ag/projects/22127 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1533-0001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1509-0010 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/221531 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bp46028 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/2024-514456-32-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/zaklady-farmafarmaceutyczne-polpharma-s-aceutyczne-polpharma-s-a/projects/2025-521722-15-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/zaklady-farmafarmaceutyczne-polpharma-s-aceutyczne-polpharma-s-a/projects/2025-522562-70-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/dompe-farmaceutici-s-p-a/projects/ldx-hv-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9490-8152 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn6019-7853 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9838-4695 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn1679-8505 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn7614-7656 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9833-8285 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn6537-7650 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9541-8116 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9733-8133 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn1644-8194 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn1644-7794 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9650-5027 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9541-4922 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9833-8421 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9490-8156 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn7442-7582 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn7442-8454 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9490-8151 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn6497-8309 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9541-7760 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9541-4923 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gruenenthal-gmbh/projects/hp7040-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/m6229-c002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/2024-510774-24-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/substipharm/projects/top009 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/rani-therapeutics-holdings/projects/grt-1c101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/dri19220 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/vp-c21-016 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/verona-pharma-ireland-limited/projects/crc2024-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/vp-c21-014 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ep395-006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/206882 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/kih24001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9640c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/s-r-o/projects/2024-519920-26-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cpit565b12101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cpit565c12101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9180c00015 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/philogen-s-p-a/projects/ph-faplu-02-23 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cfkl480a02101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cgiz943a12101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-517793-25-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cgcj904a12101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/ctno155x2101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-935-3003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/shionogi-b-v/projects/2402t1432 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/rc01t001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/tisa-818-22101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/eyp001-110-op1147 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/structure-therapeutics/projects/gsbr-1290-07 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/209664 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/blue-earth-diagnostics-ireland-ltd/projects/bs-03 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/dr-falk-pharma-gmbh/projects/nat-022-bio 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/14395 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/chjb647a02101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bioprojet-pharma/projects/p24-06 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharm-research-associates-uk-limited/projects/debio-1453-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-ag/projects/22231 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-ag/projects/22262 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-ag/projects/22819 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-ag/projects/22967 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/sad18258 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/precision-biosciences-inc/projects/pbgene-hbv-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn6022-7683 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/jasper-therapeutics/projects/jsp-cp-012 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/philogen-s-p-a/projects/ph-f8il10intra-03-24 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/xo45189 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cdak539a12103 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/mp-101-02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-7228-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-6916-010 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-6050-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-4605-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3214-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-1824-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biontech-manufacturing-gmbh/projects/bnt351-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/stemline-therapeutics-b-v/projects/men2501-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pierre-fabre-medicament/projects/kn-8701-kin2787ci101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/v540c-003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/v540a-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-2870-027 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-7228-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-6916-006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-6916-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-6916-003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-6050-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-5661-007 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-5661-006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-4646-003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-4646-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-4082-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3508-006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3214-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-2828-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-2828-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-2420-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-2420-003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-1403-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-1403-004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-1289-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-0472-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/collegium-pharmaceutical-inc/projects/pb-a-a-asc-fistula-1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/zealand-pharma-a-s/projects/zp8396-24059 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/otsuka-novel-products-gmbh/projects/358-201-00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/otsuka-novel-products-gmbh/projects/323-201-00009 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/zealand-pharma-a-s/projects/zp7570-24026 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alfasigma-s-p-a/projects/ve-cip1002-2021 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/yo45758 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c5541002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bp45932 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1443-0003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/2023-508518-40-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c5091029 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/a0281007 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c6341001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c5671001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c5661001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c5381001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c5381002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c4921002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c5171002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c4541011 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c4151006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c2321006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j1i-mc-gzqf 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9090c00010 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d702ec00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bp45669 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9961c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/denali-therapeutics/projects/dnli-k-0001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/arrivent-biopharma/projects/furmo-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/wa45032 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j1i-mc-gzqg 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bp45980 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bp44551 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharm-research-associates-uk-limited/projects/debio-0123-102 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d7980c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/aln-htt02-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c4951092 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j4p-mc-iyab 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d6830c00004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bp45378 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bp45211 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m24-742 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m25-433 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/s095031-218 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c5901001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-079-1006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j6c-ox-jkfa 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j6d-mc-jsda 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j6b-mc-ykaa 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/loxo-lnc-24001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j5m-ox-joxa 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j2s-mc-gzml 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/i8x-mc-jeca 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/90301900hnc1001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/221458 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/genmab-a-s/projects/gct1106-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c2321007 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/wo42758 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j3l-mc-ezeh 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j3r-mc-ydah 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-6916-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9440c00003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/cor1389-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/cl1-210-03 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/autolus-therapeutics-plc/projects/auto1-ms1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-360-2001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/assembly-biosciences-inc/projects/abi-4334-102 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/cor1167-102 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d8210c00006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/h-lundbeck-a-s/projects/20433a 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1447-0005 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/spvn20-clin-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cdlx313a12101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cltp001a12101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/caaa617h12101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9441c00004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2025-522633-57-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/samsung-bioepis-nl-b-v/projects/e303-1001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cullinan-therapeutics/projects/cln-978-ra-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2024-518265-10-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/cx842a2104 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/philogen-s-p-a/projects/ph-acp3ga-03-25 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/philogen-s-p-a/projects/ph-caixga-02-24 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/philogen-s-p-a/projects/ph-acp3ga-01-24 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/bal2420-cp-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cidh305x2101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bp44474 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ari-her2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/208850 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/222730 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/incb123667-203 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/arcturus-therapeutics-holdings/projects/arct-032-02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharm-research-associates-uk-limited/projects/hm-gcg-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20170104 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/tyra-biosciences/projects/tyr300-202 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20210210 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/223675 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/90014496lym1001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/64264681lym1002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cullinan-therapeutics/projects/cln-978-sj-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/toray-international-u-k-limited/projects/950p1v02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/aclaris-therapeutics/projects/ati-052-asth-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/argenx/projects/argx-119-2302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cullinan-therapeutics/projects/cln-978-sl-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20230237 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/80948543lym1002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20200040 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-53038-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/enliven-therapeutics/projects/elvn-001-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-43395-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bg-60366-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/incb-81776-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bg-75202-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/centessa-pharmaceuticals-plc/projects/lb101-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sutro-biopharma-inc/projects/reframe-p1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/kyverna-therapeutics/projects/kyv101-003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/uniqure-biopharma-b-v/projects/amt-162-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/solid-biosciences/projects/sgt-003-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/denali-therapeutics/projects/dnli-e-0002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/224035 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/loxo-btk-18001-bruin 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/engene-therapeutics/projects/eg-70-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/223050 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beigene-ireland-ltd/projects/bgb-21447-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca242-0001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/aln-5288-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20230151 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ql0911-102 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9441c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/incb-57643-103 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/incb-161734-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/incb160058-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/incb-123667-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/rapport-therapeutics/projects/rap-219-103 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/64264681lym1001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/2023-509435-11-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/67856633lym1001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/stemline-therapeutics-b-v/projects/men2312-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/df-006-1001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/cor1167-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ag120-221-c-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ag120-c-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c4161006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/ik930-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/95437446luc1001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/223054 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d7930c00003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/sad18615-mad18616 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/loxo-enc-23001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/generate-biomedicines/projects/gb-0895-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/elan-pharma-international/projects/wve-007-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/taiho-pharma-netherlands-b-v/projects/tas0612-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/prelude-therapeutics-inc/projects/prt7732-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/89862175luc1001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/88549968mpn1001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/87890387stm1001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/87801493lym1001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/87189401pcr1001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/2023-504896-26-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/70218902edi1001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hutchmed-europe-b-v/projects/2020-306-glob2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celgene-europe-limited/projects/ca061-1001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celgene-europe-limited/projects/ca061-1006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca243-0001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca111-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/arcus-biosciences/projects/arc-20 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/131i-tlx-101-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/protagenic-therapeutics-inc-new/projects/pt00114-001a 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca011-1010 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-8294-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m24-427 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/tv56286-mb-10193 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/217228 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ur001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/tesaro-bio-netherlands-b-v/projects/4010-01-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cojr520a12101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/inflarx-gmbh/projects/inf904-p1-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cullinan-therapeutics/projects/cln-049-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/proqr-therapeutics-n-v/projects/pq-0810-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/cn0140003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-1708-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/2024-519010-31-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/tyra-biosciences/projects/tyr300-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bg-c0979-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/2023-503440-14-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/223646 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ipsen-pharma/projects/clin-60250-451 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/century-therapeutics/projects/cnty-ltfu-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-ag/projects/21948 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/apc148-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/iph4502-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/aln-app-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/fs222-19101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/kyowa-kirin-holdings-b-v/projects/2223-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r22044-hv-2533 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cero-therapeutics-holdings-inc/projects/perseverance-eu 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d7860c00005 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-360-2002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/caaa601a52101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-4716-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/sor102-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/2023-504643-13-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/63733657edi1003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/seaport-therapeutics/projects/spt-300-2024-204 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/dri17476 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/acp-204-013 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/acp-204-008 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-512860-75-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/spraydye-chdr2535 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/moonlake-immunotherapeutics/projects/m1095-snspa-202 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/irst100-59 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ic-2022-02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/fapi-mn-2020 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/21477 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/curium-romania-s-r-l/projects/curcu64psm0003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/curium-romania-s-r-l/projects/curcu64psm0003-54-16-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/a-c-o-m-advanced-center-oncology/projects/p-64cu-003-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/a-c-o-m-advanced-center-oncology/projects/p-64cu-002-02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/p-gp-trd 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/c22-62 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/c19-40 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/irst185-09 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/irst100-58 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/glioma-theranostics 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d8330c00004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/d23-p006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/c24-41 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/21-513 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cvhb937a12201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/56021927pcr3015 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ista-pharma-limited/projects/rcaphm18-0018 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-1200-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-512850-10-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1509-0003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d5162c00042 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d798ac00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/genzyme-europe-b-v/projects/pdy13949 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/tg-therapeutics-inc/projects/tg1101-rms401 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/tg-therapeutics-inc/projects/tg1101-rms303 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/79635322mmy3001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/64007957mmy1001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/64007957mmy1003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/219685 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/a011-12 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-7962-031 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/a011-13 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/a011-16 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/neomatryx 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/dri13926 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/efc17757 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3475-01c 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3475-01b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3475-01a 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m19-751 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/dompe-farmaceutici-s-p-a/projects/ngf0123 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/corcept-therapeutics-inc/projects/cort125134-556 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/argenx/projects/argx-113-2317 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/oncolytics-biotech-inc/projects/reo-029 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beigene-ireland-ltd/projects/bgb-a317-a1217-302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ck-0045-cs02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1199-0378 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ab-science/projects/ab20006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ab-science/projects/ab19001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ab-science/projects/ab20009 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-620-2004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/genzyme-europe-b-v/projects/efc16035 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/v940-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/v940-007 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/moderna-biotech-spain/projects/mrna1647-p301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca224-048 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/collegium-pharmaceutical-inc/projects/cadet-pad 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/impact-pro-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celgene-europe-limited/projects/bb2121-mm-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c0371017 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c3731003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/iibsp-hea-2022-145 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3475-495 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eisai-gmbh/projects/morab-202-g000-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca116-003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/at148003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/at148006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astellas-pharma-gmbh/projects/7465-cl-0301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ipsen-pharma/projects/clin-60190-454 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ipsen-pharma/projects/clin-60190-453 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ipsen-pharma/projects/gft505b-319-1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ipsen-pharma/projects/clin-60190-463 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/im011-1071 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/im011-054 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/im011-1128 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/im011-075 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/diamedica-therapeutics/projects/dm199-2021-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d8532c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9838-4968 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9500-7730 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9388-4895 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9838-4609 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9388-7637 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9388-7700 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9838-4942 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9838-7749 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ep0224 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/n01269 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/pa0016 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/hs0005 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ja0005 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/hs0006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ps0020 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/as0014 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ps0039 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/pa0012 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca027-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ep0165 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharm-research-associates-uk-limited/projects/ptt101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/19310 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/dz2024b0002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/op-lipc02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cero-therapeutics-holdings-inc/projects/zoster-ico-n-2018-14 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-0150-0603 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/avxs-101-lt-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/uroncor-06-24 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/tcd17620 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/taiho-pharma-netherlands-b-v/projects/tas6417-302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/presave 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-international-limited/projects/gs-us-626-6216 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/dv0013 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/mg0014 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ra101495-02-302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/mg0015 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/kura-oncology/projects/ko-men-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/zeal-unlock 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/103900 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/trap-btc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celgene-europe-limited/projects/im047-023 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/214828 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/incmor-0208-305 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c1071006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c1071007 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/mor208c115 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bicycle-therapeutics/projects/bt8009-230 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-0105-1401 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/gineco-en203b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/213406 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/219590 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astellas-pharma-gmbh/projects/2215-cl-0603 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cardiol-therapeutics/projects/ccm-1862 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/verona-pharma-ireland-limited/projects/discard 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-3111-306 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-11417-304 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-11417-203 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-3111-lte1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/hovon-169 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/arn-509-003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9727c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/harmony-biosciences-holdings/projects/zyn2-cl-033 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/harmony-biosciences-holdings/projects/zyn2-cl-017 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/cset-2025-4053 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/rescue-hub 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ascendis-pharma-bone-diseases-a-s/projects/asnd0035 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-sar-2212-l-utecin 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cctl019a2205b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cytb323o12101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cytb323r12101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/kt-us-982-5968 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/kt-us-473-0133 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca209-8hw 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cero-therapeutics-holdings-inc/projects/ifct-1701 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/mia2019-ct-258 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/immunocore-ireland-limited/projects/imcgp100-202 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ip-001-18 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c3441052 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c2321008 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/ctrial-ie-14-06 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/prosema 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/isr007028 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp180614 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/curateq-biologics-s-r-o/projects/bp11-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/19-659 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-ag/projects/20510 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/irst185-04 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/c16-174 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-winthrop-industrie/projects/pta17397 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alx-oncology-holdings-inc/projects/at148009 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cero-therapeutics-holdings-inc/projects/ffcd-1605-optiprime 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cero-therapeutics-holdings-inc/projects/prodige-34-adage 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3475-03c 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-6482-034 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/verona-pharma-ireland-limited/projects/incipit 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/p170912j 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merz-pharmaceuticals-gmbh/projects/m602011014 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merz-pharmaceuticals-gmbh/projects/m602011072 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp210416 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/p170913j 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/chronia001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/a3921210 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/mo41552 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca127-1030 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/a8081075 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bo28984 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/raphael 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9490-8028 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9536-7752 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/kailera-therapeutics/projects/k9531-3107 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biontech-manufacturing-gmbh/projects/bnt122-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/promise 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/axim-biotechnologies-inc/projects/sp-mh20vyx 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/argenx/projects/argx-113-2006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/hub-mgefg-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/argenx/projects/argx-113-2003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/argenx/projects/argx-113-2309 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/argenx/projects/argx-113-2315 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/argenx/projects/argx-113-2207 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/monte-rosa-therapeutics/projects/mgnt2022 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astellas-pharma-gmbh/projects/8951-cl-0305 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biomarin-pharmaceutical-inc/projects/111-303 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biomarin-pharmaceutical-inc/projects/111-211 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biomarin-pharmaceutical-inc/projects/111-302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biomarin-pharmaceutical-inc/projects/111-212 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biomarin-pharmaceutical-inc/projects/111-210 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biomarin-pharmaceutical-inc/projects/111-205 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biomarin-pharmaceutical-inc/projects/111-308 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/eyp001-210 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/haleon-ireland-dungarvan-limited/projects/300128 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/viiv-healthcare-bv/projects/221611 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/capland 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/ptc-vs-tc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-international-limited/projects/gs-us-174-0144 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vir-biotechnology/projects/vir-2218-1006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/go39942 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ns-065-ncnp-01-302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/imgn632-0802 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ep0042-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/cset-2025-4132 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astellas-pharma-gmbh/projects/2215-cl-0201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/pevonedistat-2002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ag120-c-009 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/s095031-178 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/uro-901-3007 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ep-005 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j1s-mc-jp04 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/i3y-mc-jpcg 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/geicam-2019-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/co44657 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9722c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratoire-hra-pharma/projects/lt1695-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-1242-043 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/220735 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/amag-fer-ida-352 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/amag-fer-ckd-354 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m15-954 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m15-656 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m24-287 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m16-043 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/ho159 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m19-708 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/54179060cll2032 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d8220c00036 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d822gc00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-3111-304 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-16673-302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ipc-2024-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-11417-303cll-rr1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/co41685 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/prince 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/meda-ab/projects/covidkidney 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/dompe-farmaceutici-s-p-a/projects/ngf-tbi-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharm-research-associates-uk-limited/projects/23-03-iver-c 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/top-n53-02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharm-research-associates-uk-limited/projects/19-02-mpa-s 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharm-research-associates-uk-limited/projects/21-01-clotribet-s 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/incb-18424-326 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/incb018424-316 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/incb18424-320 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/incb018424-325 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/dompe-farmaceutici-s-p-a/projects/icy0123 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/psk04 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/cart19-be-02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/ds3201-330 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celgene-europe-limited/projects/cc-99282-nhl-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/ds3201-324 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/neurocrine-biosciences-inc/projects/nbi-98854-ats3019 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/advanced-accelerator-applications/projects/apislit-dd-d-2025-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/fariduo 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/mr45638 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/menarini-international-operations-luxembourg-s-a-miol/projects/vabor-kids-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/h-lundbeck-a-s/projects/19356a 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/h-lundbeck-a-s/projects/resolution-20007a 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/h-lundbeck-a-s/projects/19379a 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/h-lundbeck-a-s/projects/19140a 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c4951063 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c4951004-bhv3000-406 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c4951002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx22-445-122 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx22-445-123 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx20-445-112 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp230824 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/pulsar 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vir-biotechnology/projects/vir-chdv-v205 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celgene-europe-limited/projects/ca073-1020 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/ines 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/baxalta-innovations-gmbh/projects/071102 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sarepta-therapeutics/projects/5051-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/lysatra-2022-3511 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/nl79264-091-21 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/aml2521 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/sy-1425-202 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ace-cl-311-amplify 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/loxo-btk-20022 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/kura-oncology/projects/ko-men-017 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/genmab-a-s/projects/gct3013-03 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/54767414leu2002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/54767414amy3001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/ds8201-772 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cvay736a2202 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cvay736f12302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cvay736a2103 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/mpoh14 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp180592 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/iibsp-hop-2021-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20240202 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20240236 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m14-327 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m14-682 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m14-533 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m17-380 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m23-716 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m19-044 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9838-8411 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/ieo-960 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alexion-europe-sas/projects/alxn2040-pnh-303 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alexion-europe-sas/projects/alxn1210-neph-202 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/rav-iga 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alexion-europe-sas/projects/alxn1210-tma-314 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/116326 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alexion-europe-sas/projects/alxn1210-nmo-317 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alexion-europe-sas/projects/alxn1210-dgf-321 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alexion-europe-sas/projects/alxn1210-igan-325 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/tg-therapeutics-inc/projects/tg1101-rms-sc301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/tg-therapeutics-inc/projects/tg1101-rms-sc201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r4018-onc-1721 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/im011-1130 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ursopol 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/bl013 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/bl011 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cardiff-oncology/projects/spon-2002-24 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cardiff-oncology/projects/spon-2002-24-11-19-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/mibiotimi 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/vhio23002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m20-621 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/bhv4157-303 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-international-limited/projects/gs-us-576-6220 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-international-limited/projects/immu-132-11 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d5985c00002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d5989c00001-tharros 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/rin-pf-305 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d4880c00003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp190648 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/protrans-v 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/2022-009 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/ds8201-a-u106 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/asnd0029 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/asnd0038 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/vp-vly-686-3304 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/intensity-therapeutics-inc/projects/it-03 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/day101-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/day101-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vera-therapeutics/projects/vs-6766-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/otsuka-novel-products-gmbh/projects/156-12-204 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/i4v-mc-jahu 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/67652000pcr1001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-a317-316 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/i8f-mc-gpix 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j1r-mc-gzfd 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/i6t-mc-amce 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/rare-thyroid-therapeutics-international-ab/projects/mct8-2019-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/rare-thyroid-therapeutics-international-ab/projects/mct8-2021-3 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bo44157 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/go41717 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/wo39613 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bo42533 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/yo42137 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/192024-092 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/61186372nsc2007 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/tild-19-12 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/tild-24-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/adivo 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ep-262-102 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/insmed-limited/projects/ins1007-231 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/fdy-5301-302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/rpl554-ncfb-220 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/dyne-therapeutics/projects/dyne251-dmd-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/uni-betain 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/pico-trat 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/b1791094 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/nw-3509-023-iii-2024 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d5980c00048 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/cpa-560-24 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/minoryx-therapeutics-s-l/projects/mt-2-04 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/kt-us-499-0150 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/rc04t001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/300889 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/rin-pf-303 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/minoryx-therapeutics-s-l/projects/mt-3-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/223529 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/crossing 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d5242c00002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d5180c00047 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d5241c00006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/journey 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/challenge 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-gig-2003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/ms200095-0022 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/efc18241 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/irst191-05 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/s095032-211 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/23u-0160 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ono-4059-17 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/snoxa12c401 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/min-003-1806 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-mesto/projects/kct02-2023-satellite 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m18-868 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m14-239 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/verona-pharma-ireland-limited/projects/crcfc-teico-sa-2022 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bo42843 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/go40241 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/ml43332 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-mesto/projects/ef-39 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/mo43156 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/2023-1-69-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/gemcad-2103-mo4 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2021-3330-holmbrave 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cero-therapeutics-holdings-inc/projects/ifct-1805 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cero-therapeutics-holdings-inc/projects/ffcd-1709-sirtci 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/go43104 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bo42592 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/wo42633 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ib-2019-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1438-0012 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biontech-manufacturing-gmbh/projects/bnt327-03 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/beatcc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/wo41535 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/aspire 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-0160-1717 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bo39633 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/achiles 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/cset-n-2017-2608 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/kte-c19-104 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/spero-therapeutics/projects/spr994-305 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cabl001a2001b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/cml1624 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/cset-2024-4014 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/partner-therapeutics-limited/projects/etop29-25-start-lung 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20200491 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cero-therapeutics-holdings-inc/projects/gco-003-tarlanec 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp210090 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/b3461114 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cytokinetics-ireland-limited/projects/cy-6033 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/geicam-2020-08 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/wo46069 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d361fc00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d967jc00002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/d3612l00005 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/relay-therapeutics/projects/rly-2608-102 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/dompe-farmaceutici-s-p-a/projects/ngf-pced-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ib-2021-03 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/mgt-rpgr-022 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3475-02c 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/insmed-limited/projects/ins1009-203 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/insmed-limited/projects/ins1009-202 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/esr-21-21165 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/jazz-pharmaceuticals-plc/projects/zwi-zw25-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-bcg-2312 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-bcg-2011 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ijb-zephir02-2024-53-49-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-bcg-2503 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/esr-21-21447 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2020-tranexamico 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/leo-pharma-a-s/projects/lp0162-2328 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/ctqj230a12304 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ic-2019-05 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/223674 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/ds7300-188 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/pm1183-c-008-21 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/clee011q12101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/alks-4230-007 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/mito-33 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/steba-biotech-s-a/projects/clin2001ucm301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/a3921145 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20230016 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp191062 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/nct02735707 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cytb323n12101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/p160906j 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/rf-2021-12375251 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/tango-therapeutics/projects/tng908-c101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cdrb436x2x02b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/fil-tisle-hl 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cctl019g2201j 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cctl019e2202 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/i8f-mc-gphp 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/n1t-mc-malo 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/i8f-mc-gpig 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/mira-pharmaceuticals-inc/projects/m-14867-33 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/ctin816b12202 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp220806 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/v0001699 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/tv48574-imm-20036 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp200018 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/comb157g3301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-international-limited/projects/gs-us-528-6727 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-8527-011 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cvay736f12301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca082-1215 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2016-2369 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-mesto/projects/ef-41-keynote-d58 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/ieo-1411 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/icm-urc-2016-32 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/mm0125 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biogen-idec-ltd/projects/109ms306 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/tebe-rt 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ib-2019-04 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m25-204 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/vp-vec-162-3202 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/i3y-mc-jpcf 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/irst204-09 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c3441021 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-881-3003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-280-1501 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/73841937nsc3003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/ms200095-0031 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d516fc00001-adaura2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/adaura-d5164c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d5160c00048 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d5162c00048 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9103c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d5169c00001-flaura2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d516nc00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/safe-bk 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx24-ais-d10 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/t89-08-oresa 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d5982c00006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bo40729 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/mk-3475-679 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m24-528 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/dz2019e0001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-international-limited/projects/gs-us-621-6463 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/dcc-2618-03-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/angelo 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/motor 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp211035 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/exafip2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/indivior-pharmaceuticals/projects/indv-6000-406 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2023-508254-26-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/ds8201-801 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20230298 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/samsung-bioepis-nl-b-v/projects/sb27-1005 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cain457e22101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r1979-hm-1333 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/taiho-pharma-netherlands-b-v/projects/astx727-17 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/taiho-pharma-netherlands-b-v/projects/astx727-18 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/haleon-ireland-dungarvan-limited/projects/400314 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca127-1027 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r6569-onc-1933 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cpit565a12101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-4830-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cdff332a12101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/i3y-mc-jpce 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/arrowhead-pharmaceuticals-inc/projects/aroatxn2-1001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/omtx705-004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-0150-1309 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/mirage 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/adx-324-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/222725 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/54135419sui3003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biogen-idec-ltd/projects/232sm404 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biogen-idec-ltd/projects/295sm101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/moderna-biotech-spain/projects/dan-covid 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1368-0130 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1368-0025 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/travere-therapeutics/projects/rtrx-re021-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/travere-therapeutics/projects/021fsgs16010 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/d20181321 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/moonlake-immunotherapeutics/projects/m1095-psa-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/moonlake-immunotherapeutics/projects/m1095-hs-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/moonlake-immunotherapeutics/projects/m1095-hs-302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/77242113pso3006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/rm-493-035 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r3918-pnh-2021 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn8640-4245 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn8640-4263 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/20u-0014 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/quince-therapeutics/projects/iedat-04-2022 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/114055 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/embrace 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/inbrx101-01-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/viridian-therapeutics-inc-de/projects/vrdn-001-302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/mylan-dura-gmbh/projects/myl-1603n-3002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/aecopd 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/21773 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/20010 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/c12-48 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/gem-2101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ephic-dia2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d7000c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/med-004-ec-25 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/meditop-2025-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/s005183-303 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/blcl-2me-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/1062-25 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/cfa-1042-1-24 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/1019-25 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/cpo25001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/a6791042 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/saturn 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-nv/projects/cnto148uco3003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cardiol-therapeutics/projects/2-16-vi-22 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/cset-n-2020-3210 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r5458-668-alg-2219 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/dan-zoster 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/ms700568-0183 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/iibsp-sav-2025-178 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ptc-therapeutics-inc/projects/ptc923-pku-401 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/nok0024-z2023097 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9931-4553 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cabl001e2201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cabl001afr05 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/camn107ait15 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c5541010 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/savannah-d5084c0007 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/savannah 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/wn41733 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/b8011006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9720c00003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9720c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/efc17360-lumina-3 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/efc17872 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/esr-21-21284 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/iris-d3466c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cero-therapeutics-holdings-inc/projects/idea 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sarepta-therapeutics/projects/srp-9001-303 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/80202135ebf3001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/80202135fnait3001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sandoz-pharmaceuticals-d-d/projects/san-1138 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/verona-pharma-ireland-limited/projects/save-pain-2025 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/blcl-acb-pil01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/eyed-010-003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/neuraxpharm-pharmaceuticals-s-l/projects/nxptego-23-p1-4 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/oxy-aps 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20230005 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/sy-1425-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/mambo-ii 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/intensify-sz 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/monte-rosa-therapeutics/projects/f106-ct01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/77242113psa3001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/cnto1275jpa3001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/axim-biotechnologies-inc/projects/hem-ismart-sub-b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biogen-idec-ltd/projects/232sm302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biogen-idec-ltd/projects/232sm303 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/spi-62-cl-2002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-279-pso-3004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20190172 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20190009 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20190288 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20170543 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-7962-024 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-7962-008 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-7962-038 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-7962-023 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/melissa 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/dedalo 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/viridian-therapeutics-inc-de/projects/vrdn-001-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/viridian-therapeutics-inc-de/projects/vrdn-001-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp240909 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/oc-2023-005 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp230866 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/rein-therapeutics/projects/easylight-nek 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/up-cli-2023-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9078c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ori2025-16 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp200068 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp230825 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp200046 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/entrada-therapeutics/projects/entr-601-45-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sarepta-therapeutics/projects/arodux4-1001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/mira-pharmaceuticals-inc/projects/m-27134-10 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/moderna-biotech-spain/projects/mrna-1345-p201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/tg1-cl-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/tour-hekla/projects/dr230333 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/dyne-therapeutics/projects/dyne101-dm1-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cdii235a12201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alexion-europe-sas/projects/cael101-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alexion-europe-sas/projects/cael101-302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/cal101-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/aft-rap-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/rp-a501-0123 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/sinechsil 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20240092 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/genmab-a-s/projects/gct3013-02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/gim35-ribosil 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/457531 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/theravia-eu/projects/sik-fr-24-1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/trex 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/intensify-bd 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/biophenot2d 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/sprinkle-d1346c00004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/komet-d134bc00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/loxo-ret-18036 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/loxo-ret-17001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/loxo-ret-18037 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j2g-mc-jzjc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/karyopharm-therapeutics/projects/xport-mf-035 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cain457c22301e1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp200034 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/clinuvel-europe-limited/projects/cuv052 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/clinuvel-europe-limited/projects/cuv105 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/isa-hc-nk 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp200067 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/dfi17893 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/ted14856 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/advanced-accelerator-applications/projects/caaa601a22301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/arcus-biosciences/projects/prism-1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cqvm149c2201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sab-biotherapeutics/projects/sab-142-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/cl1-95012-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/splfio-174 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/zentiva-k-s/projects/perla 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn1535-8377 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/ho155 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bp45703 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn6535-4730 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9924-4437 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/17456 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn6535-4725 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/incb018424-324 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/incb-18424-309 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/viiv-healthcare-bv/projects/205888 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/mito-25-1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/co40778 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bx44273 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/go40782 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/mog001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/iibsp-ipv-2024-178 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/fil-ptcl13 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chiesi-farmaceutici-s-p-a-eu/projects/cli-06001aa1-05 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp220790 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d7402c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/go43075 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bp41072 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp200007 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/aploa-nb 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/b7981032 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/b7981027 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/b7981118 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/b7981119 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m16-066 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m16-011 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-ag/projects/14308 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c4951009 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/rml-tb 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/pdy18663 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/efc17093 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/dfi17124 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/act17209 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/lps18573 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d7025c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/destinyendometrial01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/pi21-004444 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/syndax-pharmaceuticals-inc/projects/sndx-5613-0710 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp190205 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/efc12522 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/ctrial-ie-19-34 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/lts17704 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/54767414mmy3019 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/emn20 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/incmor0208-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/efc15992 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp180603 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/the-stars-trial 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ib-2021-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j1i-mc-gzbp 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/14341 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/turn-therapeutics/projects/tpx-0005-07 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/turn-therapeutics/projects/tpx-0005-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp201075 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/nl81536-078-22 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/recordati-ireland/projects/som230-recag-pk-612 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/regoma-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/irst100-60 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celgene-europe-limited/projects/ca0561060 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celgene-europe-limited/projects/ace-536-ltfu-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/220752 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gedeon-richter-plc/projects/rgh-md-20 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alexion-europe-sas/projects/alxn2350-dcm-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/tour-hekla/projects/topgun 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/sima-spk-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharm-research-associates-uk-limited/projects/974-24 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/rdw483-0155-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/efc15858 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/efc17919a 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/cset-n-2017-2523 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/g23-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/uechup-vor-24-5 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/uechup-mem-25-6 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/uechup-lin-met-24-1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/uechup-esc-25-3 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/uechup-edo-25-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/uechup-don-23-5 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/uechup-ras-24-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/uechup-ato-24-3 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp231442 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gruenenthal-gmbh/projects/kf7039-03 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/408-c-1402 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/1462rot25ct 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/ckjx839a12402 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/ckjx839d12303 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/ckjx839b12302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biomarin-pharmaceutical-inc/projects/270-401-gener8-lte 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/co40115 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/go42216 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/co45042 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bp46016 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bc45538 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/wo41994 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bn44619 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bn44620 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/wr42221 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/gr40549 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/mr45625 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/202000842 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp200002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/otl-103-4 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cytb323j12201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp200026 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/fil-renoir12 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/fil-ricco 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ace-ly-308 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d7407c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/mor208c310 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/fil-ri-chop 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/tour-hekla/projects/dr240305 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vedolizumab-3043 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c4951013 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/prestige 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ab-science/projects/ab23005 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vedolizumab-3041 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp210084 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/tour-hekla/projects/riph-2019-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ifg-01-2024 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cero-therapeutics-holdings-inc/projects/ico-2020-01-repair 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/mundipharma-gmbh/projects/mr907-2502 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp220827 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/ultra-hero 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r7508-dvt-24116 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/baxalta-innovations-gmbh/projects/tak-755-3002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-755-2001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/rc02t001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp230834 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/uechup-alm-23-6 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/i4t-mc-jvcy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/av001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/axim-biotechnologies-inc/projects/mh22caq 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/ac220-a-u202 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ql2107-102 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/dcc-3116-01-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cero-therapeutics-holdings-inc/projects/ico-n-2013-03 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/tour-hekla/projects/dr230070 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/ly06006-mrct-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/irst100-42 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/hemaml42-nk4aml 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/efc18554 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eledon-pharmaceuticals/projects/at-1501-k209 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/fpa-as-30093 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/80202135cdp3001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/nl79088-041-21 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/64407564mmy3009 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sana-biotechnology/projects/target2020 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cero-therapeutics-holdings-inc/projects/bradi-ico-2023-15 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/dtx401-cl301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/dtx301-cl301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/spi-62-cl-2003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m16-852 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/imgn151-1001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/clobof3-17ia03 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratoire-hra-pharma/projects/rofe-iii-24-1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/s227928 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/cl1-65487-003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/68284528mmy3002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/go40554 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m22-132 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/blue-earth-diagnostics-ireland-ltd/projects/bet-psma-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/caaa617a12202 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/caaa617a12402 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/eortc-2361-gucg 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/arrowhead-pharmaceuticals-inc/projects/aroapoc3-3011 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/arrowhead-pharmaceuticals-inc/projects/aroapoc3-3004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biogen-idec-ltd/projects/105ms306 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/114180 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/armyda-amulet 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/mrx-802 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/shr3162-iii-305 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/simfib 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/crn00808-12 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/obez-302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bial-portela-companhia-s-a/projects/2021-abm-01-00010 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bial-portela-companhia-s-a/projects/2021-abm-03-00006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/mira-pharmaceuticals-inc/projects/m-27501-30 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/eortc-2029-lcg 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/tesaro-bio-netherlands-b-v/projects/pr-30-5017-c 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vanda-pharmaceuticals/projects/vp-vhx-896-3201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/matrix 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/clou064a2303b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/b7981028 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/crn00808-09 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/i3y-mc-jpef 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/crn00808-08 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/cx842a2301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j3m-mc-jzqb 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j2g-mc-jzjx 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j3m-mc-jzqh 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j6e-mc-kwan 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/dianthus-therapeutics-inc-de/projects/dnth103-mg-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/im011-055 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/h8h-mc-lahv 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-8591a-053 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d361ec00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/v940-012 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/clou064p12301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/clou064j12303b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/clou064o12301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/clou064j12301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c5091018 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c3651021 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3475-a18 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/santen-oy/projects/101380003sa 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/elite-pharmaceuticals-inc-nv/projects/lbs-008-ct05 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cmas825d12201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3475-866 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/geron-netherlands-b-v/projects/63935937mds3001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-8591-013 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/cnto1959psa3004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/noe-tsc-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/noe-tgn-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cain457m2301e1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cain457r1de01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cain457i2401 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/clou064a2304 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ab-science/projects/ab15003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/go41767 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/protocol-number-8 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharm-research-associates-uk-limited/projects/symsf2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/zenas-biopharma/projects/zb012-02-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/argenx/projects/argx-117-2302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d5982c00008 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp190131 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp220805 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/p160925j 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/p170916j 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1368-0140 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ps0021 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celgene-europe-limited/projects/rpc01-3203 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/obez-303 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/argenx/projects/argx-113-2306 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ep0162 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/vp-vec-162-3108 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/papa-can 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/tesaro-bio-netherlands-b-v/projects/213350-3000-03-005 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/moonlake-immunotherapeutics/projects/m1095-psa-302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d8610c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ionis-pharmaceuticals-inc/projects/isis-678354-cs5 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m23-784 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m16-000 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk3475-859 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3475-991 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d3253c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astellas-pharma-gmbh/projects/2693-cl-1303 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/argenx/projects/argx-113-2402 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r3918-amd-2326 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d3250c00059 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/asnd0030 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m15-998 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c4951012-bhv3000-407 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/b7981080 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharmaand-gmbh/projects/co-338-087 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ag348-c-017 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/217102 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-0616-018 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/cnto1959crd3004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d3614c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d3250c00101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/218224 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca209-577 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/22817 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alexion-europe-sas/projects/azp-3601-cli-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/apl2-c3g-310 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20230302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20160354 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20170625 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/argenx/projects/argx-113-2308 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp220826 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp201037 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp240804 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp191099 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp240792 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/wn45443 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/cto-2095 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bp44745 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/wa40404 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bn42083 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/18-791 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp-200040 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9500-4656 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/2025-521093-34-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9662-8160 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9541-7841 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9490-7678 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/clnp023b12301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/clnp023q12301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/clnp023a2301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/solo-1-d0818c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/stallergenes/projects/yobi-sl79-22 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sarepta-therapeutics/projects/arodm1-1001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9838-7859 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9388-7864 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/insmed-limited/projects/ins1009-311 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/insmed-limited/projects/ins1009-212 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/dompe-farmaceutici-s-p-a/projects/icy-akc-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d967uc00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cytokinetics-ireland-limited/projects/cy-6032 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/apg2575mg301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/jasper-therapeutics/projects/jsp-cp-011 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j2n-mc-jznz 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ap01-007 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ap01-005 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ap-lte-008 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/cbyl719a0hr01t 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celltrion-healthcare-hungary-kft/projects/ct-l03-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/irsp-psi-2024-171 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/acp-103-070 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/mo43110 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/fm-17-b01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/ml42502 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/ctrial-ie-19-17 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9090c00007 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/go42909 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/pm14-a-003-20 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/la-brp-02-25 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/hv-apl-a-001-24 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ior-bms-ist-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/ms202359-0025 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20240124 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20250114 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/ds1062-a-u102 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pyxis-oncology/projects/pyx-201-102 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/42756493blc1003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/222778 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/ds3201-343 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/omtx705-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20220028 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/a148-01pk2408 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/swedish-orphan-biovitrum-ab-publ/projects/sobi-bivv001-003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharm-research-associates-uk-limited/projects/skabup 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2020-004696-41 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/revolution-medicines/projects/rmc-lung-101b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/revolution-medicines/projects/rmc-lung-101a 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-international-limited/projects/edge-lung 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/213403 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r2810-onc-2268 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/omtx705-005 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1479-0044 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d5087c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/irst100-39 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/incb-54828-302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/incmga0012-204 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-gmp-2305 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/pearldifer 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/travere-therapeutics/projects/tvtx-tvt058-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vir-biotechnology/projects/vir-mhb1-v200 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20170724 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/aft-mxiv-08p 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cdfv890b12201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r17372-hm-2493 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-517043-32-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/partner-therapeutics-limited/projects/67-22-precoopera 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biomarin-pharmaceutical-inc/projects/165-306 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/crn00808-05 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/olema-pharmaceuticals/projects/op-1250-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/olema-pharmaceuticals/projects/op-1250-302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/gem-2303 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ukt-ikf-depeca-1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/meda-ab/projects/gemfin-mf-pacri-2401 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/summit-therapeutics/projects/smt112-3003-89-37-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ic-2022-07 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca209-9la 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/incmga-0012-304 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/ctrial-ie-12-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r2810-onc-16113 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-international-limited/projects/immu-132-13 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/1-6 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-international-limited/projects/gs-us-621-6290 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ptc-therapeutics-inc/projects/ptc923-pku-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp210075 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/tour-hekla/projects/dr200090 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/tcd17197 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/iovance-biotherapeutics-inc/projects/iov-mel-202 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/d20-p012 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/p140938j 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp220814 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ferrer-internacional-s-a/projects/pl101-als301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp220791 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx24-993-103 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sarepta-therapeutics/projects/srp-9003-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cain457r12301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/refine-2020 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/80202135fnait3003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/argenx/projects/argx-113-2009 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp191105 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp200041 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/mln0002-3025 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/mln0002-3029 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/mln0002-3024 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/fil-foll19 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celgene-europe-limited/projects/ca071-1000 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astellas-pharma-gmbh/projects/9785-cl-0123 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d5982c00007 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/217013 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/inflarx-gmbh/projects/ifx-1-p3-4 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/i3y-mc-jpcm 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-2400-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/p170922j 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r668-bp-1902 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/proicm-2019-02-pra 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/kyowa-kirin-holdings-b-v/projects/0761-016 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cellectar-biosciences/projects/dcl-16-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/ponatinib-3001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/all2418 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/eae127 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/224317 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d7230c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx21-ctx001-161 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/ctx001-121 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/norgine-b-v/projects/ner1006-01-2025 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9075c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/italfarmaco-s-p-a/projects/dsc-14-2357-50 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/lexicon-pharmaceuticals-inc/projects/lx4211-1-314-hcm 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp210089 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp201098 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/b7981094 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp211429 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/a011-14 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/loxo-btk-20023 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/loxo-btk-20020 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/loxo-btk-20019 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/fil-puma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/cic-10 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp180605 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp211034 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/efc17561 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/efc17560 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/tour-hekla/projects/dr230313 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/vp-vtr-297-1101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c6461013 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c5041018 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-gmp-2504 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c2321003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp-180610 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d926tc00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/act16146 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-0107-1718 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca239-0004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/genmab-a-s/projects/gct1055-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca224-104 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp241011 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3475-a86 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/partner-therapeutics-limited/projects/etop25-23-adopt-lung 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/pm54-a-003-25 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca2241093 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c4221022 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ifg-05-2019 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/tropion-breast05 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/revolution-medicines/projects/rmc-lung-101c 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/cnao-44-2021c 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j4g-mc-jzvd 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/co2mo 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eikon-therapeutics/projects/eik1001-006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/jazz-pharmaceuticals-plc/projects/jzp598-302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eikon-therapeutics/projects/eik1001-008 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biontech-manufacturing-gmbh/projects/bnt113-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/obi-822-011 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-bcg-2401 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/2014-hncg 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/p160601j 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/genmab-a-s/projects/gct1184-05 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/genmab-a-s/projects/gct1184-02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/act16482-04 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/p091205 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cquc398a12201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9571c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/moderna-biotech-spain/projects/mrna-3745-p102 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/sl0044 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-2870-009 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/ifom-cpt0092022po008 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/karyopharm-therapeutics/projects/xport-mf-044 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/meda-ab/projects/thalassa-2-0 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/cycad-1-d8470c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/incb123667-305 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/ds6000-109 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c6461001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2024-3967 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d798mc00002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d702bc00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cero-therapeutics-holdings-inc/projects/ifct-2401-sporadic 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-bcg-2501 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9106c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/geicam-2011-03-s1007 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ijb-synergy-012017 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/ds8201-a-u306 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cero-therapeutics-holdings-inc/projects/ifct-2103 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-7339-008 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cbyl719k12301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/v940-013 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/orion/projects/3134003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/ca209-6e8-cnn-bc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-international-limited/projects/gs-us-682-6769 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cero-therapeutics-holdings-inc/projects/fungemax 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3475-06b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-7684a-005 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biontech-manufacturing-gmbh/projects/bnt327-05 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biontech-manufacturing-gmbh/projects/bnt327-06 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biontech-manufacturing-gmbh/projects/bnt326-02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9535-4352 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn6535-7519 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/r0126321a 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/pi24-01356 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/im047-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celgene-europe-limited/projects/rpc01-3204 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celgene-europe-limited/projects/rpc01-3102 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/im047-050 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp200750 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/neoart 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca209-8tt 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-279-3002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-279-3001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-279-psa-3001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/dr-falk-pharma-gmbh/projects/bul-8-eea 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/zenas-biopharma/projects/zb020-03-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-5684-004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-5684-01a 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ewo-iso-2024-be2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chiesi-farmaceutici-s-p-a-eu/projects/cli-06001aa1-06 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bioprojet-pharma/projects/bp1-4979-p24-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bioprojet-pharma/projects/p24-03 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bioprojet-pharma/projects/p25-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biocodex/projects/stp237 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/pherflot 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/aln-ttr02-011 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/karyopharm-therapeutics/projects/xport-dlbcl-30 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/karyopharm-therapeutics/projects/xport-mm-028 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/i6t-mc-amba 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/i6t-mc-amca 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/vhio23003-omo-103-03 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cytokinetics-ireland-limited/projects/cy-1033 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp180612 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp220916 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/meda-ab/projects/bcn05-bari 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d933lc00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/gemcad-2102 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2023-3610-neosarc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/irst162-14 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-7339-013 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-7339-006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ic-2024-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp220273 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r1979-onc-1625 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/cn45320 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/cn42097 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20230309 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bn42082 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/mn45053 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/net-ms 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/mn42988 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/mn43964 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/mn45053-33-21-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-a317-290-lte1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/747-214 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/zenas-biopharma/projects/zb012-02-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/tour-hekla/projects/dr240020 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-gig-2308 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-0110-1608 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-0110-1609 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-imm-2302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d967lc00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-gig-2408 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/arcus-biosciences/projects/arc-21-edge-gastric 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca2660003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20210096 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d7986c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cero-therapeutics-holdings-inc/projects/prodige-54-samco 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3475-585 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca244-0001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/stemline-therapeutics-b-v/projects/stml-ela-0322 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/rein-therapeutics/projects/abcsg-63 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/stemline-therapeutics-b-v/projects/ela-0121 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/reddy-holding-gmbh/projects/ab-01-004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/rc-p0055 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/safe-stop-ipi-nivo 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-imm-2509-2510 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/av-951-20-304 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca043-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca224-106 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ib-2019-03 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ijb-regina-2020 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/mabxience-research-sl/projects/mb11-c-01-25 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2023-3764 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca224-047 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/eortc-1612-mg 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca209-9dw 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp200132 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/10353 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca209-8y8 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca209-142 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca209-032 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/fraction-2021 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1479-0032 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2024-3873-cabold 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bolt-biotherapeutics/projects/bbi-20201001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca001-050 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/cset-n-2018-2706 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/bct-1902 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ono-4578-10 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp220917 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/karyopharm-therapeutics/projects/xport-mf-034 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j2r-mc-yaad 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ic-2009-04 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/pi20-01514 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/esr-20-21103 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/odyssey-therapeutics/projects/od-07656-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/crn00808-11 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/042011 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/clou064c12306 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/747-213 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beigene-ireland-ltd/projects/bgb-3111-212 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp-211038 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/coav101a12308 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/219871 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/d20180135 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20170770 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-5592-127 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/224295 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/wp45338 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/survic-study 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn8640-4467 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca209-67t 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca2360001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca224-020 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca224-098 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/213400 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/213831 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/tesaro-bio-netherlands-b-v/projects/4010-03-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/67652000pcr3002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/217043 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/meq00089 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/menarini-international-operations-luxembourg-s-a-miol/projects/amil-25-obi-dys-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/efc14462 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-winthrop-industrie/projects/pta17333 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/gz-2016-11512 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/petal 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/cdf-711 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c1071005 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp200017 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-1026-011-97-19-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/galderma-international/projects/rd-06-spr-202699 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/galderma-international/projects/rd-06-spr-118163 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/galderma-international/projects/rd-06-spr-118126 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m16-109 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/basicstudy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/lupin-europe-gmbh/projects/mex-ndm-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/lupin-europe-gmbh/projects/mex-nm-303 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/trevi-therapeutics/projects/nal03-202 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/op0595-5 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp200043 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp200073 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/darotaxel 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ideaya-biosciences/projects/ide196-009 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/irfmn-9063 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/nektar-therapeutics/projects/23-358-05 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/combi-ted 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20210098 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bicycle-therapeutics/projects/bt5528-100 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c4671026 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/dipg 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cabl001j12302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/p160917 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/swedish-orphan-biovitrum-international-ab/projects/ni-0501-14 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/ptcl-s-ide 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/geicam-2018-06 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/kyverna-therapeutics/projects/kyv101-006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/neurocrine-biosciences-inc/projects/nbi-74788-cah3003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/amy106eu 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/pompe-phys-02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9311c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d7984c00002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/cfa-1042-3-26 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/s005190-206 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/s005183-297 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/cfa-1048-3-25 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/blcl-2me-02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chiesi-farmaceutici-s-p-a-eu/projects/cli-06657aa1-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9388-7741 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/fil-mozart 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/co41942 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/mo44842 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/ga45799 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/the-mirage-trial 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d7310c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d3252c00002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/410701bs 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-4482-023 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/i6t-mc-amcd 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/i6t-mc-amay 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/i6t-mc-amax 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/i6t-mc-amap 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astellas-pharma-gmbh/projects/178-cl-207 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amicus-therapeutics-europe-limited/projects/at1001-033 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/42756493blc2001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/s-r-o/projects/rafael 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-0616-013 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/rc-p0103 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d4191c00140 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c2321001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c3601010 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharm-research-associates-uk-limited/projects/22-01-mpa-c 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp230855 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/mn39158 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/mn39159 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/wn42086 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/amp101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/primera001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1123-0060 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp240911 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ml-vab-201-3248-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/tmp-08012024-3 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pasteur/projects/meq00073 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-0107-1810 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cdrb436g2401 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/20-27-patch 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/nl69517-078-19 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/tour-hekla/projects/proto-brain 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/ohb-607-202 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/verona-pharma-ireland-limited/projects/sipo20 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/verona-pharma-ireland-limited/projects/gr-2021-12373041 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/x4-pharmaceuticals-inc/projects/x4p-001-103 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/x4-pharmaceuticals-inc/projects/x4p-001-110 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1425-0003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d5180c00016 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/track-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bioprojet-pharma/projects/p11-06 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/act16753 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/dri17821 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20190135 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2021-3336 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/mo40598 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/go41944 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp200133 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cvay736k12301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cvay736k12301e1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/clnp023k12201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d6187c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp200038 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d926fc00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/danube-d419bc00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20240178 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ista-pharma-limited/projects/autop-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp211026 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca240-0029 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp230852 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp220934 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp-230842 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp211044 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp-180610-96-21-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/eortc-1820-cltf 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3475-03b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-4280a-007 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3543-007 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-1084-007 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-2870-020 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-2870-005 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-2870-019 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-2870-011 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-2870-032 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-1084-013 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-1022-016 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3475-01f 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-1022-011 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/42756493blc3005 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ag348-c-018 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ag348-c-022 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ag348-c-023 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ag348-c-020 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ag348-c-026 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/nc2022-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fate-therapeutics-inc/projects/2020-005162-33 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/inca000585-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/gimema-aml1919 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp230813 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/hsk3486-309 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/orion/projects/3124001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp230844 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp211003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/2025-gmf-1-17-49-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/caaa601a62301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp180584 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp230821 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp220808 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/inca34176-357 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/ca41705 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/genmab-a-s/projects/gct1046-06 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/conachaa 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/nl71782-078-19 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/medac-gesellschaft-fuer-klinische-spezialpraeparate-mbh/projects/mc-mtx-18-ad 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp240920 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/hovon-127-bl 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c0251010 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/hqp1351ag301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20220159 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/d20180102 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ici21-00031 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j2a-mc-gzgv 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/metformina-bone 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/p170901j 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/iovance-biotherapeutics-inc/projects/iov-mel-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/gimema-all2922 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/215360 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/nl83176-042-23 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp230869 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-5684-015 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cero-therapeutics-holdings-inc/projects/br31 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/medac-gesellschaft-fuer-klinische-spezialpraeparate-mbh/projects/mc-msc-1-agvhd 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cmbg453b12206b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/ms201924-0002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/future 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/advanced-accelerator-applications/projects/caaa601a32201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/art6043c001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/verona-pharma-ireland-limited/projects/passion 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d0817c00098 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9102c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/c16-40 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/duo-o-d081rc00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d081cc00006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/mito-35a 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/cset-2023-3603 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/bsmo-1-2018 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-0140-1812 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/rein-therapeutics/projects/abcsg-45 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d0816c00025 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/propel-d081sc00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cjsb462b12201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cdzr123a12107 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/geicam-2023-09 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/proicm-2021-04-rel 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/caaa601a42101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp200080 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gensight-biologics-s-a/projects/gs-lhon-clin-08 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/curateq-biologics-s-r-o/projects/cr213-20 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/cr44829 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cero-therapeutics-holdings-inc/projects/ifct-2003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/mineralys-therapeutics/projects/mls-101-901 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/mineralys-therapeutics/projects/mls-101-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca224-123 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cero-therapeutics-holdings-inc/projects/engic-06-fruquitas 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ascendis-pharma-endocrinology-division-a-s/projects/asnd0047 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/philogen-s-p-a/projects/ph-l19tnflom-01-23 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/keep-on 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/caaa617d12302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/caaa617c12301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/caaa617a12101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/221530 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/220723 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/219538 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ic-2019-02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/immedica-pharma-ab/projects/caeb1102-301a 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/enrich-af 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m24-052 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/mrx-803 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/vad00004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celgene-europe-limited/projects/jcar017-fol-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn8022-4392 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/zambon-spa/projects/bt-l-csa-303-fu 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r5458-onc-2274 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r5458-onc-2257 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/orchard-therapeutics-netherlands-b-v/projects/201222 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/orchard-therapeutics-netherlands-b-v/projects/otl-200-07 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/orchard-therapeutics-netherlands-b-v/projects/205756 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/neuraxpharm-pharmaceuticals-s-l/projects/nxpleve-24-p3-6 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/break-crc-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/presto 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/cph-let01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c4391025 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3475-02a 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-7902-013 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3475-b99 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/mk-3475-b60 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/mito-vulva-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3475-02d 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2017-2558 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/vhio24002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-6482-043 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/54179060mcl3004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eisai-gmbh/projects/ban2401-g000-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j2t-mc-kgbt 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j2t-mc-kgbu 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-ag/projects/20290 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-ag/projects/20289 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn1436-7724 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9535-4801 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn1436-8182 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn1436-7727 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/nadals-001-als-2021 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/i4c-mc-jtbb 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/dcc-3116-01-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2021-3401 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/rein-therapeutics/projects/lti-03-2001-renew 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/clou064c12301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/clou064m12301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/clou064c12302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/clou064j12302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/moi-a 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/b9991046 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/b7461006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/b7461039 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/efc16973 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/131i-tlx-101-003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/1634 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/eortc-2227-btg 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/iovance-biotherapeutics-inc/projects/iov-com-202 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/mariveb 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cxxb750a12201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/sepklin 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r2810-onc-1788 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/maia-biotechnology/projects/thio-104 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/cmp-001-009 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/maia-biotechnology/projects/thio-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/ms201924-0022 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r10597-onc-22114 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ior-reg-2501 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r3767-onc-2466 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r2810-onc-1624 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/cemi-first 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/cemiresist 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/partner-therapeutics-limited/projects/etop-27-23-arch 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cero-therapeutics-holdings-inc/projects/ico-2023-10 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/clee011o12001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cgvv858a12101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/ceci830a12101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-gtg-2306 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/202000894 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/clee011a2412b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/wo45654 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c4391024 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c4391001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-0140-1615 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/stemline-therapeutics-b-v/projects/stml-ela-0422 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-bcg-2409-big-2402 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d8535c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-0140-1901 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bo45853 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/solaris 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eisai-gmbh/projects/e7386-g000-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp220267 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp201185 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/ms100070-0087 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/italic-rcc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/embrace-iii-hi-risk 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/orchard-therapeutics-netherlands-b-v/projects/tigett10-mpsih 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2026-525211-14-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/eae128 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m25-059 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cjdq443e12101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/all2820 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eisai-gmbh/projects/ban2401-g000-303 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/icm-urc2016-27 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/orchard-therapeutics-netherlands-b-v/projects/otl-203-02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/cx842a2303 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharm-research-associates-uk-limited/projects/debio-4126-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-international-limited/projects/gs-us-563-5926 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/mira-pharmaceuticals-inc/projects/m-00401-10 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/tour-hekla/projects/tour006-t01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d1346c00015 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/mira-pharmaceuticals-inc/projects/m-14789-41 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp200009 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/nl55231-041-16 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/comb157g2410 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/kyverna-therapeutics/projects/kyv101-007 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/comb157g23101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/18253 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/p01351 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-ag/projects/21839 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-517112-30-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/81201887mdg3002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/nl65364-078-18 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fresenius-kabi-deutschland-gmbh/projects/kor-ped-202 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx21-121-105 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx21-445-125 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/pkcaftors 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bo25430 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/kisima-02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-339-3001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/gem-2302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/eortc-2022-mg 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c5751003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-9999-02a 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3475-04d 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-imm-2511-2512 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/philogen-s-p-a/projects/ph-ickpd1-02-21 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/summit-therapeutics/projects/smt112-3003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/at148004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-international-limited/projects/gs-us-595-6184 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/tctlr-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/cpt002-2018-po001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/gineco-ov244b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3475-091 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/v940-004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk3475-054 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3475-426 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/cl1-95029-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3475-966 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-1084-004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/prelude-therapeutics-inc/projects/prt3789-02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/samsung-bioepis-nl-b-v/projects/sb27-3004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/chimera 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/uc-bcg-2213 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/point 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/safe-stop 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/alks4230-006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d702fc00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3475-03a 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3475a-f84 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3475a-f11 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/medicenna-therapeutics/projects/mdna11-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m23-721 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3475-02b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r3767-onc-2011 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bicara-therapeutics/projects/bca101x301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/mk-3475-669 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/42756493blc3001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/io-biotech/projects/iob-013-kn-d18 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk3475-b15 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/formycon-ag/projects/fyb206-c3-02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3475-905 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/reprint 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/pelican-ipc-2015-016 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/ds1062-a-u304 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/arcus-biosciences/projects/arc-10 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/loxo-ras-20001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3475-01e 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1479-0008 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/trio041 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cero-therapeutics-holdings-inc/projects/ffcd1703 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/genmab-a-s/projects/gct1046-04 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/didac-nvalt35 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ferring-pharmaceuticals-a-s/projects/000434 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/ctrial-ie-16-12 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3475-b68 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/mito-cerv-4 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/nl82378-058-22 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-9999-01b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/108439 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/pam-umcg-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-gmp-1908 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/mito-27 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/su2c-sarc032 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ijb-keprest-2022 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp240938 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/trapezius 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ipsen-pharma/projects/a4250-015 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ista-pharma-limited/projects/etude-dapt-cto 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/tour-hekla/projects/dr220204 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alfasigma-s-p-a/projects/glpg0634-cl-329 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alfasigma-s-p-a/projects/gs-us-418-3899 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alfasigma-s-p-a/projects/gs-us-417-0304 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-ag/projects/bay-94-9027-21824 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/otsuka-novel-products-gmbh/projects/156-201-00307 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-16673-304 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1245-0256 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1378-0041 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/compare-vs 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/axim-biotechnologies-inc/projects/hem-ismart-sub-c 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/incb-18424-270 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cinc424a2x01b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp220829 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/ker050-mf-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m19-753 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/jazz-pharmaceuticals-plc/projects/empowher-208 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/jazz-pharmaceuticals-plc/projects/jzp598-303 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/jx10002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/jr-141-gs31 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/95475939adm2001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/80202135sjs3001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/80202135sle3001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/80202135iim2001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/78278343pcr3003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/77242113pso3004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/75276617aml3001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/61186372nsc3002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/61186372nsc2002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/61186372nsc2005 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/68284528mmy2012 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/noprodpapuh3001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/64407564mmy1001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/17000139blc3001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/61186372cor3001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/61186372nsc3001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/56021927pcr3001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/42756493blc3004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ac-055-315 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2020-3093-nirado 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/213824 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/213410 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/221971 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/219451 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/219369 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/219885 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/geico-137-e 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/geico78-c-atomicc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/jio-mc-jzhd 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/collegium-pharmaceutical-inc/projects/prevent-mins 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/recordati-ireland/projects/clci699c2203 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/windtree-therapeutics-inc-de/projects/04-cl-2201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/act17453 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/act16482-03 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/208887 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/eae-115 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ramiris 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/a5481092 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/61186372gic2002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9802c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/cset-n-2017-2536 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca209-9er 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/tour-hekla/projects/dr230314 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/trs-2019-00002051 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9388-7782 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r2810-onc-1787 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ista-pharma-limited/projects/mependax 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r7508-dvt-2360 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/moderna-biotech-spain/projects/mrna-1010-p304 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9077c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharm-research-associates-uk-limited/projects/etskabi 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp-211033 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/op-iptc02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/act16482-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/efc15951 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/207499 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m13-494 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/kt-us-679-0788 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/64007957mmy3006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-11417-105 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celgene-europe-limited/projects/ca057-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/arbutus-biopharma-corp/projects/ab-729-203 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/tild-19-07 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/tild-19-19 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/ds7300-202 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3475-01h 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-609-3001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/rein-therapeutics/projects/brca-p-abcsg-50 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sarepta-therapeutics/projects/srp-9001-104 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hansa-biopharma-ab/projects/20-hmedides-19 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/nl80681-078-22 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/ap24534-14-203 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/incb-84344-102 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cardiff-oncology/projects/spon-1751-19 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/fcr173011-restop 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/pcyc-1146-im 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/pcyc-1141-ca 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/pcyc-1145-lt 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celgene-europe-limited/projects/cc-220-mm-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celgene-europe-limited/projects/cc-220-mm-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/co43923 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/strong-fix 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/helsinn-birex-pharmaceuticals-ltd/projects/nepa-22-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp210369 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/pm1183-a-014-15 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/proicm-2018-01-nex 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cero-therapeutics-holdings-inc/projects/prodige-111 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/eclypse 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-gig-2411 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/proicm-2021-01-gre 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/collegium-pharmaceutical-inc/projects/gastricchimeratrial 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/travere-therapeutics/projects/021igan17001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/clnp023r12201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/clnp023c12001b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/clnp023b12001b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/clnp023i12201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/clnp023f12301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/clnp023f12302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/clnp023f12001b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ipsen-pharma/projects/d-fr-10200-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ipsen-pharma/projects/d-fr-10200-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/1525-lcg 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c6461008 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ionis-pharmaceuticals-inc/projects/ion-682884-cs2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j1i-mc-gzbu 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/io-biotech/projects/iob-022-kn-d38 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp240923 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2021-003637-11 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/lps17375 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d933qc00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/p160909 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d7029c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/emerald-1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d702gc00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/epic-study 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d910dc00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d798vc00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d910gc00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/destiny-breast07 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d6185c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp-240614 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/pacific2-d933kc00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/elan-pharma-international/projects/vib0551-p3-s2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/elan-pharma-international/projects/vib0551-p3-s1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/elan-pharma-international/projects/vib0551-p2-s2-nmo 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ijb-ifibc-2022-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/livergreen 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/green-ex 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/ckjx839c12304 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/ckjx839c12303 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/ckjx839c12001b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/ckjx839a1de02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/incb-99280-205 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/incb-99280-204 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/incagn-2385-203 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/inca033890-303 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bo41932 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/co46274 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/wo41554 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/wo46063 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/co45813 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/mito-end-4 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp220672 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alexion-europe-sas/projects/aa-hpp-407 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/livedes-study 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/cset-n-2023-3729 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d910vc00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/immuwhy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/op0595-6 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/go41854 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/partner-therapeutics-limited/projects/etop-23-22-raise 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp220729 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/immuwin 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/d9311l00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/olympian 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d419cc00002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-gig-2406 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/cset-n-2016-2454 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/partner-therapeutics-limited/projects/etop-14-18-chess 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d419ec00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-0110-1719 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d419jc00001-potomac 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d533ac00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/eortc-1740-hncg 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/iph5201-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/adjubil 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d4190c00022 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-0105-01304 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-0101-1709 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/condor 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-imm-2106 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/esr-18-13828 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cero-therapeutics-holdings-inc/projects/ifct-1802 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/d419ql00009 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/trade-hypo 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d933rc00002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d4191c00003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cero-therapeutics-holdings-inc/projects/postcard-getug-p13 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/bl-13 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ace-cl-006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/p120142 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp230867 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-0160-1406 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/co43810 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cpkc412a2218 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/moderna-biotech-spain/projects/mrna-3927-p101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/loxo-btk-20030 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/cll2323 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/eortc-1745-etf-bcg 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d8534c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/jazz-pharmaceuticals-plc/projects/zwi-zw25-202 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bo41843 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/partner-therapeutics-limited/projects/ibcsg-59-19 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-881-3001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m23-732 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/smart-jia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m23-703 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/im101-863 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/18146 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/re-jia 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m10-870 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/y-mabs-therapeutics-a-s/projects/201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/genmab-a-s/projects/gct1015-05 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biocodex/projects/sb-241 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/van00013 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d967rc00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/ds8201-724 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/mo29406 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1479-0012 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/ctrial-ie-22-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/22-571-21u-0151 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/mo41787 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bo41423 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/mo42623 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/moderna-biotech-spain/projects/mrna-3210-p101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celltrion-healthcare-hungary-kft/projects/ct-p13-3-11 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/nord-star 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/eortc-2334-btg 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-5684-003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cabl001l12101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/hidrogum21 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-international-limited/projects/gs-us-600-6165 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sutro-biopharma-inc/projects/stro-002-gm3 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/liver-aki 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/argenx/projects/argx-117-2401 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp191116 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ib2017-04 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/vp-vec-162-3502 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vir-biotechnology/projects/vir-chdv-v206 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/harmony-biosciences-holdings/projects/hbs-101-cl-312 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/nl6220204217 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/zambon-spa/projects/zb203l01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2025-521877-14-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/cnto1959crd3005 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/cnto1959pbcrd3007 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/cnto1959uco3004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/cnto1959puc3001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/cnto1959psa3005 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/cnto1959psa4002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/cnto1959uco3001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/cnto1959pso3012 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/78934804uco2001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/cnto1959crd3001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/cnto1959crd3008 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/cnto1959isd3001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/78934804crd2001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/cml1415-sustrenim 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/photonamic-gmbh-co-kg/projects/gl-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/photonamic-gmbh-co-kg/projects/krk-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/italfarmaco-s-p-a/projects/dsc-11-2357-44 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/italfarmaco-s-p-a/projects/dsc-08-2357-32 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cfty720d2311 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/paion-pharma-gmbh-eu/projects/crh07 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cero-therapeutics-holdings-inc/projects/prodige-118-pehricca 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-international-limited/projects/immu-132-06 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m22-128 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/42756493blc2003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-international-limited/projects/gs-us-592-6173 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/actuate-therapeutics-inc/projects/1801 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d8220c00027 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/wa41937 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-16673-104 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bo25323 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/wa42985 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ace-cl-007 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp211000 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp230848 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2025-521139-35-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/ca42750 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pierre-fabre-m-dicament/projects/the-papillon-study 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astra-zeneca-ab/projects/allo-hpv 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/p150957 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2024-4031 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/v503-021 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/atd002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/i5q-mc-cgas 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/i5q-mc-cgat 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/gtx-102-cl302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-international-limited/projects/gs-us-695-7156 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-international-limited/projects/gs-us-695-6509 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/gra-05-spr-0001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/clee011o12301c 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bial-portela-companhia-s-a/projects/2020-abm-01-00100 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alfasigma-s-p-a/projects/glpg-0634-cl-131 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alfasigma-s-p-a/projects/glpg0634-cl-331 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alfasigma-s-p-a/projects/glpg0634-cl-333 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/irst204-07 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/irssp-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cadpt17a12201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp220818 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp220763 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/genmab-a-s/projects/gct3014-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/genmab-a-s/projects/gct1042-02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/acrivon-therapeutics/projects/acr-368-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca244-0008 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/nab-pipac 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca240-0030 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d702nc00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/selectio-uc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ib-2018-04 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/go29527 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/17000139blc3004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j5e-mc-jzxb 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/2016-004017-27 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca209-901 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/rigel-pharmaceuticals-inc/projects/rgl-ret-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/115747 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/p160407 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn6019-7565 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/5mille-ct1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eisai-gmbh/projects/e2007-g000-236 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/vhio17002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/taiho-pharma-netherlands-b-v/projects/tas-120-203 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/taiho-pharma-netherlands-b-v/projects/tas-120-404 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/arrivent-biopharma/projects/furmo-006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/puma-biotechnology-inc/projects/puma-ali-1201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c4161001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/tv48125-cns-30084 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chiesi-farmaceutici-s-p-a-eu/projects/cli-05993ab1-08 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/fmgx-cs-302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d6973c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d6405c00002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/64007957mmy3005 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/64407564mmy3002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c3391003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/tnt-oes-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/fpa-as-30094 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/sco101-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m24-977 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/axim-biotechnologies-inc/projects/influence 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/iovance-biotherapeutics-inc/projects/iov-lun-202 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/112771 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/comb157g2399 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/avian-inf-vacc-thl20 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/cn008-0003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20200469 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/p160954j 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r2411201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/genmab-a-s/projects/gct3018-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/advanced-accelerator-applications/projects/odyssey 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/elan-pharma-international/projects/hznp-hzn-825-303 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/minoryx-therapeutics-s-l/projects/mt-1-02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/tg-therapeutics-inc/projects/tg1101-rms-ped304 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-ag/projects/21177 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-ag/projects/21467 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-ag/projects/20186 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-ag/projects/21466 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/elan-pharma-international/projects/hznp-hzn-825-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/77242113pso3002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/philogen-s-p-a/projects/ph-l19tnftmz-01-20 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/philogen-s-p-a/projects/ph-l19tnfsarc-03-18 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r3767-onc-2235 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/202000570 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/sid-women 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/nrg-gy019 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/geicam-2014-12 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/efc16158-carat 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/pi23-00797 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/eortc-2237-bcg-qlg 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d8530c00002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c4391002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j2j-ox-jzlc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/quintis 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/tour-hekla/projects/dr230286 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/effoca2021 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m24-533 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cero-therapeutics-holdings-inc/projects/engic-01-colosoto 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/bdtx-4933-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/efc14771 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/a021502 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ikf-aio-zangea 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/verona-pharma-ireland-limited/projects/pipac-verone 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3475-811 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/arcus-biosciences/projects/star-221 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/summit-therapeutics/projects/smt112-3005 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/d20180177 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/abt-c11-2020 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3475-06e 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ijg-premi-2024 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cytb323m12101b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cphe885b12201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/aml1718 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/mds0519 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cytb323g12101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/iovance-biotherapeutics-inc/projects/c-145-04 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/h-a-c-pharma/projects/hac2018-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/vacab-2022 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/c24-50 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/i5t-mc-aaci 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp201110 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-0103-1802 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9604c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp230854 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca224-1044 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ux007-cl302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp240921 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/vgfte-rop-2036 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-ag/projects/22578 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/sra-mmb-4365-219627 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bioprojet-pharma/projects/p23-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/s005190-213 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/104317 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/gen-100 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bn44621 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/stemline-therapeutics-b-v/projects/medopp545 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/snt-i-vam-025 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chiesi-farmaceutici-s-p-a-eu/projects/cli-06795aa1-09 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/cim24001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/dr-falk-pharma-gmbh/projects/cec-012-bio 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/dr-falk-pharma-gmbh/projects/nat-024-bio 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chiesi-farmaceutici-s-p-a-eu/projects/cli-010073aa1-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/cso24001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/che24001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/dse-bmp-0004-cis-ma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/dse-bmp-0002-cis-ma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/dse-bmp-0001-cis-ma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/dse-bmp-0003-cis-ma 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/hcb-2021-1309 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/arcus-biosciences/projects/arc-9 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/c5041006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c5041053 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/c5041012-apd334-303 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/axim-biotechnologies-inc/projects/siopen-pilot01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/gineco-ov243b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/uid-4270 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9612c09998 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/reinforce 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20150125 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/vhio23001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/61186372cor3002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/av-299-23-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/10949 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp240090 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/gwep17005 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/jzp926-402 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m20-638 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vedolizumab-2005 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vedolizumabsc-3003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vedolizumabsc-3004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/ms200569-0003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/ms200569-0048 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c4221008 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/mabxience-research-sl/projects/mb04-c-01-23 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celgene-europe-limited/projects/ag-221-aml-005 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celgene-europe-limited/projects/ca058-1019 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/gadocrohn 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/i7p-mc-dsag 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/i7p-mc-dsaf 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp240889 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/genzyme-europe-b-v/projects/efc13738 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/denali-therapeutics/projects/dnli-e-0007 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbott-laboratories/projects/infq-324-0476 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn9838-4608 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/ms200569-0051 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chiesi-farmaceutici-s-p-a-eu/projects/cli-06001aa1-14 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/mira-pharmaceuticals-inc/projects/m-17923-34 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-bcg-2513 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-bcg-2103 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20190184 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c4551002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/crad001m2x02b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20220043 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cytb323a12101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/1407-gucg 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca245-0001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c6461004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ic-2011-05 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp230874 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp230874-07-41-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/22u-0320 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/24u-1056 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sarepta-therapeutics/projects/4658-402 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/providence 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/p170923j 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/e-s-g-i-s 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9268c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/scarf-1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ars-pharmaceuticals/projects/epi-u02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/jasper-therapeutics/projects/jsp-cp-010 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/epi-7386-cs-010 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/ds3790-076 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ep0062-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/radar-1-crpc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/entrada-therapeutics/projects/entr-601-44-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/vay736f12301e1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cvay736s12201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp180617 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/v940-005 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c4221016 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/vhio23004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-8591b-062 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1378-0020 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1378-0018 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j2a-mc-gzgw 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/insmed-limited/projects/ins-416 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c1071015 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c1071003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cero-therapeutics-holdings-inc/projects/prodige-49-oscar 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20200041 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/help-trial 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eikon-therapeutics/projects/eik1005-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eikon-therapeutics/projects/eik1003-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cinc280a2x02b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/80202135myg3002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/hub-neu-2023-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bo42161 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp211039 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pierre-fabre-medicament/projects/ata129-ebv-302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pierre-fabre-medicament/projects/ata129-ebv-205 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eisai-gmbh/projects/e7386-j081-102 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ipsen-pharma/projects/clin-52120-464 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ipsen-pharma/projects/clin-52120-463 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/115083 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r668-ad-1434 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/lps18583 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/lps16676 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/efc18365 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/efc18366 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bausch-health-ireland-limited/projects/v01-118a-401 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bial-portela-ca-eu/projects/bia-28-6156-113 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp241664 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/doxy-wise 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/itm202302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/c25003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/tailordose-ii 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/philogen-s-p-a/projects/ph-l19tnfdox2-03-16 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/d3-penta-21 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/viiv-healthcare-bv/projects/219700 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/viiv-healthcare-bv/projects/222638 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/viiv-healthcare-bv/projects/219816 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharm-research-associates-uk-limited/projects/18-02-clotribet-c 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/i5t-mc-aaco 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-international-limited/projects/gs-us-577-6153 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/wa39085 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/mundipharma-gmbh/projects/cd101-iv-3-08 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/advanced-accelerator-applications/projects/api-ead-2024-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/api-ead-2024-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biocodex/projects/stp226 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ux143-cl301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/tour-hekla/projects/pediadex 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/quince-therapeutics/projects/iedat-05-2024 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r5458-onc-1826 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/64007957mmy3001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/68284528mmy3004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/kte-c19-102 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celgene-europe-limited/projects/bb2121-mm-003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/act16482-05 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/207495 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/act16482-06 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/b1931036 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celgene-europe-limited/projects/ca057-003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/207503 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/im011-1069 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/capture 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/iibsp-oxi-2022-124 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/res-6128-c1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/leo-pharma-a-s/projects/lp0133-2393 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bn43881 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sarepta-therapeutics/projects/srp-9001-305 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d6132c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/200925 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn7533-4470 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharm-research-associates-uk-limited/projects/debio-0123-sclc-104 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/elan-pharma-international/projects/hznp-daz-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/elan-pharma-international/projects/hznp-daz-303 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/ac220-168 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d7632c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d763qc00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/ds1062-a-u301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/ds1062-a-u202 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9260c00003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/zealand-pharma-a-s/projects/zp4207-17106 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/bcn04-dasa 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/id-078a205 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celltrion-healthcare-hungary-kft/projects/ct-p44-3-1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ftp-clin-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/aml2420 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cdzr123a02101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d5086c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/ifom-cpt008-2022-po0 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d910pc00001-volga 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-7339-012 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-6070-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/dedalus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m24-601 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/i8f-mc-gpgn 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/ds8201-a-u305 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/ds8201-a-u302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp180588 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ib-2020-05 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/spi-bel-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/isrctn12053408 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d8991c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-0150-1704 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/genmab-a-s/projects/gct1184-03 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-1022-010 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-2140-011 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/guerbet/projects/gdx-102-gdx-44-017 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/d22-p020 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d533bc00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-7902-009 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9106c00002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-2870-031 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3475-01i 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/vhio19001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c5851005 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/tg-therapeutics-inc/projects/tg1101-rms-sc101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c1131003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/genmab-a-s/projects/gct3013-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/p170919 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/4d-molecular-therapeutics/projects/4d-150-c004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/s005201-175 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/primrose-d9970c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp200491 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-390mr-205 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-390mr-204 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c2321014 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20190360 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m22-574 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/eae-2020-mm0107 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celgene-europe-limited/projects/ca057-1040 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r5458-onc-2246 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca204-185 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/eae120 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp231089 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20180257 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ijb-shapers-odn-013 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/54767414amy2009 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp220674 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/go40516 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-2870-007 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cctl019h2301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3475-04c 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-9999-01c 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/1414-rog-gucg 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cjsb462c12201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/caaa617b12203 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/115136 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/dasahivcure 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cabl001j12301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca180-226 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ipc-2022-067 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celgene-europe-limited/projects/cc-92480-mm-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m15-654 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/epo-lt-study 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/revolution-medicines/projects/rmc-6236-302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/revolution-medicines/projects/rmc-6236-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m25-586 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m25-275 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d4325c00010 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/202100617 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp211054 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/112930 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celgene-europe-limited/projects/fedr-mf-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cvay736q12202b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ideaya-biosciences/projects/ide196-002-86-66-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ideaya-biosciences/projects/ide196-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cpdr001x2x01b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ici22-00054 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratoire-hra-pharma/projects/d-cure-iv-22-1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d702kc00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2019-2894 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/univar-solutions-bv/projects/tr-004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bo42162 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bp39144 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bo42354 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bo42353 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/np303-104 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/neurocrine-biosciences-inc/projects/nbi-74788-cah2006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/panc-grp-3001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/crukd-24-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/secura-bio-limited/projects/sbi-0145-304 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn7415-4307 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn7415-4616 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn7415-4311 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chiesi-farmaceutici-s-p-a-eu/projects/cli-01535aa7-04 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chiesi-farmaceutici-s-p-a-eu/projects/cli-01535aa9-03 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20210033 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/blcl-rux-pil01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/blcl-lis-pil01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/2025-liud06004-pl-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/blcl-cab-pil01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/inhibrx-biosciences/projects/inbrx106-01-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/tour-hekla/projects/dr230330-anrs0514s 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/renoir 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/amir-fdc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/np30179 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c4971006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ukd-ikf-double-t 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cosmo-technologies-ltd/projects/cb-01-33-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/64407564mmy2006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharm-research-associates-uk-limited/projects/20-01-betasal-s 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/cartbcma-hcb-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/75276617ale1002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/pvx-2024-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sana-biotechnology/projects/pitac-mapepi 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/taiho-pharma-netherlands-b-v/projects/tas6417-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-ag/projects/22615 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d910sc00001-kunlun 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp200031 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/d24-p009 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/bcv-pa02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/b7451015 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/cset-2022-3571 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/rescue 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/co43476 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/efc17215-leap2mono 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d907hc00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/dompe-farmaceutici-s-p-a/projects/ngf-cp-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r3767-onc-2266 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r3767-onc-2208 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/wa43380 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/shield-prp 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/btiimd-03-ec-23-disc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/bpr-cp-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/shr-3680-iii-hspc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx21-ctx001-151 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx21-ctx001-141 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/ctx001-111 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx18-ctx001-131 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/tour-hekla/projects/carvecir 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gedeon-richter-plc/projects/rgh-188-203 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cardiol-therapeutics/projects/100-006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/medac-gesellschaft-fuer-klinische-spezialpraeparate-mbh/projects/mc-fludt-18-qt 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/223559 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bo43249 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/ds1062-328 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d798kc00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/ds8201-854 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/61186372hnc2002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-international-limited/projects/gs-us-699-7184-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/tesaro-bio-netherlands-b-v/projects/213357 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/sakk-16-18 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/sakk-01-18 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/116795 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/b7981041 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d361bc00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d3615c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/2017-02-32-005 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-gig-2410 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/reverse 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/circulate-spain-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/iconicplus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/cbd-esprit 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/inhibrx-biosciences/projects/ph1-inbrx-109-part-3 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/apg-2575cu101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ace-ly-004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ace-cl-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/d8227c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ace-cl-309 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d8220c00008 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ace-wm-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ace-ly-003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d8223c00016 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/sakk-38-19 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca/projects/d8220l00087 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biontech-manufacturing-gmbh/projects/bnt321-02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-512318-16-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/reprab-mito-36 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca116-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j2g-mc-jzjb 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-6482-033 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/efc16521 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/sakk-08-23 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp211176 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/all2620 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/moleculin-biotech/projects/mb-108 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/fil-column 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/cista-tb 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cytb323k12201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ijb-lbc-neocheck2018 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celgene-europe-limited/projects/ca073-1022 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d926qc00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-0103-1102 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cytb323l12201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celgene-europe-limited/projects/ca088-1007 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/hcb-onc002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/all-sctped-forum 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/eae116 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/artiva-biotherapeutics/projects/ab-101-05 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-2140-010 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d8460c00004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celltrion-healthcare-hungary-kft/projects/ct-p55-3-1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/cs1003-305 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/crisp-itcc-053 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/crd-4730-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp180560 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/p160913 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/corcept-therapeutics-inc/projects/cort125134-557 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/iibsp-oxi-2017-18 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp211055 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ic-2018-06 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp230701 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/cereal-ipc-2016-010 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp240605 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/cadillacc-trial 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ib-2019-07 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca017-078 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d516kc00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca0471009 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca209-1533 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d933ac00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/clean-duct 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d781pc00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cero-therapeutics-holdings-inc/projects/prodige85-kanalrad 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m25-713 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vita-europe-limited/projects/hyperbolic 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-676-1002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d933sc00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cardiff-oncology/projects/spon1610-17 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca2440012 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d516ac00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/v940-009 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-0120-1004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m14-671 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/kti2023 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/30july2021version6-0 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/luti-study 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2023-3720-umbrella 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp220668 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/tour-hekla/projects/pharbevacol 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp220797 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp220676 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/apg2575cc301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chiesi-farmaceutici-s-p-a-eu/projects/cli-05993aa9-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/p150952j 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-1084-014 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3475-01j 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cldk378a2x01b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/neo-cesq 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/fludex 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/seda 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp230841 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp220670 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp251262 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp211043 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp180596 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/cefosprost 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ab-oh-2025 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp221166 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp-180672 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp241591 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharming-technologies-b-v/projects/le-1102 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharming-technologies-b-v/projects/le-3302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharming-technologies-b-v/projects/le-8201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharming-technologies-b-v/projects/le-7x01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharming-technologies-b-v/projects/le-3301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celgene-europe-limited/projects/ca061-1011 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/cat-psy 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/tour-hekla/projects/dr220214 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sarepta-therapeutics/projects/4045-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/carflect-iv 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/uhkt-car19-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/smile 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cero-therapeutics-holdings-inc/projects/ifct-2101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cero-therapeutics-holdings-inc/projects/ec-120888 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3475-c93 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m25-709 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bo42864 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bicycle-therapeutics/projects/bt8009-230-31-41-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m24-633 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d6186c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m25-287 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d967sc00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca244-0010 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/u31402-a-u301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d7988c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/ds8201-793 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-4830-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/daiichi-sankyo-europe-gmbh/projects/ds7300-189 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/et-20-049 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/42756493blc2002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/61186372hnc3001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3475-365 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-2870-033 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/uhkt-car123-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/2024-515363-63-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9670c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-gig-2311 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-gig-2023 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c4221015 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d702ac00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/caaa603d12101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-bcg-2211-cappa 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-0140-1711-ucbg3 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d926pc00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-7902-015 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/222892 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/esr-17-13082 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/116162 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cacz885u2301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/taiho-pharma-netherlands-b-v/projects/tas-120-206 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/camurus-ab/projects/hs-19-657 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/camurus-ab/projects/hs-19-647 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-gig-2404 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca2660004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20210081 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3475-06c 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/lola-trial 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/arcus-biosciences/projects/peak-1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/breakpoint 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ipsen-pharma/projects/f-fr-60000-023 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/cabinmet 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ib-2020-02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/samsung-bioepis-nl-b-v/projects/sb11-2002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/rp-l301-0119 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m24-536 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m24-147 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m19-965 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/bus2020 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bo44426 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bausch-health-ireland-limited/projects/v01-122a-401 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/leo-pharma-a-s/projects/lp0160-1329 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/nl77315-078-21 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cero-therapeutics-holdings-inc/projects/ifct-1904 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/gem-2301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cero-therapeutics-holdings-inc/projects/ffcd-2006-neoraf 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c4221026 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/itcc-054-aaml1921 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/hqp1351cg301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c1071032 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merz-therapeutics-gmbh/projects/nt-ppr-eu002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20220107 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp200019 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/helsinn-birex-pharmaceuticals/projects/nepa-23-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/orion/projects/3137001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharm-research-associates-uk-limited/projects/clp22001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharm-research-associates-uk-limited/projects/clp24001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/cfa-1034-2-23 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/cfa-1034-1-23 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/blcl-tof-fda-04 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/blcl-tof-fda-03 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/blcl-tof-eu-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/blcl-tes-eu-02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/blcl-rux-fda-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/blcl-rux-eu-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/s005190-205 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/s005190-204 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/s005190-203 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/blcl-nil-fda-02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/cfa-1048-1-25 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/cfa-1048-2-25 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/blcl-lis-eu-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/blcl-lis-eu-02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/blcl-lis-eu-03 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/blcl-lis-can-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/blcl-len-fda-02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/blcl-len-fda-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/blcl-len-eu-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/blcl-len-fda-03 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/blcl-etn-anv-02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/blcl-etn-anv-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/cpo23001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/cfa-1037-1-24 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/cfa-1028-2-23 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bial-portela-ca-eu/projects/blcl-amc-02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bial-portela-ca-eu/projects/blcl-amc-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bial-portela-ca-eu/projects/blcl-amc-03 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/n-vot-24-292 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/n-linmet-24-290 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/n-lia-25-297 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/n-lia-23-282 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/n-ezeato-24-293 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/n-edo-24-285 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/n-dapmet-24-286 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/n-dapmet-24-284 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/n-dap-23-281 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/n-can-25-302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/n-linmet-24-287 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/uechup-dap-24-4 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/zaklady-farmafarmaceutyczne-polpharma-s-aceutyczne-polpharma-s-a/projects/01-emp-bio-25 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biocodex/projects/stp218 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/up0122 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ppp001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/1698-302-007 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-international-limited/projects/gs-us-563-5925 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/meda-ab/projects/dorali 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-international-limited/projects/gs-us-380-6738 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biogen-idec-ltd/projects/277hv101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/p170938j 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/220030 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/oralantiseptic-virus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/bcx7353-304 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/bcx7353-312 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ah0003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d3254c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp180351 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/221672 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/200908 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/219240 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/219855 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d516ac00003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m22-003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/300148 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/esperion-therapeutics/projects/1002-041 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/atea-pharmaceuticals/projects/at-01b-008 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-6482-024 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-6482-011 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/pro-rct-acaros-2018 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1479-0001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d6972c00003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d6972c00006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d6972c00002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d6974c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/baxhtn-d6970c00002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/bax24-d6970c00009 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/ms100070-0176 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/nl75848-056-20 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/chasit 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/i4v-mc-khab 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d6402c00012 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/blue-earth-diagnostics-ireland-ltd/projects/bjt-778-302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/blue-earth-diagnostics-ireland-ltd/projects/bjt-778-303 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/3tr-ics-copd 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bicycle-therapeutics/projects/bt8009-100 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/apg2575cg301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/axim-biotechnologies-inc/projects/brigaped-itcc-098 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/insmed-limited/projects/the-birch-study 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/btxclintrialv1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp230823 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ipsen-pharma/projects/clin-52120-452 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/nl68231-078-18 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biontech-manufacturing-gmbh/projects/bnt327-07 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca2660001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca2660006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca2660002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biontech-manufacturing-gmbh/projects/bnt323-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r2810-onc-2045 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biontech-manufacturing-gmbh/projects/bnt111-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca258-0001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biomarin-pharmaceutical-inc/projects/333-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/elechtraplatinum 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/ginonc-ect 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3475-667 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c4221023 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hipra-human-health-s-l/projects/hipra-hh-17 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biogen-idec-ltd/projects/230le306 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biogen-idec-ltd/projects/230le304 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biogen-idec-ltd/projects/230le303 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biogen-idec-ltd/projects/230le301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1403-0008 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1378-0023 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1305-0046 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1305-0029 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biohaven-bioscience-ireland-limited/projects/bhv8000-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-11417-204 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-11417-108 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-11417-103 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-11417-302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-schering-pharma-ag/projects/23026 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cero-therapeutics-holdings-inc/projects/ifct-2502 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-2870-022 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c6461003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m24-311 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/irst153-09 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m24-064 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp241020 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp191110 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca011-023 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/meda-ab/projects/trep-ab 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celgene-europe-limited/projects/ca073-1003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/genmab-a-s/projects/gct3013-05 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/fil-v-rbac 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/stemness-crc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/clarity-pt01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/panama-12782 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bolt-biotherapeutics/projects/bbi-20231001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca126-0015 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-ag/projects/19920 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/p01351-25-67-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ib-2017-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9723c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/i4v-mc-jaip 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/i4v-mc-jajj 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/i4v-mc-jahx 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/14v-mc-jajk 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/i4v-mc-jahw 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp211036 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cbaf312d2301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/taiho-pharma-netherlands-b-v/projects/astx030-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celgene-europe-limited/projects/cc-486-nscl-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/sy-1425-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/inca34176-254 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1438-0011 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/gemcad-1802 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bo39610 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/abc-hcc 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-1084-012 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/wo42178 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/cl3-95005-006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/22590 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/blueprint-medicines-netherlands-b-v/projects/blu-285-2203 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/blueprint-medicines-netherlands-b-v/projects/blu-285-3101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/blueprint-medicines-netherlands-b-v/projects/blu-285-2404 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astellas-pharma-gmbh/projects/isee2009 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/atdc-pici 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/pst012021 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/elan-pharma-international/projects/ocus-mode-ct-v1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/7098 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/116130 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m24-305 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m24-859 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m23-712 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/3101-312-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cassiopea-s-p-a/projects/cb-03-01-39 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/formycon-ag/projects/fyb206-c1-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/p130937 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cabl001i12202 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/istituto-gentili-s-r-l/projects/irfmn-7557-8154 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/224083 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/222253 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/212496 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/217848 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/222090 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/219815 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/16-739 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20190529 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20190531 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/b7471015 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cero-therapeutics-holdings-inc/projects/prodige-104-a 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alexion-europe-sas/projects/alxn1210-tma-313 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alexion-europe-sas/projects/alxn1210-igan-320 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d346bc00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d3463c00003-jasmine 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d3465c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharming-technologies-b-v/projects/le-6101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/swedish-orphan-biovitrum-international-ab/projects/sm25-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/dph001-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/dph001-01-96-18-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/p-sp420-thal-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/dbp-053-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharming-technologies-b-v/projects/le-5101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/987-24 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/988-24 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/upada-02-24 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/upada-01-24 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/tamsu-13-24 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/tamsu-12-24 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ruxol-18-24 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ponat-14-25 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/naltr-17-24 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/marib-04-25 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/lisde-06-24 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/lisde-01-25 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/imati-10-25 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/deada-07-23 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/clari-21-24 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/briva-10-24 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/trame-13-25 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/deucr-08-25 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/deucr-07-25 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/bupro-05-25 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/lamot-04-24 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/enzal-15-24 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/enzal-16-24 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/bosut-09-24 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/mesal-20-24 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/mesal-19-24 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/upada-03-24 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/bupro-06-25 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/lacos-06-23 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ivaca-05-23 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/empag-05-24 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/viiv-healthcare-bv/projects/221794 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ferring-pharmaceuticals-a-s/projects/000426 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ferring-pharmaceuticals-a-s/projects/000427 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/co43805 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d7860c00004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/swedish-orphan-biovitrum-ab-publ/projects/sobi-pegcet-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/stp938-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/np39488 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/tv44749-ba-10196 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/corcept-therapeutics-inc/projects/cort125134-452 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/tiosmi 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/acumen-pharmaceuticals/projects/acu193-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/wn45447 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/219867 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/aln-ttrsc02-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/aln-ttrsc02-007 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/efc17600 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/efc17559 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/dp-10027 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/iibsp-ami-2024-33 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/star-2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp230847 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx20-121-104 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/abp-2019 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/imgn853-0424 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/alofisel-4001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celgene-europe-limited/projects/ca058-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/p150941j 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2g-msc-gvhd 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/acav2018 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bo40336 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bo42777 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/nl77596-042-21 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp230673 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-0140-1208 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/cset-2014-2126 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c4391022 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cytokinetics-ireland-limited/projects/cy-6023 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cytokinetics-ireland-limited/projects/cy-6022 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r668-as-2373 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astellas-pharma-gmbh/projects/pmr-ec-1206 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/leo-pharma-a-s/projects/lp0162-1336 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/leo-pharma-a-s/projects/lp0162-1335 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/adipgen 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/partner-therapeutics-limited/projects/etop-22-22-adeppt 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/lgon-ct-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharm-research-associates-uk-limited/projects/23-01-clindatret-g 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/aspire-trial 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/genmab-a-s/projects/gct1046-07 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/genmab-a-s/projects/gct1046-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/dan-rsv 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/b7451023 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/b7451031 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/caaa614a12101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/gilead-sciences-international-limited/projects/gs-us-592-6238 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/genmab-a-s/projects/gct1042-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ipsen-pharma/projects/d-us-60010-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/proicm-2020-04-gab 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/wo39608 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/vespa 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cero-therapeutics-holdings-inc/projects/ico-2023-14 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/i3y-mc-jpcs 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/smx-22-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/i3y-mc-jpeh 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/i3y-mc-jpei 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d8410c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d6900c00003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9481c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d5336c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9090c00008 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d7261c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d7405c00001-syrus 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d8311c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d7080c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp211057 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m19-063 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/apg2575ag301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/blueprint-medicines-netherlands-b-v/projects/blu-263-2101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alx-oncology-holdings-inc/projects/at148002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/syndax-pharmaceuticals-inc/projects/sndx-6352-0504 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/avec-119 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-imm-2101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ior-iisml42037 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/autolus-therapeutics-plc/projects/auto-lt1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/autolus-therapeutics-plc/projects/auto1-sl2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/efc17919b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/lts17043-31-18-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/ckjx839a12309 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/intensify-mdd 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/neo-tim 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/2015-2335 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/atn-106 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/nibit-ml-1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/taiho-pharma-netherlands-b-v/projects/astx727-07 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/taiho-pharma-netherlands-b-v/projects/astx727-03 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ohirc-20150866 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/tour-hekla/projects/dr200091 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/apl2-pnh-209 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/apl2-c3g-204 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astellas-pharma-gmbh/projects/8951-cl-0302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astellas-pharma-gmbh/projects/8951-cl-0301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astellas-pharma-gmbh/projects/8951-cl-5201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astellas-pharma-gmbh/projects/8951-cl-0103 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astellas-pharma-gmbh/projects/5541-cl-0201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/cset-2025-4116 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astellas-pharma-gmbh/projects/1570-cl-0101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cabl001i12201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cabl001a2302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/art0380c001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/arrowhead-pharmaceuticals-inc/projects/aroapoc3-3003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/arrowhead-pharmaceuticals-inc/projects/aroapoc3-3009 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/nl75882-078-20 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/iibps-don-2022-43 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/ho161 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/argenx/projects/argx-113-2008 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/all3024 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/eortc-2238-gucg 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cero-therapeutics-holdings-inc/projects/prodige-51-gastfox 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j6m-mc-jsgd 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/109883 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/axim-biotechnologies-inc/projects/mb24thr 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3543-006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/neuraxpharm-pharmaceuticals-s-l/projects/gfc-bemd-01-nxp-23 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/p160929j 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp221107 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp200011 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp241013 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp210085 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/p150924 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/camo959a12103 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/tour-hekla/projects/dr230005 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp180690 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/p160916j 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/nl77347-042-22 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alexion-europe-sas/projects/alxn2420-acro-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alexion-europe-sas/projects/alxn1850-hpp-303 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/allerdog 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/swedish-orphan-biovitrum-ab-publ/projects/sobi-bivv001-004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/swedish-orphan-biovitrum-ab-publ/projects/sobi-bivv001-005 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/swedish-orphan-biovitrum-ab-publ/projects/sobi-bivv001-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/clee011x2107 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cbyl719c2303 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cbyl719x2402 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/aln-ttrsc04-004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/54659 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celltrion-healthcare-hungary-kft/projects/ct-p51-3-1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/pdc-lung-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/aligos-therapeutics/projects/alg-000184-202 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/moleculin-biotech/projects/mb-106 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/go42286 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/oj-kdc01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/snt-iv-vam-011 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/cl3-95031-007 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/s095031-210 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-577-3001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ferring-pharmaceuticals-a-s/projects/000425 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ferring-pharmaceuticals-a-s/projects/000423 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-mesto/projects/chrd-2419 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/adaptive-biotechnologies-corp/projects/gcar-7213 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/1537-lymg 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/c25004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp230831 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/i4v-mc-jaja 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratoire-hra-pharma/projects/arg-01-2024 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/tour-hekla/projects/dr230297 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp230836 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cardiol-therapeutics/projects/rm21 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/piccoleto-iv-epic-38 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cardiol-therapeutics/projects/ba-scad 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/optim-pre26 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/inhibrx-biosciences/projects/ph2-inbrx-109-sa-cs 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/collegium-pharmaceutical-inc/projects/aerd-cov19 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-1026-011 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ac102-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/etna 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cdzr123c12101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/pbp-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/uc-gtg-2301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/caaa617b12302 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20230239 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/64091742pcr3001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/gim31-neo-agile 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/i3y-mc-jpbl 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/rgx-314-3101-m23-409 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m24-885 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m24-541 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m16-194 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m25-540 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ab-science/projects/ab18001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/azd5462-d9090c00012 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9609c00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d8991c00002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d5985c00008 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d6970c00004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d7260c00007 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/curevac-ag/projects/cv-hnlc-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/spi-62-cl-1002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1501-0002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1443-0002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1404-0008 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1368-0151 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn1436-7615 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/sfy17741 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1463-0001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/hs-10296-108 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novo-nordisk-a-s/projects/nn6497-8316 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-ag/projects/22128 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/pa0019 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/dv0012 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/snt-i-vam-026 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-ag/projects/22598 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r1979-onc-1504 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-ag/projects/22342 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-ag/projects/22537 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-ag/projects/22676 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/221377 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/300134 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/222110 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d967yc00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/ted18162 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d3560c00817 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d3615c00005 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/pdy18058 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/int22854 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/recordati-ireland/projects/som230-recag-pk-0605 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/221362 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/b3461115 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/219729 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/219728 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/a160-01ad2502 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/mabxience-research-sl/projects/mb12-c-02-24 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/0352-2190 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/0352-2189 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ipsen-pharma/projects/d-fr-60010-015 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m23-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/dr-falk-pharma-gmbh/projects/nuc-011-bio 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ipsen-pharma/projects/clin-60250-450 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c4921008 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/vhio20002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astellas-pharma-gmbh/projects/2215-cl-5201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/14040047 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/67953964mdd1010 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1397-0029 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1509-0014 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1509-0002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1516-0004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1245-0358 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1378-0025 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1479-0019 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/0248-0690 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1366-0042 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/0248-0689 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1479-0015 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1479-0014 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1509-0007 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1305-0119 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1434-0021 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1479-0047 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1305-0113 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1378-0024 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1447-0007 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/02api2024 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/kiniksa-pharmaceuticals-international-plc/projects/kpl-404-c221 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/s-r-o/projects/01-2023-pozlab 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/zaklady-farmafarmaceutyczne-polpharma-s-aceutyczne-polpharma-s-a/projects/01-amo-cla-bio-25 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/zaklady-farmafarmaceutyczne-polpharma-s-aceutyczne-polpharma-s-a/projects/01-dap-bio-24 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/pb016-01-02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/039-c-a-md23341 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/01inda2024 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/s-r-o/projects/204-pkt-202301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/01api2024 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/pcv-lite-i 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/efc17359 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/tetralite-ib 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/24eu-lip03 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/206785 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ic-2020-06 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/ology-bioservices-ireland-ltd/projects/eae140 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/ckfa115a12101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/fondazione-telethon-ets/projects/hepavac-201 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/cset-n-2020-3138 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/otsuka-novel-products-gmbh/projects/vis171-103 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharm-research-associates-uk-limited/projects/debio0123-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/act18064 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/italfarmaco-s-p-a/projects/itf2357-60 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/212895 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/k-321-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-ag/projects/21820 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/id-080-111 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/recordati-ireland/projects/som230-recag-cl-0576 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/lisde-14-24 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/bupro-08-24 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/bupro-07-24 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/mesal-02-25 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/mesal-03-25 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cdak539a12102 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celgene-europe-limited/projects/cc-90011-sclc-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cldk378a2120c 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/54767414mmy2093 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-1045-004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/mylan-dura-gmbh/projects/epin-ijs-1002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bn42644 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/gzr33-t1d-us101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/gl-uli-1001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/ms200569-0065 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m16-573 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bp44956 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bp45248 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bo45287 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c3421063 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c4551007 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c4891038 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/hdp-102-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c4551010 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c4891037 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astellas-pharma-gmbh/projects/2693-cl-2101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/a6281331 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c5091010 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bp42230 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bn44083 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/kura-oncology/projects/ko-men-008 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/wn45319 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d9180c00011 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r5458-onc-2012 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/co42800 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/ga43191 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bp43131 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bp43015 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/0439-24 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/wp43295 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bp41628 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/b3461131 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m22-716 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m22-947 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m25-292 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/nurix-therapeutics/projects/nx-5948-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/r5054-onc-1843 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bo42203 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bp42233 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m15-531 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20230127 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m24-291 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/autolus-therapeutics-plc/projects/auto1-sl1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/nitrais-03-2024 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/tmc207tbc1006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bp45228 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bo43936 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ly03010-ct-eur-102 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/gn43271 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/mabxience-research-sl/projects/mb04-a-01-23 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/laboratorios-tillomed-spain-s-l-u/projects/lt-02-19 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bo45217 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/wn43174 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/go45006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/gn41791 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bo29554 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/go44096 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bo44178 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/go45434 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bn45398 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d933ic00001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/can-201-ndg 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/advicenne-s-a/projects/b06cs 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/lidexu 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/astrazeneca-ab/projects/d5985c00009 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/haleon-ireland-dungarvan-limited/projects/300141 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hutchmed-europe-b-v/projects/2018-523-00us1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/philogen-s-p-a/projects/ph-l19il2cork-01-25 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/sta101jg 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/cchf-np-1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/209626-dreamm-12 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/209627-dreamm-13 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca235-0001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/gl-uli-1001-46-73-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/vhio24001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/vhio24001-60-28-00 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/karyopharm-therapeutics/projects/kcp-330-009 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/209628 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/223584 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/dcr-phxc-204 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m20-258 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ace-ly-106 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/67856633lym1002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/64407564mmy1002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/79635322mmy1002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/78278343pcr1003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/64407564mmy1005 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/adc-therapeutics-sa/projects/adct-402-105 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beigene-ireland-ltd/projects/bgb-a317-a3055-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3475-04b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca001-044 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/incyte-biosciences-distribution-b-v/projects/incb-00928-104 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/crn09682-191 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/ms700623-0061 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/inflarx-gmbh/projects/inf904-p1-3 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/gbp-nib1-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/77242113pso1009 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/rho-11-003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/90189892aml1001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/88998377lym1001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/solomon-i 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/arv-ba-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cullinan-therapeutics/projects/cln-619-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m23-385 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/m21-404 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/camurus-ab/projects/hs-24-787 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/89853413aml1001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/87562761mmy1001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/78278343pcr1001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/im060-0001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/hutchmed-europe-b-v/projects/2020-306-glob1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celgene-europe-limited/projects/ca1190002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-3227-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-b2033-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/20160323 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/64007957mmy1008 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sutro-biopharma-inc/projects/stro-002-gm2 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vir-biotechnology/projects/vir-5818-v101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/wn43194 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ray104ct 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/64407564mmy1004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/gineco-ce111b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/fs120-19101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celltrion-healthcare-hungary-kft/projects/ct-p51-1-1 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/222291 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/cp543-1017 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/73841937nsc1001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/67896062pah1011 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/roche-registration-limited/projects/bp42772 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ijb-zephir02-2024 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/dante-flot8 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/enliven-therapeutics/projects/elvn-002-003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/ca209-9dx 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/projects/c4951003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/20725 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/camp4-therapeutics-corp/projects/cps-101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/maze-therapeutics/projects/ngam-13 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j3l-mc-ezef 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/generate-biomedicines/projects/gb-0895-301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/eli-lilly-co/projects/j3k-mc-kiab 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/chiesi-farmaceutici-s-p-a-eu/projects/cli-10067aa1-02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/arrowhead-pharmaceuticals-inc/projects/aromuc5ac-1001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/aln-ttrsc02-003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/arrowhead-pharmaceuticals-inc/projects/arorage-1001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-pharmaceutica-n-v/projects/vac52416bac3001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/213823 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/ap101-02 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp201028 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/moderna-biotech-spain/projects/mrna-3705-p101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/glaxosmithkline-biologicals-s-a/projects/218672 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/biogen-idec-ltd/projects/299ig301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/aln-agt01-008 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/celgene-europe-limited/projects/ace-536-mf-002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp230833 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/efc17599-aqua 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/mg0008 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/mg0006 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3475-b98 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp220673 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/abbvie-deutschland-gmbh-co-kg/projects/imgn853-0425 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cvay736q12301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-2400-01a 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-2870-023 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/sl0046 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-2870-036 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-2870-021 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/77242113uco2001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-2870-012 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-2870-015 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/clnp023a2002b 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cjdq443b12301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk2870-004 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/denali-therapeutics/projects/dnli-h-0001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/gem-plasmacar 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/sanofi-pharma-bristol-myers-squibb/projects/lts17043 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/janssen-cilag-international-n-v/projects/56021927pcr3002 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/caaa802a12101 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pari-pharma-gmbh/projects/aphp200020 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/skb264-ii-04 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-3475-06d 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/merck-sharp-and-dohme/projects/mk-2870-010 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/geron-netherlands-b-v/projects/grn163lmyf3001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/cvay736o12301 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/kl264-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/vita-europe-limited/projects/festa 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/disc-medicine/projects/pump-iv 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/cancer-prevention-pharma-ireland-limited/projects/20-348 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/ijg-storm-2024 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/cdr132l-p2-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/institut-f-r-biomedizinische-analytik-nmr-imaging-gmbh/projects/inmunocell-ctmv 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bayer-ag/projects/22597 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/adt-2022-003 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/2022-01 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/pharma-mar-s-a/projects/adt-2023-001 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/bristol-myers-squibb-pfizer-eeig/projects/cv027-010 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/1378-0043 2026-05-26 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/cinryze-acute-antibody-mediated-rejection-amr 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/cinryze-500-u-hereditary-angioedema-hae 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/cinryze-500-hereditary-angioedema-hae 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/gdx012-leukemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/ciclesonide-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/ciclesonide-allergic-rhinitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/cdpath-crohn-s-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/cardiovascular-drugs-strategies-high-risk-hypertensive-patients 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/candesartan-type-2-diabetes 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/candesartan-type-1-diabetes 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/candesartan-heart-failure 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/candesartan-cilexetil-type-1-diabetes 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/candesartan-cilexetil-stroke 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/candesartan-cerebrovascular-accident 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/candesartan-and-standard-chronic-heart-disease-t-heart-failure 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/candesartan-and-hydrochlorothiazide-obesity 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/calcitriol-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/calcichew-d3-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/calcichew-d3-calcium-and-vitamin-d-deficiencies 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/caffeine-colitis-ulcerative 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/cabozantinib-metastatic-prostate-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/cabozantinib-advanced-renal-cell-carcinoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/cabozantinib-advanced-hepatocellular-carcinoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/c1-inhibitor-human-traumatic-brain-injury 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/c1-inhibitor-human-c1-inh-hereditary-angioedema 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/c1-esterase-inhibitor-injection-cinryze-subarachnoid-hemorrhage-aneurysmal 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/c1-esterase-inhibitor-human-liquid-hereditary-angioedema-hae 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/c1-esterase-inhibitor-human-c1inh-nf-hereditary-angioedema 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/budesonide-oral-suspension-eosinophilic-esophagitis-eoe 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/calcium-500-mg-and-vitamin-d3-800-iu-calcium-deficiency 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/budesonide-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/budesonide-eosinophilic-esophagitis-eoe 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/brigatinib-nsclc-stage-iii 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/candesartan-cilexetil-and-hydrochlorothiazide-hypertension 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/brigatinib-nsclc 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/brigatinib-non-small-cell-lung-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/brigatinib-neurofibromatosis-type-2 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/brigatinib-lymphoma-large-cell-anaplastic 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/brigatinib-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/brigatinib-carcinoma-non-small-cell-lung 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/brigatinib-anaplastic-lymphoma-kinase-positive-alk-anaplast 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/celaderm-frozen-cultured-epidermal-allograft-leg-ulcer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/brigatinib-anaplastic-large-cell-lymphoma-alk-positive 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/brigatinib-alk-positive-advanced-nsclc 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/brigatinib-alk-advanced-nsclc 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/ciclesonide-xrp1526-respiratory-tract-diseases 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/brentuximabvedotin-bv-hodgkin-lymphoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/brentuximab-vedotin-t-cell-lymphoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/brentuximab-vedotin-relapsed-or-refractory-hodgkin-lymphoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/cinryze-hereditary-angioedema 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/brentuximab-vedotin-primary-cutaneous-anaplastic-large-cell-lymphoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/brentuximab-vedotin-malignant-neoplasms-stated-as-primary-lymphoid-h 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/brentuximab-vedotin-lymphoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/brentuximab-vedotin-in-combination-with-tisleliz-nk-t-cell-lymphoma-nos 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/brentuximab-vedotin-hodgkin-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/brentuximab-vedotin-enteropathy-associated-t-cell-lymphoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/brentuximab-vedotin-diffuse-large-b-cell-lymphoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/bortezomib-recurrent-plasma-cell-myeloma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/bortezomib-plasma-cell-myeloma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/bortezomib-non-germinal-b-cell-like-gcb-diffuse-large-b-cel 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/blood-sampling-alpha-galactosidase-lysogb3-fabry-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/blinatumomab-accelerated-phase-chronic-myelogenous-leukemia-b 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/binimetinib-alk-gene-rearrangement 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/bax855-hemophilia-a 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/bax69-single-route-arm-refractory-ovarian-cancer-with-recurrent-symptom 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/bax69-infusional-5-fu-lv-metastatic-colorectal-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/bax326-hemophilia-b 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/bax-888-hemophilia-a 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/bax-326-recombinant-factor-ix-hemophilia-b 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/bax-326-hemophilia-b 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/b-mad-chemotherapy-extranodal-nk-t-cell-lymphoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/azilsartan-pediatric-hypertension 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/azilsartan-medoxomil-with-or-without-add-on-chlo-hypertension 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/azilsartan-medoxomil-tak-491-hypertension 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/azilsartan-medoxomil-placebo-essential-hypertension 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/azilsartan-medoxomil-hypertension 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/azilsartan-medoxomil-and-olmesartan-hypertension 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/azilsartan-medoxomil-and-chlorthalidone-safety 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/azilsartan-medoxomil-and-chlorthalidone-hypertension 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/azilsartan-medoxomil-and-chlorthalidone-essential-hypertension 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/azilsartan-medoxomil-and-amlodipine-hypertension 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/azilsartan-medoximil-hypertension 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/azilsartan-hypertension 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/azilsartan-essential-hypertension-with-stable-angina-and-dy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/azilsartan-essential-hypertension-complicated-by-type-2-dia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/azacitidine-myelodysplastic-syndromes 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/azacitidine-myelodysplastic-syndrome 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/aspirin-and-or-clopidogrel-early-gastric-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/askbio009-hemophilia-b 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/ascs-cx401-company-code-anal-fistula 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/aralast-np-chronic-obstructive-pulmonary-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/aralast-np-60-mg-kg-chronic-obstructive-pulmonary-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/aralast-alpha1-proteinase-inhibitor-alpha1-antitrypsin-deficiency 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/ao-128-impaired-glucose-tolerance-igt 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/antihemophilic-factor-recombinant-porcine-sequen-hemophilia-a 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/antihemophilic-factor-recombinant-plasma-albumin-hemophilia-a 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/antihemophilic-factor-recombinant-manufactured-p-hemophilia-a 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/antihemophilic-factor-manufactured-and-formulate-hemophilia-a 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/antidepressant-spd489-lisdexamfetamine-dimesylat-major-depressive-disorder 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/anti-macrophage-migration-inhibitory-factor-anti-systemic-lupus-erythematosus 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/anti-macrophage-migration-inhibitory-factor-anti-metastatic-adenocarcinoma-of-the-colon-or-rectum 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/anagrelide-thrombocythemia-hemorrhagic 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/anagrelide-hydrochloride-essential-thrombocythemia-et 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/anagrelide-hydrochloride-essential-thrombocythaemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/anagrelide-0-5-mg-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/ampicillin-surgical-site-infection 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/amoxicillin-mmx-placebo-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/amlodipine-hypertension 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/amg-706-non-small-cell-lung-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/amg-706-advanced-gastrointestinal-stromal-tumor 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/amg-479-adenocarcinoma-of-the-pancreas 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/alx1-11-osteoporosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/alx1-11-drug-osteoporosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/alx1-11-50-mcg-osteoporosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/alx-0600-crohn-s-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/alpha1-proteinase-inhibitor-covid19 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/alpha1-proteinase-inhibitor-alpha1-antitrypsin-deficiency 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/alpha1-proteinase-inhibitor-alpha-1-antitrypsin-deficiency 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/alogliptin-pioglitazone-diabetes-mellitus-type-2 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/alogliptin-pharmacokinetics-and-pharmacodynamics 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/alogliptin-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/alogliptin-diabetes-mellitus-type-2 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/alogliptin-benzoate-diabetes-mellitus-type-2 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/alogliptin-and-voglibose-type-2-diabetes-mellitus 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/alogliptin-and-pioglitazone-type-2-diabetes-mellitus 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/alogliptin-and-metformin-type-2-diabetes-mellitus 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/alogliptin-and-metformin-diabetes-mellitus 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/alogliptin-and-insulin-diabetes-mellitus 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/alogliptin-and-glyburide-diabetes-mellitus 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/alogliptin-and-glimepiride-type-2-diabetes-mellitus 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/alisertib-small-cell-lung-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/alisertib-relapsed-peripheral-t-cell-lymphoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/alisertib-ovarian-carcinoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/alisertib-mln8237-diffuse-large-b-cell-lymphoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/alisertib-malignant-rhabdoid-tumor 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/alisertib-diffuse-large-b-cell-lymphoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/alisertib-b-cell-follicular-lymphoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/alisertib-advanced-solid-tumors 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/alisertib-advanced-malignancies 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/alisertib-adenocarcinoma-of-the-prostate 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/alisertib-acute-myeloid-leukemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/alisertib-acute-myelogenous-leukemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/alisertib-acinar-cell-adenocarcinoma-of-the-pancreas 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/agalsidase-alfa-fabry-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/aes-103-sickle-cell-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/aerosolized-recombinant-alpha-1-antitrypsin-alpha1-antitrypsin-deficiency 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/adjuvant-excipients-norovirus 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/adclec-syn1-car-t-cells-acute-myeloid-leukemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/adcetris-levact-clinical-efficacy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/adalimumab-crohn-s-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/ad-4833-15-mg-diabetes-mellitus 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/actovegin-post-stroke-cognitive-impairment-psci 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/actovegin-peripheral-arterial-diseases 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/actos-pioglitazone-multiple-sclerosis-relapsing-remitting 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/851b-papillomavirus-infections 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/75mg-shp647-pf-00547659-ulcerative-colitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/68ga-mln6907-imaging-of-solid-gastrointestinal-tumors 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/30-mg-dexlansoprazole-capsules-manufactured-at-t-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/bax-826-hemophilia-a 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/25mcg-rhpth-1-84-hypoparathyroidism 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/25-mg-ontamalimab-crohn-s-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/19-t2-28z1xx-trac-t-cell-b-cell-lymphoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/19-t2-28z1xx-car-t-cells-diffuse-large-b-cell-lymphoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/14c-tak-954-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/14c-tak-385-oral-solution-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/14c-subasumstat-solid-tumors 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/14c-alisertib-advanced-solid-tumors 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/1-tachosil-hemostatic-sponge-9-5-cm-x-4-8-cm-pla-prostate-or-bladder-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/1-84-parathyroid-hormone-shoulder-fractures 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/ziv-aflibercept-uveal-melanoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/summit-therapeutics/projects/ivonescimab-ivonescimab 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/ziv-aflibercept-metastatic-uveal-melanoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/ziv-aflibercept-lymphoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/ziv-aflibercept-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/vv1-melanoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/vonsetamig-lupus-nephritis-ln 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/vonsetamig-chronic-kidney-disease-ckd 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/vidutolimod-merkel-cell-carcinoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/vegf-trap-neovascular-age-related-macular-degeneration 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/vegf-trap-macular-degeneration 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/vegf-trap-eye-macular-degeneration 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/vegf-trap-eye-diabetic-macular-edema 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/vegf-trap-eye-bay86-5321-myopia-pathological 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/vegf-trap-eye-bay86-5321-macular-edema 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/vegf-trap-eye-bay86-5321-diabetes-mellitus 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/vegf-trap-eye-2-0mg-macular-edema-secondary-to-central-retinal-vein 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/ubamatamab-smarcb1-deficient-malignancies 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/ubamatamab-recurrent-ovarian-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/ubamatamab-ovarian-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/ubamatamab-advanced-metastatic-non-small-cell-lung-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/trevogrumab-part-a-obesity 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/tirzepatide-obesity 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/suptavumab-30-mg-kg-respiratory-syncytial-virus-infections 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/subconjunctival-aflibercept-corneal-neovascularization 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/sub-tenon-injection-of-saline-followed-by-a-sub-thyroid-eye-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/sns-101-anti-vista-solid-tumor-adult 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/sdregn2810-advanced-non-small-cell-lung-carcinoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/sc-daric33-acute-myeloid-leukemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/sarilumab-sar153191-regn88-rheumatoid-arthritis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/sarilumab-sar153191-regn88-polymyalgia-rheumatica 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/sarilumab-sar153191-regn88-juvenile-idiopathic-arthritis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/sarilumab-sar153191-giant-cell-arteritis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/sarilumab-sar153191-corona-virus-infection 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/sarilumab-rheumatoid-arthritis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/sarilumab-ra 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/sarilumab-polymyalgia-rheumatica 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/sarilumab-morphea-plaque-form 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/sarilumab-juvenile-idiopathic-arthritis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/sarilumab-ankylosing-spondylitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/sar444881-solid-tumors 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/sar440340-chronic-obstructive-pulmonary-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/sar440340-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/sar231893-regn668-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/sar231893-regn668-dp1-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/sar231893-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/sar153191-regn88-rheumatoid-arthritis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/s095018-non-small-cell-lung-cancer-nsclc 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/rilonacept-scleroderma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/rilonacept-il-1-trap-systemic-juvenile-idiopathic-arthritis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/rilonacept-gout 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/rilonacept-cold-contact-urticaria 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/rilonacept-chronic-kidney-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/rilonacept-autoimmune-neurosensory-hearing-loss-anshl 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/rilonacept-acute-gout-flare 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/rilonacept-80-mg-intercritical-gout 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/rilonacept-160-mg-familial-cold-autoinflammatory-syndrome-fcas 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/rescue-intravitreal-aflibercept-injection-neovascular-polypoidal-choroidal-vasculopathy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regv131-hemophilia-b 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/jazz-pharmaceuticals-plc/projects/caphosol-oral-mucositis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn9933-venous-thromboembolism 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn9933-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn9533-healthy-volunteer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn910-3-neovascular-age-related-macular-degeneration 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn910-3-diabetic-macular-edema 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/sarilumab-covid-19 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn9035-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn88-rheumatoid-arthritis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn7999-non-transfusion-dependent-beta-thalassemia-ntdt 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn7999-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn7544-sepsis-induced-hypotension 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn7544-postural-orthostatic-tachycardia-syndrome-pots 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn7544-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn7508-venous-thromboembolism-vte 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn7508-venous-thromboembolism 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn7508-symptomatic-venous-thromboembolism-vte 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn7508-peripheral-artery-disease-pad 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn7508-iv-healthy-volunteer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn7508-cancer-associated-thrombosis-cat 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn7508-atrial-fibrillation-af 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn728-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn727-sar236553-hypercholesterolemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn727-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn727-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn7257-severe-aplastic-anemia-saa 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/vitamin-a-sepsis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn7075-advanced-solid-tumors 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn7041-active-noninfectious-uveitis-affecting-the-poste 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn668-injection-rate-1-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn668-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn668-dermatitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn6569-squamous-cell-carcinoma-of-head-and-neck 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn6490-healthy-volunteer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn5713-allergic-rhinitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn5713-allergic-conjunctivitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn5713-5714-5715-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn5678-prostate-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn5678-metastatic-castration-resistant-prostate-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn5668-ovarian-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn5459-relapsed-multiple-myeloma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn5381-uncontrolled-hypertension 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn5381-heart-failure 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn5093-m114-advanced-nsclc 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn5069-osteoarthritis-of-the-knee 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn5069-healthy-volunteer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn475-sciatica 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn475-sar164877-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn475-sar164877-back-pain 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn475-sar164877-abdominal-pain-upper 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn475-osteoarthritis-of-the-knee 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn475-osteoarthritis-knee 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn475-osteoarthritis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn4659-carcinoma-non-small-cell-lung 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn4461-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn4461-familial-partial-lipodystrophy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn4336-metastatic-castration-resistant-prostate-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn421-sar153192-advanced-solid-malignancies 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn3918-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn3767-malignancies 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn3500-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn3500-atopic-dermatitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn3500-asthma-allergic 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn3500-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn3470-3471-3479-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn2810-recurrent-squamous-cell-carcinoma-of-head 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn2810-prostate-cancer-metastatic 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn2810-non-small-cell-lung-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn2810-melanoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn2810-ipi-non-small-cell-lung-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn2810-advanced-malignancies 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn2477-regn1033-sporadic-inclusion-body-myositis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn2477-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn2477-fibrodysplasia-ossificans-progressiva 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn2222-sar438584-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn2222-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn22044-healthy-volunteer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn2176-3-neovascular-wet-age-related-macular-degeneration 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn2176-3-neovascular-age-related-macular-degeneration 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn20934-overweight-or-obesity 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn20423-healthy-volunteer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn2009-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn1908-allergic-conjunctivitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn1908-1909-allergy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn1908-1909-allergic-rhinitis-due-to-cat-allergy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn17092-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn15505-metastatic-castration-resistant-prostate-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn15160-iv-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn1500-metabolic-disorders 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn1500-hypertriglyceridemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn1500-250-mg-sc-15-mg-kg-iv-450-mg-sc-homozygous-familial-hypercholesterolemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn1908-1909-cat-allergy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn14284-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn14256-sars-cov-2 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn13335-pulmonary-arterial-hypertension-pah 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn13335-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn1193-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn1193-diabetes-mellitus-type-2 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn1154-or-placebo-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn10933-regn10987-healthy-participants 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn10933-regn10987-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn10933-regn10987-combination-therapy-covid-19 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn1400-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn10597-melanoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn1033-sar391786-sarcopenia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn1033-sar391786-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn1033-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/ranibizumab-macular-degeneration 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/r475-thermal-injury-pain 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/prompt-aflibercept-diabetic-retinopathy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/prompt-aflibercept-diabetic-macular-edema 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/praluent-heterozygous-familial-hypercholesterolemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/pozelimab-paroxysmal-nocturnal-hemoglobinuria 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/pozelimab-healthy-volunteer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/pozelimab-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/pozelimab-geographic-atrophy-ga 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/pozelimab-chaple-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/pozelimab-cemdisiran-sporadic-inclusion-body-myositis-sibm 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/pozelimab-cemdisiran-generalized-myasthenia-gravis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/pozelimab-cd55-deficient-protein-losing-enteropathy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/pozelimab-age-related-macular-degeneration-amd 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/placebo-heterozygous-familial-hypercholesterolemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/placebo-gout 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/placebo-generalized-lipodystrophy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/placebo-for-dupilumab-nasal-polyps 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/placebo-for-alirocumab-hypercholesterolemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/placebo-colorectal-neoplasms 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/placebo-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/pexastimogene-devacirepvec-pexa-vec-renal-cell-carcinoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/oxaliplatin-colorectal-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/olatorepatide-overweight-or-obesity 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/odronextamab-relapsed-refractory-follicular-lymphoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/odronextamab-recurrent-diffuse-large-b-cell-lymphoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/odronextamab-multiple-dose-levels-non-hodgkin-lymphoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/odronextamab-follicular-lymphoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/odronextamab-diffuse-large-b-cell-lymphoma-dlbcl 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/odronextamab-b-cell-non-hodgkins-lymphoma-b-nhl 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/ntla-2001-transthyretin-amyloidosis-attr-with-cardiomyopat 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/nexiguran-ziclumeran-neuromuscular-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/nesvacumab-regn910-sar307746-solid-tumors 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/motixafortide-pancreatic-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/mibavademab-monogenic-obesity 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/mibavademab-generalized-lipodystrophy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/mibavademab-functional-hypothalamic-amenorrhea-fha 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/maat033-capsule-nsclc-advanced-non-small-cell-lung-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/lmt-atorvastatin-simvastatin-or-rosuvastatin-heterozygous-familial-hypercholesterolemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/linvoseltamab-smoldering-multiple-myeloma-smm 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/linvoseltamab-relapsed-refractory-systemic-light-chain-amyloid 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/linvoseltamab-relapsed-refractory-multiple-myeloma-rrmm 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/linvoseltamab-relapsed-refractory-multiple-myeloma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/linvoseltamab-relapsed-and-or-refractory-multiple-myeloma-rrmm 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/linvoseltamab-recurrent-multiple-myeloma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/linvoseltamab-multiple-myeloma-mm 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/linvoseltamab-multiple-myeloma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/linvoseltamab-monoclonal-gammopathy-of-undetermined-significan 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/linvoseltamab-high-risk-smoldering-multiple-myeloma-hr-smm 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/linvoseltamab-food-allergy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/itepekimab-sar440340-chronic-rhinosinusitis-without-nasal-polyps 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/itepekimab-sar440340-chronic-rhinosinusitis-with-nasal-polyps 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/itepekimab-sar440340-chronic-obstructive-pulmonary-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/itepekimab-sar440340-bronchiectasis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/itepekimab-ai-chronic-obstructive-pulmonary-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/isa101b-squamous-cell-carcinoma-of-the-oropharynx 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/ipilimumab-stage-iii-prostate-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/intravitreal-aflibercept-injection-macular-degeneration 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/intravitreal-aflibercept-injection-iai-proliferative-diabetic-retinopathy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/intravitreal-aflibercept-injection-iai-eylea-bay-diabetic-macular-edema 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/intravitreal-aflibercept-injection-iai-eylea-bay-branch-retinal-vein-occlusion 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/intravitreal-aflibercept-injection-iai-chorioretinal-vascular-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/intravitreal-aflibercept-injection-iai-age-related-macular-degeneration-amd 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/intravitreal-aflibercept-injection-diabetic-macular-edema 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/intravitreal-aflibercept-injection-cystoid-macular-edema 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/intravitreal-aflibercept-injection-central-serous-chorioretinopathy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/intravitreal-aflibercept-injection-central-retinal-vein-occlusion 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/intravitreal-aflibercept-injection-age-related-macular-degeneration 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/intravitreal-aflibercept-injection-2mg-neovascular-age-related-macular-degeneration 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/intravitreal-aflibercept-injection-2-0mg-polypoidal-choroidal-vasculopathy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/intravitreal-aflibercept-diabetic-macular-edema 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/hyperpolarized-xe129-pulmonary-artery-hypertension 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/gluten-powder-celiac-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/gemcitabine-bladder-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/garetosmab-obesity 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/garetosmab-fibrodysplasia-ossificans-progressiva-fop 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/garetosmab-fibrodysplasia-ossificans-progressiva 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/garetosmab-fibrodyplasia-ossificans-progressiva-fop 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/fianlimab-resectable-non-small-cell-lung-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/fianlimab-non-small-cell-lung-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/fianlimab-melanoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/fianlimab-cemiplimab-melanoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/fianlimab-advanced-renal-cell-carcinoma-arcc 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/fianlimab-advanced-non-small-cell-lung-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/fdc-fianlimab-cemiplimab-head-and-neck-squamous-cell-carcinoma-hnscc 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/fasinumab-osteoarthritis-of-the-knee-or-hip 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/fasinumab-osteoarthritis-knee 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/fasinumab-low-back-pain 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/fasinumab-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/fasinumab-chronic-low-back-pain 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/fasinumab-ai-osteoarthritis-knee 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/eylea-intravitreal-aflibercept-vegf-trap-eye-bay-macular-degeneration 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/eylea-aflibercept-bay86-5321-retinopathy-of-prematurity-rop 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/evinacumab-severe-hypertriglyceridemia-shtg 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/evinacumab-hypertriglyceridemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/evinacumab-hypercholesterolemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/evinacumab-homozygous-familial-hypercholesterolemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/evinacumab-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/ervebo-ebola-virus-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/encorafenib-binimetinib-melanoma-braf-v600e-k-mutated 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupixent-atopic-dermatitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupixent-allergic-rhinoconjunctivitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-wheezing 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-severe-atopic-dermatitis-ad 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-sar231893-regn668-chronic-rhinosinusitis-phenotype-with-nasal-poly 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-sar231893-regn668-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-sar231893-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-sar231893-healthy-volunteer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-sar231893-dermatitis-atopic 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-sar231893-cold-urticaria 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-sar231893-chronic-spontaneous-urticaria 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-sar231893-chronic-rhinosinusitis-without-nasal-polyps 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-sar231893-chronic-rhinosinusitis-with-nasal-polyps 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-sar231893-chronic-obstructive-pulmonary-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-sar231893-neurodermatitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-sar231893-atopic-dermatitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/fianlimab-advanced-melanoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-sar231893-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-sar231893-allergic-fungal-rhinosinusitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-pruritis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-prurigo-nodularis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-prostate-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-prefilled-syringe-nasal-polyps 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-prefilled-syringe-asthma-control 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-peanut-allergy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-only-product-atopic-dermatitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-moderate-to-severe-atopic-hand-and-foot-dermatit 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-moderate-to-severe-atopic-dermatitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-lichen-simplex-chronicus 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-keloid 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-injectable-product-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-eosinophilic-oesophagitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-eosinophilic-gastritis-eog 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-eosinophilic-esophagitis-eoe 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-eosinophilic-esophagitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-eczema 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-dermatitis-atopic 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-dermal-hypersensitivity-reaction 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-colitis-ulcerative 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-chronic-sinusitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-chronic-rhinosinusitis-with-nasal-polyps 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-chronic-obstructive-pulmonary-disease-copd 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-chronic-obstructive-pulmonary-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-bullous-pemphigoid 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-blinded-eosinophilic-gastritis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-atopic-keratoconjunctivitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-atopic-disorders 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-atopic-dermatitis-ad 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-atopic-dermatitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-asthma-allergic 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-alopecia-areata 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-allergies-food-milk 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-allergic-rhinitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-allergic-contact-dermatitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-300mg-solution-for-injection-pruritus 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/dupilumab-300-mg-2-ml-subcutaneous-solution-dupi-eosinophilic-esophagitis-eoe 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/degarelix-prostate-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/db-oto-congenital-hearing-loss-secondary-to-biallelic-m 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/colchicine-colcrys-intercritical-gout 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cmp-001-squamous-cell-carcinoma-of-head-and-neck 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cmp-001-non-small-cell-lung-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cmp-001-melanoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cmp-001-malignant-melanoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cisplatin-head-and-neck-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cemiplimab-rwlc-non-small-cell-lung-cancer-stage-iii 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cemiplimab-rwlc-merkel-cell-carcinoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cemiplimab-rwlc-head-and-neck-squamous-cell-carcinoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cemiplimab-rwlc-cutaneous-squamous-cell-carcinoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cemiplimab-relapsed-refractory-aggressive-b-cell-lymphoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cemiplimab-recurrent-lung-non-small-cell-carcinoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cemiplimab-plus-gemcitabine-pancreatic-ductal-adenocarcinoma-mpdac 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cemiplimab-pleural-mesotheliomas 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cemiplimab-nsclc 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cemiplimab-non-small-cell-lung-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cemiplimab-monotherapy-relapsed-solid-tumor 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cemiplimab-metastatic-solid-tumor 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cemiplimab-melanoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cemiplimab-lung-cancer-nsclc 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cemiplimab-lung-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cemiplimab-locally-recurrent-oral-cavity-squamous-cell-carc 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cemiplimab-locally-advanced-head-and-neck-squamous-cell-car 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cemiplimab-locally-advanced-basal-cell-carcinoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cemiplimab-hpv-related-squamous-cell-carcinoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cemiplimab-hormone-receptor-positive-breast-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cemiplimab-hodgkin-lymphoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cemiplimab-hiv-infections 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cemiplimab-high-grade-glioma-hgg 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cemiplimab-hepatitis-b-virus 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cemiplimab-head-and-neck-squamous-cell-carcinoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cemiplimab-fianlimab-fixed-dose-combination-fdc-colon-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cemiplimab-epithelial-ovarian-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cemiplimab-cutaneous-squamous-cell-carcinoma-cscc 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cemiplimab-cutaneous-squamous-cell-carcinoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cemiplimab-cutaneous-basal-cell-carcinoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cemiplimab-colorectal-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cemiplimab-colon-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cemiplimab-colon-and-rectal-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cemiplimab-colo-rectal-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cemiplimab-cervical-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cemiplimab-carcinoma-non-small-cell-lung 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cemiplimab-carcinoma-basal-cell 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cemiplimab-bladder-urothelial-carcinoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cemiplimab-basal-cell-carcinoma-bcc 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cemiplimab-anaplastic-thyroid-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cemiplimab-advanced-malignancies 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cemiplimab-advanced-cutaneous-squamous-cell-carcinoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cemiplimab-advanced-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cemiplimab-350-mg-intravenous-solution-clear-cell-renal-cell-carcinoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cemiplimab-350-mg-i-v-on-day-1-of-every-21-days-merkel-cell-carcinoma-stage-i 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/cemdisiran-paroxysmal-nocturnal-hemoglobinuria 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/casirivimab-imdevimab-immunocompromised 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/casirivimab-imdevimab-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/casirivimab-imdevimab-covid-19 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/casirivimab-imdevimab-combination-therapy-covid-19 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/casirivimab-and-imdevimab-antibody-cocktail-covid-19 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/capecitabine-colorectal-cancer-metastatic 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/bpx-601-prostate-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/bpx-601-metastatic-castration-resistant-prostate-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/bnt116-advanced-non-small-cell-lung-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/bnt111-melanoma-stage-iii 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/bbt369-diffuse-large-b-cell-lymphoma-dlbcl 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/ave0005-aflibercept-colorectal-neoplasms 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/atorvastatin-hypercholesterolemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aspirin-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aspirin-healthy-volunteer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aspirin-challenge-aspirin-exacerbated-respiratory-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/asp8374-glioblastoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/arm-1-cemiplimab-hepatocellular-carcinoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aln-sod-amyotrophic-lateral-sclerosis-als 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aln-snca-parkinsons-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aln-pnp-nonalcoholic-fatty-liver-disease-nafld 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aln-pnp-metabolic-dysfunction-associated-steatotic-liver 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aln-pnp-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aln-hsd-metabolic-dysfunction-associated-steatohepatitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aln-f1202-healthy-volunteer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aln-cideb-metabolic-dysfunction-associated-steatotic-liver 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aln-cfb-paroxysmal-nocturnal-hemoglobinuria-pnh 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aln-apoc3-dyslipidemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aln-ang3-diabetic-kidney-disease-dkd 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/alirocumab-type2-diabetes 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/alirocumab-stroke 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/alirocumab-solution-hypercholesterolemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/alirocumab-sepsis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/alirocumab-sar236553-regn727-hypercholesterolemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/alirocumab-sar236553-regn727-hypercholesterolaemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/alirocumab-sar236553-hypercholesterolemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/alirocumab-sar236553-hypercholesterolaemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/alirocumab-non-small-cell-lung-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/alirocumab-nephrotic-syndrome 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/alirocumab-myocardial-infarction 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/alirocumab-hypercholesterolemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/alirocumab-hypercholesterolaemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/alirocumab-homozygous-familial-hypercholesterolemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/alirocumab-dyslipidemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/alirocumab-coronary-vessel 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/alirocumab-atherosclerotic-cardiovascular-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/alirocumab-atherosclerosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/alirocumab-and-cemiplimab-non-small-cell-lung-cancer-nsclc 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/alirocumab-150-mg-ml-subcutaneous-injection-saphenous-vein-graft-atherosclerosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/alirocumab-150-mg-ml-praluent-hemodialysis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aflibercept-ziv-aflibercept-ave0005-vegf-trap-za-pulmonary-diseases 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aflibercept-ziv-aflibercept-ave0005-vegf-trap-za-pancreatic-neoplasm 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aflibercept-ziv-aflibercept-ave0005-vegf-trap-za-ovarian-neoplasms 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aflibercept-ziv-aflibercept-ave0005-vegf-trap-za-neoplasms 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aflibercept-ziv-aflibercept-ave0005-vegf-trap-za-carcinoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aflibercept-vegf-trap-eye-eylea-bay86-5321-highe-macular-edema-secondary-to-retinal-vein-occlusio 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aflibercept-submacular-vascularized-pigment-epithelial-detac 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aflibercept-retinal-vein-occlusion 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aflibercept-radiation-retinopathy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aflibercept-prostatic-neoplasms 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aflibercept-proliferative-diabetic-retinopathy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aflibercept-ophthalmic-wet-macular-degeneration 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aflibercept-neovascular-wet-age-related-macular-degeneration 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aflibercept-neovascular-macular-degeneration 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aflibercept-lymphoma-non-hodgkin 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aflibercept-irvine-gass-syndrome 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aflibercept-injection-vegf-trap-eye-bay86-5321-macular-degeneration 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aflibercept-injection-eylea-vegf-trap-eye-bay86-retinal-vein-occlusion 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aflibercept-injection-diabetic-retinopathy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aflibercept-high-dose-vegf-trap-eye-bay86-5321-neovascular-age-related-macular-degeneration 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aflibercept-folfiri-metastatic-colorectal-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aflibercept-fibrovascular-pigment-epithelial-detachment 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aflibercept-eylea-vegf-trap-eye-bay86-5321-wet-macular-degeneration 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aflibercept-eylea-vegf-trap-eye-bay86-5321-neovascular-macular-degeneration 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aflibercept-eylea-vegf-trap-eye-bay86-5321-macular-edema 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aflibercept-eylea-vegf-trap-eye-bay86-5321-macular-degeneration 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aflibercept-eylea-bay86-5321-glaucoma-neovascular 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aflibercept-eylea-bay-86-5321-glaucoma-neovascular 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aflibercept-exudative-macular-degeneration 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aflibercept-every-2-months-radiation-retinopathy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aflibercept-diabetic-retinopathy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aflibercept-diabetic-macular-edema 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aflibercept-colorectal-cancer-metastatic 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aflibercept-bay86-5321-eylea-diabetic-macular-edema 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aflibercept-ave0005-neoplasms 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aflibercept-ave0005-neoplasm-malignant 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aflibercept-ave0005-colorectal-cancer-metastatic 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aflibercept-ave0005-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aflibercept-age-related-macular-degeneration 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aflibercept-advanced-carcinoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aflibercept-8-mg-vegf-trap-eye-bay86-5321-diabetic-macular-edema-dme 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aflibercept-8-mg-pfs-diabetic-macular-edema-dme 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aflibercept-8-mg-neovascular-age-related-macular-degeneration 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aflibercept-2-0-mg-macular-edema-with-central-retinal-vein-occlusio 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aflibercept-2-0-mg-diabetic-macular-edema 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/aflibercept-2-0-mg-age-related-macular-degeneration 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/89zr-dfo-regn5054-advanced-solid-tumor 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/89zr-dfo-regn3504-advanced-pd-l1-positive-malignancies 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/8-mg-aflibercept-bay-86-5321-high-dose-diabetic-macular-edema 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/2-mg-intravitreous-aflibercept-injection-proliferative-diabetic-retinopathy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tachosil-hemorrhage 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/2-0-mg-intravitreal-aflibercept-diabetic-macular-edema 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-993-pain 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-993-diabetic-peripheral-neuropathic-pain 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-993-acute-pain 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-985-or-matching-placebo-chronic-hepatitis-c 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-973-pain 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-950-hepatitis-c 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-880-diabetes-mellitus-type-1 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-864-alpha1-antitrypsin-deficiency 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-864-alpha-1-antitrypsin-deficiency 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-840-apol1-mediated-kidney-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-828-cystic-fibrosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-814-alpha-1-antitrypsin-deficiency 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-809-cystic-fibrosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-787-influenza-virus 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-770-in-development-for-cystic-fibrosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-770-cystic-fibrosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-765-psoriasis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-765-partial-epilepsy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-765-part-a-epilepsy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-708-acute-pain 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-702-rheumatoid-arthritis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-670-myotonic-dystrophy-type-1-dm1 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-668-alpha-1-antitrypsin-deficiency 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-661-plus-ivacaftor-combination-cystic-fibrosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-661-ivacaftor-cystic-fibrosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-661-cystic-fibrosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-659-tez-iva-cystic-fibrosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-708-pain 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-659-cystic-fibrosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-634-alpha-1-antitrypsin-deficiency 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-581-cystic-fibrosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-561-cystic-fibrosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-548-painful-lumbosacral-radiculopathy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-548-acute-pain 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-522-mrna-therapy-cystic-fibrosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/china-sxt-pharmaceuticals/projects/chidamide-aml 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-509-rheumatoid-arthritis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-509-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-445-tez-iva-cystic-fibrosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-440-cystic-fibrosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-433-narcolepsy-type-1-nt1 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-407-autosomal-dominant-polycystic-kidney-disease-adp 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-548-pain 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-371-primary-ciliary-dyskinesia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-371-hs-cystic-fibrosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-272-cystic-fibrosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-264-type-1-diabetes 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-222-chronic-hepatitis-c-virus 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-210-cervical-spinal-cord-injury 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-152-cystic-fibrosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-150-small-fiber-neuropathy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-150-osteoarthritis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-150-acute-pain 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-147-proteinuric-kidney-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-147-glomerulosclerosis-focal-segmental 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-147-focal-segmental-glomerulosclerosis-fsgs 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-121-cystic-fibrosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tachosil-group-lymphocele 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-118-cystic-fibrosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vnz-tez-d-iva-cystic-fibrosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vch-759-bch-27759-hepatitis-c-chronic 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vch-222-or-matching-placebo-hepatitis-c 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vch-222-hepatitis-c 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vc-02-combination-product-type-1-diabetes-mellitus-with-hypoglycemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vanzacaftor-cystic-fibrosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/treatment-sequence-ab-hepatitis-c 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/tezacaftor-ivacaftor-ivacaftor-cystic-fibrosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/tezacaftor-ivacaftor-cystic-fibrosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/tez-iva-cystic-fibrosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/tez-cystic-fibrosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/telaprevir-vx-950-hepatic-insufficiency 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/telaprevir-or-matching-placebo-hepatitis-c 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/telaprevir-moxifloxacin-placebo-hepatitis-c 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/telaprevir-hepatitis-c-chronic 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/telaprevir-hepatitis-c 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/telaprevir-healthy-participants 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/telaprevir-formulation-a-chronic-hepatitis-c 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/telaprevir-chronic-hepatitis-c-virus-infection 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/telaprevir-chronic-hepatitis-c 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/telaprevir-and-sofosbuvir-hepatitis-c-chronic 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/suzetrigine-suz-acute-pain 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/suzetrigine-pain-acute-postoperative 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/alisertib-solid-tumors 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/suzetrigine-pain 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/suzetrigine-diabetic-peripheral-neuropathy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vch-916-hcv-infection 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/suzetrigine-diabetic-peripheral-neuropathic-pain 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/suzetrigine-acute-pain 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/suz-pain 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/suz-acute-pain 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/standard-ogtt-cystic-fibrosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/ribavirin-genotype-1-chronic-hepatitis-c 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/ribavirin-chronic-hepatitis-c 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/prednisone-drug-interactions 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/povetacicept-primary-membranous-nephropathy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/povetacicept-myasthenia-gravis-generalized 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/povetacicept-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/placebo-rheumatoid-arthritis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/vx-150-pain 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/placebo-pain 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/placebo-matched-to-vx-121-suspension-cystic-fibrosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/placebo-cystic-fibrosis-homozygous-for-the-f508del-cftr 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/pegylated-interferon-alfa-2a-infection 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/pegylated-interferon-alfa-2a-hepatitis-c 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/peginterferon-chronic-hepatitis-c 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/p-1037-cystic-fibrosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/mp-424-telaprevir-hepatitis-c 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/mp-424-telaprevir-chronic-hepatitis-c 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/mp-424-hepatitis-c 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/mp-424-h-peg-ifn-a-2b-rbv-hepatitis-c 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/mp-424-chronic-hepatitis-c 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/merimepodib-hepatitis-c 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/lumacaftor-plus-ivacaftor-combination-cystic-fibrosis-homozygous-or-heterozygous-for-t 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/lumacaftor-plus-ivacaftor-combination-cystic-fibrosis-homozygous-for-the-f508del-cftr 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/lumacaftor-cystic-fibrosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/lumacaftor-200-mg-q12h-ivacaftor-250-mg-q12h-hepatic-impairment 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/lum-iva-cystic-fibrosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/lum-cystic-fibrosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/ixp-renal-impairment 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/ivacaftor-cystic-fibrosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/ivacaftor-chronic-obstructive-pulmonary-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/ivacaftor-25-mg-75-mg-cystic-fibrosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/ivacaftor-150-mg-chronic-obstructive-pulmonary-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/iva-cystic-fibrosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/inaxaplin-proteinuric-kidney-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/exa-cel-sickle-cell-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/ixp-focal-segmental-glomerulosclerosis-fsgs 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/ctx001-beta-thalassemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/cethrin-spinal-cord-injury 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/biricodar-dicitrate-lung-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/biological-vaccine-type-1-diabetes 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/avn944-refractory-solid-tumors 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/avn944-pancreatic-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/avn-944-capsules-for-oral-administration-acute-leukemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/als-002200-hepatitis-c-chronic 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/io-biotech/projects/io102-nsclc 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/sunshine-biopharma/projects/sss11-gout 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/adynovate-hemophilia-a 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/china-sxt-pharmaceuticals/projects/zs802-hemophilia-a 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/advate-hemophilia-a 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn846-pruritus 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/china-sxt-pharmaceuticals/projects/oxygen-sepsis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/bright-minds-biosciences-inc/projects/study-agent-smoking 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/nektar-therapeutics/projects/nktr-262-melanoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn846-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn5381-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/china-sxt-pharmaceuticals/projects/hpv-t-solid-tumor 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/regeneron-pharmaceuticals-inc/projects/regn5093-nsclc 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/supernus-pharmaceuticals-inc/projects/tpm-xr-epilepsy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/actuate-therapeutics-inc/projects/9-ing-41-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/lisata-therapeutics-inc/projects/clbs119-covid-19 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/inovio-pharmaceuticals-inc/projects/v930-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/precision-biosciences-inc/projects/anti-cd19-car-nk-nhl 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/als-002158-hepatitis-c-chronic 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/tg-therapeutics-inc/projects/tg-1801-cll 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/coenzyme-q10-charcot-marie-tooth-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/cocoavia-supplement-cold-exposure 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/coartem-artemether-lumefantrine-combination-malaria 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/co-trimoxazole-960mg-dispersible-tablet-spontaneous-bacterial-peritonitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/cmf-regimen-breast-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/clp-nutrition-child-nutritional-status 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/clobetasol-propionate-colon-adenocarcinoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/cladribine-mavenclad-advanced-multiple-sclerosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/citrus-limonoid-beverage-hypercholesterolemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/citalopram-low-mood 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/cisplatin-bladder-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/cisplatin-advanced-cholangiocarcinoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/ciprofloxacin-crohn-s-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/ciprofloxacin-acute-lymphoblastic-leukaemia-category 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/soy-protein-photoaging 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/alpn-101-systemic-lupus-erythematosus 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/chr-2797-tosedostat-advanced-solid-tumors 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/cholecalciferol-vitamin-d-vigantol-oil-respiratory-tract-infections 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/cholecalciferol-vitamin-d-deficiency 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/cholecalciferol-chronic-obstructive-pulmonary-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/cholecalciferol-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/cho-pro-high-altitude 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/chlorhexidine-pneumonia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/chlorhexidine-peri-implantitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/chlorhexidine-infant-newborn-diseases 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/d-chad63-ca-malaria 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/chemotherapy-transitional-cell-carcinoma-of-ureter 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/chemotherapy-malignant-mesothelioma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/ch14-18-nci-neuroblastoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/cetrorelix-acetate-infertility 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/ceralasertib-gynaecological-cancers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/cellulose-sulfate-gel-6-hiv-infection 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/cefecin-tab-acute-sinusitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/cediranib-alveolar-soft-part-sarcoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/ce-marked-philips-motiva-system-copd 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/cct3833-melanoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/carraguard-pc-515-hiv-infections 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/cardiac-mri-with-gadolinium-contrast-heart-failure 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/carboplatin-recurrent-fallopian-tube-carcinoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/carboplatin-plus-paclitaxel-ovarian-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/carboplatin-hormone-refractory-prostate-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/carboplatin-breast-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/carbetocin-short-infusion-complications-cesarean-section 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/carbetocin-post-partum-haemorrhage 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/capsule-1-or-capsule-2-pregnancy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/celecoxib-breast-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/camostat-mesilate-severe-acute-respiratory-syndrome 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/camel-milk-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/cam2020-m2sr-h3n2-influenza-vaccine-influenza-vaccine 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/calcium-vitamin-d-stress-fracture 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/calcium-vitamin-d-nutrition-status 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/calcium-gluconate-trauma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/caffeine-post-dural-puncture-headache 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/cabozantinib-oral-tablet-neurofibromatosis-1 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/cabg-mitral-valve-annuloplasty-mitral-regurgitation 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/bupivacaine-postoperative-pain 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/bupivacaine-liposome-injection-osteoarthritis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/bupivacaine-amputation-stumps 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/brentuximab-vedotin-ann-arbor-stage-ib-hodgkin-lymphoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/ls11-neurofibroma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/breathlessness-support-service-breathless-patients-with-any-established-underly 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/bpmri-prostate-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/botulinum-toxin-a-low-back-pain 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/boost-to-the-tumour-bed-early-breast-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/bont-a-traumatic-brain-injury 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/bomedemstat-myelofibrosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/blueberry-cranberry-green-tea-extract-cocoa-stress-psychological 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/itx-5061-hepatitis-c 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/blf-bovine-lactoferrin-neonatal-sepsis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/bipap-synchrony-chronic-obstructive-pulmonary-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/bipap-procedure-chronic-obstructive-pulmonary-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/biomarker-transplantation-liver 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/biofoam-surgical-matrix-intraoperative-bleeding 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/bio-300-oral-powder-acute-radiation-syndrome 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/bevacizumab-recurrent-glioblastoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/bevacizumab-metastatic-melanoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/bevacizumab-colorectal-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/bevacizumab-colorectal-adenocarcinoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/bep-500-stage-i-testicular-non-seminomatous-germ-cell-tu 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/benzyl-penicillin-pneumonia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/bemarituzumab-flot-regimen-gastric-and-gastro-oesophageal-junction-gej-aden 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/behavior-therapy-autism-spectrum-disorder 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/beclometasone-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/bcg-tuberculosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/bal-glu-energy-supply-deficiency 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/b-cit-and-spect-imaging-parkinson-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/azithromycin-typhoid-fever 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/azithromycin-malnutrition-in-pregnancy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/azd8931-metastatic-colorectal-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/azd6738-breast-neoplasm 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/azd5363-adenocarcinoma-of-the-prostate 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/azd5069-metastatic-castration-resistant-prostate-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/azd2014-neurofibromatosis-2 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/azd2014-3-on-4-off-weekly-paclitaxel-advanced-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/avutometinib-glioblastoma-multiforme-gbm 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/avastin-bevacizumab-corneal-neovascularization 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/autologous-volar-fibroblast-injection-into-the-t-amputation 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/autologous-skin-fibroblasts-wounds-and-injuries 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/autologous-skin-fibroblasts-amputation 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/autologous-room-temperature-stored-platelet-tran-reversal-of-platelet-aggregation-inhibitors 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/autologous-fat-transfer-wound 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/autologous-engineered-urethral-construct-urologic-diseases 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/atra-pancreatic-adenocarcinoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/atovaquone-oral-suspension-locally-advanced-non-small-cell-lung-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/atorvastatin-major-coronary-event 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/atorvastatin-calcium-traumatic-brain-injury 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/atorvastatin-20mg-cardiovascular-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/atezolizumab-locally-advanced-hepatocellular-carcinoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/astx660-advanced-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/aspirin-vestibular-schwannoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/aspirin-and-atorvastatin-cardiovascular-risk-factor 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/aspirin-75mg-acute-lung-injury 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/asparaginase-lymphoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/artemether-lumefantrine-uncomplicated-malaria 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/artemether-lumefantrine-combination-plasmodium-vivax-infection 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/artemether-lumefantrine-aln-uncomplicated-malaria 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/aromatase-inhibitors-breast-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/arn-75039-oral-capsules-healthy-adult-participants 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/arm-b-a-combination-of-pentoxifylline-and-tocoph-head-and-neck-fibrosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/arm-a-abc-3tc-nnrti-human-immunodeficiency-virus 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/arcofolin-5-methyltetrahydrofolate-pre-eclampsia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/apple-cider-vinegar-kidney-stones-urolithiasis-hypocitraturia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/apixaban-cerebral-vein-thrombosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/antipyrine-benzocaine-otic-solution-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/antiplatelet-aspirin-dipyridamole-clopidogrel-cervical-artery-dissection 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/antioxidant-berry-supplementation-heat-intolerance 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/antibody-ub-421-hiv-1-infection-in-adults-asymptomatic 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/antibody-ub-421-hiv-1-infection-in-adults 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/anti-thymocyte-globulin-leukemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/anti-cs6-bsigg-product-lot-pd1601105cs-healthy-volunteer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/anti-cd40-agonist-monoclonal-antibody-cdx-1140-ovarian-clear-cell-adenocarcinoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/anplag-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/anodal-tdcs-stroke 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/anastrozole-breast-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/anakinra-100mg-and-placebo-depo-medrone-gout 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/amoxycillin-non-severe-pneumonia-with-wheeze 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/amobarbital-gel-one-one-dose-osteoarthritis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/amlodipine-depression 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/amino-acid-based-formula-cow-milk-allergy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/ambulatory-oxygen-lung-disease-fibroid-chronic 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/alvac-hiv-vcp1521-aidsvax-hiv-infection 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/alteplase-or-tenecteplase-cva-cerebrovascular-accident 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/alteplase-myocardial-infarction 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/alpelisib-breast-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/allopurinol-gout 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/allopregnanolone-injection-traumatic-brain-injury 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/allogeneic-msc-mesenchymal-stromal-cells 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/allogeneic-human-mesenchymal-stem-cells-hmscs-non-ischemic-dilated-cardiomyopathy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/allergy-immunotherapy-allergy-shots-eosinophilic-esophagitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/alfuzosin-kidney-stones 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/alemtuzumab-kidney-transplantation 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/aldesleukin-type-1-diabetes 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/green-tea-extract-dysbiosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/albendazole-helminthiasis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/albendazole-ascariasis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/albendazole-400-mg-and-or-vitamin-a-malnutrition 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/al-coartem-malaria 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/afatinib-and-paclitaxel-esophageal-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/aerobic-exercise-training-prostate-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/adoptive-cell-therapy-with-tumor-infiltrating-ly-urothelial-carcinoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/administration-of-ui087-diabetes-mellitus-type-2 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/administration-of-ui068-diabetes-mellitus-type-2 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/administration-of-ui018-hyperlipemia-mixed 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/adenovirus-psa-vaccine-hormone-refractory-prostate-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/adaptive-planning-organ-localisation-a-polo-plan-bladder-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/acupuncture-migraine-headaches 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/active-tdcs-task-oriented-practice-cervical-spinal-cord-injruy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/active-tdcs-and-cognitive-training-intervention-brain-concussion 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/active-procedure-low-back-pain 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/active-ctc-assessment-adenocarcinoma-of-the-prostate 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/active-ctbs-post-concussion-syndrome 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/acetylsalicylic-acid-precancerous-condition 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/acceptance-and-commitment-therapy-stroke 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/accelerated-intermittent-theta-burst-stimulation-long-covid 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/acalabrutinib-mantle-cell-lymphoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/abituzumab-metastatic-colorectal-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/abiraterone-acetate-prostate-cancer-adenocarcinoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/abiraterone-acetate-metastatic-castration-resistant-prostate-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/abamectin-and-fenpyroximate-malaria 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/95-condensed-proanthocyanidins-from-grape-seed-e-iron-deficiency-anemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/89zr-trastuzumab-breast-cancer-metastases 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/89zr-dfo-ys5-prostate-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/70-ml-red-beetroot-juice-overweight 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/600-mg-ibuprofen-tibial-fractures 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/60-mg-prednisone-airway-inflammation 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/4-aminopyridine-spinal-muscular-atrophy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/3t-mr-imaging-of-the-cervical-spinal-cord-cervical-spondylosis-with-myelopathy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/3-dimensional-conformal-radiation-therapy-head-and-neck-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/3-4-methylenedioxymethamphetamine-mdma-post-traumatic-stress-disorder 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/2mg-buprenex-and-380mg-vivitrol-post-traumatic-stress-disorder 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/225ac-j591-prostate-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/2-mg-melatonin-anxiety 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/2-deoxyglucose-prostate-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/18f-v-6-bp-lung-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/18f-peg6-ipqa-lung-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/177lu-psma-617-metastatic-hormone-naive-prostate-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/177lu-j591-prostate-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/123i-ibvm-and-spect-imaging-parkinson-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/123i-b-cit-parkinson-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/123i-5-ia-parkinson-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/10-ge-xenokidney-esrd-end-stage-renal-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/1-1-1-blood-transfusion-ratio-trauma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/1-0-c31g-savvy-vaginal-gel-hiv-infections 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/0-2-mg-kg-ketamine-depression 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/revolution-medicines/projects/vociprotafib-metastatic-neoplasm 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/revolution-medicines/projects/tng462-pdac 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/revolution-medicines/projects/rmc-9805-non-small-cell-lung-cancer-nsclc 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/revolution-medicines/projects/rmc-6236-pancreatic-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/revolution-medicines/projects/rmc-6236-non-small-cell-lung-cancer-nsclc 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/revolution-medicines/projects/rmc-6236-colorectal-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/revolution-medicines/projects/rmc-5552-solid-tumors 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/revolution-medicines/projects/rmc-5127-non-small-cell-lung-cancer-nsclc 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/revolution-medicines/projects/rmc-4630-solid-tumor 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/revolution-medicines/projects/rmc-4630-non-small-cell-lung-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/revolution-medicines/projects/daraxonrasib-pancreatic-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/revolution-medicines/projects/daraxonrasib-nsclc-non-small-cell-lung-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/revolution-medicines/projects/daraxonrasib-advanced-solid-tumors 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/zw25-zanidatamab-her2-amplified-biliary-tract-cancers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/zanubrutinib-waldenstr-m-s-macroglobulinemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/zanubrutinib-relapsed-refractory-follicular-non-hodgkin-lymph 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/zanubrutinib-relapsed-refractory-follicular-lymphoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/zanubrutinib-relapsed-diffuse-large-b-cell-lymphoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/zanubrutinib-primary-membranous-nephropathy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/zanubrutinib-mature-b-cell-malignancies 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/zanubrutinib-mantle-cell-lymphoma-non-hodgkin-lymphoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/vertex-pharmaceuticals-inc-ma/projects/14c-vx-993-pain 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/zanubrutinib-follicular-lymphoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/zanubrutinib-diffuse-large-b-cell-lymphoma-dlbcl 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/zanubrutinib-chronic-lymphocytic-leukemia-small-lymphocytic-l 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/zanubrutinib-chronic-lymphocytic-leukemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/zanubrutinib-b-cell-malignancies 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/zanidatamab-gastric-neoplasms 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/tislelizumab-urothelial-carcinoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/tislelizumab-resectable-esophageal-squamous-cell-carcinoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/tislelizumab-non-small-cell-lung-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/tislelizumab-gastroesophageal-adenocarcinoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/tislelizumab-esophageal-squamous-cell-carcinoma-escc 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/tislelizumab-colorectal-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/tislelizumab-classical-hodgkin-lymphoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/tislelizumab-advanced-unresectable-gastric-adenocarcinoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/tarlatamab-extensive-stage-small-cell-lung-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/surzebiclimab-locally-advanced-or-metastatic-solid-tumors-for 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/sonrotoclax-waldenstrom-macroglobulinemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/sonrotoclax-relapsed-refractory-multiple-myeloma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/sonrotoclax-mantle-cell-lymphoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/rituximab-chronic-lymphocytic-leukemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/pd-1-pd-l1-inhibitors-borderline-resectable-carcinoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/pamiparib-capsule-ovarian-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/long-course-radiotherapy-capecitabine-pd-1-monoc-colorectal-neoplasms 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/lifirafenib-solid-tumor-adult 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/lbl-007-esophageal-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/io-202-solid-tumor-adult 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/io-108-advanced-solid-tumor 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/gimistotug-non-small-cell-lung-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/drug-bg-t187-advanced-solid-tumor 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/ccrt-with-maintenance-tislelizumab-and-metronomi-nasopharyngeal-carcinoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/blinatumomab-relapsed-refractory-b-cell-precursor-acute-lymph 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/blinatumomab-b-cell-precursor-acute-lymphoblastic-leukemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-r046-solid-tumor 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-c354-advanced-solid-tumor 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-b455-advanced-solid-tumor 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-b3227-advanced-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-a445-urothelial-carcinoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-a3055-advanced-solid-tumor 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-58067-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-58067-advanced-solid-tumor 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-53038-metastatic-solid-tumors 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-45035-rheumatoid-arthritis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-43395-hr-her2-breast-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-43395-advanced-solid-tumor 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-26808-advanced-solid-tumor 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-21447-relapsed-non-hodgkin-lymphoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-21447-hormone-receptor-positive-breast-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-16673-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-16673-cll 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-16673-chronic-spontaneous-urticaria 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-16673-chronic-lymphocytic-leukemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-16673-b-cell-malignancy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-11417-acute-myeloid-leukemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-10188-chronic-lymphocytic-leukemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bg-c9074-advanced-solid-tumor 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bg-c137-advanced-solid-tumor 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bg-c0979-advanced-solid-tumor 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bg-c0902-solid-tumors 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bg-89894-advanced-or-metastatic-mtap-deleted-solid-tumors 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-11417-mature-b-cell-malignancies 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bg-75202-breast-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bg-75098-advanced-solid-tumor 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bg-71332-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bg-68501-breast-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bg-60366-non-small-cell-lung-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/amg-509-prostate-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/zilebesiran-mild-to-moderate-hypertension 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/zilebesiran-high-cardiovascular-risk 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/vir-2218-hepatitis-b-chronic 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/vir-2218-chronic-hepatitis-b 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/revusiran-transthyretin-ttr-mediated-amyloidosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/revusiran-aln-ttrsc-transthyretin-ttr-mediated-familial-amyloidotic 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/pozelimab-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/placebo-transthyretin-amyloidosis-attr-with-cardiomyopat 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/placebo-primary-hyperoxaluria-type-1-ph1 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/placebo-hypertension 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/patisiran-ttr-mediated-amyloidosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/patisiran-polyneuropathies 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/patisiran-amyloidosis-familial 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/patisiran-aln-ttr02-ttr-mediated-amyloidosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/patisiran-aln-ttr02-transthyretin-ttr-mediated-amyloidosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/lumasiran-primary-hyperoxaluria-type-1-ph1 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/lumasiran-primary-hyperoxaluria-type-1 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/lumasiran-primary-hyperoxaluria 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/lumasiran-haemodialysis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/indapamide-hypertension 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/givosiran-aln-as1-acute-intermittent-porphyria 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/givosiran-acute-intermittent-porphyria-aip 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/givosiran-acute-intermittent-porphyria 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/givosiran-acute-hepatic-porphyria 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/computer-algorithm-for-attr-transthyretin-amyloidosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/aln-xdh-gout 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/aln-vsp02-solid-tumors 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/aln-ttrsc04-transthyretin-mediated-amyloidosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/aln-ttrsc-revusiran-ttr-mediated-amyloidosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/aln-ttrsc-revusiran-for-subcutaneous-administrat-ttr-mediated-amyloidosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/aln-ttr02-ttr-mediated-amyloidosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/aln-ttr01-transthyretin-mediated-amyloidosis-attr 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/aln-rsv01-respiratory-syncytial-virus-infections 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/aln-pcssc-hypercholesterolemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/aln-pcs02-elevated-ldl-cholesterol-ldl-c 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/aln-khk-type-2-diabetes-mellitus-t2dm 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/aln-htt02-huntington-s-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/aln-hsd-nonalcoholic-steatohepatitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/aln-cc5-paroxysmal-nocturnal-hemoglobinuria-pnh 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/aln-bcat-advanced-hepatocellular-carcinoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/aln-app-early-onset-alzheimer-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/aln-agt01-rvr-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/aln-agt01-hypertension 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/aln-aat02-zz-type-alpha-1-antitrypsin-deficiency-liver-dis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/aln-6400-von-willebrand-disease-vwd 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/aln-6400-hereditary-hemorrhagic-telangiectasia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/aln-5288-alzheimer-s-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/aln-4915-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/aln-4324-type-2-diabetes-mellitus-t2dm 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/aln-4324-obese-or-overweight-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/aln-4285-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/99mtc-pyrophosphate-scintigraphy-transthyretin-amyloidosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/zolpidem-10-mg-tablets-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/zoloft-100-mg-tablets-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/zaleplon-10-mg-capsules-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/volcolon-sugar-free-constipation 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/venlafaxine-hydrochloride-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/valacyclovir-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/ursodiol-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/tvb-009-osteoporosis-postmenopausal 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/tv48108-chronic-obstructive-pulmonary-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/tv46017-chronic-obstructive-pulmonary-disease-copd 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/tv-46763-pain 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/tv-46046-contraception 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/tv-46000-schizophrenia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/tv-45070-postherpetic-neuralgia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/tv-45070-pharmacokinetics 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/tv-44749-schizophrenia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/tv-1380-150-mg-cocaine-addiction 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/tv-1106-growth-hormone-deficiency 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/treatment-a-fp-mdpi-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/trandolapril-4-mg-tablets-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/tp-38-recurrent-glioblastoma-multiforme 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/tp-38-glioblastoma-multiforme 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/topiramate-tablets-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/topiramate-capsules-25-mg-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/topiramate-2-x-25-mg-tablet-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/tl011-anti-cd20-for-the-treatment-of-rheumatoid-rheumatoid-arthritis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/tizanidine-sublingual-or-oral-muscle-spasticity 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/tiotropium-hfa-bai-5-mcg-chronic-obstructive-pulmonary-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/tev-56286-test-healthy-participants 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/tev-56286-multiple-system-atrophy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/tev-56286-healthy-participants 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/tev-56248-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/tev-53408-vitiligo 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/tev-53408-celiac-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/tev-53275-dose-a-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/tev-50717-tourette-syndrome 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/tev-50717-cerebral-palsy-dyskinetic 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/tev-48574-dose-regimen-a-crohn-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/tev-48574-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/tev-48125-1-pharmacokinetics 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/tev-45779-chronic-urticaria 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/terbinafine-hcl-250mg-tablets-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/tbo-filgrastim-neutropenia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/tbo-filgrastim-healthy-participants 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/tamsulosin-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/talampanel-non-radiolabeled-14c-talampanel-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/talampanel-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/talampanel-glioblastoma-multiforme 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/talampanel-epilepsy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/talampanel-dyskinesias 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/talampanel-amyotrophic-lateral-sclerosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/tak-573-relapsed-and-or-refractory-multiple-myeloma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/tacrolimus-bid-medication-adherence 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/t-jet-containing-tevtropin-growth-hormone-deficiency 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/sumatriptan-succinate-migraine-disorders 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/sumatriptan-succinate-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/sublingual-tizanidine-hcl-traumatic-brain-injury 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/stemex-hematologic-malignancies 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/shared-solutions-plus-ms-center-v-shared-solutio-multiple-sclerosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/seasonale-levonorgestrel-lng-ethinyl-estradiol-e-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/seasonale-levonorgestrel-and-ethinyl-estradiol-osteopenia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/sdx-105-non-hodgkin-s-lymphoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/sdx-101-r-etodolac-multiple-myeloma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/sd-809-tourette-syndrome 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/sd-809-chorea-associated-with-huntington-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/sd-809-chorea 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/sce-b-nocturnal-vasomotor-symptoms 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/ropinirole-hcl-0-25-mg-tablets-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/risperidone-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/ribavirin-200-mg-tablets-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/reslizumab-severe-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/reslizumab-iv-absolute-bioavailability 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/reslizumab-eosinophils-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/reslizumab-eosinophilic-esophagitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/reslizumab-eosinophilic-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/reslizumab-asthma-eosinophilic 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/reslizumab-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/rasagiline-restless-legs-syndrome 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/rasagiline-progressive-supranuclear-palsy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/rasagiline-placebo-parkinson-s-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/rasagiline-mesylate-parkinson-s-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/rasagiline-mesylate-multiple-system-atrophy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/rasagiline-depressive-symptoms 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/ramipril-10-mg-capsule-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/qvar-beclometasone-dipropionate-hfa-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/qvar-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/provigil-200-mg-chronic-shift-work-sleep-disorder 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/prot-cl-np101-015-01-acute-migraine 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/progesterone-vaginal-ring-pharmacokinetics 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/pravastatin-sodium-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/lexicon-pharmaceuticals-inc/projects/lx4211-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/adial-pharmaceuticals-inc/projects/axitinib-melanoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/pravastatin-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/pramipexole-dihydrochloride-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/placebo-primary-progressive-multiple-sclerosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/placebo-mdpi-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/paroxetine-hcl-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/pantoprazole-sodium-40-mg-delayed-release-tablet-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/paclitaxel-bevacizumab-liposomal-doxorubicin-cap-human-epidermal-growth-factor-2-negative-carcino 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/oxymetazoline-hydrochloride-rosacea 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/oxybutinyn-vaginal-ring-4mg-overactive-bladder 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/oxcarbazepine-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/oravescent-fentanyl-pain 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/oravescent-fentanyl-ovf-pain 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/oravescent-fentanyl-low-back-pain 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/oravescent-fentanyl-citrate-chronic-neuropathic-pain 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/oravescent-fentanyl-citrate-chronic-low-back-pain 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/oral-cep-701-myeloma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/omacetaxine-myelodysplastic-syndromes 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/omacetaxine-mepesuccinate-hematologic-malignancies 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/omacetaxine-mepesuccinate-chronic-myeloid-leukemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/omacetaxine-hematologic-tumors 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/omacetaxine-acute-myelogenous-leukemia-aml 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/olanzapine-extended-release-schizophrenia-schizoaffective-disorder 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/obatoclax-mesylate-metastatic-melanoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/obatoclax-mesylate-mantle-cell-lymphoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/obatoclax-mesylate-lymphoma-follicular 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/obatoclax-mesylate-gx15-070ms-myelofibrosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/obatoclax-mesylate-gx15-070ms-hodgkin-s-lymphoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/obatoclax-mesylate-gx15-070ms-hematological-malignancies 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/obatoclax-mesylate-carboplatine-and-etoposide-extensive-stage-small-cell-lung-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/obatoclax-extensive-stage-small-cell-lung-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/obatoclax-aml 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/np101-sumatriptan-iontophoretic-transdermal-patc-migraine-disorders 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/np101-compare-bioequivalence-patches-previously-used-i 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/norethindrone-ethinyl-estradiol-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/norethindrone-ethinyl-estradiol-bioequivalence 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/non-pegylated-liposomal-doxorubicin-tubular-breast-cancer-stage-ii 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/nevirapine-hiv-1 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/neugranin-chemotherapy-induced-neutropenia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/nebulized-ivx-0142-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/naproxen-menorrhagia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/myocet-early-primary-breast-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/mycophenolate-mofetil-myfenax-stable-renal-transplant-recipients 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/mycophenolate-mofetil-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/mometasone-furoate-seasonal-allergic-rhinitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/moexipril-hcl-hydrochlorothiazide-15-25-mg-table-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/modakafusp-alfa-neoplasms 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/modakafusp-alfa-multiple-myeloma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/modafinil-sleep-apnea-obstructive 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/modafinil-narcolepsy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/modafinil-attention-deficit-hyperactivity-disorder 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/np101-migraine-disorders 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/modafinil-adhd 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/mirtazapine-15-mg-orally-disintegrating-tablets-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/metronidazole-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/obatoclax-mesylate-250-ml-lung-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/metronidazole-bacterial-vaginosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/methylprednisolone-multiple-sclerosis-ms 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/meloxicam-15-mg-tablets-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/obatoclax-mesylate-gx15-070ms-myelodysplastic-syndromes 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/medroxyprogesterone-acetate-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/losartan-potassium-hydrochlorothiazide-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/losartan-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/liposomal-doxorubicin-hydrochloride-breast-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/lipegfilgrastim-pharmacokinetics 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/lipegfilgrastim-ewing-family-of-tumors-rhabdomyosarcoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/lipegfilgrastim-aggressive-b-cell-non-hodgkin-lymphomas-at-high 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/omacetaxine-leukemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/li-squamous-cell-carcinoma-of-the-oral-cavity 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/levonorgestrel-ee-0-15-0-03-mg-and-ee-0-01-mg-ta-contraception 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/levonorgestrel-ee-0-15-0-03-and-ee-0-01-mg-table-dysmenorrhea 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/ondansetron-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/levetiracetam-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/lestaurtinib-polycythemia-vera 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/leflunomide-20-mg-tablets-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/oravescent-fentanyl-citrate-pain 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/lbr-101-iv-bioavailability-and-pharmacokinetics 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/lbr-101-high-dose-episodic-migraine-headache 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/lbr-101-high-dose-chronic-migraine 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/larazotide-acetate-celiac-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/laquinimod-relapsing-remitting-multiple-sclerosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/topiramate-25-mg-capsules-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/laquinimod-relapsing-multiple-sclerosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/pagoclone-stuttering 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/laquinimod-pharmacokinetics 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/laquinimod-multiple-sclerosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/laquinimod-lupus-nephritis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/placebo-nasal-aerosol-perennial-allergic-rhinitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/laquinimod-lupus-arthritis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/laquinimod-huntington-s-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/laquinimod-crohn-s-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/pravastatin-sodium-80-mg-tablets-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/laquinimod-0-6-relapsing-multiple-sclerosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/laquinimod-0-3-relapsing-remitting-multiple-sclerosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/lansoprazole-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/lamotrigine-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/lamotrigine-25-mg-chewable-tablets-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/ketamine-treatment-resistant-depression 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/inhaled-delta-8-thc-300mcg-or-600mcg-per-dose-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/rasagiline-dementia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/infusion-of-myocet-cerebral-lymphoma-b-cell-refractory 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/imiquimod-cream-3-75-actinic-keratosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/hydroxychloroquine-hcq-covid-19 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/rasagiline-parkinson-s-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/hydrocodone-er-low-back-pain 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/hydrocodone-er-chronic-pain 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/hydrocodone-bitartrate-extended-release-tablet-renal-impairment 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/rasagiline-sleep-disturbances 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/hydrocodone-bitartrate-extended-release-tablet-hepatic-impairment 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/homoharringtonine-myeloid-leukemia-chronic 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/hgh-viaderm-system-hgh-or-somatropin-growth-hormone-deficiency 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/gx15-070ms-chronic-lymphocytic-leukemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/granisetron-hydrochloride-1-mg-tablets-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/gmx1777-solid-tumors-and-lymphomas 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/glyburide-metformin-5-mg-500-mg-tablets-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/reslizumab-severe-persistent-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/glucophage-xr-750-mg-tablets-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/glimepiride-4-mg-tablets-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/glatiramer-acetate-with-minocycline-relapse-remitting-multiple-sclerosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/rowasa-4-gm-60-ml-rectal-enema-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/glatiramer-acetate-relapsing-remitting-multiple-sclerosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/glatiramer-acetate-optic-neuritis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/glatiramer-acetate-n-acetylcysteine-relapse-remitting-multiple-sclerosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/sd-809-tardive-dyskinesia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/glatiramer-acetate-multiple-sclerosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/glatiramer-acetate-injection-with-oral-cetirizin-multiple-sclerosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/glatiramer-acetate-ga-relapsing-remitting-multiple-sclerosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/glatiramer-acetate-ga-40-mg-relapsing-remitting-multiple-sclerosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/glatiramer-acetate-db-multiple-sclerosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/glatiramer-acetate-crohns-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/glatiramer-acetate-20-mg-relapsing-remitting-multiple-sclerosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/sublingual-tizanidine-12-mg-spasticity 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/glatiramer-acetate-20-mg-relapse-remitting-multiple-sclerosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/glatiramer-acetate-20-mg-0-5-ml-multiple-sclerosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/generic-ivermectin-lotion-0-5-head-lice 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/synthetic-conjugated-estrogens-b-menopause 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/generic-estradiol-vaginal-cream-usp-0-01-atrophic-vaginitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/generic-budesonide-formoterol-fumarate-dihydrate-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/gabitril-tiagabine-hydrochloride-cep-6671-general-anxiety-disorder 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/talampanel-als 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/gabitril-generalized-anxiety-disorder 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/gabitril-anxiety-disorders 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/gabitril-anxiety-disorder 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/ga-20-mg-ml-relapsing-remitting-multiple-sclerosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/fs-mdpi-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/fremanezumab-prefilled-syringe-ajovy-migraine-disorders 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/fremanezumab-post-traumatic-headache 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/tapinarof-cream-1-plaque-type-psorisis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/fremanezumab-migraine-prophylaxis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/fremanezumab-migraine 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/fremanezumab-interstitial-cystitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/tev-45478-nonalcoholic-steatohepatitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/fremanezumab-fibromyalgia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/fremanezumab-episodic-cluster-headache 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/fremanezumab-cluster-headache 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/tev-48574-crohn-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/fremanezumab-chronic-cluster-headache 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/fp-mdpi-persistent-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/fp-mdpi-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/fp-abs-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/formoterol-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/fluticasone-propionate-seasonal-allergic-rhinitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/fluticasone-propionate-salmeterol-fs-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/tev-56278-advanced-solid-tumors 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/fluticasone-propionate-pressurized-metered-dose-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/fluticasone-propionate-mdpi-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/fluticasone-propionate-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/tiotropium-hfa-bai-4-5-mcg-copd 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/fluticasone-propionate-and-salmeterol-inhalation-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/fluoxetine-hydrochloride-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/finasteride-5-mg-tablets-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/tl011-dlbcl 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/fexofenadine-180-mg-tablets-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/fentanyl-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/fentanyl-buccal-tablets-pain 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/fentanyl-buccal-tablets-compared-with-immediate-chronic-pain 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/fentanyl-buccal-tablet-fbt-cancer-pain 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/fentanyl-buccal-tablet-chronic-pain 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/fentanyl-buccal-tablet-advanced-cancers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/trifarotene-0-005-topical-cream-acne-vulgaris 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/famciclovir-500-mg-tablets-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/extrafine-hfa-beclomethasone-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/11c-cppc-pet-ligand-als 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/tv-45070-osteoarthritis-of-the-knee 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/etiprednol-dicloacetate-crohn-s-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/estradiol-norethindrone-acetate-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/estradiol-dyspareunia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/tv-46046-400-mg-ml-pregnancy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/edratide-systemic-lupus-erythematosus 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/duvakitug-ulcerative-colitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/duvakitug-crohn-s-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/drospirenone-ethinyl-estradiol-gianvi-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/dr-5001-respiratory-tract-diseases 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/dr-3001a-urinary-incontinence 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/dr-3001-overactive-bladder 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/venlafaxine-25-mg-tablets-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/dr-2041a-menopause 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/dr-2021a-amenorrhea 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/dr-2011-infertility 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/zithromax-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/dr-2001a-endometriosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/dr-104-emergency-contraception 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/dr-1031-breakthrough-bleeding 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/aln-2232-obesity 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/dr-103-pregnancy-prevention 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/dr-1021-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/dr-1021-contraception 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/dr-102-contraception 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/dr-1011-contraception 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/doxycycline-monohydrate-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/donepezil-hydrochloride-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/aln-aat-antitrypsin-deficiency-liver-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/donepezil-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/divalproex-sodium-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/digoxin-heart-failure 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/aln-agt01-rvr-hypertension 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/diclofenac-sodium-topical-gel-multiple-sclerosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/diclofenac-sodium-actinic-keratosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/dexmethylphenidate-hydrochloride-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/aln-hbv-hepatitis-b 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/deutetrabenazine-oral-capsule-tardive-dyskinesia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/deutetrabenazine-huntington-s-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/deutetrabenazine-huntington-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/deutetrabenazine-6-mg-dystonia-primary 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/desogestrel-ethinyl-estradiol-and-ethinyl-estrad-hemostasis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/desogestrel-ethinyl-estradiol-and-ethinyl-estrad-follicle-development 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/desmopressin-acetate-0-2-mg-tablets-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/aln-ttr02-patisiran-administered-by-intravenous-ttr-mediated-amyloidosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/delayed-release-6mp-or-calcitriol-vs-purinethol-crohn-s-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/delayed-release-6-mercaptopurine-crohns-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/delayed-release-6-mercaptopurine-crohn-s-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/aln-ttrsc02-transthyretin-mediated-amyloidosis-attr-amyloido 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/decitabine-acute-myeloid-leukemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/cytarabine-acute-myeloid-leukemia-with-multilineage-dysplas 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/cytarabine-acute-myeloid-leukemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/cemdisiran-atypical-hemolytic-uremic-syndrome 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/cyproterone-acetate-5-prostate-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/cyclobenzaprine-hydrochloride-chronic-migraine 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/custirsen-sodium-castrate-resistant-prostate-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/custirsen-prostate-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/custirsen-paclitaxel-and-carboplatin-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/custirsen-cardiac-conduction-and-repolarization 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/ct-011-primary-hepatocellular-carcinoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/lumasiran-ph1 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/ct-011-chronic-hepatitis-c 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/copaxone-multiple-sclerosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/clindamycin-300-mg-capsule-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/lumasiran-recurrent-calcium-oxalate-kidney-stone-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/clarithromycin-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/clarithromycin-er-500-mg-tablets-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/cilostazol-50-mg-tablets-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/patisiran-amyloidosis-hereditary 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/cilostazol-100-mg-tablets-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/chlorambucil-chronic-lymphocytic-leukemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/cep-9722-solid-tumors-or-mantle-cell-lymphoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/cep-9722-solid-tumors 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/cep-9722-solid-tumor 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/cep-701-prostate-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/cep-701-acute-myeloid-leukemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/revusiran-aln-ttrsc-ttr-mediated-amyloidosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/cep-701-60mg-leukemia-myeloid 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/cep-701-20mg-psoriasis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/cep-37440-solid-tumors 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc/projects/vutrisiran-transthyretin-amyloidosis-attr-with-cardiomyopat 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/cep-37251-bone-loss 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/cep-37250-khk2804-solid-tumour 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/cep-37247-sciatica 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/atezolizumab-advanced-liver-cancers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/cep-33457-systemic-lupus-erythematosus 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/cep-26401-cognitive-impairment 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/cep-18770-multiple-myeloma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/cep-1347-10mg-parkinson-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/cep-11981-kinase-inhibitor-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/cep-10953-armodafinil-narcolepsy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/cenestin-0-3-mg-tablets-hot-flashes 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bg-a3004-skin-diseases 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/cefzil-500-mg-tablets-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/cefprozil-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/cefprozil-for-oral-suspension-250-mg-5-ml-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bg-c477-advanced-solid-tumors 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/cefdinir-for-oral-suspension-250-mg-5ml-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/cefdinir-capsules-300-mg-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/cefadroxil-500-mg-capsules-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-15025-advanced-solid-tumor 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/cd56-enriched-donor-lymphocyte-infusion-multiple-myeloma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/carvedilol-25-mg-tablets-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/carboplatin-tubular-breast-cancer-stage-ii 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/ultragenyx-pharmaceutical/projects/midodrine-syncope 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/placebo-spiromax-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/carboplatin-prostatic-neoplasm 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/buspar-30-mg-tablet-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-24714-solid-tumor-adult 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/bupropion-hcl-depressive-disorder 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/buprenorphine-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/adial-pharmaceuticals-inc/projects/ad04-ondansetron-alcohol-use-disorder 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-45035-healthy-participants 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/aeon-biopharma/projects/use-of-mitomycin-c-mmc-in-trabeculectomy-glaucoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/budesonide-formoterol-spiromax-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/budesonide-formoterol-fumarate-dihydrate-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/bgb-58067-glioblastoma-gbm 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/budesonide-and-formoterol-fumarate-dehydrate-bf-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/bronchodilator-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/bicalutamide-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/bendamustine-non-hodgkin-s-lymphoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/bendamustine-multiple-myeloma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/bendamustine-mantle-cell-lymphoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/bendamustine-malignancy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/io-202-aml-with-monocytic-differentiation 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/bendamustine-leukemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/bendamustine-hydrochloride-non-hodgkin-s-lymphoma-nhl 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/bendamustine-hydrochloride-non-hodgkin-lymphoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/cyclophosphamide-recurrent-transformed-chronic-lymphocytic-leukem 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/bendamustine-hodgkin-lymphoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/bendamustine-hcl-non-hodgkin-s-lymphoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/bendamustine-and-rituximab-non-hodgkin-s-lymphoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/io-108-solid-tumor-adult 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/benazepril-hcl-40-mg-tablets-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/beeam-multiple-myeloma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/beclomethasone-qvar-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/beclomethasone-dipropionate-seasonal-allergic-rhinitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/beclomethasone-dipropionate-rhinitis-allergic-perennial 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/beclomethasone-dipropionate-hydrofluoroalkane-hf-rhinitis-allergic-perennial 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/beclomethasone-dipropionate-hfa-nasal-aerosol-seasonal-allergic-rhinitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/sonrotoclax-chronic-lymphocytic-leukemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/beclomethasone-dipropionate-hfa-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/beclomethasone-dipropionate-breath-actuated-inha-persistent-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/beclomethasone-dipropionate-bai-pharmacokinetics 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/subcutaneous-tislelizumab-metastatic-gastric-adenocarcinoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/beclomethasone-dipropionate-bai-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/beclomethasone-dipropionate-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/rehabilitation-stroke 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/tislelizumab-bgb-a317-msi-h-dmmr-solid-tumors 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/beclomethasone-dipropionate-640-persistent-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/beclomethasone-dipropionate-qvar-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/bdp-nasal-aerosol-allergic-rhinitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/bdp-hfa-seasonal-allergic-rhinitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/bdp-hfa-nasal-aerosol-allergic-rhinitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/bdp-allergic-rhinitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/balugrastim-solid-tumors 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/tunlametinib-pd-1-mab-gastric-adenocarcinoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/balugrastim-chemotherapy-induced-neutropenia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/azithromycin-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/azithromycin-600-mg-tablet-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/zanubrutinib-chronic-lymphocytic-leukemia-cll 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/azilect-parkinson-s-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/azelastine-hydrochloride-and-fluticasone-propion-seasonal-allergic-rhinitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/autologous-mesenchymal-stem-cells-implantation-tibial-fracture 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/zanubrutinib-mantle-cell-lymphoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/arsenic-trioxide-lung-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/arsenic-trioxide-chronic-myelogenous-leukemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/arsenic-trioxide-acute-promyelocytic-leukemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/arsenic-trioxide-acute-myeloid-leukemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/armodafinil-traumatic-brain-injury 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/armodafinil-sleep-disorders 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/armodafinil-sleep-apnea 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/armodafinil-schizophrenia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/armodafinil-narcolepsy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/armodafinil-menopause 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/armodafinil-excessive-sleepiness 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/revolution-medicines/projects/elironrasib-non-small-cell-lung-cancer-nsclc 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/armodafinil-excessive-daytime-sleepiness 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/armodafinil-depression 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/armodafinil-bipolar-i-depression 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/revolution-medicines/projects/rmc-5552-glioblastoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/armodafinil-250-mg-day-obstructive-sleep-apnea 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/armodafinil-150-mg-day-obstructive-sleep-apnea 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/armodafinil-150-mg-day-fatigue 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/armodafinil-150-mg-day-excessive-sleepiness 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/armodafinil-100-to-250-mg-day-excessive-daytime-sleepiness 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/meat-biscuit-hiv-infections 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/arava-20-mg-tablets-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/0-1-bupivacaine-pregnancy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/anle138b-tev-56286-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/anastrozole-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/amoxicillin-clavulanic-acid-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/1-intranasal-oxytocin-spray-autism-spectrum-disorder 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/amlodipine-besylate-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/amlodipine-benazepril-10-mg-20-mg-capsules-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/alprazolam-extended-release-3-mg-tablets-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/123i-cit-parkinson-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/alfacalcidol-accidental-falls 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/alendronate-sodium-tablets-70mg-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/alcohol-wipes-vs-no-alcohol-wipes-multiple-sclerosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/albuterol-sulfate-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/albuterol-sulfate-abs-chronic-obstructive-pulmonary-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/albuterol-spiromax-exercise-induced-bronchoconstriction-eib 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/albuterol-spiromax-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/20-grams-protein-muscle-disuse 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/albuterol-mdpi-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/albuterol-hfa-mdi-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/albuterol-hfa-boi-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/3-dimensional-conformal-radiation-therapy-bladder-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/albuterol-emdpi-ds-pulmonary-disease-chronic-obstructive 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/anastrozole-teva-pharmaceuticals-usa-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/albuterol-emdpi-ds-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/50-000-units-ergocalciferol-pruritis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/albuterol-dry-powder-inhaler-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/albuterol-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/albuterol-aerosol-by-hfa-mdi-exercise-induced-bronchospasm 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/airduo-digihaler-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/advair-diskus100-50-g-asthma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/adasuve-bipolar 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/adapalene-acne-vulgaris 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/abemaciclib-breast-cancer-female 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/actiq-oral-transmucosal-fentanyl-citrate-otfc-pain 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/actiq-oral-transmucosal-fentanyl-citrate-breakthrough-pain 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/actiq-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/academic-detailing-prostate-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/acr16-huntington-s-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/acr16-huntington-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/abemaciclib-triple-negative-breast-neoplasms 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/acetazolamide-hypobaric-hypoxia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/a-60-mg-dose-of-the-hydrocodone-bitartrate-exten-pain 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/91-day-levonorgestrel-oral-contraceptive-migraine 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/91-day-levonorgestrel-oral-contraceptive-hemostasis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/91-day-levonorgestrel-oral-contraceptive-bone-mineral-density 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/90-mg-dose-of-the-hydrocodone-bitartrate-extende-pain 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/80-mg-dr-6mp-crohn-s-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/600-mg-amoxicillin-42-9-mg-clavulanate-postassiu-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/acupuncture-persian-gulf-syndrome 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/5-mg-500-mg-metaglip-tablets-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/5-mg-500-mg-glipizide-metformin-hydrochloride-ta-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/45-mg-hydrocodone-bitartrate-extended-release-ta-drug-abuse 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/administration-of-ui058-gerd 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/40-mg-glatiramer-acetate-amyotrophic-lateral-sclerosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/16-mg-buprenorphine-with-4-mg-naloxone-sublingua-evaluation-of-qtc-interval 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/zed1227-sige-celiac-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/advair-hfa-altitude-edema 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/zasocitinib-plaque-psoriasis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/zasocitinib-nonsegmental-vitiligo 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/zasocitinib-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/zasocitinib-dose-a-hidradenitis-suppurativa 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/zasocitinib-crohn-s-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/yf-17d-dengue 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vyvanse-lisdexamfetamine-dimesylate-attention-deficit-hyperactivity-disorder-adhd 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/albumin-human-burn-injury 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vyvanse-lisdexamfetamine-dimesylate-adhd 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vpriv-gaucher-disease-type-1 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vp20621-clostridium-difficile-infection 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/aliskiren-iga-nephropathy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/teva-pharmaceutical-industries-ltd/projects/agee-cream-multiple-sclerosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vp-20629-friedreich-s-ataxia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vortioxetine-unipolar-major-depression 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/allogeneic-msc-s-application-to-the-burn-wounds-skin-burn-degree-second 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vortioxetine-type2-diabetes 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vortioxetine-treatment-outcome 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vortioxetine-tbi 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vortioxetine-tablets-major-depressive-disorder 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vortioxetine-severe-hepatic-impairment 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vortioxetine-schizophrenia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vortioxetine-lu-aa21004-depressive-disorder-major 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/amiloride-secondary-progressive-multiple-sclerosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vortioxetine-iv-depressive-disorder-major 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vortioxetine-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vortioxetine-healthy-adult-participants 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/amodiaquine-plus-artesunate-co-administration-malaria 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vortioxetine-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vortioxetine-generalized-anxiety-disorder 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vortioxetine-depressive-disorder 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/angiotensin-1-7-traumatic-brain-injury 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vortioxetine-binge-eating-disorder 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vortioxetine-10-mg-day-depressive-disorder-major 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vortioxetine-10-mg-age-related-cognitive-decline 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vonvendi-von-willebrand-disease-vwd 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vonoprazan-reflux-esophagitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vonoprazan-helicobacter-pylori 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vonoprazan-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/antiepileptic-drug-therapy-epilepsy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vonoprazan-gastroesophageal-reflux 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vortioxetine-depression 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vonoprazan-erosive-esophagitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/apd811-pulmonary-arterial-hypertension 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vonicog-alfa-von-willebrand-disease-vwd 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vonicog-alfa-von-willebrand-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/von-willebrand-factor-recombinant-von-willebrand-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/aripiprazole-hyperprolactinemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vitamin-d-covid-19 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/venticute-pneumonia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/veltuzumab-rheumatoid-arthritis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/velaglucerase-alfa-gaucher-disease-type-3 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/velaglucerase-alfa-gaucher-disease-type-1 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/velaglucerase-alfa-gaucher-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vedolizumab-sc-ulcerative-colitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/artesunate-amodiaquine-combination-malaria-falciparum 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vedolizumab-sc-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vedolizumab-sc-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vedolizumab-primary-sclerosing-cholangitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/aspirin-node-positive-her2-negative-breast-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vedolizumab-pouchitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vedolizumab-placebo-pouchitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vedolizumab-placebo-hematopoietic-stem-cells 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/atezolizumab-metastatic-colorectal-carcinoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vedolizumab-moderately-to-severely-active-crohn-s-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vedolizumab-iv-moderately-to-severely-active-ulcerative-colitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vedolizumab-iv-crohn-s-disease-cd 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vedolizumab-iv-crohn-s-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vedolizumab-iv-colitis-ulcerative 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vedolizumab-intravenous-injection-ulcerative-colitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vedolizumab-crohn-s-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/autologous-human-schwann-cell-peripheral-nerve-injury 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vedolizumab-crohn-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vedolizumab-collagenous-gastritis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vedolizumab-celiac-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/autologous-tissue-engineered-corpora-urologic-diseases 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vedolizumab-allogeneic-hematopoietic-stem-cell-transplantati 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vedolizumab-300-mg-injection-entyvio-immune-checkpoint-inhibitor-related-colitis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/vedolizumab-300-mg-colitis-ulcerative 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/axitinib-clear-cell-metastatic-renal-cell-carcinoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/umuline-nph-type-2-diabetes 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/udenafil-erectile-dysfunction 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tvp-1012-parkinson-s-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tvp-1012-1mg-parkinson-s-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/troxacitabine-leukemia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/trifluridine-tipiracil-metastatic-oesogastric-adenocarcinoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/trelagliptin-type-2-diabetes-mellitus 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/azithromycin-pill-chronic-obstructive-pulmonary-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/trelagliptin-25-mg-type-2-diabetes-mellitus 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/trebananib-3-mg-kg-neoplasms-advanced-solid 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/treatment-algorithm-a-colitis-ulcerative 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/bcg-tokyo-172-vaccine-tuberculosis-infection 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tislelizumab-minimal-residual-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/timp-glia-celiac-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/theophylline-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/binimetinib-metastatic-colorectal-carcinoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tetravalent-dengue-vaccine-tdv-dengue-fever 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tetravalent-dengue-vaccine-tdv-dengue 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/teduglutide-short-bowel-syndrome 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/teduglutide-postoperative-fistula 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/teduglutide-pharmacokinetics-and-safety-of-elevated-doses 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/teduglutide-hepatic-impairment 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/teduglutide-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/binimetinib-locally-advanced-pancreatic-carcinoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/teduglutide-alx-0600-crohn-s-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/teduglutide-0-05mg-kg-short-bowel-syndrome 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/teduglutide-0-05-mg-kg-d-short-bowel-syndrome 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/biospecimen-collection-glioma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/ted-short-bowel-syndrome 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/technochrom-c1-inh-kit-hereditary-angioedema-hae 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tdv-low-dose-dengue-fever 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/blueberries-healthy-adults 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tdv-liquid-formulation-1-dengue-fever 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tdv-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tdv-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tdv-dengue-fever 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/td-8954-enteral-feeding-intolerance 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tbio-6517-solid-tumor 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tap-144-sr-6m-prostate-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/brachytherapy-prostate-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tap-144-sr-6m-premenopausal-breast-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/catalyst-pharmaceuticals-inc/projects/bt-001-type2-diabetes 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/takeda-s-tetravalent-dengue-vaccine-candidate-td-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/bubble-enhanced-fast-befast-abdominal-trauma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/revolution-medicines/projects/rmc-4630-solid-tumors 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/takeda-s-dengue-tetravalent-vaccine-live-attenua-dengue-fever 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/takc-02-healthy-volunteer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/ca-vit-d-bone-health 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak228-lymphoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-994-oral-tablet-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-994-narcolepsy-type-1-nt1 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-994-narcolepsy-type-1-nt-1 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-994-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/beone-medicines/projects/sonrotoclax-cll 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-994-healthy-participants 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/cambridge-weight-plan-diabetes 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-988-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-981-relapsed-and-or-refractory-multiple-myeloma-rrmm 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-981-neoplasms 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/campylobacter-jejuni-strain-cg8421-campylobacter-infections 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-981-lymphoma-non-hodgkin 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-981-head-and-neck-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/legend-biotech-corp/projects/celastrol-safety-issues 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/carbidopa-multiple-sclerosis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-981-advanced-or-metastatic-solid-tumors 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-954-renal-impairment 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-954-placebo-postoperative-gastrointestinal-dysfunction 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-954-hepatic-impairment 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-954-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-954-healthy-participants 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-954-diabetic-gastroparesis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/cd105-yb-1-sox2-cdh3-mdm2-polyepitope-plasmid-dn-her2-negative-breast-carcinoma 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-954-critical-illness 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-951-postoperative-nausea-and-vomiting-ponv 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-951-placebo-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/celecoxib-head-and-neck-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-951-nausea-and-vomitting 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-951-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-951-healthy-volunteer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/cetuximab-braf-v600e-negative 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-935-tablets-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-935-oral-tablet-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-935-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-935-healthy-volunteer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-935-epilepsy-molecular-mechanisms-of-pharmalogical-a 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-935-developmental-and-or-epileptic-encephalopathies 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-931-pic-neoplasms-advanced-solid 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/chloroquine-malaria-falciparum 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-931-nonhematologic-neoplasms-advanced 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-931-metastatic-pancreatic-cancer 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-925-obstructive-sleep-apnea 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/cholecalciferol-crohn-disease 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-925-idiopathic-hypersomnia 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-925-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-925-healthy-participants-and-patients-with-narcoleps 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/ciclosporin-myocardial-reperfusion-injury 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-925-healthy-participants 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-919-coronavirus-disease-covid-19 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-915-suspension-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-915-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-906-oral-capsule-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-906-maleate-healthy-participants 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-906-maleate-diabetic-gastroparesis 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/clinical-center-reference-endotoxin-ccre-healthy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-906-maleate-diabetes-mellitus-and-gastroparesis-idiopathic-g 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-906-japanese-healthy-adult-male-participants 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-906-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/cnp8-burns 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-881-primary-immunodeficiency-diseases-pid 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-881-healthy-volunteers 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-881-chronic-inflammatory-demyelinating-polyradiculon 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/united-therapeutics-corp/projects/coenzyme-q10-and-lisinopril-duchenne-muscular-dystrophy 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/takeda-pharmaceutical-co-ltd/projects/tak-875-type-2-diabetes-mellitus 2026-05-23 monthly 0.6 https://novapharmanews.com/companies/legend-biotech-corp/projects/celastrol-safety 2026-05-23 monthly 0.6